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Abstract
Amphibian population decline is a recognised phenomenon spanning at least the last 
40  years,  and  it  is  likely  that  a  number  of  factors  have  contributed,  including 
environmental contamination. Amphibians are vulnerable to agrochemical uptake as 
they must  breed in  water,  and often spend the aquatic  phase of  their  lifecycle  in 
agricultural water bodies, which may contain a complex mixture of biologically active 
chemicals.  Endocrine  disrupting  compounds  may  cause  reproductive  effects  in 
humans and wildlife, although the link between pesticides and endocrine disruption is 
largely  unknown.  Therefore,  in  this  study,  the  role  of  pesticides  in  endocrine 
disruption,  in relation to amphibian metamorphosis and reproductive development, 
was  investigated.  To  achieve  this  objective,  population  data  were  used  to  select 
suitable field sites, water from which was tested for endocrine activity using the yeast 
estrogen/androgen screen, hepatocyte culture (estrogenic response), and a transgenic 
Xenopus test (thyroid disruption). Toad (Bufo bufo) specimens from a subsample of 
these sites were used to compare morphology, thyroidal, and gonadal development of 
caged and wild-caught tadpoles/metamorphs, to their laboratory-raised counterparts. 
In addition, environmentally relevant pesticides were tested for endocrine effects  in 
vitro, and a short-term in vivo exposure was used to assess the predictive ability of the 
in vitro screens in Xenopus. Mortality of Bufo bufo was high in both laboratory-reared 
and caged  individuals,  which  hindered  the  interpretation  of  results  due  to  low  n 
values.  However,  laboratory-reared  individuals  from  different  sites  had  distinct 
morphology  and  gonadal  differentiation,  possibly  suggesting  maternal  transfer,  a 
latent effect of the pond environment, and/or genetic effects. In addition, caged and 
wild-caught individuals were smaller, metamorphosed later, and had retarded gonadal 
differentiation or increased incidence of intersex, compared to their laboratory-reared 
counterparts.  Extracts  of  water  samples  from these sites  were predominantly  anti-
estrogenic, and/or anti-androgenic in yeast based assays, and this was also the effect 
observed in response to environmentally relevant pesticides tested in the same assays. 
Pesticides also affected ovarian steroidogenesis in vitro, and pentachlorophenol had a 
reprotoxic effect on adult female Xenopus laevis. Data reported in this study suggest 
there  may be endocrine disrupting effects  in  native amphibians in the agricultural 
landscape, although further investigation is needed to confirm these findings. 
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Chapter 1
Introduction & Literature Review
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1.1 Overview
Over  the  past  century,  researchers  from  various  countries  have  reported  local 
amphibian declines, however, it wasn’t until the first world congress of herpetology in 
1989  (Cambridge  U.K.),  that  local  declines  were  collated  and  recognised  as  a 
worldwide phenomenon. Since then,  amphibian population decline is a recognised 
trend spanning at least the last 40 years , and Houlahan et al.  quantified this decline 
by analyses of datasets from North America and Europe. It is likely that a number of 
factors  have  contributed  ,  including,  habitat  destruction  and  modification,  climate 
change, increased UV exposure, introduction of non-indigenous species and infections 
(e.g. chytrid fungus, ranavirus), and adverse effects of environmental contaminants . 
Amphibians are vulnerable to agrochemical uptake as they must breed in water, and 
often spend the aquatic phase of their lifecycle in agricultural water bodies. They also 
have  highly  permeable  skin,  and  thus  are  exposed  to  contaminants  through  both 
aquatic  and  terrestrial  sources.  Therefore,  eutrophication  of  water  bodies  through 
fertilizer  use,  and  use  of  pesticides  and  herbicides,  could  be  instrumental  in  the 
decline observed . 
Endocrine  disruption  (ED)  is  the  process  by  which  homeostasis  of  the  endocrine 
system is altered by exogenous factors, and is thought to be contributing to decreased 
fertility  and  increased  hormone  sensitive  cancers  in  humans  .  In  men,  decreased 
semen quality and sperm density has been reported from 1934-1996 , which has been 
linked  to  increased  incidence  of  hypospadias  and  cryptochordism,  and  increased 
incidence  of  testicular  cancer  .  It  has  been  suggested  that  endocrine  disrupting 
compounds  may  be  causing  the  effects  observed,  although  definitive  evidence  is 
lacking . In women, increased incidence of breast cancer has occurred in the western 
world,  though this may be an artefact of better  screening methods,  rather than an 
actual trend . In addition, polycystic ovarian syndrome has been associated with an 
excess of androgen levels in utero , although evidence that it is a result of exogenous 
endocrine disruptors is scarce . However, decreased fertility, caused by disturbances 
to ovulation,  the menstrual  cycle,  and spontaneous abortions,  have been linked to 
pesticide exposure . The concept of toxicity of pesticides to wildlife was first detected 
when top predator birds (e.g. peregrine falcon, sparrowhawk, bald eagle, Baltic white-
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tailed  sea  eagles)  experienced severe  population  declines  in  the  1960’s.  This  was 
found to be due to eggshell thinning, and was causally related to DDT, as residues 
were  found  in  the  eggshells  of  these  species.  Subsequent  studies  revealed  that 
accumulation  of  DDE affected  normal  calcium transport  and  metabolism through 
inhibition of microsomal Ca2+-ATPase in eggshell gland epithelium, which reduced 
shell thickness . Concern about aquatic ED was triggered by the discovery that large 
numbers  of  fish  were  becoming  feminised  in  rivers  in  the  UK.  Soon  after, 
feminisation was related to sewage effluent containing the synthetic estrogen ethinyl 
estradiol , and was subsequently reported to be a nationwide phenomenon . It was also 
shown that fish with mixed testicular and ovarian tissue, a condition called ‘intersex’, 
had reduced fertility compared to normal fish .  In contrast to feminisation in fish, 
masculinisation of gastropod molluscs has been reported in  response to  tributyltin 
(TBT), which is used as an anti-foulant on boats. This condition is called ‘imposex’, 
and resulted in collapse of populations of Dogwhelk populations in coastal South-
West England . It later became clear that the effects of TBT were widespread, and it 
was  affecting  a  wide  range  of  mollusc  species.  Since  the  use  of  TBT has  been 
restricted,  populations  have  recovered  .  Neither  EE2  nor  TBT  are  likely  to  be 
environmentally relevant to amphibians, as they are not generally found in effluent 
receiving  large  rivers/canals,  and  never  in  the  marine  environment.  Instead, 
amphibians  commonly  breed  in  small  water  bodies,  which  are  often  situated  in 
agricultural landscapes. Studies have related local amphibian decline to agrochemical 
usage , but endocrine endpoints were not measured in these cases. Recently, Hayes et 
al.  ,  reported  that  low  dose  pesticide  mixtures  (including  alachlor,  atrazine,  and 
cyfluthrin)  increased  corticosterone  levels  in  Xenopus  laevis,  and  inhibited 
metamorphosis in  Rana pipiens (Northern Leopard frog). In addition, Reeder  et al. 
reported  an  association  between  incidence  of  intersex  with  spatial  and  temporal 
declines in Cricket frog (Acris crepitans) populations. Atrazine levels were also found 
to affect hormone concentrations in Xenopus in their natural environment of S.Africa . 
Laboratory  exposures  to  single  agrochemicals  have  been  reported  to  affect  the 
endocrine system in amphibians , though negative results have also been reported .
In the UK, the period of heavy agrochemical usage was also the time when the most 
marked declines in anuran populations were recorded, although the causes for these 
declines have not been specifically linked to either agrochemicals or an endocrine 
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disrupting  effect.  Therefore,  the  aim  of  this  research  was  to  assess  endocrine 
disruption  in  amphibians  from UK agricultural  freshwaters  by  field  work,  and  to 
assess the endocrine disrupting potential of environmentally relevant agrochemicals in 
the laboratory
1.2 Population Change in the U.K.
Over the last 100 years, agricultural intensification and urban development, leading to 
habitat alteration and pollution, has often had deleterious effects on the native wildlife 
and ecosystems. Many aquatic habitats have disappeared completely due to coastal 
development,  lowered  water  table,  and  agricultural  ‘improvement’,  particularly 
affecting amphibians due to their dependence on water for reproduction. Indications 
of declines of amphibian populations in the UK have been reported since the turn of 
the century , but it wasn’t until the 1960’s that drastic decline was documented . For 
example,  adult  frogs  (Rana temporaria)  decreased from three or  four  per  acre  in 
Hertfordshire in the 1930’s, which was regarded to be a “fair average” for the British 
Isles , to an average of 0.1 adult frog (Rana temporaria) per acre by 1971 . Natterjack 
toads also decreased dramatically over this time period .  
There are three species of anuran generally regarded to be native to England: 1 frog 
species (Rana temporaria), and 2 toad species (Bufo bufo, Bufo calamita). There are a 
number  of  populations  of  the  Pool  frog  (Rana  lessonae)  and  Edible  frog  (Rana 
esculenta) in the south east of England, resulting from frequent introductions. While it 
is possible that the former is native, these species, and the Natterjack toad, will not be 
considered further, due to their limited distribution in the UK. In addition, there are 3 
urodele species in the U.K. (Triturus helvetica, Triturus vulgaris, Triturus cristatus), 
which will also not be considered further as they are not as widespread as the common 
frog and toad; and in the case of the latter, are heavily protected due to their rare 
status. Furthermore, the laboratory-based tests used in the present research were based 
on anuran tissue, and extrapolation to urodeles may not be accurate, due to differences 
in their biology and lifecycle. 
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1.2.1 Habitat Alteration in the U.K. in Relation to the Common Frog 
and Toad
Although there is little information on change of anuran population’s pre-1930, it can 
be estimated that declines did indeed occur over this time period due to habitat loss, 
although to  a  lesser  extent  than in  later  years.  The most  fundamental  changes  in 
habitat were the loss of small water bodies over all England (see Table 1.1), and it 
was estimated that  70% of  pools/marshes  have been lost  in  the UK over  the last 
century .  There are  also personal  accounts of  disappearance of  these habitats,  for 
example, from Yorkshire “Local farmers who remember the area in the ‘twenties and 
earlier’ speak of several small ponds and a number of minor streams…….which are 
no longer found” .
Historic Pond Use Modern Use Change
Village pond for drinking Village pond – ornamental
Reservoir – drinking
Ponds were in the community, now 
isolated,  one  reservoir  supplies 
many people.
Farmyard pond for watering stock Farmyard pond ornamental No longer essential part of farm life.
Roadside pond was watering hole 
for passing stock
Balancing  pond,  road  run-off, 
trapping pollutants
Complete change of use
Field  pond/hedgerow  pond  was 
watering hole for stock
Field pond/hedgerow pond Rarely  maintained,  infrequently 
used  (water  now  piped  to  grazing 
stock),  sites  occasionally  still 
present
Woodland pond Woodland pond Often completely wooded over
Ornamental lake Ornamental lake No change  but  reduced in  number 
5
due  to  fewer  houses  with  large 
grounds
Garden pond Garden pond Many  now  exist,  important  as 
wildlife ponds
Stew pond (fish pond for supply) Fishing lake Originally essential for winter food, 
now popular leisure activity
Fish farms Intensively managed
Duck pond Duck pond Was  for  supply  of  fowl,  now 
ornamental
Mill pond Mill pond No change but little used
Stag pound to contain animals No longer found
Icehouse pond for refrigeration No longer found
Watercress beds Watercress beds Less frequent
Natural  ponds  where  springs 
emerge etc.
Natural  ponds  where  spring 
emerge etc. 
Lowered  water  table  has  reduced 
numbers
Golf course ponds Becoming more frequent
Garden centre ponds Becoming more frequent
Table  1.1  –  Change  in  pond usage  over  the  past  100  years  relating  to  urbanisation  and 
agricultural  intensification.  Reproduced  (modified)  with  permission  from  Wycherley  and 
Anstis , and refers to Tandridge District in Surrey, but can be applied to Britain in general.
The  1930’s  were  probably  a  time  of  resurgence  of  some  populations  due  to  the 
recession, which resulted in much agricultural land becoming derelict , whereas the 
1940’s  heralded the acceleration of  urbanisation,  industrialisation,  and agricultural 
reform, at least in part due to the demands put on the country during World War II. 
The  changes  in  rural  life  are  thought  to  have  had  an  especially  large  impact  on 
anurans,  with  intensive  planting  of  arable  crops,  applications  of  fertilisers  and 
pesticides,  the  destruction  of  ponds  and  hedgerows,  and  intensive  forestry.  In 
addition, traditional agricultural practices, which had formerly maintained heaths and 
dunes,  were abandoned and natural  succession occurred in the remaining areas of 
these habitats .  At the end of this decade the first report of UK herpetofauna was 
published,  and  even  though  it  only  indicated  the  presence/absence  of  reptile  and 
amphibian species, and not relative abundance, it is still interesting to note that at this 
time both the common frog and toad were present in every vice county of England . 
Cooke  reported a slight decline in the common frog over this decade (index of change 
1941-1945 = -0.04; 1946-1950 = -0.10), no information on the toad was available, but 
was assumed to be similar. In the 1950’s, Cooke  reported a more marked decline in 
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distribution of the common frog and toad than had been reported for the 1940’s. It is 
probable that as well as increased habitat loss, the effects of changes made in the 
1940’s were only now being reflected in anuran numbers.
1.2.2 Agrochemical Usage and Decline in the Common Frog & Toad
    
It wasn’t until the early 1960’s that dramatic decreases in numbers of common frog 
and toads were reported and the impact of agrochemicals was implicated . For both 
the common frog and toad,  declines on agricultural  land were severe in the early 
1960’s and less so in late 1960’s, which correlates with use of cyclodiene insecticides 
and DDT in the early 1960’s, but a lesser effect as they were phased out of use . The 
pattern  of  decline  coincides  with  other  wildlife  species,  such  as  the  Kestrel, 
Sparrowhawk, and Barn owl, which declined during the late 1950’s and early 1960’s, 
mainly as a result of being poisoned by agricultural chemicals .  Bird declines and 
anuran declines were most marked in East England, which was the most intensively 
farmed area in England. 
Area 1951-1955 1956-1960 1961-1965 1966-1970
Bufo Rana Bufo Rana Bufo Rana Bufo Rana
S.W 
Devon/Cornwall
- 0.06 - 0.06 - 0.04 - 0.04 - 0.17 - 0.16 - 0.04 - 0.16
S 
Oxon/Glos
- 0.4 - 0.2 - 0.33 - 0.25 - 0.5 - 0.4 - 0.45 - 0.36
SE 
Sussex/Kent/ Surrey/Hants
- 0.5 - 0.21 - 0.23 - 0.19 - 0.5 - 0.4 - 0.45 - 0.4
SE Midlands
London & N. home counties.
- 0.17 - 0.33 - 0.25 - 0.33 - 0.52 - 0.55 - 0.54 - 0.65
East Anglia 
Norfolk/ Suffolk
- 0.08 - 0.1 - 0.14 - 0.17 - 0.48 - 0.5 - 0.37 - 0.14
Midlands 
Warwicks
- 0.25 0 - 0.25 - 0.07 - 0.33 - 0.4 - 0.53 - 0.24
NW Midlands 
Ches/ Derby/Lancs
+ 0.13 0 + 0.08 - 0.09 - 0.4 - 0.35 - 0.52 - 0.42
NE Midlands 
Lincs/ E & W Yorks/Notts
0 - 0.21 - 0.17 - 0.15 - 0.27 - 0.39 - 0.34 - 0.53
North 
Incl. N Yorks
- 0.5 - 0.25 - 0.33 - 0.29 - 0.29 - 0.23 0 - 0.35
Total - 0.14 - 0.15 - 0.15 - 0.17 - 0.4 - 0.43 - 0.36 - 0.38
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Table 1.2 – Changes in status for the common frog and toad in England. “Bufo” refers 
to Bufo bufo, the common toad, and “Rana” to Rana pipiens, the common frog. Index 
of change = (No. replies stating ‘increase’ – No. replies stating ‘decrease’)/(Total no. 
of replies – No. of replies stating ‘no longer found’), reproduced from Cooke .
As a result of declines in wildlife observed at the time of organochlorine pesticide use, 
Cooke   investigated  the  effects  of  dichlorodiphenyltrichloroethane  (DDT)   and 
dieldrin on amphibians. Both pesticides caused hyperactivity, shuddering, abnormal 
snout development,  interference with tail  resorption,  and mortality,  although these 
effects were only observed at high concentrations, which would only be encountered 
in ponds that had been sprayed directly. In addition, the herbicide atrazine were also 
implicated in frog declines at this time . Collection by schoolchildren and scientists 
was also cited as a reason for decline up to the end of 1960 , although Cooke  argued 
that although large numbers were taken, population decline was not correlated with 
areas from which they were taken. 
1.2.3 Urbanisation and the Garden Pond
Population surveys during the 1970’s , and the 1980’s , revealed a more pronounced 
decline in the toad than the frog (Table 1.3). This was attributed to an increase in the 
creation of garden ponds , which are more suitable breeding habitats for frogs than 
toads, the latter breeding in older  and larger/deeper  water bodies. Indeed, during the 
1980’s populations of the frog increased, whereas the toad continued to decline.
Area 1970-1980 1980-1990
Bufo Rana Bufo Rana
South West - 0.22 - 0.09 + 0.86 - 0.07
South - 0.09 + 0.06 - 0.21 + 0.37
South East + 0.23 + 0.33 - 0.21 + 0.27
West Midlands - 0.25 - 0.06 - 0.38 + 0.29
East Midlands + 0.17 + 0.3 + 0.06 + 0.26
East Anglia - 0.21 - 0.18 - 0.03 + 0.07
North West - 0.05 - 0.08 + 0.4 - 0.06
North East - 0.35 - 0.19 - 0.1 + 0.06
Mean - 0.14 - 0.03 - 0.08 + 0.19
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Table 1.3 – Changes of status of the Common frog and toad in England. “Bufo” refers 
to Bufo bufo, the common toad, and “Rana” to Rana pipiens, the common frog. Taken 
from Cooke & Scorgie (1983); Hilton-Brown & Oldham (1991).
Although some groups had been active in carrying toads across roads since the early 
1900’s, it wasn’t until 1972  that the problem of road-associated mortality of toads 
was reported. The reason for toad-specific road mortality is that, unlike frogs, they 
display a high fidelity to their breeding site. Therefore, they may travel large distances 
to return to this breeding site, and consequently often need to cross roads . In 1989, 
concern related to road mortality was converted into action by coordination with local 
herpetological groups, with the setting up of the “Toads on Roads” scheme, which is 
run  by  “Froglife”  (registered  charity  no.  1093372).  However,  it  appears  that  the 
implementation of this scheme has not prevented toad declines, as declines are still 
observed in Central, South, and South Eastern areas, and especially in rural areas . 
The reason for this decline in toads is unknown, but one possibility is a decrease in 
genetic diversity of populations caused by habitat  fragmentation as toads in small 
urban populations were found to have a lower genetic diversity than those of larger 
rural populations. In addition, significantly higher mortality and abnormalities were 
reported in tadpoles form smaller populations . They also had relatively lower genetic 
diversity than frogs from the same area . 
Area (Rural data) Bufo bufo Rana temporaria
West + 0.05 - 0.15
Central - 0.38 - 0.07
East/South East - 0.3 - 0.05
North + 0.13 + 0.06
Total Rural - 0.16 - 0.09
Total Urban - 0.04 + 0.2
Table 1.4 – Changes in Status of Frog and Toad in England during 1990’s. Taken 
from Carrier and Beebee (2003).
Data from tables 1.2-1.4 were compiled and presented graphically (Figure 1.1). It is 
clear from this that the largest declines were observed 1960-1970, and that although 
frog  populations  appear  to  have  recovered,  toad  populations  have  continued  to 
decline. Although the data used for these analyses are qualitative, and were carried out 
by non-expert volunteers, it was similarly compiled and thus is probably unbiased.
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Figure 1.1 – Change in the status of the common frog, and common toad, in England 
in the last 60 years. (Index of change = (No. replies stating ‘increase’ – No. replies 
stating ‘decrease’)/(Total no. of replies – No. of replies stating ‘no longer found’)).
1.3 Endocrine System and Potential Targets for 
Endocrine Disruptors
The  vertebrate  endocrine  system  is  complex  and  involves  a  range  of  different 
components to achieve homeostasis, which include periphery and target organs, and 
the circulatory system. Endocrine disruptors (EDs) can bind to the hormone’s receptor 
and mimic the hormone (agonist), or bind to the receptor without eliciting a response, 
and thus prevent the endogenous hormone from binding (antagonist). They can also 
stimulate  or  inhibit  enzymatic  biotransformation,  either  in  the  target  organ 
(steroidogenesis)  or  in  a  periphery  organ  (primarily  the  liver  via  hepatic 
biotransformation), thereby causing increased/decreased availability of the hormone. 
In the circulatory system, they can also act  by interfering with binding to serum-
binding proteins, thereby altering free hormone concentrations in the serum. Lastly, 
they can act upstream via the central nervous system, by interfering with the secretion 
of gonadotropins (luteinising hormone: LH; follicle stimulating hormone: FSH), and 
thyroid  stimulating  hormone  (TSH),  which  in  turn  stimulate  the  production  of 
hormones. Alterations to the endocrine system via these routes (and/or others) can 
lead to various effects, including altered growth and development, and sex reversal. 
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1.3.1 Hormone Receptors
The majority of published reports on EDs have focused on the in vitro capability for 
compounds  to  bind to,  and  initiate,  hormone receptor  responses.  Tests  have  been 
developed to  detect  agents  that  interact  directly  with the hormone receptor  in  the 
absence of the endogenous ligand , or agents that inhibit binding by adding the test 
compound and the endogenous ligand simultaneously . The best known of these are 
cell  proliferation  assays  and  reporter  gene  expression  assays.  In  the  former, 
proliferation of cells that are dependant upon hormones for stimulation of growth are 
measured,  for  example,  proliferation  of  human  breast  cancer  cells  (MCF-7)  in 
response  to  estrogenic  compounds .  The  latter  is  a  measure of  gene  transcription 
induction following hormone receptor activation, and are based on mammalian cell 
lines or yeast  strains.  Cells  are  transfected with a reporter  plasmid,  and contain a 
hormone response element coupled to  a  reported gene,  such as  β-galactosidase or 
luciferase  .  The  receptors  that  have  received  the  most  attention  thus  far  are  the 
estrogen  receptor  (ERα/β),  the  androgen  receptor  (AR),  and  the  thyroid  receptor 
(TRα/β) . Other receptors that have been implicated in endocrine disruption include 
the arylhydrocarbon receptor , the retinoic X receptor , and the pregnane X receptor , 
though their importance is less well understood. 
In the present study three in vitro assays were used to detect receptor mediated (anti-) 
estrogens/androgens.  The  recombinant  yeast  assay  was  used  to  detect  (anti-) 
estrogenic/androgenic  activity  via  receptor  mediated  effects.  The  amphibian 
hepatocyte  monolayer  was  used  to  detect  estrogenicity  of  parent  compounds  and 
hepatic biotransformation products, via vitellogenin measurement, and the germinal 
vesicle  breakdown  assay  (GVBD)  was  used  to  detect  anti-androgenic  activity  in 
amphibian tissue.
1.3.2 Hepatic Biotransformation
Hepatic biotransformation often decreases the bioavailability of hormones, whereas 
gonadal  steroidogenesis  increases  bioavailable  hormones,  resulting  in  dynamic 
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homeostatic control of hormone levels within the organism via these processes . There 
are several categories of reaction occurring in the liver that change the activity of 
steroid  hormones  including,  hydroxylation,  conjugation,  and oxido-reduction, 
resulting in water soluble compounds that are excreted in the urine (You, 2004). In 
addition to metabolism of endogenous steroid hormones, the liver is also involved in 
the metabolism of xenobiotics. Under normal circumstances the liver acts to detoxify 
xenobiotics,  leading  to  excretion  of  the  compound,  however,  in  some  cases  it 
metabolises a  compound  to  a  more  biologically  active  metabolite  . 
Induction/inhibition  of  biotransformation  enzymes  by  agrochemicals  may  alter 
circulating steroid hormone levels, as has been demonstrated in field studies , and in 
the laboratory . 
In the present study, the relative importance of parent compound and metabolite will 
be assessed through comparison of estrogenic activity in the yeast estrogen screen 
(YES), and vitellogenin (VTG) production by hepatocytes.
1.3.3 Central Nervous System and Sex Steroid Synthesis
The regulation of  gonadal  tissue in  adult  vertebrates  occurs  via  the hypothalamo-
pituitary-gonadal axis (Figure 1.2). Testosterone (T), dihydrotestosterone (DHT), and 
17β-estradiol (E2) are thought to be the main controlling factors in the release of the 
gonadotropins LH and FSH, which in turn stimulate steroidogenic enzymes and thus 
stimulate  biosynthesis  of  various  steroid  hormones (Figure  1.3).  Steroid  synthesis 
begins with the conversion of cholesterol to pregnenolone by cholesterol side-chain 
cleavage (P450scc), and subsequent conversion to progesterone by 3β-hydroxysteroid 
dehydrogenase  (3β-HSD),  which  together  are  the  precursors  of  all  other  steroid 
hormones .  In addition,  the steroidogenic enzymes aromatase (P450arom) and 5α-
reductase (5αR),  convert  androgens  to estrogens (e.g.  T→E2),  and T to the more 
potent  androgen  DHT,  respectively  .  In  addition,  two  pathways  of  enzymatic 
conversion occur, the Δ5 pathway typically occurs in the adrenal cortex and stops 
with  the  production  of  dehydroepiandrosterone,  and  may  be  the  main  source  of 
androgens needed for conversion to estrogens in females, whereas the Δ4 pathway is 
predominant in males and occurs within the testes . Steroid hormones influence the 
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hypothalamus  by  altering  the  secretion  gonadotropin-releasing  hormone  (GnRH), 
which would in turn alter LH/FSH secretion, and/or act directly on the pituitary by 
altering its sensitivity to GnRH; and activin/inhibin are also thought to have a role in 
regulating  FSH  release  .  It  is  well  established  that  amphibians  produce  GnRH  , 
LH/FSH ,  and activin/inhibin ,  and that  pituitary gonadotrophs contain LH/FSH . 
Neither androgenic or estrogenic receptors have been identified on the GnRH neuron, 
however there appears to be an abundance of receptors on other neurons, which are 
situated  in  close  proximity  to  the  GnRH neurons  .  The  role  of  DHT and  E2  in 
gonadotropin  release  has  been  shown  in  bullfrogs  (Rana  catesbeiana),  whereby 
gonadectomy  caused  a  chronic  increase  in  levels  of  LH  and  FSH,  which  were 
remediated by implantation of DHT or E2 . DHT also acted on the pituitary directly, 
by increasing it’s responsiveness to GnRH stimulation in gonadectomised male and 
female bullfrogs . Similarly, treatment of adult male and female Xenopus laevis with 
EE2  inhibited  LH  levels  in  the  brain/pituitary,  and  treatment  with  methyl 
dihydrotestosterone (mDHT) inhibited LH production in males but not females . 
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Figure 1.2. Vertebrate hypothalamo-pituitary-gonadal axis. See text for details.
Figure 1.3. Enzymatic conversions of hormones. Note that 5α dihydrotestosterone is a 
more potent androgen than testosterone, it also cannot be aromatised to 17β estradiol, 
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In  the developing amphibian,  levels  of  LH, and FSH increase dramatically  at  the 
beginning  of  metamorphic  climax  (as  does  TSH,  see  section  1.4).  There  is  a 
concurrent rise in brain GnRH content and plasma levels of FSH and LH, although 
this  only  occurs  after  prometamorphosis  .  In  addition,  GnRH  neurons  reach  the 
median eminence at around the time when tadpoles begin to metamorphose , which 
indicates  that  the  hypothalamo-pituitary-gonadal  axis  becomes  functional  at  early 
metamorphic climax . This is sustained by the fact when 2 intraperitoneal injections of 
GnRH are given, LH/FSH secretion is not stimulated in prometamorphic tadpoles, but 
is  in  metamorphic  climax  tadpoles  (Fiorentino  et  al.,  unpublished  data,  reported 
within Fiorentino et al., 1999), and plasma levels of sex steroids increase significantly 
from levels in premetamorphic tadpoles to levels in climax tadpoles (Di Fiore, Pinelli, 
D’Aniello,  Rastogi,  unpublished  data,  reported  within  Fiorentino  et  al.,  1999).  In 
these  studies  the  sex  of  tadpoles  was  not  reported,  presumably  because  gonadal 
differentiation was not complete at the time of testing. However, it has recently been 
reported that during ontogeny of Xenopus laevis, gonadal aromatase activity was 10-
fold higher in females than males at  all  stages where sex differentiation could be 
identified (Gosner stage 56-2 weeks post metamorphosis), and 5α-R was 2-fold higher 
in males than females from Gosner stage 60-66 . It has also been reported that DHT 
levels  are  approximately  10-fold  higher  in  male  than  female  bullfrogs  in  adults, 
subadults  (lacked external  sex specific  features),  and young metamorphs (recently 
metamorphosed), and that estradiol levels were higher in female than male subadults . 
The same authors reported that treatment with a GnRH agonist, increased levels of 
LH and FSH to a larger extent in males than females in the bullfrog (adult, subadult, 
and  young  metamorphs),  and  that  pituitary  responsiveness  to  a  GnRH  agonist 
occurred earlier in development in males than females (but both post-metamorphosis). 
In  Rana catesbeiana it  was reported that the ovary was less dependent on GnRH 
secretion for development than the testes , and that the pituitary of adult males was 
also  more  responsive  to  GnRH than  adult  females  .  This  indicates  that  testicular 
development is more dependant on gonadotropin release than ovarian development. 
Indeed, it was reported that the tadpole (pre- and pro-metamorphic) ovarian fragments 
were able to synthesise and secrete estradiol independently of the pituitary, but only 
until metamorphosis , suggesting an independence of the ovary from gonadotropin 
stimulation in  development.  Lastly,  removal  of  the  pituitary (hypophysectomy) in 
larval  B. americanus, did not affect gonadal development, but subsequent testicular 
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development  was retarded,  whereas no effect  on the ovary was observed (Chang, 
1955). Similarly, hypophysectomy of adult B.arenarum  or adult Rana esculenta  did 
not cause ovarian atrophy, but did provoke testicular atrophy. However, these studies 
operated over a short time frame (months), and eventually later stages of oogenesis 
and  vitellogenesis  are  inhibited  in  hypophysectomised  females,  but  no  effect  is 
observed  on  primary  oocytes  .  Therefore,  the  hypothalamo-pituitary-gonadal  axis 
differs in males and females during ontogeny, and these differences persist in adults. 
The relative roles of LH and FSH differ in their function. In males, LH stimulates 
spermiation  (release  of  spermatozoa  from  seminiferous  tubules)  and  androgen 
production, whereas FSH stimulates spermatogenesis (development of spermatogonia 
to  spermatozoa).  In  females,  whereby  LH  stimulated  ovulation,  and  FSH evokes 
ovarian growth without causing ovulation . These findings have been corroborated by 
more recent data,  whereby FSH levels  were closely correlated to vitellogenin and 
estradiol  production  in  female  Rana  esculenta,  and  LH  was  closely  related  to 
androgen production in male Rana esculenta during the reproductive cycle in adults . 
During  the  annual  reproductive  cycle  in  Rana  esculenta,  the  highest  levels  of 
gonadotropins  and  androgens  were  observed  in  the  Spring,  which  coincided  with 
reproductive  activity  of  this  species  ,  and  gonadotropins  have  been  shown  to 
upregulate testicular steroidogenic enzyme activity in  Xenopus laevis in vivo and in 
vitro , which would result in the increased hormone levels observed. 
In  the  present  study,  gonadal  steroidogenesis  was  assessed  by  in  vitro culture  of 
Xenopus ovarian fragments. Ovulation and hormone production (P, T, E2) by tissue 
was measured to determine possible inhibition/stimulation of steroidogenic enzymes. 
Specific effects on the central nervous system were not assessed, however, the effects 
on the whole organism were assessed through toad sampling.
1.3.4 Sex differentiation and determination
Sex  differentiation,  defined  as  the  development  of  testes  or  ovaries  from 
undifferentiated  gonad,  and  sex  determination  defined  as  mechanisms  that  direct 
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sex/gonadal differentiation ,  are  fundamental  endocrinological  features of  animals, 
and are highly conserved among vertebrates . Perturbation to the endocrine system via 
the  mechanisms  described  above  (and/or  others),  may  ultimately  result  in  altered 
fecundity of a population. In amphibians, there is considerable plasticity in phenotypic 
sex,  whereby  administration  with  sex  steroids  often  results  in  the  representative 
phenotype developing or mixed testicular/ovarian tissue . The sex-determining factor 
seems to be located in, or relayed by, the somatic tissue of the gonad, as implantation 
of a testis into a female causes masculinisation of the remaining gonad . However, if 
primordial germ cells (PGCs) are transferred to the opposite sex gonad, and the sex of 
the host develops normally . 
In the present study, gonadal histology of  B.bufo specimens from laboratory-reared, 
caged,  and  wild-caught  individuals  were  used  to  determine  effects  on  gonadal 
differentiation.
1.4 Thyroid System & Metamorphosis
Metamorphosis  (a  change  in  form  or  structure)  is  a  dramatic  example  of 
postembryonic development, and is tightly controlled by hormones . In amphibians, 
the  activity  of  the  thyroid  gland  and  levels  of  thyroid  hormone  (TH)  change 
throughout metamorphosis. During premetamorphosis (when hindlimbs start to grow), 
TH levels are constant but low, during prometamorphosis (hindlimbs fully developed) 
increasing activity of the thyroid gland and increasing levels of TH are observed. The 
activity of the thyroid gland reaches its highest levels at the beginning of metamorphic 
climax (forelimbs come out of their sockets), and during the first stages of climax (tail 
begins to regress). In the later stages of climax, the thyroid gland activity decreases, 
and TH levels fall to those observed in postmetamorphic animals . Various hormones 
control the rate and timing of metamorphosis via inhibitory and excitatory signals 
acting through the hypothalamo-pituitary-thyroid axis . Corticoid and thyroid levels 
increase  concurrently  during  metamorphosis  of  the  developing  tadpole  ,  and 
corticosterone  inhibits  the  rate  of  metamorphosis  during  early  development  and 
accelerates the rate during late development . The inhibitory effect may be due to 
negative feedback of corticosterone on the hypothalamus, thereby reducing secretion 
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of corticotropin-releasing factor, which in turn causes a decrease in TH production by 
decreasing  stimulation  of  thyrotropin-releasing  hormone  .  Stimulation  in  the  later 
stages may occur due to the role of corticosterone in converting thyroxine (T4) to the 
biologically active TH triiodothyronine (T3) , and enhancing the binding of T3 to its 
receptor .  As a result of the higher levels of circulating thyroid hormones later in 
development,  increasing  corticosterone  at  this  stage  increases  the  rate  of 
metamorphosis  .  The  thyroid  also  seems  to  have  a  degree  of  autonomy  during 
metamorphosis  and  a  local  positive  feedback effect  of  thyroid  hormone upon the 
thyroid hormone receptors has been reported . Studies using prolactin demonstrated 
the links between T3,  prolactin,  and mRNA transcripts  involved in autoregulation. 
When  Xenopus laevis tadpoles were exposed to either T3,  or T3 and prolactin, the 
prolactin inhibited the upregulation in mRNA transcripts which was observed in the 
T3  only treatment. Concurrent experiments using isolated tails demonstrated that this 
effect  on mRNA transcription could also be observed in  the failure  of  the tail  to 
regress in the T3 and prolactin treatment . 
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Figure 1.3. The vertebrate thyroid system (autoregulation, and influence of binding 
proteins not shown). See text for details.
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1.4.1 Effects of External Factors on the Thyroid System
External factors, such as nutrition, competition, and temperature, can affect the rate of 
metamorphosis. For the developing tadpole, there is a trade-off between capitalising 
on an abundant food supply to attain a large size at metamorphosis, and the risk of 
staying in a potentially dangerous habitat. Therefore, good nutrition results in larger 
metamorphs,  which  complete  metamorphosis  at  a  younger  age  .  Intraspecific 
competition and decreased food availability have been shown to increase the length of 
larval period , whereas a larval diet consisting of high protein caused a decrease in 
time to metamorphose and an increase in size at metamorphosis . Higher temperatures 
increase the rate of metamorphosis, as well as affecting the extent that exogenous 
steroids  affect  metamorphosis  .  In  addition,  corticosterone  increases  the  rate  of 
metamorphosis, and is a hormone which is related to stress, and therefore, it may be 
responsible  for  stress-induced  metamorphosis,  such  as  the  acceleration  of 
metamorphosis during pond drying . The sex steroids, estradiol and testosterone, have 
been  shown  to  inhibit  larval  development  in  Rana  pipiens  ,  and  inhibited  tail 
resorption in vivo but not in vitro in Xenopus laevis ; the latter study suggesting that 
sex steroids do not interact with circulating thyroid hormone levels peripherally, but 
instead inhibit the thyroid axis more centrally . There is also some evidence that other 
hypothalamic  substances  may  play  a  role  in  regulating  thyrotropin,  such  as, 
somatostatin, dopamine, and glucocorticoids; which all have a inhibitory effect upon 
thyrotropin release .   
1.4.2 Targets of the Thyroid System
The  thyroid  system  has  various  possible  targets  for  EDs,  including,  centrally 
controlled TH synthesis (hypothalamo-pituitary-thyroid axis), peripherally controlled 
conversion  of  T4 to  T3 by  deiodination  enzymes,  and  excretion  of  T3 by  hepatic 
metabolism . The thyroid also has considerable capacity to compensate for disruption 
of its normal status. Thyroid follicles are capable of upregulating production of T4, 
resulting in hypertrophy and hyperplasia of epithelial cells of the follicles, which can 
be observed histologically. Deiodination enzymes can also alter the proportion of T3 
to T4 and thereby alter activity of circulating TH, and there is also a considerable store 
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of  T4 in  thyroid  colloid.  Therefore,  short  term  exposure  to  thyroid  disrupting 
compounds may result in underestimation of the effect of these compounds . Receptor 
mediated effects and disruption of TH synthesis have been reported in response to a 
range  of  synthetic  chemicals,  including  ammonium  perchlorate  ,  and  various 
pesticides, such as DDT, amitrole, thiocarbamates , acetochlor, trifluralin, terbutryn , 
and organophosphates . In addition to receptor mediated effects, disruption of binding 
to  TH-binding  proteins  has  also  been  shown  to  be  a  target  for  some  endocrine 
disrupting compounds, for example, polychlorintated biphenyls  and DES, ioxynil and 
pentachlorophenol . In amphibians, thyroid sensitive endpoints, such as time taken to 
forelimb  emergence  and  completion  of  metamorphosis,  and  hindlimb  length,  are 
routinely recorded. Therefore, there are more reports on the effects of pesticides on 
the thyroid axis than the hypothalamo-pituitary-gonadal axis.
In the present study, disruption to the thyroid axis was assessed by comparison of 
morphological and histological analysis of thyroid sensitive endpoints in laboratory-
reared and field collected individuals. 
1.5 Endocrine Disrupting Agrochemicals
The ED potential of currently used agrochemicals in the U.K. is largely unknown, and 
in most  cases,  least  is  known about  those detected most  often and at  the highest 
concentrations. The U.S.A. has the largest world expenditure on pesticides (30% of 
herbicides, 24% of insecticides, 9% of fungicides, and 29% of others, Kiely  et al., 
2004), and has a markedly different pesticide profile than the U.K. (Table 1.5). For 
example, of the 69 pesticides found above 0.01 µg/L in the U.K. in 2004/2005, only 7 
were present in the top 25 used in the U.S.A. in 2001 (Kiely et al., 2004). Therefore, 
pesticides that are environmentally relevant to the U.K. may not be well researched 
due to their relatively low global use. Herbicides and plant growth regulators were the 
highest use agrochemicals worldwide (37%), followed by ‘others’ (29%), insecticides 
(24%) and fungicides (9%) in 2001 . This pattern was loosely followed in the U.K., 
where  of  the  69  pesticides  found  above  0.01µg/L  in  2004/2005,  62%  were 
herbicides/plant growth regulators, 33% were insecticides, and 4% were fungicides 
(Table 1.5). In addition to the scarcity of information about environmentally relevant 
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pesticides,  there  is  also  generally  very  little  information  pertaining  to  pesticide 
induced ED in amphibians. Therefore, a review of the major classes of pesticides and 
their effects in a wide range of assays and organisms is reported here. 
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Table 1.5 – Levels of agrochemicals measured in U.K. freshwaters in 2004/2005 (Environment Agency Copyright 2007, duplicated as Appendix 
1), and pesticide expenditure in the U.S.A. in 2001 (Kiely et al., 2004).
Herbicides/Plant Growth Regulators
Mode of Action Type Compound Mean 
(µg/L)
Range 
(µg/L)
Median 
(µg/L)
Incidence
(> 0.01 µg/L)
Median x 
Incidence
Rank
UK      US
Synthetic auxin Phenoxy- acids Mecoprop 6.593 0.028-6180 0.1 1444 144.4 1
MCPA 12.052 0.04-4700 0.152 615 93.48 4
2,4-D 40.348 0.04-18600 0.140 488 68.32 5 5
Dichlorprop 5.112 0.04-561 0.200 120 24 9
2,4-DB 0.315 0.04-1.4 0.200 35 7 17
MCPB 0.296 0.04-1.81 0.1 65 6.5 19
2,4,5-T 0.077 0.02-0.352 0.059 24 1.416 44
4-CPA 0.165 0.04-0.995 0.075 12 0.9 49
Benzoic Acid Dicamba 89.617 0.035-5090 0.1 57 5.7 21 24
2,3,6-TBA 0.814 0.01-4.4 0.21 19 3.99 26
Pyridinecarboxylic acid Fluroxypyr 0.315 0.044-4.54 0.084 26 2.184 32
Triclopyr 0.097 0.03-0.34 0.061 27 1.647 39
Clopyralid 0.093 0.04-0.37 0.05 12 0.6 53
Unknown Benazolin 0.908 0.05-4.150 0.585 21 12.285 14
Photosynthetic electron 
transport inhibitor Urea Diuron 0.652 0.016-28 0.131 785 102.835 2
Isoproturon 0.443 0.02-29.5 0.150 635 95.25 3
Chlorotoluron 0.271 0.021-5.87 0.077 217 16.709 10
Linuron 0.123 0.2-1.4 0.057 74 4.218 24
Monuron 0.346 0.04-0.94 0.196 9 1.764 36
Fenuron 0.129 0.07-0.213 0.124 10 1.24 46
Neburon 0.055 0.04-0.089 0.053 7 0.371 54
Triazine Simazine 0.067 0.01-2.24 0.038 1444 54.872 6 23
Atrazine 0.053 0.01-1.96 0.024 1464 35.136 7 2
Trietazine 1.559 0.01-5.91 0.925 18 16.65 11
Terbutryn 0.134 0.01-4 0.027 148 3.996 25
22
Propazine 1.075 0.5-2.76 0.567 5 2.835 30
Benzothiadiazinone Bentazone 0.121 0.04-1.75 0.07 137 9.59 15
Hydroxybenzonitrile Bromoxynil 0.838 0.04-6.5 0.35 18 6.3 20
Pyridazinone Chloridazon 0.573 0.04-1.73 0.32 7 2.24 31
Uncoupler of oxidative 
phosphorylation Dinitrophenol DNOC (insecticide)  0.274 0.04-1.8 0.1 17 1.7 38
Unknown
Pentachlorophenol 
(biocide) 0.304 0.016-2.74 0.163 93 15.159 12
Inhibits cell division (blocks 
microtubule function) Carbamate Chlorpropham 4.816 0.01-269.6 0.089 103 9.167 16
Carbetamide 0.264 0.05-0.744 0.297 17 5.049 23
Benzamide Propyzamide 2.55 0.01-310 0.042 124 5.208 22
Dinitroaniline Trifluralin 0.038 0.01-3.06 0.018 183 3.294 28 12
Inhibits cell division (blocks 
protein synthesis) Chloroacetamide Metazochlor 0.048 0.01-0.588 0.019 82 1.558 40
Inhibts cell division (blocks 
sterol synthesis) Triazole Paclobutrazol 0.021 0.01-0.038 0.02 9 0.18 62
Inhibiton of cell wall 
synthesis Benzonitrile Dichlobenil 0.168 0.01-10.6 0.026 122 3.172 29
Chitin synthesis inhibitor Benzoylurea Diflubenzuron 0.11 0.04-0.87 0.058 21 1.218 47
Inhibits lipid synthesis Benzofuron Ethofunesate 0.573 0.01-13.3 0.023 76 1.748 37
Thiocarbamate Tri-allate 0.016 0.01-0.035 0.012 13 0.156 63
Inhibits synthesis of 
essential amino acids Glycine Derivative Glyphosate 27.95 0.11-1600 0.229 149 34.121 8 1
Insecticides & Fungicides (f)
Mode of Action Type Compound Mean 
(µg/L)
Range   
(µg/L)
Median 
(µg/L)
Incidence
(> 0.01 µg/L)
Median x 
Incidence
Rank
UK      US
Nerve Poison (affects 
sodium balance in nerves) Organochlorine DDT 0.025 0.01-0.094 0.02 21 0.42 53
TDE (DDD) 0.027 0.014-0.11 0.018 11 0.198 61
Antagonist of the GABA 
receptor Cyclodiene organochlorine Dieldrin 5.647 0.01-153.4 0.096 69 6.624 18
23
Aldrin 0.05 0.011-0.312 0.024 15 0.36 55
HCH 0.019 0.01-0.055 0.017 14 0.238 60
Cholinestersae inhibition Organophosphate Diazinon 0.046 0.01-0.535 0.03 451 13.53 13
Parathion 0.754 0.012-3 0.085 17 1.445 43
Mevinphos 0.33 0.01-2.53 0.03 29 0.87 50
Dimethoate 0.055 0.011-0.367 0.024 29 0.696 51
Azinphos-methyl 0.053 0.01-0.178 0.032 11 0.352 56
Malathion 0.03 0.01-0.109 0.019 17 0.323 57 6
Fenitrothion 0.068 0.013-0.137 0.06 4 0.24 59
Propetamphos 0.019 0.01-0.034 0.016 7 0.112 64
Chlorfenvinphos 0.032 0.015-0.073 0.023 4 0.092 66
Triazophos 0.013 0.01-0.02 0.01 6 0.06 67
Carbamate Pirimicarb 0.328 0.011-8.86 0.085 46 3.91 27
Nerve poison (blocks 
sodium transport in nerves) Pyrethroid Permethrin 1166.8 0.01-26400 0.029 30 0.87 50
Cypermethrin 0.033 0.012-0.093 0.024 11 0.264 58
Inhibition of digestive 
enzymes Mitin Sulcofuron 0.523 0.25-0.75 0.545 4 2.18 33
Flucofuron 0.293 0.18-0.52 0.255 6 1.53 41
Unknown Eulan 0.107 0.02-0.7 0.07 14 0.98 48
Uncoupler of oxidative 
phosphorylation Organotin Tributyltin 0.089 0.01-7.9 0.016 115 1.84 34
Dibutyltin 0.034 0.01-0.4 0.017 87         1.479   42
Inhibition of beta-tubulin 
synthesis Benzimadazole Carbendazim (f) 0.11 0.023-0.516 0.069 20 1.38 45
Inhibtion of ergosterol 
synthesis Triazole Flutriafol (f) 0.072 0.012-0.162 0.068 26 1.768 35
Morpholine Fenpropimorph (f) 0.03 0.018-0.064 0.02 5 0.1 65
Lipid peroxidation Chlorphenyl/nitroaniline Tecnazene (f) 0.013 0.01-0.21 0.011 4 0.044 68
(f) = fungicide
24
1.5.1 Insecticides
1.5.1.1 Organochlorines
The organochlorine DDT was the first pesticide to be linked with adverse effects, and 
with endocrine disruption, in wildlife . A major route of biotransformation of DDT is 
dehydrochlorination  to  the  more  persistent  metabolite 
dichlorodiphenyldichloroethylene (DDE), which has a very long half-life (10+ years 
in soil), and both have a high potential for bioaccumulation . DDT has been shown to 
be  estrogenic  in  various  test  systems.  VTG  induction  was  observed  in  adult 
Trachemys scripta and  Xenopus laevis injected with o,p’-DDT for 7 days , and sex 
reversal was observed in male Oryzias latipes (Japanese Medaka) eggs injected with 
227 ng . Noriega & Hayes  reported an estrogenic effect on coloration of Hyperolius 
argus (reed  frog)  when  immersed  in  0.1  µg/L  o,p’-DDT,  but  not  p,p’-DDT.  In 
contrast,  in Ambystoma  tigrinum,  technical  grade  DDT  (80%  p,p’-DDT  &  20% 
o,p’-DDT) had an anti-estrogenic effect on Mullerian ducts when immersed in 10 
µg/L, but DDE was estrogenic . In situ, DDE  was associated with alligator population 
decline in Lake Apopka (Florida), where a major pesticide spill containing high levels 
of DDT was correlated with poorly organized testes and small phalli in males, and 
polyovular follicles and multinucleated oocytes in females . The estrogenic effects of 
o,p’-DDT and DDE observed in vivo are consistent with estrogenic activity observed 
in vitro. Both congeners of DDT were estrogenic in the E-Screen as 10 µM (Soto et 
al.  1994),  and,  when tested at  lower concentrations,  o,p’-DDT was a more potent 
estrogen than technical grade DDT or p,p’-DDT alone . DDE was also estrogenic, 
albeit  at  levels  approximately  2  orders  of  magnitude  less  than  o,p’-DDT  . 
Interestingly, both DDT congeners and DDE were also anti-androgenic in various cell 
based test systems , and have also been shown to be anti-progestogenic . Due to their 
persistence  in  the  environment  and  continuing  use  worldwide,  the  endocrine 
disrupting (EDg) activity  of  DDT and metabolites cause concern for  wildlife  and 
humans. However, they are of limited environmental relevance in the U.K., where use 
has  been  severely  restricted  since  the  1960’s,  and  were  found  rarely  in  low 
concentrations  in  2004/05  (e.g.  DDT  was  ranked  53,  Table  1.5).  Other 
organochlorines  have  also  been  classified  as  EDs  ,  for  example,  methoxychlor  , 
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endosulfan  ,  lindane  ,  and  toxaphene  ,  however,  similarly  to  DDT,  they  are  not 
environmentally relevant to the U.K. Dieldrin is the most environmentally relevant 
organochlorine in the U.K. (ranked 18, Table 1.5), but it has been reported to have 
little  or no ED activity ,  although it  is  highly toxic  to developing amphibians  at 
environmentally  relevant  concentrations  (Table  1.5).  Therefore,  it  is  unlikely  that 
organochlorine insecticides are causing ED in U.K. amphibians, but there may be a 
toxic effect on embryos and tadpoles.
1.5.1.2 Organophosphates and Carbamates
The use  of  organochlorines  was largely  phased  out  in  the  1960’s,  and  they  were 
gradually  replaced  by  organophosphates  (OPs)  and  carbamates,  which  were  more 
readily  biodegradable.  OPs are  the most  common type  of  insecticide  or  fungicide 
detected above 0.01 µg/L in the U.K. (Table 1.5). Their mode of action in the target 
organism is via enzyme (cholinesterase) inhibition (Tomlin, 2006). Interestingly, they 
possess  little  interaction  with  hormone  receptors  ,  but  do  affect  steroidogenic 
enzymes. For example, dimethoate inhibited CYP450scc in Leydig tumour cell line , 
and  diazinon  inhibited  cortisol  secretion  in  adrenocortical  cells  .  A  field  study 
investigating  amphibian  population  decline  in  California  associated  decreasing 
populations with decreased acetylcholinesterase activity, and also found higher OP 
residues (chlorpyrifos & diazinon) in frog tissues from these individuals . Diazinon 
was the highest ranked insecticide or fungicide detected in the U.K. (rank 13, Table 
1.5), and had a reprotoxic effect on the ovary of  Lepomis macrochirus  (Bluegill) 
exposed to 60 µg/L , which was accompanied by decreased estradiol levels . Other 
OPs  have  also  been  identified  as  EDs  in  vivo,  for  example,  parathion  in  mice  , 
dimethoate in rats ,  fish ,  & ewes ,  fenitrothion in fish ,  and malathion in quail . 
However, these compounds are rarely found in U.K. freshwaters (ranked 43-59, Table 
5.1).  Similarly  to  OPs,  carbamates  possess  little  receptor  binding  activity  ,  but 
pirimicarb,  and  propamocarb  induced  aromatase  activity  in  human  placental 
microsomes  ,  and  chlorpyrifos  induced  various  CYP450  hydroxylases  in  a  cell 
transcription assay . The only carbamate found in the U.K. above 0.01 µg/L was 
pirimicarb (ranked  27,  Table  1.5),  however,  the  maximum  concentration  it  was 
detected at was 8.9 µg/L, compared to 11900 µg/L (50 µM) used by Andersen et al. 
(2002), and therefore, carbamates are unlikely to be effecting amphibians in the UK.
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1.5.1.3 Pyrethroids
The  insecticidal  properties  of  pyrethrum,  a  product  made  from  Chrysanthemum 
flowers  has  long  been  known,  and  natural  pyrethrins  served  as  a  model  for  the 
development of synthetic pyrethroids. Natural pyrethrins degredate very quickly in 
sunlight  (hours),  however,  synthetic  pyrethroids  are  more  stable  and  can  last  for 
months  or  even  years  in  soil  (Tomlin,  2006).  The  often  adsorb  strongly  to  soil 
particles,  but  during  storm  events  are  washed  into  nearby  water  bodies,  thereby 
inducing  a  spike  in  contamination  level  .  They are  widely  used  insecticides,  and 
examples include permethrin, cypermethrin, fenvalerate and deltamethrin, although 
only permethrin and cypermethrin were detected in the U.K. in 2004/05 (ranked 50 & 
58, respectively, Table 1.5). They have an agonistic effect on the estrogen receptor in 
the  µM  range,  which  has  been  shown  in  various  cell  based  test  systems  ,  and 
metabolites of deltamethrin and cypermethrin are also anti-androgenic over a similar 
range . Permethrin and cypermethrin have also been shown to induce transcription of 
CYP450  hydroxylases  ,  which  catalyze  the  hydroxylation  of  testosterone,  and 
therefore  could  result  in  lowered  levels  of  circulating  testosterone.  Indeed, 
cypermethrin  has  been  associated  with  decreased  anogenital  distance  and  relative 
prostate  weight  in  male  rat  pups  after  perinatal  exposure  ,  which  are  indicative 
endpoints of anti-androgenic activity ,  and could result  from decreased circulating 
testosterone levels. Cypermethrin also decreased hatching rate, and increased time to 
metamorphosis in  Rana arvalis tadpoles exposed to 1 & 10 µg/L , however, levels 
found in the environment were below this level (maximum measured concentration: 
0.0002 µM, 0.093 µg/L). Permethrin, on the other hand, was found at much higher 
levels (maximum measured concentration: 67.5 µM, 26400 µg/L), which are similar 
to effective concentrations in vitro, indicating a possible effect on amphibians at point 
source areas.
1.5.2 Herbicides
1.5.2.1 Triazines
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The triazines are widely used herbicides worldwide, atrazine was the second most 
commonly used pesticide in the U.S.A. in 2001 ,  and simazine and atrazine were 
among the highest ranked agrochemicals in the UK (6 & 7 respectively, Table 1.5). 
Research  has  indicated  that  atrazine  is  an endocrine  disruptor  in  rats  ,  fish ,  and 
amphibians  .  In  amphibians,  the  most  commonly  reported  effect  was 
feminisation/demasculinisation  upon  exposure  to  0.1-25  µg/L,  either  through 
decreased testosterone levels ,  or histological abnormalities .  Concentrations at the 
lower  end  of  this  range  are  comparable  to  levels  found in  the  U.K.  environment 
(maximum measured concentration 1.96 µg/L, Table 1.5), and thus are a cause for 
concern. Most studies have reported that triazines or their metabolites do not interact 
with hormone receptors , but  have been reported to affect steroidogenic enzymes in 
vitro . Atrazine upregulated aromatase in human adrenocortical cells  , but this effect 
could not be verified in vivo . Atrazine and the metabolite deethylatrazine,  inhibited 
5α-R and 17βHSD activity in male rat pituitary cell suspension, and in male rats  in 
vivo . In addition, atrazine inhibited adenocorticotropic hormone (ACTH) stimulated 
cortisol secretion in steroidogenic cells of the rainbow trout  and Rana catesbeiana, 
but  not  Xenopus  laevis ;  indicating  a  species  specific  response.  Concentrations 
eliciting a response in vitro were in the low µM range (1 µM = 215 µg/L), which is 
higher  than levels  found in  the  environment,  however,  due  to  effects  observed in 
aquatic organisms in vivo this compound remains a cause for concern, as does the less 
tested triazine, simazine.
1.5.2.2 Phenoxy-Carboxylic Acids
The  phenoxy  herbicides  2-methyl-4-chlorophenoxyacetic  acid (MCPA), 
dichlorophenoxyacetic  acid (2,4-D),  and  mecoprop  are  among  the  highest  ranked 
agrochemicals in the U.K. (1, 4, & 5 respectively, Table 1.5), and 2,4-D was also the 
5th most commonly used pesticide in the U.S. in 2001 ,  however,  their  effects on 
humans and wildlife are not well defined. MCPA caused testicular degeneration in the 
seminiferous  tubules  of  rats  fed  112  mg/kg/day  ,  and  increased  hepatic  enzyme 
activity in female newts exposed to 800 mg/L , however, this is much higher than 
levels  found  in  the  environment  (maximum  detected  concentration:  4.7  mg/L). 
Mecoprop was not estrogenic or anti-estrogenic  in vitro ,  but  had a slightly toxic 
effect on murine embryos exposed to 0.5 µg/L . 2,4-D decreased circulating thyroxine 
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levels in ewes exposed to 30 mg/kg/week, but, estradiol, cortisol and LH levels were 
unaffected  .  In  vitro,  Xenopus oocyte  maturation  was  irreversibly  inhibited  by 
exposure to 10 mM 2,4-D ,  however,  this corresponds to 2.2 g/L, which is  much 
higher than levels found in the environment (maximum detected concentration: 18.6 
mg/L). However, the LC50 of 2,4-D to  Bufo melanosticus larvae was 8.05 mg/L , 
suggesting that toxicity could occur at point source locations.
1.5.2.3 Ureas
The  ureas  are  also  highly  ranked  herbicides  in  the  UK,  for  example,  diuron, 
chlorotoluron, linuron and isoproturon were ranked 2nd, 3rd, 10th, & 24th, respectively 
(Table 1.5). However, similarly to the phenoxy herbicides, little is known of their ED 
effects,  especially  in  the  case  of  chlorotoluron,  where  no  reports  were  available. 
Diuron had no effect on fish testicular or ovarian steroidogenesis in vitro at 0.1 or 1 
mM . In addition, no effect was observed on prostate 5α-R activity up to 100 µM , or 
placental aromatase activity up to 50 µM . It also did not interact with the estrogen 
receptor , but was weakly anti-androgenic . Considering it’s weak/absent endocrine 
effects  in  vitro,  perhaps  it  is  not  surprising  that  diuron  had  minimal  effects  on 
reproductive parameters in rats exposed  in vivo . At similar concentrations, linuron 
also did not interact with the estrogen receptor , and didn’t inhibit placental aromatase 
acitivity . However, it had approximately 3 times more potent anti-androgenic activity 
than diuron , and inhibited prostate 5α-R activity by 50% at 86 µM . In vivo, several 
studies have shown anti-androgenic activity of linuron on reproductive parameters in 
rats,  and  the  mechanism  of  action  was  hypothesised  to  be  at  least  partly  via 
antagonism  of  the  androgen  receptor  .  Anti-androgenic  activity  has  also  been 
demonstrated in an aquatic exposure study, whereby inhibition of spiggin production 
in female Stickleback exposed to 150 µg/L was reported (Katsiadaki et  al.  2006). 
However, in the latter study, no effect was observed at 15 µg/L, which is still an order 
of  magnitude  higher  than  the  maximum  concentration  detected  in  the  U.K.  in 
2004/2005 (1.4 µg/L), indicating it may not pose a risk to amphibians. Isoproturon is 
the least well studied of the phenoxy herbicides, and to the author’s knowledge, just 
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one publication has tested for endocrine effects  in vitro, and no estrogenic or anti-
estrogenic activity was observed . However, it has been shown to cause mortality and 
developmental deformities in  Bombina bombina (fire-bellied toad) tadpoles exposed 
to 0.1-100 µg/L , which is within the range of environmental levels (0.02-29.5 µg/L, 
Table 1.5). 
1.5.2.4 Other Herbicides
Other herbicides that do not fall into the above categories but are environmentally 
relevant  include,  dicamba,  2,3,6-trichlorobenzoic  acid  (2,3,6-TBA),  benazolin, 
bentazone,  bromoxynil,  pentachlorophenol  (PCP),  trifluralin,  and  glyphosate  (see 
Table 1.5 for details).  Of these, no information pertaining to the EDg potential of 
dicamba, 2,3,6-TBA, benazolin, bentazone, or bromoxynil could be obtained. PCP is 
used  as  an  insecticide,  fungicide,  and  herbicide  and  thus  has  a  wide  range  of 
applications, agriculturally, and industrially, but its primary use is to protect timber 
from wood-boring insects and fungal rots (Tomlin, 2006). PCP use has been restricted 
in  Europe  since  1991  ,  but  it  was  still  detected  in  surface  waters  in  the  U.K.in 
2004/05, and was ranked 12th (Table 1.5). It has previously been reported to have anti-
estrogenic activity in vitro , although estrogenic  and anti-androgenic activity were not 
observed ,  and it had no effect on aromatase activity .  In a series of publications, 
Beard and Rawlings have demonstrated various reproductive effects in mammals, for 
example,  decreased  whelping  rate  in  mink  ,  increased  severity  of  oviductal 
intraepithelial cysts in ewes , and seminiferous tubule atrophy in rams . Interestingly, 
serum hormone and gonadotropin levels were unaffected in these studies, suggesting a 
direct toxic effect on reproductive tissues. Indeed, in vitro PCP irreversibly inhibited 
ovulation of Zebrafish oocytes at > 0.6 µM , and caused toxicity in rat sertoli cells at 
10 nM . Furthermore, PCP reduced the number of eggs laid, and their subsequent 
hatching rates, and induced formation of testis-ova in Japanese medaka exposed to 50-
200 µg/L  . The maximum measured concentration in 2004/05 was 2.74 µg/L (0.01 
µM), which is lower than effective concentrations reported above, however it has the 
potential to bioaccumulate ; and therefore, may pose a risk to amphibians.
Trifluralin  (dinitroaniline  herbicide,  ranked 28th in  UK and 12th in  US)  decreased 
thyroxine,  increased  estradiol,  and  decreased  LH  concentrations  in  ewes  fed  35 
mg/kg/week for 5 weeks . However, it did not interact with the estrogen or androgen 
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receptor in a gene transcription assay , or the estrogen receptor in a proliferation assay 
, and had no effect on thyroid responsive endpoints in mice . Glyphosate is a glycine 
derivative  and was ranked 8th in  the  U.K.  and  1st in  the  U.S.A.  (Table  1.5).  The 
herbicide formulation Roundup®, which contains glyphosate as the active ingredient, 
caused formation of testis-ova and increased time to metamorphosis in larval  Rana 
pipiens, whereas glyphosate alone did not have an effect . Roundup ® also had a more 
potent excitatory effect on aromatase activity in human placental cells than glyphosate 
alone . These effects were probably due to the adjuvents present in Roundup ®, as 
they are designed to facilitate entry into the cell . In support of this theory, the most 
effective  formulations  of  glyphosate  based  herbicides  in  R.pipiens were  those 
containing the surfactant polyethoxylated tallowamine (POEA), which also elicited a 
response alone . Roundup ® also decreased E2 levels, and reproductive success of 
Jundía (Rhamda quelen) exposed to 3.6 mg/L for 40 days . This suggests that the 
‘active’ ingredient of a pesticide may not always be the compound most likely to 
affect wildlife, but little is known about the relative effects of pesticide adjuvents . 
The  mechanism  of  action  of  glyphosate/Roundup  ®,  may  be  via  inhibition  of 
steroidogenic acute regulatory protein (StAR) expression, which transports cholesterol 
to  the  inner  mitochondrial  membrane  for  conversion  to  steroid  hormones  .  The 
maximum measured concentration of glyphosate in the UK was 1.6 mg/L (Table 1.5), 
but glyphosate had no effect on amphibians when tested alone . Roundup ® is the 
most common formulation of glyphosate (Tomlin, 2006), however, the aquatic levels 
of  POEA are  unknown,  and  therefore,  the  risk  of  glyphosate  based  pesticides  to 
amphibians in the UK is also unknown.
1.5.3 Fungicides
Fungicides constitute the smallest group of agrochemicals found in U.K. freshwaters, 
and only four  (carbendazim,  flutriafol,  fenpropimorph, and tecnazene) were found 
above  0.01  µg/L  in  2004/05  (Table  1.5).  Carbendazim  is  a  metabolite  of  the 
benzimidazole fungicide benomyl, and this conversion occurs rapidly in water (~ 2 
hours) and animal tissues (Tomlin, 2006). It is reported to cause infertility, testicular 
atrophy and abnormal spermiogenesis, and occlusion of the effernet ductules in rats . 
In  addition,  it  caused  histological  alterations  in  thyroid  and adrenals,  of  rat  pups 
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exposed in utero , and adults , but no effects on other thyroid or pituitary hormones 
were observed . The toxic mode of action in the target organism is by inhibition of 
mitosis via inhibition of beta-tubulin synthesis, which is similar to the physiological 
effects observed in rats where decreasing presence of microtubules in the Sertoli cells 
of the testis was reported . It  is debatable as to whether this constitutes endocrine 
disruption per se, or general toxicity, as the endocrine system is not affected, although 
it causes major disruption of an endocrine organ. No information could be obtained on 
the other fungicides detected, although flutriafol is an azole fungicide, and this class 
of fungicides has been shown to inhibit aromatase in vitro . Other fungicides are also 
EDs, for example, vinclozolin is a potent anti-androgen in vivo  and in vitro , which is 
thought to be due to it’s metabolites  , and mancozeb inhibited spermatogenesis in 
mice , and rats . In addition,  mancozeb affected the thyroid system and increased the 
weight of the thyroid gland in hemicastrated rats  ,  and inhibited the iodide pump 
essential for the production of T4 . It  also inhibited cortisol secretion in Xenopus 
adrenocortical cells in vitro . However, these fungicides were not present in the UK 
(Table 1.5). 
1.5.4 Nitrate
There  is  some evidence  that  nitrate  could  have  an endocrine  disrupting effect  on 
steroidogenesis  in  rats,  and  possibly  in  alligators.  Panesar   reported  that  nitrate 
inhibited  gonadotropin-stimulated  steroidogenesis  in  mouse  leydig  tumour  cells, 
possibly  via  conversion  to  nitric  oxide  and  consequent  inhibition  of  intracellular 
cyclic adenosine monophosphate or inhibition of cytochrome P-450 enzymes. Panesar 
&  Chan   also  demonstrated  that  nitrite  and,  to  a  lesser  degree  nitrate,  inhibited 
androgen steroidogenesis,  resulting  in  decreased  testosterone  production  in  mouse 
leydig tumour cells (LOEC’s: 5 mM & 40 mM). The same authors also exposed rats 
to  nitrate  and  nitrite  to  50  mg/L  in  drinking  water  (as  sodium nitrite  or  sodium 
nitrate), which caused a reduction in circulating corticosterone and testosterone levels; 
and concluded that the possible mechanism of action was via inhibition of cytochrome 
P-450 enzymes. There is also circumstantial evidence that nitrate causes a decrease in 
testosterone concentration in alligators, as a strong negative correlation was found 
between these two variables,  where pesticide contamination was minimal  .  Where 
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nitrate concentrations in lake water exceeded 10 mg/L, testosterone levels in juvenile 
alligators fell by 50%, and they were also reported to have smaller penises (Louis 
Guillette, pers. comm.). Further to this investigation, Guillete & Edwards  reported 
that increased nitrate concentrations (up to 5 mg/L) were correlated with decreased 
sperm  counts  and  increased  teste  weight  in  mosquitofish  collected  from  nitrate-
contaminated springs.
1.5.5 Mixtures
Mixtures are more environmentally relevant than single chemicals, but are not useful 
in determining the mechanism of action of individual chemicals, as it is not possible 
to attribute an effect to a specific compound. In addition, making a ‘typical’ mixture 
that is representative of the agricultural environment is difficult, as compounds and 
concentrations in the environment will  differ greatly depending on meteorological, 
geological, and geographical factors, as well as the crop type. This is different from 
riverine environments, where sewage effluent and industrial effluent discharge a fairly 
well known composition of compounds in the environment, and in the case of sewage 
treatment works, this discharge is also fairly constant. Typical estrogenic compounds 
from these pollution sources include EE2, bisphenol-A, and alkylphenols, which have 
been well studied both singly , and to a lesser extent in mixtures . These estrogenic 
compounds are generally accepted to act in an additive manner, whereby exposure to 
a mixture containing a concentration of each compound that did not have an effect, 
causes an effect when combined . Sumpter et al.  successfully modeled the effects of 
mixtures of estrogens on fish in a riverine environment, however, effects of mixtures 
of agrochemicals are more complex to predict. This is partly because, unlike synthetic 
estrogens, which function by stimulating the estrogen receptor, agrochemicals have 
diverse modes of action (Table 1.5), and partly because less is known about their 
individual ED effects.
1.5.5.1 Laboratory
In amphibians, mixture studies have mainly focused on thyroid and growth endpoints, 
such as time to, and size at, metamorphosis. Hayes  et al.  reported that mixtures of 
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agrochemicals  had  a  more  pronounced  effect  on  amphibian  time  and  size  at 
metamorphosis than any compound alone, indicating an additive effect. Sullivan & 
Spence , and Allran & Karasov  analysed the mixture effect of atrazine and nitrate on 
growth parameters and metamorphosis  Xenopus laevis, but no effect was observed. 
However, Orton et al.  reported a mixture effect of altered gonadal development and 
sex ratios in Rana pipiens exposed to the same compounds at similar concentrations. 
In addition, Gray et al.  reported that vinclozolin and procymidone acted additively in 
the Hershberger assay, and Birkoj et al.  reported that a combination of deltamethrin, 
methiocarb, prochloraz, simazine, and tribenuron-methyl were anti-androgenic in rats, 
where  no  effects  were  observed  with  the  single  compounds  at  the  same  doses; 
suggesting an additive effect. 
1.5.5.2 Field
Field  studies  in  agricultural  areas  have  also  attempted  to  describe  the  endocrine 
disrupting effects of agrochemicals, though in the absence of chemical analysis, it is 
not  known if  agrochemicals  indeed caused  reported  effects.  In  a  series  of  papers 
Guillette  and  co-workers  reported  that  alligators  from  a  contaminated  site  had 
abnormally  small  phalli,  skewed  sex  hormone  ratios  (estrogen:testosterone),  and 
males had reduced testosterone concentrations . The authors related these parameters 
to a pesticide spill containing the organochlorines dicofol and DDT (both congeners) 
in the contaminated lake, although agricultural land also bordered the lake. Further 
research  indicated  that  these  effects  may  have  been  caused  by  altered  hepatic 
biotransformation  enzyme  activity,  which  was  observed  in  alligators  from  the 
contaminated lake compared to the reference site. Particularly, activity was sexually 
dimorphic in the reference site, but this dimorphism was lost in individuals from the 
contaminated sites . However, although hepatic enzyme activity was reduced in the 
contaminated lakes, this was not correlated with plasma sex steroid levels , suggesting 
it may not be a good measure of perturbation to hormone levels. In a distinct water 
catchment, the impact of agricultural activity was assessed to determine if the effects 
observed  previously  were  site-specific.  Similar  effects  were  observed,  whereby 
female alligators from the most contaminated site had reduced plasma testosterone 
and estradiol, and males from this site had smaller phallus size , indicating the effects 
may  be  related  to  agrochemicals.  There  is  very  little  comparative  research  using 
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amphibians, however, Fort  et al.  reported that exposure of  Xenopus laevis to pond 
water  and sediment  extracts  from reference and polluted ponds caused a  delay in 
metamorphosis.
1.6 Conclusion
It is clear that there has been a decline in populations of the common frog and toad in 
the U.K. over the past hundred years, and that in some parts of the country this decline 
is  continuing,  especially  in  the  case  of  toads.  Habitat modification  is  the  most 
obvious, and indeed the most important, cause of population decline up to the present, 
however, agrochemicals may also play a significant role. The extent to which decline 
is related to agrochemical usage is unknown, and this is exacerbated by the lack of 
knowledge of ED effects of currently used pesticides in the U.K. Most of the reported 
data on the ED effects of pesticides are from mammalian cell lines, and are focused 
on  the  ability  of  a  single  compound,  which  is  often  not  relevant  to  the  U.K. 
environment,  to  stimulate  hormone  receptors.  Considering  that  many  pesticides 
function by inhibiting active processes, such as electron transport or enzyme activity, 
these  routes  of  ED  are  underrepresented  in  the  literature.  For  example,  most 
organochlorines act by antagonism of the GABA receptor, and many have receptor 
mediated  effects  in  test  systems  ,  whereas  OPs  and carbamates  act  by  inhibiting 
acetylcholinesterase,  and  are  less  active  at  the  receptor   but  inhibit  enzymes  .  In 
addition,  at  present  there  are  no  standardised  tests  using  an amphibian  model  for 
testing endocrine disruption, and therefore there is a need for rapid and cost-effective 
screening tools to detect and characterise EDs in relation to amphibians.  Standardised 
in  vitro  and  in  vivo tests  are  generally  of  mammalian  origin  and  have  limited 
applicability  to  amphibians.  One exception  to  this  is  the  Xenopus Metamorphosis 
Assay (XEMA), which is currently undergoing standardisation and validation . The 
U.K.  is  in  a  unique  situation  concerning  long-term  qualitative  population  data, 
however, since 1990 UK herpetological research has all but disappeared (excluding 
the work by Beebee). Therefore, the aim of this study was to assess whether there is 
evidence  for  alterations  in  thyroid function  and reproductive parameters  in  native 
amphibian populations, specifically in relation to agrochemicals. The objectives were:
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1. To use  in vitro tests and population data for selection of sites with varying 
levels of agrochemical input, and to compare development of caged and wild-
caught  tadpoles/metamorphs  from  these  sites  to  their  laboratory-reared 
counterparts. Measured endpoints included morphometric parameters, thyroid 
and gonad histology.
2. To  develop  and  validate  amphibian  bioassays  to  better  estimate  risk  of 
compounds to amphibians. The bioassays that were developed (with varying 
success)  were:  Hepatocyte  culture  and  VTG  induction  to  test  for  (anti-) 
estrogens;  germinal  vesicle  breakdown  assay  (GVBD)  for  testing  (anti-) 
androgens;  use  of  a  transgenic  tadpole  to  test  for  (anti-)  thyroids;  oocyte 
ovulation to test for inhibition/stimulation of steroidogenesis. These bioassays 
were used to  detect  ED activity  of  water extracts  from selected sites,  and 
environmentally relevant pesticides.
Chapter 2
Endocrine Disruption in Native 
Amphibians
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2.1 Overview
Feminisation of fish caused by sewage effluent in rivers , and imposex caused by TBT 
in molluscs , are well characterised examples of ED in the environment. Amphibians 
typically inhabit agricultural environments, and although pesticides are often shown to 
have EDg activity in laboratory exposures (see Chapter 1, section 1.5), evidence of 
ED in environmentally exposed individuals is less well defined. Pesticides have been 
associated  with  tadpole  abnormalities  in  caged  studies  ,  and  declining  amphibian 
populations  have  been  associated  with  decreased  cholinesterase  activity  and 
increasing concentrations of organophosphates . In addition, Fellers  et al.  reported 
higher concentrations of DDE, γ-chlordane, and trans-nonachlor in whole frog tissues 
from  a  declining  population  than  a  stable  population,  and  associated  this  to 
agrochemical spray drift. Similarly, Davidson & Knapp  reported that spray drifts of 
pesticides were instrumental in decline of Rana muscosa, and had a more significant 
contribution than the presence of fish in ponds. Although these studies demonstrate a 
probable  link  between  amphibian  population  declines  and  pesticides,  they  do  not 
specifically  indicate  evidence  of  ED.  Reeder  et  al.   addressed  this  question  by 
histological analysis of gonads of Cricket frogs (Acris crepitans) in Illinois (USA). 
Firstly (1998), a significant correlation between levels of polychlorinated biphenyls 
(PCBs) and polychlorinated dibenzofurans with incidence of intersex was reported, 
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and this correlation also approached significance with concentrations of atrazine (p = 
0.07). Secondly (2005), using historical specimens over the 1830-2001, incidence of 
intersex was shown to increase during the period of industrial growth (1930-1945), 
was highest during the period of industrialisation and use of organochlorines (1946-
1959), and decreased when sales of DDT were restricted (1960-1979). In addition, the 
incidence was highest in urban industrialised areas, intermediate in agricultural areas, 
and lowest in non-agricultural/industrial areas, indicating that industrial contaminants 
are  stronger  inducers  of  intersexuality  than agrochemicals;  but  that  both probably 
contributed to the effects observed. In reptiles, Guillette et al.  reported small phalli, 
skewed  sex  hormone  ratios,  and  reduced  testosterone  concentrations  in  males 
collected from a lake contaminated with a pesticide spill (organochlorines), compared 
to those collected from a reference site (see Chapter 1, section 1.5.5.2 for details). In 
addition to  in situ  experimental  designs,  another approach to assessing ED in the 
environment is to use water extracts in in vitro or short-term in vivo screens. Although 
environmental  samples  from  agricultural  sites  have  been  analysed  for  pesticide 
residues , and for toxicity to amphibians , there is a lack of published research on the 
endocrine  effects  of  agricultural  extracts.  To  the  authors  knowledge,  endocrine 
endpoints have been assessed only once , whereby pond extracts inhibited the thyroid 
axis (observed as tail resorption inhibition), although the proximity of these ponds to 
agricultural land was not reported. 
The field work component of this project was designed to investigate the evidence for 
ED in native amphibians in the U.K. agricultural environment. Water sampling was 
carried out over two breeding seasons (July 2004 and April-June 2005), and animal 
specimens were collected in the third breeding season (April-August 2006). During 
the first breeding season, due to limited time available (the present project began in 
March 2004), a water sample from only one location was taken and processed by 
solid-phase  extraction.  Training  in  two  amphibian  ED  bioassays  (hepatocyte 
monolayer  and  transgenic  assay),  was  completed  using  this  sample  as  the  test 
substrate. In the second breeding season, water samples were collected by passive 
accumulation devices (PADs), but due to unforeseen problems with the amphibian 
bioassays,  were  instead  tested  for  ED  activity  using  the  yeast  estrogen/androgen 
screens (Routledge  et al.  1996,  Sohoni  and Sumpter,  1998).  In  the third breeding 
season,  toads  were  sampled  from  selected  sites  across  England  and  Wales,  and 
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compared morphologically and histologically to their laboratory-reared counterparts. 
Water  samples  were  also  collected  from  these  sites  with  PADs,  however,  these 
samples were not available for testing. 
2.2 Breeding Season One
2.2.1 Introduction
The selected site was situated in a drainage ditch in the fens in East Anglia, due to the 
high agricultural intensity in this area and the presence of toad populations (Arnold 
Cooke,  pers.  comm.).  A  site  situated  in  fenland  was  also  chosen  because  of  its 
topography,  as  the water  bodies  consist  of  a  network of  irrigation ditches (where 
amphibians  breed),  and  thus  broadly  similar  water  pesticide  profiles  could  be 
expected across this region. Water was extracted by solid-phase extraction with C18 
and OASIS cartridges. The former extracts more lipophilic compounds, whereas the 
latter extract hydrophilic compounds and intermediate compounds, although there is 
also  overlap  between the  cartridges  .  Extraction  of  water  samples  by  solid-phase 
extraction is a validated technique and has been used previously, both in laboratory 
and in field samples . In the present study, both extracted samples (C18 and OASIS) 
were tested  in  two amphibian bioassays:  the  hepatocyte  monolayer  for  estrogenic 
activity, and the transgenic tadpole assay for thyroidal activity (in association with 
Towa-Kagaku, Japan).
2.2.1.1 Hepatocyte Monolayer
The hepatocyte monolayer assay is based on the production of vitellogenin (VTG) in 
response  to  stimulation  of  hepatic  ERs  by  estrogenic  compounds.  VTG  is  a 
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phospholipoglycoprotein egg-yolk precursor protein and is secreted by the liver of 
mature  females  in  oviparous  vertebrates.  Following  secretion,  it  enters  the 
bloodstream and is incorporated into oocytes as yolk, and thus causes growth and 
development of the ovarian follicle; a process called vitellogenesis. Synthesis of VTG 
occurs naturally in females in  response to  circulating estrogens,  but  this  does not 
occur naturally in males, due to the low circulating levels of endogenous estrogens in 
the bloodstream. However,  males can be induced to produce VTG in response to 
exogenous estrogen stimulation, and therefore it is a useful biomarker of estrogenic 
exposure in males . In addition, the in vitro response can be indicative of the in vivo 
effect (Jones et al., 2000), and due to the large range in potential VTG concentrations 
produced by the liver, VTG induction is a useful bioassay for samples with unknown 
estrogenicity (Sumpter and Jobling, 1995). Hepatocyte culture has been found to be 
relatively insensitive to estradiol compared with human cell lines, and yeast based 
assays (Jones  et al., 2000). However, liver cells have the advantage of possessing a 
relatively  complete  set  of  biotransformation  activities  ,  so  the  effects  of  hepatic 
metabolites  are  concurrently  tested  in  vitro,  which  may result  in  a  more  accurate 
prediction of in vivo effects (Smeets et al., 1999). VTG has often been used to assess 
the response of fish to sewage treatment works effluent , and has also been indicated 
in estrogenic pollution in the marine environment in vivo . Fish hepatocyte culture has 
been widely used for testing contaminants including pesticides, for example, DDT , 
dieldrin, and aldrin  induced VTG production in Rainbow trout (Okoumassoun et al., 
2002a) and Channel Catfish (Monteverdi and Di Guilio, 1998) hepatocytes, whereas 
methoxychlor did not .  In addition, the dicarboximide fungicide procymidone was 
estrogenic using rainbow trout hepatocytes . Species-specific differences in the VTG 
response to estrogenic chemicals seem to be marginal in fish (Sumpter and Jobling, 
1995), however, differences in sensitivity between species have been reported. For 
example,  Smeets  et  al.  reported  induction  of  VTG by methoxychlor  using  Carp 
hepatocytes, whereas no effect was observed in Channel Catfish hepatocytes (Schlenk 
et al., 1997), and Monteverdi and Di Giulio (1999) reported different magnitude of 
effects of synthetic estrogens in Channel Catfish hepatocytes compared to Rainbow 
trout.  There are no studies  comparing the VTG response to  estrogens in fish and 
amphibians, and therefore it is unknown if extrapolation between fish and amphibians 
is accurate, however, it is likely that the general effect would be the same (Sumpter 
and Jobling, 1995). VTG, as a biomarker of estrogen exposure, has been used to test 
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synthetic estrogens in Xenopus laevis in vitro, using isolated hepatocytes , and in vivo 
following  intraperitoneal  injection  of  adults  .  Few  studies  have  used  isolated 
amphibian  hepatocytes  for  testing  agricultural  compounds,  but  Rankouhi  et  al. 
reported no estrogenic activity of methoxychlor using Rana temporaria hepatocytes, 
and Lutz and Kloas (1999) reported weak estrogenic activity of DDT using Xenopus 
laevis hepatocytes. In addition, aquatic exposure to toxaphene and dieldrin stimulated 
VTG production in adult  Xenopus alone but not in combination , and injection with 
DDT in adult  Xenopus and Trachemys scripta also stimulated VTG . To the authors 
knowledge, VTG stimulation has only been used once as a biomarker of estrogenicity 
in vivo in relation to agricultural pollution, whereby Okoumassoun  et al.,  reported 
that  VTG was significantly  correlated with organochlorine pesticide  levels  in  fish 
(Tilapia).  In  addition,  Hurter  et  al.  used  liver  slices  from  Xenopus to  test 
environmental samples from sewage effluent, lake water, and dam water. All were 
found to be estrogenic, but it was not reported what types of pollutants the lake and 
dam water were likely to contain.
2.2.1.2 Transgenic Tadpole Assay
In contrast  to estrogenic effects  of compounds,  which are thought to be primarily 
receptor-mediated,  the  thyroid  axis  contains  multiple  possible  sites  of  action,  and 
relatively little is known about the main targets for endocrine disruptors (see Chapter 
1, section 1.4.2). Therefore, in order to test the thyroid system effectively, an in vivo 
experimental  design  was  chosen  in  preference  to  in  vitro tests.  At  present,  the 
‘Xenopus Metamorphosis Assay’ (XEMA) is being validated by the Organisation for 
Economic Co-operation and development (OECD), to be used as a short-term screen 
to test for thyroid disrupting chemicals . In XEMA, Xenopus tadpoles are exposed to a 
water control, a positive control, a negative control, or the test compound, for a period 
of  between  7  and  28  days.  At  the  end  of  the  exposure  period,  thyroid  sensitive 
morphological endpoints, such as developmental stage and hindlimb length (HLL), 
are measured for comparison with the controls (Opitz  et al., 2005). The transgenic 
tadpole assay used here follows a similar experimental design as XEMA. However, 
the test  organism carries a  transgene containing the TRβ gene promoter  sequence 
linked to a green fluorescent protein gene, which results in a visible response when 
the TRβ is stimulated/inhibited by endogenous or exogenous thyroid active substances 
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. It is thought that TRβ plays the prime role in inducing the changes taking place at the 
climax stage of metamorphosis, because the expression level of the gene correlates 
well  with  the  rise  in  the  active  form  of  thyroid  hormone  (T3)  in  blood  during 
metamorphosis . In addition,  Xenopus TRβ gene was shown to contain the thyroid 
responsive element (TRE) in its transcriptional regulatory region and has previously 
been shown to increase expression during premetamorphosis and metamorphic climax 
after  treatment  with T3 (Oofusa  et al.,  2001).  It  was anticipated that by using the 
transgenic tadpole in preference to normal  Xenopus tadpole, it would be possible to 
decrease the exposure time needed and to increase sensitivity of the assay, as gene 
transcription  changes  may  be  detected  before  morphological  changes  occur  .  TH 
stimulates a series of morphological changes that occur during metamorphosis of the 
anuran tadpole to the adult frog . Exposure studies using anurans as the test organism 
often measure thyroid sensitive morphometric endpoints, such as time to metamorphic 
climax  or  forelimb  emergence,  and  hindlimb  length,  as  standard  experimental 
protocol. Coady et al.  and Carr et al.  reported weak inhibition of metamorphosis in 
response to environmentally relevant exposure to atrazine in Xenopus, although Orton 
et al.  and Allran and Karasov  reported no such effect on Rana pipiens larvae. Howe 
et al.  reported that glyphosate based pesticides, such as Roundup ®, increased the 
time  to  metamorphosis  in  Rana  pipiens  tadpoles  at  environmentally  relevant 
concentrations, and Fordham et al.   reported that malathion had the same effect, but 
only at concentrations above 1000 µg/L, which are highly unlikely to be found in the 
environment.  Howard  et al.  reported that carbaryl,  chlorpyrifos,  and imidacloprid 
increased the time to metamorphosis at  0.1 x LC50 in  Pseudacris triseriata, Bufo 
americanus  and  Rana sphenocephala, although the environmental relevance of this 
study is also questionable due to the high concentrations used (imidacloprid: 18450-
46800;  carbaryl:  5158-6317;  chlorpyrifos:  112-132  µg/L).  In  addition,  Fort  et  al. 
reported  that  methoxychlor  delayed  hindlimb  differentiation,  inhibited  rate  of  tail 
resorption, and caused follicular hyperplasia in the thyroid glands of Xenopus tadpoles 
exposed to 0.1 mg/L. In addition, in a mesocosm mixture exposure (methyl mercury, 
atrazine,  monosodium methanearsonate,  & chlorpyrifos),  atrazine  and chlorpyrifos 
concentrations (concentration range: atrazine – 0 to 230 µg/L; chlorpyrifos – 0 to 4.65 
µg/L) were correlated with delayed metamorphosis in Hyla chrysoscelis . In contrast, 
Cheek  et al.  reported decreased time to forelimb emergence in  Xenopus tadpoles 
when exposed to acetochlor and T3, although acetochlor had no effect alone.
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To the author’s knowledge, no field studies with amphibians related to agrochemical 
exposure have been reported. However, in alligators, histological alterations in the 
thyroid gland have been reported from an agriculturally contaminated site compared 
to  a  reference  site  .  The  thyroid  gland  from  individuals  collected  from  the 
contaminated site had increased epithelial cell area and decreased colloid, which are 
both  indicators  of  suppressed  thyroid  gland  activity.  In  addition,  ammonium 
perchlorate (a by-product of explosives) has been shown to retard metamorphosis and 
cause histological abnormalities in laboratory-exposed amphibians ,  and this effect 
was corroborated by effects observed in the field (Theodorakis et al., 2006). 
2.2.2 Methods
2.2.2.1 Water Sampling
The selected  site  in  breeding  season  1  was  Ibberson’s  Pump station  (IP)  in  East 
Anglia  (x,y  coordinates  =  535900,  288000).  Pesticides  detected  in  this  area  in 
2004/2005 were 2,4-D (max: 60 ng/L, percentage of times detected: 14%), atrazine 
(45  ng/L,  86%),  bentazone  (200 ng/L,  14%),  chloropropham (2140 ng/L,  100%), 
dieldrin  (3  ng/L,  4%),  diuron  (1008  ng/L,  100%),  mecoprop  (120  ng/L,  43%), 
simazine (235 ng/L, 100%), and tributyltin (2 ng/L, 6%) (see Appendix 2, pp 288-
297). Water samples were collected from IP in 12 x 2.5 litre amber glass bottles (total 
= 30 litres) on 27th July 2004, and 0.5 % methanol (MeOH: 12.5 ml per bottle) was 
added to each bottle to minimise biodegradation of the sample. At the time of water 
collection  physical  parameters  at  the  test  site  were  also  noted  and  water  quality 
parameters  were  measured  (temperature  (temp),  pH,  dissolved  oxygen  (DO), 
conductivity), at the time of water collection. Bottles were stored overnight at 40C at 
Brunel University. On the following day, samples were filtered with glass microfibre 
filters (GF/F circles 150 mm, Whatman, UK), which have a pore size of 0.7 μm, to 
remove debris prior to solid-phase extraction. The filtered samples were then passed 
through  either  C18 (Waters,  UK),  or  OASIS  (Waters,  UK)  cartridges  (1500  ml 
sample/cartridge (x10) for C18, and 750 ml/cartridge (x20) for OASIS), for a total of 
15 L water sample per cartridge type. Cartridges were primed prior to addition of the 
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sample by passing 5ml of distilled water, followed by methanol, and again by distilled 
water, using a flow rate of 5-10 ml/minute. Pre-filter discs and cartridges were stored 
at -80C until shipment to Towa-Kagaku Company Ltd. (Hiroshima, Japan) on dry ice 
(4 day shipment) in August 2004. The glass microfilters were eluted in methanol, by 
ultrasonic wave (yamato 2510 BRANSON) for 5 min. Cartridges were eluted with 
methanol  (C18 =  30ml/cartridge,  OASIS  =  5ml/cartridge)  using  a  flow  rate  of  ~ 
5ml/minute.  Extracts  from filters  and cartridges were combined for each cartridge 
type (separate samples for C18 and OASIS extracts), and placed in round bottomed 
flasks for evaporation (yamato rotary evaporator RE 440), for approximately 2 hours. 
Samples were further evaporated with nitrogen gas, until they had a volume of 1.5 ml, 
which resulted in x10000 concentration of the original water sample (15 L). Methanol 
(MeOH) stocks were stored at 40C until use in bioassays.
2.2.2.2 Hepatocyte Monolayer
2.2.2.2.1 Culture Media
Culture media used for hepatocyte culture was: 50% Leibovitz L-15 medium (Sigma), 
containing:  1  μg/ml  insulin  (dissolved  in  10  mM  HCl  solution,  Sigma),  10  nM 
dexamethasone  (Sigma),  0.05%  glucose  (Sigma)  and  antibiotics  (50  units/ml  of 
penicillin  and  50  μg/ml  streptomycin).  Collagenase  (Wako  Pure  Chemicals  Co., 
Japan) solutions (0.1 % and 0.06 %) were prepared in perfusion media: 0.55% NaCl, 
0.014% KCl, 1 mM pyruvate, 0.1% glucose, 0.02% NaHCO 3 , 0.5% BSA, 10 mM 
HEPES (pH 7.4). The 0.06% solution was used for in situ liver perfusion, and the 0.1 
% solution was used for incubation of the perfused liver. All media were sterilized by 
filtration prior to use (DURAPORE Membrane Filter, Millipore: 0.22 μm).
2.2.2.2.2 Hepatocyte Culture
To avoid contamination of cell culture by micro-organisms, frogs were cleaned by 
dipping them in 10-20 mg/L KMn2O4 for 1-2 hr, and were anaesthetised by injection 
with  0.5-1  ml  of  20  mg/ml  MS-222.  Hepatocytes  were  isolated  from adult  male 
Xenopus laevis liver according to a one-step perfusion method. The body cavity was 
opened and a needle connected to silicon tubing and a peristaltic pump (MASTER 
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FLEX 6-600 RPM, Cole-Parmer Instrument Co.), was inserted through the heart into 
the hepatic vein. 100-200 ml collagenase solution was perfused through the liver over 
a time span of 5-10 minutes. The partially digested liver was then removed from the 
body cavity, minced with scissors, and incubated in collagenase solution (10-20 ml) at 
25°C for  15-30  min,  whilst  gently  shaking.  Following  incubation,  the  tissue  was 
suspended by glass pipette (large pore size: > 3 mm), and sieved through a sterilized 
nylon mesh (120 μm pore size) to remove structural tissue. The cell suspension was 
centrifuged at 200 rpm (20g) for 2 min, the supernatant was removed by pipette, and 
the cell pellet was re-suspended in media. This step was repeated 3/4 times to ensure 
complete  removal  of  collagenase  solution.  In  some  cases  the  cell  suspension 
contained a dark layer of pigment  cells,  which were removed by gently expelling 
media on to the upper phase of the cells, and then removing the supernatant. The cell 
density was counted and adjusted to a cell  concentration of 1 x 105 cells/ml with 
culture media. On average, 3 x 107 - 5 x 107 hepatocytes were prepared from one 
mature male  Xenopus laevis. The cells were inoculated into 96-well  tissue culture 
plates at a density of 3-4 x 104 cells/well (0.3 ml of the cell suspension for each well), 
and incubated at 220C. On the following day the culture medium was replaced with 
fresh culture medium, 0.2 ml was removed from each well and replaced with 0.2 ml 
of fresh medium, and this was repeated twice. The cells are cultured for 2/3 days to 
allow growth of cells on the substratum of the plates, and to thereby form a monolayer 
(Figure 2.1). In some cases the cells did not extend on the substratum after 3 days, and 
were  therefore  discarded.  In  situ  liver  perfusion  with  collagenase  results  in 
hepatocytes that are structurally intact, and they retain many of their normal  in vivo 
characteristics, such as the ability to consume or produce glucose, respond to a variety 
of hormones, and synthesise lipids, RNA and protein .
1 2 3
45
Figure 2.1. Isolated  Xenopus hepatocytes on day 1 (1), day 3 (2), and day 6 (3) of 
culture,  showing recovery  of  cells  (1,2),  and  formation of  a  monolayer  (3).  x200 
magnification (courtesy of N.Mitsui, Towa-Kagaku, Japan).
2.2.2.2.3 Exposure to Test Compounds 
The cell culture media were replaced with fresh media (0.2 ml removed, 0.2 ml added, 
0.2 ml removed) to remove metabolic by-products of cell respiration and replenish 
nutrients,  prior  to  the  start  of  exposure.  50  μl  of  fresh  medium was  then  added, 
resulting in a total of 150 μl in the wells. Hepatocytes were exposed to media only, a 
solvent control, estradiol (positive control), or a water extract, by addition of 150 μl of 
test media (a 2-fold dilution). Final concentrations of E2 in the positive control wells 
were: 1.11, 0.37, 0.11, and 0.037 nM, and each well also contained 0.01% methanol 
(MeOH). Final concentrations of extracts were: 0.25, 0.5, 1, 2.5, 5, and 10-fold of the 
original water sample. Due to serial dilution of the sample extracts in media, MeOH 
concentrations in these wells ranged from 0.1 – 0.0025, and therefore, 0.1, 0.05, and 
0.025 % MeOH were used as additional solvent controls. The cells were exposed to 
these concentrations twice over the 8 day incubation period. The first exposure was at 
2/3 days  after  inoculation  (depending on  cell  recovery),  and the second exposure 
occurred 3 days after the first exposure. The test media were removed 3 days after the 
second exposure for analysis of vitellogenin and albumin concentrations by ELISA. 
Each sample and controls were tested in triplicate wells, and this experimental design 
was also repeated a total of 3 times.
 
2.2.2.2.4 ELISA Analysis
After 6 days of exposure, 0.2 ml of the culture media was removed and added to 96-
well  microtiter  plates  for  dilution.  Test  media  from the  1.1  and 0.3 nM estradiol 
exposure medias were diluted 10-fold, and 0.1 and 0.03 nM estradiol exposure media 
was  diluted  2-fold,  with  sample  diluent  solution  from the  ELISA  kit  (phosphate 
buffered saline, PBS). Concentration of VTG in culture media was measured using a 
sandwich ELISA for VTG (kindly donated by Japan Envirochemicals), and according 
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to the manual of the VTG-ELISA kit. Briefly, samples were added to plates that had 
been pre-coated with VTG antibody, followed by addition of the second antibody, and 
a colometric reagent . Albumin (ALB) levels were also measured using a sandwich 
ELISA, and were used to verify cell viability. The remaining diluted media samples 
were further diluted by 5-fold or 25-fold to achieve a total of a 50-fold dilution for use 
in the ALB ELISA (previously diluted either 10-fold or 2-fold for VTG analysis). For 
the ALB ELISA, 96-well microtitre plates (MaxisorpII, Nunc) were coated with 50 µl 
of  5  μg/ml  solution  (in  PBS:  Phosphate  Buffered  Saline)  per  well  of  albumin 
antibody, covered, and incubated at 40C overnight. Following incubation, wells were 
washed 3 times with 0.1% Tween 20-containing PBS (tPBS), and excess liquid was 
removed  by  tapping  onto  paper  towel.  This  washing  step  was  repeated  prior  to 
addition of each component, and plates were incubated for 1 hour at room temperature 
after addition of each component. Addition to reagents to wells were as follows: 300 
μl of blocking reagent (0.5% Blockace in tPBS); 50 μl of standard albumin antigen or 
sample;  50  µl  of  the  second  antibody  (HRP-labelled);  100  μl  of  the  chromogen 
(TMBZ) in TMBZ buffer (Japan Envirochemicals Ltd., Japan); 100 μl of 1M H2SO4 
solution. Absorbance readings were determined with a spectrophotometer (Muliskan 
JX, Thermo labsystems) at 450 and 600 nm.
2.2.2.3 Transgenic Assay
2.2.2.3.1 Tadpoles
Spawning  of  transgenic  Xenopus  laevis was  induced  by  injection  with  human 
chorionic gonadotropin (HCG). Eggs and tadpoles were maintained at 22 ± 1 0C, pH 
7.4 ± 0.3, and dissolved oxygen (DO)  7.3 ± 0.5, and a 12:12 hour light:dark cycle, 
prior  to  and  during  exposure.  During  the  pre-exposure  period,  a  complete  water 
change was performed every 48 hours, and tadpoles were fed Sera Micron ad libitum 
(Sera GmbH, Heinsberg, Germany). These tadpoles were of variable fluorescence and 
on the day before exposure tadpoles were separated into groups according to their 
fluorescence and stage, using a fluorescence dissecting microscope (MZ FLIII, Leica). 
Categories for fluorescence were --, -+, or ++, and only ++ tadpoles (see Figure 2.2) 
of Gosner stage 51/52  were selected for the exposure experiments. Stage 52 was 
chosen  as  the  starting  stage  as  low  but  increasing  levels  of  endogenous  thyroid 
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hormone are present at this stage , and therefore it was anticipated that this would 
allow  identification  of  both  antagonistic  (suppression  of  fluorescence  relative  to 
controls) and agonistic effects (increase in fluorescence relative to controls).
Figure 2.2 Transgenic Xenopus tadpoles.
2.2.2.3.2 Experimental Design
The  day  after  tadpole  selection,  80  tadpoles  were  placed  in  individual  glass 
containers, and total length, hindlimb length, and fluorescence were measured before 
being randomly assigned to tanks. No significant differences in these parameters were 
observed between tanks at this stage (ANOVA p > 0.05). Larvae were reared in aged 
tap water only, or containing: 0.01% methanol (methanol control), thyroxine (T4, 2 
µg/L), propylthiouracil (PTU, 20 mg/L), or C18/OASIS extracts (0.25, 0.5, or 1-fold of 
original water concentration), for 10 days. Two replicate tanks containing 4 L were 
used  per  treatment,  and  three  larvae  were  placed  in  each  tank.  Water  quality 
parameters (temperature, pH, and DO) were measured daily prior to feeding. Total 
length, HLL, stage, and fluorescence were measured prior to exposure, and on days 5, 
and 10. On days 5 and 10, tadpoles were removed carefully with a net and placed in 
individual glass containers. Total length was measured with callipers, and the other 
parameters were measured by taking photographs (Leica DC 200 camera), both with 
and without the fluorescence filter on the microscope (MZ FLII, Leica). Photographs 
were  analysed  with  Image-Pro  plus  (version  4).  Weight  was  also  measured  after 
euthanisation  on  day  10,  to  observe  if  the  tadpoles  had  normal  growth  over  the 
exposure period. During the first 5 days of exposure, 100 mg/tadpole Sera Micron 
(Sera GmbH, Heinsberg, Germany) was added to the tanks daily, and after day 5 this 
was increased to 150 mg/tadpole. A 100% water change was performed on day 5 of 
exposure after the tadpoles had been removed for measurements, and tadpoles were 
then returned to their respective tanks. 
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2.2.2.3.3. Calculations
The dissolved oxygen was measured twice with a 1 minute interval and the average of 
these two measurements was reported. The fluorescence density was measured and 
this number was divided by the total amount of pixels in the photograph to obtain the 
‘fluorescence/pixel’, this was to normalise data as photographs were mistakenly taken 
at different pixel densities.
2.2.2.3.4 Statistics
Data were normally distributed therefore, differences between conditions were tested 
using ANOVA, and differences between pairs were tested using the student’s t-test.
2.2.3 Results
2.2.3.1 Hepatocyte Monolayer
The addition of E2 induced VTG production in a dose dependant manner up to 0.37 
nM, and each well contained the same amount of viable cells, as measured by ALB 
production (Figure 2.3, A). In addition, MeOH had no effect on VTG production, and 
good replication between plates was also observed (Figure 2.3, B).
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Figure 2.3. Effects of E2 (Panel A) and MeOH (Panel B) on vitellogenin (VTG) and 
albumin (ALB) production by cultured Xenopus hepatocytes. Values are means ± SE 
based on triplicate wells.
Exposure  of  cultured  hepatocytes  to  both  C18 and  OASIS  extracts  significantly 
increased VTG production in a dose dependant manner at 2.5-fold, 5-fold, and 10-fold 
concentrations of the original water sample (ANOVA P < 0.01). The OASIS extract 
also  induced  higher  VTG  production  than  the  C18 extract,  but  only  at  10-fold 
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concentration of the extract (t-test P = 0.02). In addition, there was the same number 
of viable cells in each well, as measured by albumin production (Figure 2.4).
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Figure 2.4. The effect of water sample extracts (Oasis or C18) obtained from IP, on 
vitellogenin (VTG) and albumin (ALB) production of cultured Xenopus hepatocytes. 
Cells were exposed to 0.25, 0.5, 1, 2.5, 5, and 10-fold of the original water sample, or 
media only (control). Values are means ± SE based on triplicate wells, and over 3 
separate plates. * denotes significant difference from control.
2.2.3.2 Transgenic Tadpole Assay
A total of 10 % mortality was observed over all tanks, and within treatments it was 
highest in control and PTU treatments (22 %), followed by MeOH, 0.5-fold Oasis, 
0.25-fold  C18,  and  T4 (11  %),  mortality  was  not  observed  in  other  conditions. 
Significant differences between conditions was not observed in total body length over 
the experimental period (days 0, 5, & 20), or weight at day 10 (average weight over 
all treatments 198.9 ± 6.9, ANOVA p > 0.05). T4 treatment significantly increased the 
stage of tadpoles at day 10 compared to all other treatments (t-test  p  < 0.01, Figure 
2.5).  HLL  and  fluorescence  were  increased  in  the  T4 treated  tadpoles  at  day  5, 
compared to all treatments (t-test  p  < 0.05), except the OASIS 0.5-fold (t-test  p  > 
0.22). At day 10 the HLL and fluorescence were increased compared to all treatments 
(t-test  p < 0.026,  Figure 2.6).  HLL and fluorescence  response  was  similar  across 
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treatments, and no significant difference between these parameters was observed at 
day 5 or 10 (t-test p > 0.05).
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Figure 2.5 – Stage measured over the 10 day exposure period. Tadpoles were exposed 
to aged tap water (control) MeOH (0.01 %), or 0.25, 0.5, or 1-fold concentration of 
either Oasis or C18 water extracts (in MeOH). * denotes significant difference of T4 
treated tadpoles compared to all other treatments. Values are mean ± SE, n = 6, 5 or 4 
(depending on mortality). 
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Figure 2.6 – Hindlimb length (Panel A) and fluorescence (Panel B) measured over the 
10 day exposure period.  Tadpoles were exposed to aged tap water only (control), 
MeOH (0.01 %), or 0.25, 0.5, or 1-fold concentration of either Oasis or C18 water 
extracts (in MEOH). * denotes significant difference of T4 tadpoles compared to all 
other  treatments.  *1 denotes  significant  difference  of  T4 tadpoles  compared  to  all 
treatments except Oasis 0.5-fold. Values are mean ± SE, n = 6, 5 or 4 (depending on 
mortality).
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2.2.4 Discussion
2.2.4.1 Hepatocyte Monolayer
Estrogenic  activity  was  observed  in  response  to  the  extracts  at  ≥  2.5-fold 
concentration  of  the  original  water  sample.  During  the  extraction  process  it  is 
probable that  the nature of the water  sample changed to  some degree,  potentially 
including the breakdown of estrogenic compounds . Therefore, activity observed at 
the  lower  concentrations  (2.5  and  5-fold)  indicate  that  amphibians  at  IP  may  be 
exposed  to  estrogenic  compounds.  Although  various  organochlorines  ,  and  the 
fungicide  procymidone  ,  have  been  shown  to  induce  VTG  production,  these 
compounds  are  not  prevalent  in  the  UK  (see  Appendix  1). However, 
pentachlorophenol (PCP), which is found more often in the U.K., has been shown to 
upregulate vitellogenin production in fish hepatocytes in vitro  and in vivo . However, 
it was not detected in this area (Appendix 2 pp 288-297). Atrazine (max: 28 ng/L), 
simazine (max: 235 ng/L), mecoprop (max: 120 ng/L),  dieldrin (max: 3 ng/L), diuron 
(max:  1008 ng/L) were detected in this  area,  however,  these pesticides have been 
reported not to interact with the estrogen receptor  . To the author’s knowledge, the 
receptor mediated effects of other pesticides found in this area (2,4-D (max: 60 ng/L), 
chloropropham  (max:  2140 ng/L),  tributyltin  (max:  2  ng/L))  are  not  known.  The 
sample extract contained a mixture of compounds,  resulting in estrogenic activity, 
however, the identities of these compounds are unknown. Reports on the interaction 
of pesticide mixtures at the estrogen receptor have focused on pesticides that are not 
present in the UK environment . However, the most commonly reported interaction of 
pesticides was of an additive effect, and pesticide mixtures have also been reported to 
act additively in amphibian growth and development . Therefore, although the nature 
of the mixture is unknown, and pesticides detected in this area are not reported to 
interact with the estrogen receptor (or have not been tested), additive effects may have 
contributed to estrogenic activity observed. In addition to pesticides, the samples may 
have contained natural and/or synthetic estrogens from sewage effluent or manure 
fertiliser. The nearest sewage treatment plant to IP was located approximately 20 km 
away, and due to the topography of the fens (connected irrigation ditches), may have 
contributed to the estrogenic activity observed in the sample. 
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 Despite lack of chemical analysis of the extract, the hepatocyte monolayer assay has 
proved useful for detecting estrogenic activity of aquatic agricultural samples. There 
is  generally  a  good  correlation  between  in  vitro and  in  vivo measures  of  VTG 
induction in response to a wide range of contaminants, and therefore  in vitro VTG 
production is considered to be a reliable endpoint to predict effects in vivo (Jones et 
al., 2000). However, it is not known how increased VTG levels could affect the health 
of individuals or populations. In females, the possible effects range from healthier 
offspring, due to increased resources in the early stages of life, to less healthy adults, 
due to rapid use of energy stores .  In males, it  is not known if VTG induction is 
associated with feminisation or lowered fecundity, although elevated VTG levels in 
the plasma have been associated with intersexuality in wild roach , and intersex fish 
have been reported to have reduced fertility .
2.2.4.2 Transgenic Tadpole Assay
None of the treatments affected mortality or total length, indicating there were not 
treatment-specific effects on tadpole growth. T4 stimulated all of the thyroid sensitive 
endpoints  measured,  but  neither  PTU nor  the  water  extracts  had  any  effect.  The 
weight and developmental stage of tadpoles after 10 days was decreased compared to 
normal  Xenopus development (O. Tooi pers. comm.,  Opitz  et al.,  2005).  After 10 
days, it could be expected that tadpoles in the control water would have reached stage 
56/57, and have a weight of approximately 500 mg, however, in this experiment, they 
only reached stage 54, and had an average weight of 198 mg. It is unknown why the 
tadpoles had retarded growth and development.  Previous experiments in the same 
laboratory reported a significant inhibition of development when exposed to the same 
concentration of PTU for 7 and 14 days (O. Tooi pers. comm.). Perhaps the lack of 
effect of PTU was due to adverse experimental conditions, such as food shortage or 
poor  water  quality,  which  affected  the  overall  growth  and  development  of  the 
tadpoles. Indeed, there was a total of 10% mortality across all groups in the 10 day 
exposure period, which is relatively high for  Xenopus laevis . The lack of effect of 
PTU  may  have  been  caused  by  this  slow  development  as  at  stage  52  very  low 
endogenous thyroid hormone is detected in the developing tadpole, and it isn’t until 
stage 54/55 that thyroid hormone levels begin to increase substantially (Opitz  et al., 
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2005). Therefore, perhaps the circulating levels of endogenous T4 were too low for 
PTU  (or  the  water  samples)  to  have  an  observable  antagonistic  effect  over  the 
exposure period.  
It was anticipated that fluorescence would be a more sensitive endpoint for detection 
of perturbation to the thyroid system, than HLL, but this was not found to be the case. 
Fluorescence  was  measured  by  fluorescence  density  of  the  selected  area,  and 
therefore, confounding factors such as shadow or melanocytes may have altered the 
results.  This  problem  was  exacerbated  by  the  method  of  selecting  the  area  for 
fluorescence measurement  using a  computer  mouse,  leading to  possible  erroneous 
selection of areas of shadow at the edge of the hindlimb. Therefore, it is possible that 
a  dark  area  of  shadow  or  melanocyte  could  considerably  affect  the  fluorescence 
density measured. Modifications to the method used for measuring fluorescence may 
sufficiently reduce confounding effects of shadows and melanocytes. For example, 
the tadpole will fluoresce for some time after euthanisation, and therefore it would be 
possible  to  measure  fluorescence  in  homogenised  tissue  at  the  end  of  exposure. 
However, as optimisation of this assay was beyond the scope of the present study, and 
there was no indication that fluorescence would prove to be more sensitive than HLL, 
this assay was not used again.
2.3 Breeding Season Two
2.3.1 Introduction
The aim of the field work undertaken during breeding season two was to identify 
agricultural water bodies in England and Wales with toad (Bufo bufo) populations and 
endocrine disrupting activity. Sites were selected based on estimated agrochemical 
input, and presence of toad populations. It was important that sites had reported toad 
populations,  as  a  subsample  of  sites  were  selected  for  toad  sampling  in  breeding 
season  three.  Water  extracts  were  obtained  from  selected  sites  by  passive 
accumulation devices (PADs), rather than the grab sampling method used in breeding 
season one, resulting in time-integrated extracts (see section 2.3.1.1). These extracts 
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were then tested for (anti-) estrogenic and (anti-) androgenic activity using the yeast 
estrogen/androgen screens. 
2.3.1.1 Passive Accumulation Devices (PADs)
Measuring pesticide levels in the aquatic environment by time-integrated sampling 
methods overcame the risk of missing episodic contamination due to storm events and 
pesticide run-off . Sediment, biota, and PADs have been used to measure pesticide 
levels, and there are problems associated with each method. Using sediment samples, 
it  is  impossible  to  assess  the  influence  of  factors  such  as  sediment 
bioturbation/resuspension events,  sediment  sorbent  quality,  and degradation rates  . 
Using biota will give the most accurate prediction of what the animal is being exposed 
to in situ, as the influence of depuration and uptake rates, and uptake through diet, are 
all incorporated . However, mortality may occur and uptake and depuration rates may 
be influenced by the condition of the animal. Most importantly for the present study, 
PAD  deployment  produces  an  extracted  sample  that  can  be  used  for  testing  in 
laboratory bioassays, as well as for chemical analysis. Grab-samples can also be used 
to obtain extracted samples, however, there are practical considerations of collecting 
and extracting large volumes of water for use in bioassays. In addition, grab-sampling 
does  not  distinguish  between  bioavailable  and  non-bioavailable  fractions  of  the 
sample (Kot  et al.,  2000), whereas PADs, comprised of a porous membrane filled 
with sequestration media, are designed to mimic the parts of animals that are involved 
in uptake and bioconcentration (e.g. gills and lipid).
The semipermeable membrane device (SPMD) is one of the most widely used PADs 
and consists of a thin film of high purity triolein (1,2,3-tri-[cis-9-octacenoyl]glycerol), 
sealed inside a layflat, thin-walled tube of nonporous, low density polyethylene. The 
diameters of the transient cavities in the tubing are about 10 Å, preventing uptake of 
contaminant molecules associated with dissolved organic matter or particulates , and 
thereby allowing only  bioavailable  compounds to  be  sequestered  .  Huckins  et  al. 
developed  the  SPMD,  and  found  similar  uptake  rates  of  purified  Grass  Carp 
(Ctenopharyngodon  idella)  lipid  and  the  synthetic  lipid  triolein,  although  triolein 
sequestered higher concentrations. The mass of an analyte sequestered by the SPMD 
is affected by: The concentration of compound in water, although this does not affect 
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the uptake rate; temperature of the water (higher temperature results in faster uptake 
rates); duration of exposure; biofouling of the membrane; and most importantly, the 
log  Kow  of  the  compound  (Kot  et  al.,  2000).  SPMDs  sequester  non-ionic 
hydrophobic compounds with a log Kow > 3. A linear relationship between uptake 
rate  and  log  Kow  was  reported  for  selected  classes  of  compounds,  such  as 
organochlorines and PCBs, with a log Kow between 3-6 . A decrease in sequestration 
rates was observed for compounds with log Kow values > 6, which is similar to the 
pattern observed in bioconcentration rates in fish . Indeed, studies comparing uptake 
rate of PCBs and PAHs by SPMDs and biota reported similar sequestration profiles 
across  a  range  of  compounds,  although  SPMDs  generally  sequestered  higher 
concentrations than biota .  Other classes of pesticides that have been shown to be 
sequestered  by  SPMDs  include  hydrophobic  pyrethroids  ,  hydrophobic 
organophosphates , and others . Uptake rates of compounds with log Kow’s of < 3, 
which  includes  many  pesticides,  have  rarely  been  tested,  and  thus  are  not  well 
defined.  Wang  et  al.  reported  a  similar  pattern  of  sequestration  of  relatively 
hydrophilic  compounds  to  more  hydrophobic  compounds,  whereby  SPMDs 
sequestered nitroaromatics with log Kow’s of 1.4-2.4 to a larger extent than goldfish, 
and the  pattern  of  uptake  was similar.  In  addition,  atrazine  was  detected  in  field 
deployed  SPMDs  and  has  a  log  Kow  of  2.61  (Wang  et  al.,  1999a).  However, 
Sabaliunas and Sodergren (1997) reported that two hydrophilic herbicides, propachlor 
(log Kow=2.3)  and  alachlor  (log  Kow=2.1),  were  not  sequestered  in  a  laboratory 
study, suggesting that log Kow values may not be accurate in estimating sequestration 
of  more  hydrophilic  compounds.  Lastly,  with  the  exception  of  dieldrin,  trifluralin 
(Sabaliunas  and  Sodergren,  1997),  and  atrazine  ,  few  compounds  that  are 
environmentally  relevant  to  the  UK  have  been  tested  in  laboratory  exposures  or 
measured in extracts of field deployed devices, and therefore it is unknown to what 
extent pesticides here will be taken up by the SPMDs.
Due to concern over pesticide bioaccumulation,  many modern pesticides have log 
Kow’s < 3, and therefore may not be sequestered by SPMDs. In order to extract the 
more  hydrophilic  compounds  from  the  selected  sites,  the  polar  organic  chemical 
integrative sampler (POCIS), which sequesters compounds with a log Kow < 4, was 
also deployed. The POCIS is comprised of a sorbent mixture (80:20 (weight:weight) 
Isolute ENV + :Ambersorb 1500 dispersed on S-X3 BioBeads) sandwiched between 
58
two polyethersulfone membranes .  They were developed much more recently than 
SPMDs,  and thus there are less data  available  on compounds that  they sequester. 
However, laboratory exposures of POCIS have shown them to sequester a number of 
environmentally relevant pesticides, including diazinon, diuron, isoproturon, atrazine , 
and atrazine metabolites (Petty  et al., 2004). Furthermore, in a field deployment in 
Denmark,  29  out  of  46  polar  pesticides  were  detected  with  POCIS,  including 
previously unreported pesticides that are environmentally relevant to the UK, such as 
bentazone, 2,4-D, MCPA, and fenpropimorph . In a field deployment in the Thames 
estuary, diuron and isoproturon were identified in the extracts, and using laboratory 
calibration data, environmental levels were estimated. Grab samples were also taken 
at the time of POCIS deployment, for comparison to estimated environmental levels. 
Levels  measured in the grab samples were between 1.2 to 4.5-fold different from 
those estimated using the POCIS, with one sample below the limit of detection in 
POCIS but present at 40 ng/L in grab sample (Alvarez  et al., 2004), indicating that 
further calibration studies are needed for accurate estimation of environmental levels.
The  rationale  for  using  PADs  was  to  obtain  an  extract  of  pond  water  that  was 
integrative over a developmentally relevant time period in the endocrine system of 
amphibians. The period of water sampling coincided with metamorphosis from early 
tadpole  to  climax  stages  of  metamorphosis,  thus  encompassing  the  period  when 
gonadal differentiation and thyroid axis stimulation occur. 
2.3.1.2 Yeast Screen
Receptor mediated ED occurs through mimicking (agonism) or blocking (antagonism) 
endogenous  hormone  receptor  binding.  To date,  the  majority  of  in  vitro tests  for 
endocrine  disruption  have  focused  on  hormone  receptors,  with  estrogen  receptor 
agonism  and  androgen  receptor  antagonism  being  the  most  common  .  The 
recombinant yeast screen consists of yeast cells transfected with the human estrogen 
(yeast estrogen screen: YES) or androgen receptor (yeast androgen screen: YAS), and 
a colour change is observed if (anti-) estrogenic/androgenic compounds are present. It 
is a sensitive, reproducible, rapid, and ethical technique, and a high throughput of 
compounds is possible . However, yeast have limited capacity for metabolism, and 
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therefore can only provide preliminary data for various compounds that may be active 
in vivo . Pesticides have been shown to possess (anti-) estrogenic and anti-androgenic 
activity in the yeast screen, although androgenic activity has not been observed . For 
example, o,p’- DDT and p,p’-DDT have estrogenic and anti-androgenic activity , and 
diuron  was  weakly  estrogenic  (Noguerol  et  al.,  2006).  In  addition,  fenarimol 
(fungicide) and dicofol (insecticide) were estrogenic, although other pesticides tested, 
such as, PCP, chlorpyriphos, diuron and linuron were reported to have no effect on 
the estrogen or androgen receptor . In contrast, Jung et al. (2004) reported that PCP 
was anti-estrogenic, though no effect was observed with other pesticides,  such as, 
aldicarb,  carbaryl,  and  trifluralin.  Several  pyrethroid  insecticides,  including 
permethrin, fenvalerate and cypermethrin, and their metabolites have been shown to 
possess  (anti-)  estrogenic  and  anti-androgenic  activity  ,  and  the  metabolites  of 
pyrethroids appear to be more potent EDs than the parent compounds (Tyler  et al., 
2000). As mentioned, the composition of the extracts I collected was unknown, and 
only the pyrethroids, PCP, and diuron are present in the UK, and have been shown to 
be active in the yeast screen.
Various studies have used yeast screens to assess estrogenic activity of environmental 
samples in relation to sewage treatment works , however, to the author’s knowledge 
the YES has only been used once in relation to pesticide contamination. Petty et al. 
(2004)  used  POCIS  samplers  in  a  constructed  wetland,  which  received  urban 
wastewater and inflow from the Missouri river. Atrazine and its metabolites, propoxur 
(a carbamate insecticide), and nonylphenol were analytically identified in the extract, 
which was also found to be estrogenic in the YES. Estrogenicity may have been due 
to the nonylphenol in the extract, as the “alkylphenol” effect of creeping across plates 
was observed. 
2.3.1.3 Species Selection
As mentioned previously (Chapter 1, section 1.2) populations of the Common Toad, 
Bufo bufo, have been decreasing in the south of England at least since the 1940’s. 
There are various possible reasons for this decline, although road associated mortality 
is probably the most important .  Toad-specific mortality on roads occurs because, 
unlike frogs, toads display high fidelity to one breeding site and may travel large 
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distances and cross roads to reach their breeding site . It was calculated that 24-40 
cars per hour killed approximately 50% of migrating B.bufo . More recently, Hels and 
Buchwald  modelled the probability of survival of an individual toad crossing a road, 
and  concluded  that  its  chances  of  survival  depended  on  the  number  of  vehicles 
passing per unit time and the width of the tyres. Since both of these parameters are 
likely to have increased over the years, it is likely that road-associated mortality has 
also increased. In the UK, local groups had been active in carrying toads across roads 
since  the  early  1900’s,  but  it  wasn’t  until  the  1989  that  coordination  of  local 
herpetological groups occurred, with the setting up of the “Toads on Roads” scheme 
(run  by  Froglife,  registered  charity:  1088255).  A  by-product  of  this  scheme  is 
historical recording of the number of toads carried across roads, as well as any dead 
toads observed on the road and, therefore, trends in populations at individual sites 
over time can be analysed. If a toad population is stable, then the numbers killed by 
traffic should increase over time, as the volume of traffic increased, however, if traffic 
levels become too high then toad losses may become unsustainable and the population 
will decline . 
Despite the toads on roads scheme there is evidence to suggest that the common toad 
is still decreasing in Central, South, and South Eastern areas, and especially in rural 
areas . However, the findings reported in that study should be treated with caution, as 
they were based on questionnaires sent to local groups, whereby participants were 
requested to indicate population status (increase, decline, stable, extinct, uncertain) for 
sites that had been monitored for at  least  5 years.  If  indeed this  recent decline is 
substantiated, it may be due to a decrease in genetic diversity of populations caused 
by habitat fragmentation , as toads in small urban populations were found to have a 
lower genetic diversity than those of larger rural populations, and tadpoles from the 
former  displayed significantly  higher  mortality  and abnormalities  .  They also had 
relatively lower genetic diversity than common frogs in the same area . 
In addition to the possible decline in this species in England, toads were also chosen 
in preference to frogs for a number of other reasons. Firstly, the toads on roads data 
indicate, at the very least, where a toad population exists, and at best the trend of the 
population over time, assisting in site selection. Secondly, due to their high fidelity to 
breeding sites, it can be expected that any effects seen are ongoing at that site, and 
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may be related to the toad count data. Thirdly, frogs breed primarily in garden ponds 
(see Chapter 1), which would not typically give an accurate assessment of effects 
caused by chemicals in the agricultural environment. 
2.3.2 Methods
2.3.2.1 Site Selection
Toads  on  roads  data  were  combined  with  pesticide  use  intensity  data  (POPPIE 
database,  Environment  Agency,  U.K.).  The  POPPIE  database  is  an  Environment 
Agency resource consisting of estimated surface level concentrations of pesticides, 
which have been analytically verified, on a catchment level basis. Using these two 
datasets,  10  sites  were  chosen  across  England  and  Wales  with  varying  levels  of 
pesticides and with known toad populations. These sites were located in 4 clusters 
(Figure  2.7).  The  first  cluster  was  located  in  E.  Anglia,  and  contained  a  low,  a 
medium, and a high risk site. The low risk site, Woodwalton fen (abbreviation = WW, 
grid reference = TL225837), was an enclosed pond located within the fenlands. It was 
the only site without a toad population but was chosen as a reference site for the 
medium and high risk sites in E.Anglia. The medium risk site, 20 foot river (20’, 
TL322972) and was located in a drainage ditch in the fens, which forms part of a 
connected  network  of  canals.  The  high  risk  site,  Sporle  (SP,  TF854102),  was  an 
isolated  pond  that  was  surrounded  by  arable  agriculture.  The  second  cluster  was 
located in the North of England and also contained a low, a medium, and a high risk. 
The low risk site, Little Hayfield (LH, SK031879), was located in Derbyshire at the 
bottom of a small valley, where no agricultural activity was visible. The medium risk 
site, Repton Shrubs (RS, SK310230), was located in Derbyshire, in a pond bordering 
pastural agriculture. The high risk site, Oxton Bogs (OB, SK615512), was located in 
Nottinghamshire, and was a pond surrounded by arable agriculture. The third cluster 
was located in the midlands and contained a medium and a high risk site. The medium 
risk site, Church Lench pool (CL, SP025505), was located in Herefordshire. The pool 
was used for fishing, and orchards were observed in close proximity to the pool. The 
high  risk  site,  Layes  Pool  (LP,  SO802658),  was  located  in  Worcesteshire,  and 
bordered arable agriculture on one side and pasture on the other. The final cluster was 
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based on toad populations rather than agrochemical levels. It was comprised of two 
low risk sites, Yatton (YT, ST425752) and Pant-y-Llyn (PYL, SN606166), the former 
had a decreasing population and the latter an increasing population of toads. YT was 
situated on the edge of North Somerset County Nature Reserve (which is a SSSI: Site 
of Special Scientific Interest), and no visible agriculture could be observed. The pond 
at PYL is a turlough, and thus has no groundwater inflow or outflow, and was situated 
at  the  edge  of  a  SSSI  (Carmel  Woods).  Please  note,  site  selection  work  was 
undertaken primarily by Dr. Daniel Pickford (Brunel University, U.K.), with limited 
input from the author. 
Figure  2.7.  Map  showing  selected  sites  in  England  and  Wales.  Higher  total 
agrochemical  use intensity  is  indicated by darker  background colour.  See text  for 
details.
2.3.2.2 Water Sampling
Water samples were obtained by deployment of SPMD and POCIS samplers at each 
site for 29 days during April-May 2005. This is a typical exposure time for these 
devices, and saturation of samplers was not expected over this time period , and was 
E.Anglia- SP (high)
  - 20’ (medium)
  - WW (low)
Midlands- LP (high)
   - CL (medium)
Low Exposure -PYL ( Pop)
            -YT ( Pop)
63
North - OB (high)
- RS (medium)
- LH (low)
designed  to  coincide  with  tadpole  thyroidal  and  gonadal  development.  Three 
membranes of each type were deployed in steel cages and submerged approximately 
0.5 metres below the water surface. The water depth was measured, and a galvanised 
steel chain was cut to the appropriate length. The chain was attached to a buoy at one 
end, threaded through loops in the steel cage containing the PADs, and tied round a 
concrete  building  block  at  the  other  end  (sampling  PADs).  Membranes  and 
deployment devices were obtained from Exposmeter (Tavelsjo, Sweden). They were 
placed in the pond, where they were suspended in the water column, and thus it was 
presumed that normal fluctuations in water level over the sampling period would not 
affect submersion. As a procedural control for each site (‘field blank’), one membrane 
of each type was exposed to air for the duration of deployment, and again at retrieval, 
of the sampling PADs. Field blanks were stored at -200C in the intervening period (29 
days).  Both sampling PADs and field blanks  were stored at  -200C after  arrival  at 
Brunel University, and were transported to and from the sampling sites on ice. Water 
quality parameters (temperature,  pH, DO, specific conductivity,  and salinity) were 
measured  (YSI  556 handheld  multiparameter  system,  YSI  Hydrodata)  at  3  points 
within  2 metres  of  the deployed PADs,  at  deployment  and  retrieval  of  PADs.  In 
addition, 3 water samples taken from the same sites were measured for nitrite, nitrate, 
phosphate, iodine (Hanna C200 36 parameter colorimeter, Hanna Instruments), and 
water hardness (General Hardness test kit, Nutrafin).       
2.3.2.3 Sample Extraction
Elution of chemicals bound to the SPMD’s followed the official guidelines , and the 
POCIS followed instructions outlined previously . All glassware used in the extraction 
process were solvent rinsed (MeOH x 2 followed by ethanol (EtOH) x1) and dried in 
a fume hood prior to use. All  solvents used in the extraction process were HPLC 
grade. Each SPMD was rinsed in 200 ml hexane in a glass beaker for 20/30 seconds 
to remove surface adherents. The SPMD was inspected for holes in the membrane, 
and any observed were isolated by heat sealing. They were then placed in a stainless 
steel  tray and washed with running tap water and surface debris  was removed by 
scrubbing with a toothbrush. Following this, the SPMD was submerged in 1-M HCl 
for 30 seconds, rinsed with tap water, submerged in acetone and isopropanol for 30 
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seconds each, and was then dried on solvent rinsed aluminium foil. Each SPMD was 
dialysed in 250 ml glass bottles by incubation with hexane (200 mls, 18 hours, 180C), 
followed by further incubation with fresh hexane (200mls, 4 hours, 180C). The hexane 
from these two extractions were combined, and evaporated with nitrogen gas. Each 
POCIS membrane was cut open with a solvent rinsed stainless steel blade and the 
sorbent was collected on solvent rinsed aluminium foil. Sorbent was mixed from 3 
membranes retrieved from each cage (one cage at each site). The sorbent was placed 
in a glass gravity flow chromatography column fitted with a glass wool plug and 
stopcock.  Sorbent  was  dialysed  by  incubation  with  eluent  (1:1:8  ratio  of 
methanol:toluene:dichloromethane,  25  mls,  2  minutes)  in  the  glass  column.  The 
stopcock was then opened, and a further 50 mls of eluent was passed through the 
sorbent. Extracts were collected in 100 ml glass bottles, and dried with nitrogen gas. 
EtOH (10 mls) was added to each glass bottle and mixed vigorously (x2), followed by 
decanting into a glass vial (28 ml volume), and again, evaporation of EtOH. Glass 
vials containing dried SPMD and POCIS extracts, were re-suspended in 2.04 mls of 
EtOH per membrane. 
2.3.2.3.1 Calculation of Uptake Rate 
In this study, it was not possible to accurately estimate ambient levels at sampling 
sites,  as  in  the absence  of  chemical  analysis  it  was  not  known what  the  samples 
contained,  and  therefore,  uptake  rates  were  impossible  to  determine.  In  addition, 
uptake rates of the majority of pesticides that are environmentally relevant to the U.K. 
aquatic  environment  are  not  known,  making  extrapolations  using  the  literature 
difficult. Therefore, an estimate based on uptake rates of organochlorine pesticides 
was used to determine a concentration factor of the extract. Although organochlorines 
are generally not present in the UK at concentrations previously used for calibration 
studies of SPMDs , ambient concentration of compounds does not affect the uptake 
rate by PADs, which was expected to be linear for the duration of the exposure period 
(Huckins et al., 2002b; Alvarez et al., 2004). Nevertheless, it should be noted that the 
concentration factor is a relative value of the quantity of compound extracted per Litre 
of water, per day of deployment, used within this study, and not an estimation of 
environmental levels.  Calculation of the concentration factor  comprised of  several 
stages: 
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1. Data reported in Huckins et al.,  was used to correlate uptake rate and log Kow 
of organochlorines at 13.70C, which was the average temperature over all sites 
over the sampling period (Figure 2.8).
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Figure 2.8. Uptake rate (Litres/Day) of a range of organochlorines with varying 
log Kow’s at 13.70C by a SPMD membrane.
2. Pesticide concentrations  in  catchments  that  contained a  sampling site  were 
collated  (using  POPPIE  database),  and  the  average  concentration  of  each 
pesticide from all sites between April-June was calculated 
3. The organochlorine equation (Figure 2.8) was applied to pesticides with an 
average of > 1 ng/L and a log Kow > 3 (a total of 80 pesticides were found 
above >1 ng/L, and of these 27 compounds had a log Kow > 3). 
4. The  average  uptake  rate  of  these  pesticides  was  calculated  (1.4  L/d),  was 
multiplied by 29 (days spent in the water) and by 3 (3 membranes per sample 
were deployed), resulting in an equivalent of 122.4 Litres over the sampling 
period for each site. 
5. A x 20000 stock was prepared by adding 2.04 mls ethanol per membrane (6.12 
mls  for  sampling  PADs,  2.04  mls  for  the  field  blanks).  Therefore,  the 
composition of compounds that were in 122.4 Litres of water, were reduced to 
a volume of 6.12 mls. 
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The calculated uptake rate was similar to a previous study using SPMDs, where the 
composition of the water was unknown .
2.3.2.4 Yeast Screen
The recombinant yeast estrogen screen (YES), including preparation of the growth 
medium, has been described previously . Briefly, stimulation of the transfected human 
estrogen  receptor  causes  the  release  of  β-galactosidase,  which  metabolises  a 
chromogenic substrate (chlorophenol red-β-D-galactopyranoside), and thereby causes 
a colour change in the media, which is measured by absorbance (540 nm, Spectramax 
340pc, Molecular Devices, CA, USA). The growth of yeast cells was also measured 
(at 620 nm), and the 620 nm value of the EtOH only wells (‘blank’) was subtracted 
from the 620 nm value of the exposed well, and this value was subtracted from the 
absorbance value at 540 nm of the corresponding well. The yeast androgen screen 
follows  the  same  principle,  but  yeast  were  transfected  with  the  human  androgen 
receptor  instead  of  the  human  estrogen  receptor  .  The  anti-screens  function  by 
inhibition of receptor binding, via co-incubation with the agonist (E2 or T), and the 
test compound. Standards for each screen were as follows: E2 for the estrogen screen 
(10 to 0.0049 nM); 4-Hydroxytamoxifen (OH-T) for the anti-estrogen screen (25 to 
0.01 µM); T for the androgen screen (50 to 0.02 nM); and flutamide (FLUT) for the 
anti-androgen screen (50 to 0.02 µM). They were run in duplicate in each assay, and 
ethanol and media only controls were also run in each assay. Standards were serially 
diluted 12 times, in two-fold steps, and 10 µL of each concentration were then added 
to a 96-well microtiter plate and allowed to evaporate to dryness. After evaporation, 
200 µL of medium containing CPRG and yeast (8 x 105 cells/ml) were added to each 
well. For the anti-estrogen/androgen screens, 0.25 nM E2, or 2.5 nM T, was added to 
the media prior to addition to the wells. Initially, sampling and field blank extracts 
were  tested  at  x2000  concentration  (x10  dilution  of  the  concentrated  extract),  in 
duplicate in each screen. To achieve this concentration, 20 µL of extract was added 
per well, evaporated to dryness, and subsequently diluted x 10 by the addition of the 
yeast containing growth media (200 µL). Subsequently, samples were serially diluted 
in two-fold steps over 12 wells (x2000 - x0.97 concentration), and the field blanks 
were again tested at x2000. Therefore, the top concentration (x2000) of sampling and 
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field blank extracts were tested twice, and the dose response curve of the sampling 
extracts was tested once. 
2.3.2.4.1 Calculations
Hormone equivalents were calculated for each screen using the following equation :
EE/OHE/TE/FE =  
                                
EE = E2 equivalents, OHE = OH-T equivalents, TE = T equivalents, FE = FLUT 
equivalents  (FEs).  Equivalents  were  calculated  where  the  absorbance  value  that 
represents  the  EC50 of  the  standard  was reached by  the  samples.  The  field  blank 
extract absorbance values were converted to percentage values to allow comparison 
between assays.
2.3.3 Results
PADs were lost from RS in the Northern cluster, they were found lying on the bank 
when the site was visited for PAD retrieval. In addition, the PADs at LH were half 
submerged  in  the  bottom sediment  of  the  pond  upon retrieval.  Biofouling  of  the 
membranes can lower the exchange rate between SPMDs and ambient water , but was 
minimal at all sites.
 
2.3.3.1 Site Characteristics
Water quality varied between sites, but values were within those expected for normal 
amphibian development (Table 2.1). Temperature, and pH were similar between sites, 
whereas conductivity,  salinity, and hardness differed markedly.  These values were 
correlated, and were highest at WW & 20’, which also had the lowest altitude (1 & -1 
metres). DO levels also differed between sites. Phosphate was detected at more sites, 
and in higher concentrations, than nitrate. Iodine was detected at varying levels at all 
sites  except  WW.  Toad  tadpoles  were  not  observed  at  WW,  or  LP,  but  where 
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EC50 (Standard)
EC50 (Sample)
observed, development was similar across sites,  except at  OB, where it  was more 
advanced.
WW 20’ SP LH OB YT PYL CL LP
Temp (0C) 13.9 ( 0.9) 15.6 (0.2) 12.3 (0.4) 13.5 (1.6) 14.6 (1.45) 13.3 (2.1) 11.8 (1.5) 14.4 (1.2) 15.5 (0.05)
Cond.(µS/cm) 1322 (62) 2866 (55) 491 (41.6) 152 (17) 1113 (128) 462 (73.2) 187 (14) 500 (34) 494 (89)
Salinity (ppt) 0.81 (0.1) 1.67 (0.2) 0.3 (0.03) 0.1 (0.01) 0.7 (0.06) 0.29 (0.03) 0.12 (0) 0.31 (0.02) 0.30 (0.06)
Oxygen(mg/L) 6.1 (1.5) 14.5 (1.9) 12 (4) 10.2 (0.7) 8.6 (1.47) 13.2 (1.68) 9.62 (0.75) 10.8 (1.28) 11.21 (1.9)
pH 6.82 (0.1) 8.02 (0.2) 7.6 (0.7) 6.2 (0.1) 7.46 (0.39) 7.91 (0.2) 7.09 (0.17) 6.91 (0.14) 7.92 (.011)
Hard. (mg/L) 807 (93) 773 (53.5) 250 (30.1) 93 (13.4) 397 (3.34) 233 (01) 86.67 (01) 253 (01) 240 (20.1)
Nitrate (mg/L) 0 0 0 0 1.67 (0.97) 0 0.05 (0.05) 0 0
Nitrite (mg/L) 0 0 0 0 0.04 (0) 0 0 0 0
Phos. (mg/L) 0.5 (0.06) 2.47 (0.7) 1.31 (0.9) 0.48 (0.16) 0.64 (0.15) 1.57 (01) 0.4 (0.28) 0.31 (01) 0.522 (0.2)
Iodine (mg/L) 0 0.08 (0.1) 0.1 (0.1) 0.03 (0) 0.03 (0) 0.05 (0.05) 0.02 (0.02) 0.03 (0.03) 0.8 (0.37)
Altitude (m) 1 -1 58 206 71 5 145 96 45
T. Abundance None Few Many Few Some Few Few Many None
Stage (G)* 28 28 28-29 30-33 28 28 29
Table  2.1.  Water  quality  at  the  sampling  sites.  Values  are  means  (SE)  values 
measured at  PAD deployment  and retrieval,  n =  2.  Temp = temperature,  Cond = 
specific conductivity, Hard = hardness, Phos = phosphate, T = Toad. G = Gosner. * = 
stage observed at time of PAD retrieval. (01) indicates only one value is available for 
this parameter.
2.3.3.2 Hormonal Activity
None of  the  samples  from the  SPMD extracts  were  estrogenic  (data  not  shown), 
whereas most of the POCIS samples displayed some estrogenic activity. The most 
strongly estrogenic extracts were WW and 20’. OB, SP, PYL, YT, CL & LH were 
weakly estrogenic, though no estrogenic activity was observed at LP (Figure 2.9). All 
SPMD extracts except for OB and WW were anti-estrogenic (Figure 2.10), and at the 
highest concentration tested YT and LP were more strongly anti-estrogenic than the 
standard. Substantially less anti-estrogenic activity was observed in response to the 
POCIS extracts, where only LP was anti-estrogenic, although WW was estrogenic in 
this  screen  (Figure  2.11).  None  of  the  samples  tested  were  androgenic  (data  not 
shown). Anti-androgenic activity was observed in response to SPMD extracts (Figure 
2.12),  and  WW,  YT,  & LP were  the  strongest  anti-androgens.  Similarly  to  anti-
estrogenic activity, anti-androgenic activity was less pronounced in response to the 
POCIS extracts, but was also highest at WW & LP (Figure 2.13). 
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Figure 2.9. Estrogenic activity of POCIS extracts from each site in the YES. Extracts 
were serially diluted in 2-fold steps, over the concentration range of x2000-x0.97 of 
the nominal water concentration. 17β-estradiol (E2) was also serially diluted in 2-fold 
steps, over the concentration range of 10-0.0049 nM. Plates were incubated at 280C 
for 7 days. Values are calculated absorbance values (see section 2.3.2.6), and each 
data point represents a single value. WW = woodlwalton fen, 20’ = twenty foot river, 
SP = sporle, LH = little hayfield, OB = oxton bogs, PYL – Pant-y-Llyn, YT = yatton, 
CL = church lench, LP = layes pool.
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Figure 2.10. Anti-estrogenic activity of SPMD extracts from each site. Extracts were serially 
diluted in 2-fold steps, over the concentration range of x2000-x0.97 of the nominal water 
concentration. Hydroxytamoxifen (OH-T) was also serially diluted in 2-fold steps, over the 
concentration range of 25-0.01 µM. Plates were incubated at 280C for 5 days. Values are 
calculated absorbance values (see section 2.3.2.6),  and each data point represents a single 
value. Control = ethanol only exposed wells, for other abbreviations see Figure 2.9. 
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Figure  2.11.  Anti-estrogenic  activity  of  POCIS  extracts  from each  site.  Each  data  point 
represents a single value. For experimental details see Figure 2.10, for other abbreviations see 
Figure 2.9. 
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Figure 2.12. Anti-androgenic activity displayed by SPMD extracts from each site. Each data 
point  represents  a  single  value.  Extracts  were  serially  diluted  in  2-fold  steps,  over  the 
concentration range of x2000-x0.97 of the nominal water concentration. Flutamide (Flut) was 
also serially diluted in 2-fold steps, over the concentration range of 50-0.02 µM. Plates were 
incubated at 280C for 5 days. Values are calculated absorbance values (see section 2.3.2.6), 
and each data point represents a single value. Control = ethanol only exposed wells, for other 
abbreviations see Figure 2.9. 
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Figure  2.13.  Anti-androgenic  activity  of  POCIS extracts  from each  site.  Each  data  point 
represents a single value. For experimental details see Figure 2.12, for other abbreviations see 
Figure 2.9.   
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Endocrine  equivalents  from  SPMD  and  POCIS  extracts  were  calculated,  and 
combined  to  assess  the  overall  estrogenic,  anti-estrogenic,  and  anti-androgenic 
activity  from each site,  and to  compare with the original  risk estimated from the 
POPPIE  database  (Table  2.2).  The  POPPIE  database  did  not  predict  endocrine 
response in the yeast screen in all cases except at LP, where high risk was correlated 
with a high anti-estrogenic/androgenic activity. Where a particular type of endocrine 
activity was observed, it originated primarily from one type of PAD across all sites, 
thus,  estrogenic  activity  was  observed  in  the  POCIS  extracts,  and  anti-
estrogenic/androgenic activity in the SPMD extracts. Lastly, each extract was active 
in at least one screen. 
SITE
YES
E2 eq. (nM)
S P
Total
YES
A-YES
OHT eq. (nM)
S P
Total
A-YES
A-YAS
Flut eq. (nM)
S P
Total
A-YAS RISK
WW 0 0.71 0.71 0 0 0 0.25 0.15 0.4 L
20’ 0 0.17 0.17 0.15 0 0.15 0.06 0.01 0.07 M
SP 0 0.01 0.01 0.18 0 0.18 0 0.01 0.01 H
LH 0 0.01 0.01 0.4 0 0.4 0 0.01 0.01 L
OB 0 0.01 0.01 0 0 0 0 0.01 0.01 H
PYL 0 0.01 0.01 0.2 0 0.2 0 0 0 L
YT 0 0.01 0.01 1 0 1 0.69 0.01 0.7 L
CL 0 0.01 0.01 0.17 0 0.17 0 0 0 M
LP 0 0 0 0.86 0.3 0.89 0.25 0.2 0.45 H
Total 0 0.94 0.94 2.96 0.3 2.99 1.25 0.4 1.47
Table 2.2. Endocrine equivalent values for each site and in different membranes. S = 
SPMD, P = POCIS, L = Low, M = Medium, H = High, eq. = equivalent. The nominal 
value of 0.01 was given to extracts that had weak endocrine activity (no part of the 
curve reached the EC50 value).
2.3.3.3 Field Blanks
Endocrine  activity  was  also  observed  in  field  blank  extracts,  and  is  presented  as 
percentages of the maximal response (YES: no response = 0 %, maximal stimulatory 
response = 100 %; anti-YES/YAS: no response = 100 %, maximal inhibitory response 
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= 0 %). There appeared to be a background level of activity from both types of PADs, 
which  was  more  pronounced  in  the  POCIS,  compared  to  the  SPMD,  extracts. 
Background estrogenicity of POCIS field blanks were ~20 %, and SPMD field blanks 
were  <  5  % (Figure  2.14,  A).  Background  anti-estrogenic  effects  of  POCIS  and 
SPMD extracts was ~80 %, and background anti-androgenic effects for POCIS was 
~70 %, and SPMD ~ 80 % (Figure  2.14,  B).  In  addition  to  background activity, 
POCIS field blank extracts from YT were highly estrogenic in the YES (103.9 %, 
Figure 2.14,  A),  and the  anti-YES (158.8 %,  Figure  2.14,  B).  Three SPMD field 
blanks were estrogenic (WW = 22.1 %; LH = 36.7 %; YT = 37.4 %, Figure 2.14, A), 
although no estrogenic activity was observed in the sampling SPMDs from these sites. 
In addition,  WW and 20’ were anti-androgenic (87.3 % and 69.2 %, respectively, 
Figure 2.14, B).
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Figure 2.14. Endocrine activity of field blanks (% of maximal stimulatory/inhibitory 
response).  For the purpose of this  representation,  the no effect level  for the yeast 
estrogen screen is 0 % (Panel A), and for the anti-estrogen/androgen screens is 100 % 
(Panel B). Values are mean ± se of duplicate wells, run over two assays. P = POCIS 
extract, S = SPMD extract, YES = yeast estrogen screen, A-YES = yeast anti-estrogen 
screen, A-YAS = yeast anti-androgen screen.
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2.3.4 Discussion
2.3.4.1 Hormonal Activity
All sites were active in at least one screen, and samples were generally more potent in 
the anti-YES/YAS than  the  YES (no  activity  observed  in  the  YAS).  The  highest 
estrogenic activity was observed at WW (POCIS), the highest anti-estrogenic activity 
was observed at YT (SPMD) followed by LP (POCIS & SPMD), and the highest anti-
androgenic activity at YT (SPMD), followed by WW & LP (POCIS & SPMD). The 
amount of activity at sites was not related to estimated risk, which may have been due 
to a number of factors. Firstly, the POPPIE database reports pesticide concentrations 
on a catchment level basis, and extrapolation from such a large area to estimate risk in 
a small, sometimes isolated, water body was probably inaccurate. Secondly, the most 
recent dataset that was available was from 1998, and pesticide profiles are likely to 
have changed considerably since then. Lastly, in the absence of analytical chemistry, 
it is unknown if pesticide concentrations in the samples was correlated with estimated 
risk, however, even if this correlation exists, it would not necessarily correspond to 
endocrinological effects observed. Due to these reasons, this dataset was not used as a 
guide  of  agrochemical  pollution  in  further  experiments  (see  Appendix  1  for  UK 
pesticide concentrations in 2004/2005). 
Estrogenic activity was observed in the POCIS extracts and not the SPMD extracts, 
and only at WW and 20’. WW was designed to be the low risk site for the E.Anglia 
cluster,  however,  it  was  highly  estrogenic.  The  site  at  WW  is  comprised  of  20 
artificial  ponds,  and  it  was  discovered  that  some  of  ponds  had  been  used  for  a 
mesocosm  exposure  study  .  They  were  dosed  with  1  mg/L  of  either  diquat  or 
dichlobenil, and although it is not known which ponds were exposed, neither of these 
compounds are persistent in the environment , so it is highly unlikely they would still 
be present in the ponds. It was also discovered that Roundup ® (active ingredient 
Glyphosate)  had been used between 2001-2003 to  remove scrub from around the 
ponds (A.Cooke, pers comm), however, again, glyphosate is not a persistent pesticide 
(Tomlin, 2006). Interestingly, the activity profile of sampling extracts was similar at 
WW and 20’, which may indicate that the PADs were similarly exposed. There may 
76
have been  groundwater  contamination  if  the  water  table  was elevated,  as  WW is 
situated only 1 metre above sea level, and WW and 20’ had very similar water quality 
profiles,  which  were  distinct  from  other  sites.  This  included  highly  elevated 
conductivity and salinity values, suggesting there may have been seawater input. The 
pond at  WW may also have  been contaminated by pesticides  via  spray drift  ,  as 
SPMD field blanks were estrogenic, and POCIS field blanks were anti-androgenic. 
Spraying was observed on adjacent land during PAD deployment, and it is known that 
SPMDs can sample air-borne contaminants, such as PCBs , DDE , and pyrethroid 
insecticides  ,  however,  uptake  of  air  borne  contaminants  by  POCIS has  not  been 
reported.  Unlike  the  other  sites  that  were  isolated  ponds,  20’  was  situated  in  an 
irrigation  ditch  forming  a  network  of  canals,  and  thus  resembled  a  riverine 
environment. Synthetic and natural estrogens are known to be sampled by the POCIS 
membrane  ,  and  weak  estrogenic  activity  connected  to  sewage  outflow has  been 
identified in this area . Therefore, PADs may have been contaminated with natural 
and synthetic estrogens, causing the estrogenic effects observed at WW and 20’. 
Anti-estrogenic/androgenic activity was more widespread than estrogenic activity, and 
the  highest  activity  was  observed  at  YT  and  LP.  Pesticides  detected  in  the  area 
surrounding  both  these  sites  were  atrazine  (max:  0.16  µg/L),  MCPA  (max:  0.22 
µg/L), mecoprop (max: 1.03 µg/L). Other pesticides detected near to YT (appendix 2, 
pp 260-280) were fluroxypyr (max: 0.06 µg/L), and simazine (max: 0.06 µg/L), and 
near to LP (appendix 2, pp 296-318) included, 2,4-D (max: 0.24 µg/L), isoproturon 
(max: 1.9 µg/L), and PCP (max: 2.7 µg/L). Apart from anti-estrogenic effect of PCP , 
the receptor mediated affects of these compounds have either not been tested or no 
activity was observed (see Chapter 1, section 1.5). Therefore, the source of the anti-
estrogenic/androgenic activity observed at various sites is difficult to identify (but see 
Chapter 4), but due to the widespread and potent anti-activity, it  is important that 
these effects are tested more thoroughly in relation to pesticide exposure.
The  endocrine  activity  observed  in  the  field  blanks  was  unexpected.  Petty  et al. 
reported no uptake of pesticides or pharmaceuticals in field blanks of POCIS, and no 
effect was observed in the YES. In contrast, SPMD field blanks were reported to be 
toxic to developing amphibians to the same extent as sampling membranes (Bridges 
et al., 2004). The authors’ did not discuss the possible causes for toxicity observed, 
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however, despite the distinct endpoints compared to the present study, residual effects 
of  field  blanks  are  also  indicated.  As  mentioned,  SPMDs  can  sample  air-borne 
contaminants,  and alkyl  hydrocarbons and phthalates have been identified in field 
blanks in two separate deployments . Some phthalates are estrogenic  , and this effect 
has been observed in the YES (Harris  et al., 1997). They are ubiquitous industrial 
pollutants and have been measured atmospherically in areas as diverse as the North 
Sea , the Arctic , and the urban environment , therefore, they may be contributing to 
estrogenic effects of field blanks. In other studies using field deployed SPMDs, field 
blanks were not reported to have been used , or possible effects were not reported , 
and therefore, comparisons cannot be made. 
As  described,  it  was  not  possible  to  estimate  environmental  levels  of  pesticides, 
therefore,  it  is  not  known  if  activities  observed  are  environmentally  relevant. 
However, in a similar experimental design with SPMDs, Bridges et al.  estimated an 
uptake  rate  of  1  litre/day/SPMD  and  used  this  value  to  estimate  risk  to  native 
amphibians. The authors’ rationale was that uptake of hydrophobic compounds varied 
from 0.01-2 L/day/SPMD, and uptake in invertebrates and fishes ranged from 0.03-8 
L/day (see Bridges  et al., 2004 and references therein), and thus the estimate of 1 
L/d/SPMD was considered ‘conservative’. In the present study, an uptake rate of 1.4 
L/day/PAD was estimated, which would result in a relatively more dilute sample if 
reconstituted to ‘ambient’ levels, than that used be Bridges et al. (2004). The authors’ 
reported tadpole deformities in response to extracts tested at estimated ambient levels, 
and their concentration was 12% more concentrated than LOEC reported here (x20 
concentration of extract). Uptake rate by POCIS may have been somewhat slower, as 
Matthiessen et al. reported an uptake rate of 0.129 L/day/POCIS of E2, and Alvarez 
et  al. (2004)  reported  uptake  rates  of  0.045  L/day/POCIS  for  diuron,  and  0.086 
L/day/POCIS  for  isoproturon.  Therefore,  it  is  likely  that  POCIS  extracts  were 
substantially  more  dilute  than  SPMD extracts.  Indeed  SPMD extracts  were  more 
active  in  the  anti-YES/YAS,  although  only  the  POCIS  extract  was  estrogenic. 
Therefore, despite the unknown nature of the extracts, and the uncertainty of ambient 
levels, there is evidence that amphibians may be at risk of EDs at these sites. 
2.3.4.2 Site Selection
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In  E.Anglia,  the  low  risk  site  (WW)  was  highly  estrogenic,  moderately  anti-
androgenic, and weakly anti-estrogenic, which was surprising as it was a pond located 
inside a nature reserve. It was meant as a reference site, but was endocrinologically 
active, and did not have a toad population. Therefore, it was decided that 20’ would 
be used in breeding season three as it had high activity and an amphibian population. 
The sites in the Northern cluster were problematic. Firstly, one of the samplers was 
taken out of the water and left on the bank (RS), so this sample was lost. Secondly, 
the high risk site had the lowest activity of all the sites tested (OB). Thirdly, although 
moderately high activity was identified at the low risk site (LH) the PADs were partly 
submerged in sediment when retrieved, therefore it is not known if endocrine effects 
observed were derived from uptake from the water or the sediment. Furthermore, due 
to practicalities of repeated sampling in breeding season three, sites in the North of 
England would  only  have  been  used  if  results  from this  stage  were  encouraging. 
Therefore, it  was decided that sites in the north of England would not be used in 
breeding season three. In the midlands cluster, the high risk site (LP) was highly anti-
estrogenic  and  anti-androgenic,  and  the  medium  risk  site  was  moderately  anti-
estrogenic (CL). LP and CL are thought to have distinct agrochemical input compared 
to sites from E.Anglia, as the former is bordered by pasture and arable agriculture, 
whereas the latter is situated near orchards. The pattern of endocrine effects was also 
distinct, as no estrogenic activity was observed, but potent anti-estrogenic and anti-
androgenic  effects  were  observed.  In  addition,  these  sites  were  situated  at  higher 
altitudes, had lower conductivity/salinity values, and no activity in the field blanks 
was observed (above background levels). Therefore, due to the distinct nature of these 
sites, it was decided that one would be selected for use in breeding season three. No 
tadpoles were observed at LP, however, the activity was high at this site, whereas low 
activity was observed at CL, but tadpoles were also observed. Water visibility was 
poor at LP during PAD deployment/ retrieval, and D.Pickford and the author were 
informed by the landowners that toadspawn and toads were often observed. Therefore 
it was decided to use LP in breeding season three.
In the cluster based on toad populations, the highest overall activity of all sites was 
observed at the site with reported declining populations (YT), and moderate to low 
activity at the site with increasing populations (PYL). YT borders a SSSI, and was 
thought to be a relatively unpolluted site. Compared to other sites, high phosphate 
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levels  were  measured  at  YT,  possibly  indicating  contamination  with  fertiliser.  A 
livestock farm was observed bordering one side of the pond, and animal waste was 
present  on  the  path  between  the  farm and  the  pond.  Relatively  low activity  was 
observed at PYL, and a healthy toad population had been recorded. In addition, low 
phosphate and nitrate levels were recorded. Therefore, PYL served as the ‘reference’ 
site for comparison of ‘polluted’ sites, and YT was also used in breeding season three.
Therefore, in breeding season three, 4 sites were analysed further: 20’ river in the fens 
(arable),  LP  in  the  midlands  (arable  and  pasture),  YT  in  Somerset  (unknown 
pollutants), and PYL in Camarthenshire (‘reference site’). 
2.4 Breeding Season Three
2.4.1 Introduction
The  aim  of  breeding  season  three  was  to  assess  the  impact  of  selected  sites  on 
survivorship, morphology, sex determination/differentiation, and the thyroid axis in 
the common toad (Bufo bufo). Caged and wild caught individuals from each site were 
analysed morphometrically, and the gonad and thyroid were analysed histologically. 
Toadspawn  from  each  site  was  also  collected  and  reared  in  aged  tap  water 
(“laboratory-reared”)  for  comparison  to  caged  and  wild-caught  individuals. 
Laboratory-reared individuals from each site also eliminated confounding variables 
caused  by  regional  differences  in  gonadal  development  within  the  same  species, 
which is a well known phenomenon on amphibians . Although water extracts were 
obtained with PADs,  these samples  were not  available  for analysis  in  the present 
project.
2.4.1.1 Gonadal Development in Bufo
 A description of sex differentiation in amphibians has been described previously (see 
Chapter  1,  sections  1.3.3  &  1.3.4),  therefore  comparative  features  of  Bufonidae 
species will be described here. Spermatogenesis and oogenesis of Bufonidae species 
follow  the  same  pattern  as  that  of  other  vertebrates  ,  but  retarded  gonadal 
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development in comparison to other amphibians has been reported .  Distinction of 
sexes by histological analysis has been reported to occur approximately at forelimb 
emergence  in  various  species,  including,  B.japonicus  formosus ,  B.bufo ,  and 
B.lentiginosus . Sex races in species of Bufonidae have often been reported as semi-
differentiated,  whereby,  all  individuals  first  develop  as  females,  and  sex  is 
permanently  differentiated  by  completion  of  metamorphosis  .  Since  gonadal 
development of only post-metamorphic individuals will be analysed in the present 
study, the question of sex races may not be relevant. However, one study reported that 
differentiation  of  the  permanent  sex  was  not  complete  by  the  fifteenth  day  after 
metamorphosis  .  Therefore,  a  predominance of females  at  early  stages of gonadal 
differentiation  may  be  an  artefact  of  differentiation  rates,  rather  than  a  result  of 
external factors. In a series of papers King  demonstrated that there was no effect of 
temperature,  nutrition,  egg  ripeness,  or  source  of  spermatozoan,  on  sex  ratios  in 
B.lentiginosus. In a total of over 10000 animals analysed, deviation of sex ratio was 
rarely more than 10% of the expected 50:50 male:female ratio. In other laboratory 
studies, the sex ratio of B.bufo did not deviate by more than 10 % , or B.americanus . 
2.4.1.1.1. Effects of Exogenous compounds on Sexual Differentiation in Bufonids
Various compounds, including gonadotropins and steroid hormones, have been shown 
to influence gonadal differentiation, and species-specific differences have also been 
reported. Larval treatment with 0.1 mg/L E2 induced feminisation of gonads in B.bufo 
and  B.americaus , but no effect was observed in  B.vulgaris exposed to 1 mg/L  or 
B.boreas exposed  to  0.3  mg/L  .  In  addition,  retardation  of  differentiation  was 
observed  in  B.americus tadpoles  exposed  to  0.5  or  1  mg/L  E2  (Chang,  1955). 
Testosterone was less effective than E2, and had no effect on gonadal differentiation 
in  B.boreas exposed  to  0.4  mg/L  ,  or  B.bufo exposed  to  1  mg/L  .  In  addition, 
methyltestosterone (MT) had no effect on B.americanus exposed to 0.02, 0.05, or 0.1 
mg/L, but retardation of development was observed in tadpoles exposed to 0.5 mg/L 
(Chang, 1955). Responses to estrogens and androgens may have been due to a local 
effect on the gonad in low doses, and inhibition of gonadotropin release in higher 
doses, leading to retardation of development. Indeed, DHT had a potent inhibitory 
effect on gonadal differentiation in B.bufo (Petrini and Zaccanti, 1998), and is thought 
to  have  a  stronger  negative  feedback  effect  in  the  hypothalamo-pituitary-gonadal 
81
system than testosterone (see Chapter 1, section 1.3.3). FSH may upregulate 5α-R 
activity,  resulting  in  higher  DHT levels,  as  has  been  observed  in  rats  ,  as  larval 
treatment with FSH caused masculinisation of gonads of  B.vulgaris , and the same 
effect was observed in injection of metamorphosed, but undifferentiated, B.arenarum 
(1  month  post-metamorphosis)  with  FSH  .  It  has  been  reported  that  ovarian 
differentiation  in  Bufonids  is  less  dependant  on  gonadotropins  than  testicular 
differentiation, and that the pituitary of adult male toads is more responsive to GnRH 
than adult  females (see Chapter 1,  section 1.3.3),  therefore,  feminisation could be 
explained  by  a  lack  of  gonadotropins.  However,  injection  of  undifferentiated 
B.arenarum (1 month post-metamorphosis) with LH caused feminisation. Perhaps LH 
had a  negative  feedback  effect  on  the  hypothalamus,  resulting  in  decreased  FSH 
production, which may be required for masculinisation of genetic males. Interestingly, 
treatment  of  B.bufo with  a  5α-reductase  inhibitor  (17βC:  4-androstene-3-one-17β-
carboxylic acid), enhanced gonadal differentiation of both sexes (Petrini and Zaccanti, 
1998), and exposure to an aromatase inhibitor (4-OHA: 4-hydroxy-4-androstene-3,17-
dione) caused masculinisation in  B.bufo (Pertini and Zaccanti, 1998). There are not 
enough background data to accurately interpret these results, however, it seems likely 
that  both  gonadotropins,  through  the  hypothalamo-pituitary-gonadal  axis,  and 
hormones,  through a  local  effect  on the gonad,  influence sexual  differentiation in 
toads.
2.4.1.1.2. Bidder’s Organ 
Bufonidae species are unique among amphibians in that they possess a Bidder’s organ 
(BO), which lies anteriorly to the gonad and is present in juveniles of both sexes. It 
normally persists in adult males, but becomes continuous with the ovary in females 
after  approximately  1  year  ,  and  thus  often  disappears  completely  .  It  has  been 
detected  in  all  Bufonidae  species  studied  thus  far,  including B.canorus,  B.viridis,  
B.fowleri,  B.americanus,  B.vulgaris, B.lentiginosus, B.quercicus ,  and  B.bufo .  BO 
develops  much more  rapidly than the  gonad,  and attains  a  large  size  before  it  is 
possible to ascertain sex of the individual . The BO is a rudimentary ovary, and its 
development  consists  of  two  oogenic  growth  phases,  and  therefore,  a  bimodal 
distribution  of  oocyte  size  can  be  observed  in  early  life  (<  60  days  post 
metamorphosis).  The  first  phase  begins  at  Gosner  stage  34  ,  and  the  second  at 
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completion of metamorphosis (Zaccanti et al., 1971, Falconi et al., 2007). In females, 
a  clear  distinction  between  BO  and  the  ovary  can  be  observed,  and  in  males  a 
‘mesogonad’ with the appearance of an immature ovary located between BO and the 
teste  was  sometimes  observed  (Zaccanti  et  al.,  1971).  It  has  been  reported  that 
removal of the ovary may induce development of BO into a functional ovary, but this 
has not been well studied (reported in Witschi, 1933). In contrast, many studies have 
reported the development of a functional ovary upon orchidectomy. This ‘ovary’ can 
produce fertilizable eggs, although, orchidectomised toads only develop rudimentary 
oviducts, and therefore cannot release the eggs . BO oocytes from orchidectomised 
toads  and  ovaries  are  functionally  similar,  both  in  protein  expression  ,  and 
steroidogenic  enzyme  activity  (3β-HSD,  17β-HSD)  .  Bufonids  are  not  true 
hermaphrodites,  as  they  do  not  possess  functional  ovarian  and  testicular  tissue 
simultaneously, however, it has been proposed that BO is evidence of hermaphroditic 
ancestry of Bufonids, and perhaps all amphibians (Witschi, 1933). Interestingly, if 
male Xenopus larvae are treated with estrogens for a short time near the critical sex-
determining period, the cephalic portion of the gonad develops into an ovarian-like 
structure,  and  the  posterior  develops  into  a  teste  ,  suggesting  the  potential  for  a 
cephalic ovarian structure in other species. 
Development and maintenance of gonadal function in amphibians is at least partly 
controlled by gonadotropins (see Chapter 1, section 1.3.3), and BO degenerated after 
removal  of  the  pituitary  in  adult  B.bufo ,  but  increased  in  weight  after  pituitary 
implantation in adult  B.arenarum ; suggesting gonadotropins also have a role in BO 
maintenance.  Indeed,  gonadotropin  treatment  (PMSG:  pregnant  mare’s  serum 
gonadotropin;  &  HCG:  human  chorionic  gonadotropin)  enhanced  the  stimulating 
effect of orchidectomy on BO development in  B.woodhousii (Pancak-Roessler and 
Norris,  1991),  and  gonadectomy in  Rana esculenta has  been  reported  to  increase 
gonadotropin  levels  .  Therefore,  the  development  of  BO into  an  ovary  following 
orchidectomy may be due to the lack of negative feedback on the pituitary, leading to 
an increase in gonadotropin levels (Pancak-Roessler and Norris, 1991). Interestingly, 
BO size  was  not  affected  by  gonadotropins  in  animals  with  intact  testes,  despite 
increased  gonadotropin  levels  (Pancak-Roessler  and  Norris,  1991),  and  similarly, 
bidderian  levels  of  3β-HSD  and  17β-HSD  were  stimulated  by  gonadotropins  in 
orchidectomised toads, but this response was not observed in intact toads (Pancak-
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Roessler and Norris, 1991). Increased incidence of atretic follicles was also observed 
in intact males treated with gonadotropins (Pancak-Roessler and Norris, 1991), and 
many degenerated bidderian oocytes were found in B.japonicus formosus at the same 
time  of  year  as  enhanced  gonadotropin  levels  .  Thus,  the  presence  of  the  teste 
maintains the development of BO in an undifferentiated state, even in the presence of 
increased gonadotropin levels, and may induce oocyte atresia (Pancak-Roessler and 
Norris, 1991). The nature of this control is unknown, however, androgens may play a 
role as amphibian teste size increases in the breeding season, and this increase is 
positively correlated with testosterone levels , and an inverse relationship between BO 
and teste size has been reported . In support of this hypothesis, reproductively active 
male B.woodhousii are reported to have smaller BOs, compared to non-reproductively 
active  individuals  ,  and  testosterone  treatment  caused  atrophy  of  BO  in  adult 
B.melanostictus ,  and inhibition of BO growth in developing  B.bufo .  In addition, 
treatment with testosterone propionate or MT depressed growth of BO, including a 
reduction in oocyte number and size, in larval B.vulgaris . Both testosterone and DHT 
have been reported to decrease the size of the BO, and inhibit its development in 
larval B.bufo , and treatment with FSH, which had previously been reported to cause 
masculinisation, reduced the size of BO and of bidderian oocytes in B.vulgaris . The 
androgen  responsible  for  inhibiting  BO  development  in  vivo may  be  DHT,  as 
treatment with a 5α-R inhibitor (17βC: 2 mg/L), accelerated BO differentiation, and 
increased BO size, in larval  B.bufo . Although, in a later study, the same laboratory 
reported the opposite effect on BO in response to 17βC, under similar experimental 
conditions (Petrini & Zaccanti, 1998), therefore, to elucidate the role of androgens in 
bidderian  differentiation  and  growth  requires  further  investigation.  The  reported 
effects  of  estrogens  on  BO  are  generally  similar  to  that  of  androgens;  that  is, 
inhibition of development in larvae and degeneration in adults is normally observed, 
at  least  in  response  to  high  concentrations.  In  a  larval  study  using  B.vulgaris  
formosus,  exposure  to  0.5-1  mg/L  estradiol  or  estrone  caused  retardation  of  the 
development of BO (Takahashi, 1956), as was observed in larval  B.bufo exposed to 
0.1 mg/L estradiol (Petrini and Zaccanti, 1998). In adults, orchidectomised or intact 
B.bufo were  treated  with  diethylstilbestrol  dipropionate  (DES)  implants  for  10 
months.  In  intact  toads,  treatment  with  high  concentrations  (1000-100  µg/week) 
caused  degeneration  of  the  diplotenic  oocytes  in  BO,  whereas  low  doses  (50-1 
µg/week), enhanced development of BO. In orchidectomised toads, larger BOs were 
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observed, and enhanced BO development was observed in toads receiving 1 µg/week 
DES . Similarly, Basu & Mondal  treated intact  B.melanstictus adult males with an 
estradiol  implant,  resulting  in  dosage  of  approximately  1  mg/week,  and  reported 
degeneration  of  bidderian  oocytes.  Therefore,  in  adults,  an  inhibitory  effect  of 
estrogens on BO is reported at high concentrations, whereas a stimulatory effect is 
reported  at  lower  concentrations.  Similarly  to  effects  observed  on  the  gonad,  the 
reported effect on BO may be due to negative feedback by the exogenous compounds, 
leading to reduced gonadotropin release at high concentrations, but a local stimulatory 
effect at lower concentrations.
2.4.1.2 Thyroidal Development
The morphology , and function  of the thyroid system in Bufonidae does not appear to 
be  distinct  from  other  amphibians.  Therefore,  for  a  general  description  of  the 
amphibian thyroid system see Chapter 1 (section 1.4).
2.4.2 Methods
2.4.2.1 Experimental Design
In March/April 2006 toadspawn was collected from the 4 sites selected from breeding 
season two (Yatton: YT; Pant-y-Llyn: PYL; twenty-foot river: 20’; Layes pool: LP), 
and reared in aged tap water in the laboratory and in cages deployed at each site. 
Spawn was collected from between 2-4 different strings, although it is not known 
whether these originated from different females. 9 groups of 100 eggs were counted 
and placed in separate 50 ml centrifuge tubes with site  water.  The developmental 
stage of embryos at this time was between gastrulation and late cleavage . At 180C, 
embryos of  Rana pipiens reach the late cleavage stage at 21 hours post-fertilisation 
(Rugh,  1951),  therefore,  it  is  likely  that  the  eggs  collected  had  been  laid  in  the 
previous few days. Four cages were deployed at each site, and 100 eggs were placed 
in each cage. The remaining eggs (5 x 100) were transported to the laboratory in a 
cooled ice box. Cage design was similar to that used by Cooke . Square plastic plant 
pots (Wyevale Garden centre, 35x35x25), were leached in tap water for 48 hours. The 
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middle panels on each side of the pot were removed, leaving a large rectangular gap 
on each side. The pots were then lined with fine plastic mesh (~ 1 mm diameter) to 
allow  free  flow  of  water  and  nutrients  into  the  cage,  but  prevent  tadpoles  from 
escaping. Bubble-wrap was tied around the rim of the pot to assist flotation of the 
cage, so that tadpoles could reach the water surface (Figure 2.15). Upon deployment 
of the cages, ~2 metres of nylon wire was tied round each bottom corner of the cage, 
and the other end of this wire was tied around a breezeblock. 
Figure 2.15. Diagram of the cage used for tadpole sampling at selected sites (Panel 
A), and a photograph of the cage at PYL (Panel B).
Laboratory-reared individuals were kept in 20 Litre glass aquaria containing 12 Litre 
aged tap water, in a shaded outside environment. 5 replicate tanks were used per site, 
each containing 100 eggs collected previously. During embryo development prior to 
hatching  (~3  weeks),  water  quality  (temperature,  pH,  DO),  and  ammonia  (NH3+) 
levels  were  tested  every  7  days.  Ammonia  values  were  converted  to  unionised 
ammonia (NH3), using temperature, and pH values. Conductivity (µS/cm) was also 
measured once at the beginning of exposure. Water quality was good, and therefore, 
no water change was carried out  during this period.  At  hatching (~ 3 weeks post 
collection),  the number  of  hatched individuals  and abnormal  larvae were counted. 
Any abnormal embryos were removed and fixed in 10% neutral buffered formalin 
(NBF). The laboratory-reared individuals were culled to maintain good water quality, 
resulting in 40 larvae per tank. At this time, tanks were emptied and cleaned, before 
returning larvae to their respective tanks. Following hatching, water change (75%) 
was conducted every 48 hours, and water quality was measured prior to each change. 
There is a critical period in metamorphosis when mass mortality occurs by drowning, 
A B
86
if metamorphosing individuals cannot reach air (F.Orton, unpublished observation). 
Therefore, when tail regression began to be observed (~ 6 weeks post hatch), most of 
the  water  was  drained  from  tanks,  and  they  were  tilted  to  allow  emergence  of 
metamorphs. Sphagnum moss was also added to the tanks, to facilitate emergence. To 
avoid loss by drowning of caged individuals,  they were brought  to the laboratory 
when forelimb emergence (FLE) occurred at each site, and were kept under the same 
regime as laboratory-reared individuals, except site water was used instead of aged tap 
water.  The  young  metamorphs  were  transferred  to  vivariums  on  completion  of 
metamorphosis. Vivariums were made from plastic rat boxes (21x33x19 cm), covered 
with muslin cloth, which was held in place with elastic. The bottom of the vivarium 
was  originally  covered  with  compost,  followed  by  a  layer  of  sphagnum  moss. 
However, when the transferred metamorphs were checked the next day, almost 100% 
mortality had occurred. Therefore, the vivariums were cleaned, and the bottom was 
covered with damp sphagnum moss only. A shallow ceramic dish filled with water 
was also placed in the corner of each vivarium. Animals were initially fed wingless 
Drosophila  (Blades  Biological,  UK),  and  when  they  were  larger,  micro-crickets 
(Blades  Biological,  UK),  every  48  hours.  The  vivariums  were  also  checked  for 
moisture  at  feeding,  and  water  was added to  sphagnum moss  and ceramic  dishes 
where necessary. 
Time of spawn-deposition by amphibians is controlled mainly by temperature. Due to 
distinct environments at each site, detection of spawn, and therefore cage deployment, 
was carried out at different times at each site (YT – 29.03.06; PYL – 2.04.06; 20’ – 
3.04.06; LP – 5.04.06). Development of embryos and therefore time to hatching, also 
varied between sites, therefore, sampling was carried out on different dates from each 
site according to hatching date (see Figure 2.16). Animals were sampled at 5 time 
points following hatching (5, 7, 9, 12, and 15 weeks post hatch), based on date when 
all embryos had hatched (hatch date: YT – 21.04.07, PYL & 20’ – 24.04.07; LP – 
25.04.07). These sampling points will be described as time points (TP) 1, 2, 3, 4, and 
5, from this point onwards. At each time point, wild caught individuals were sampled, 
when found, from each site. At larval stages, tadpoles were caught with a net, and 
after metamorphosis, the area surrounding the pond was searched for metamorphs. TP 
1  &  2  occurred  prior  to  metamorphosis,  and  therefore  samples  were  of  larval 
individuals  taken  from  their  cages  at  the  various  sites.  Between  TP  2-3, 
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metamorphosis  occurred  in  most  of  the  individuals,  and  the  remaining  caged 
individuals were brought to the laboratory by sampling TP 3. Mortality was measured 
at 3 times during exposure: Firstly, initial hatching success, secondly, during larval 
period (up to TP 2), and finally, during metamorphic period (up to end of exposure). 
In addition, the incidence of forelimb emergence (FLE) was noted at TP 2 (see Figure 
2.16). In the field environment, water quality parameters (temperature, pH, DO, and 
conductivity)  were  measured  (YSI  556  handheld  multiparameter  system,  YSI 
Hydrodata UK) at the time of egg retrieval, hatching, and TP 1, 2, and 3 (5 times). 
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Figure  2.16.  Experimental  design  of  laboratory  (Lab)  and  field  site  (Cage) 
observations and sampling points  during embryonic,  larval,  and post-metamorphic 
development of Bufo bufo. See text for details.
2.4.2.2 Animals
At  each  sampling  TP,  laboratory-reared,  caged,  and  wild  caught  specimens  were 
anaesthetised by immersion in MS-222, and sacrificed by pithing. Laboratory-reared 
individuals were dabbed on tissue to remove excess water, and weighed (wgt). The 
total  length  (TL),  snout-vent  length  (SVL),  and  the  hindlimb  length  (HLL),  was 
measured with digital  callipers,  and the developmental stage was noted .  Samples 
were then fixed in neutral buffered formalin (NBF: Sigma, U.K.). Caged and wild 
specimens  were  fixed  in  NBF  prior  to  morphological  measurements,  due  to 
practicalities of taking measurements in the field environment. Therefore, correction 
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factors for weight, TL, SVL, and HLL, were calculated using measurements from 
before and after  NBF treatment  of  laboratory-reared specimens (see  Appendix 3). 
HLE, developmental stage, and FLE are thyroid sensitive morphological endpoints. 
Due  to  size  differences  between  groups,  hindlimb  length  was  expressed  as  a 
proportion of snout-vent length (HLL/SVL). A condition factor was also calculated by 
dividing the weight of the individual by SVL (wgt/SVL). Specimens were dissected 
by opening the body cavity, the intestines were removed. The gonads were removed 
for histological analysis by dissection of the middle portion of the animal by cutting 
just below the forelimbs and above the hindlimbs. The head was also cut away from 
the body, and this tissue contained the thyroid. Tissue was placed in Bouins’ solution 
for decalcification (20 hours), followed by 70% industrial methylated spirits (IMS: 24 
hours). They were placed in a tissue processor (Shandon Citadel 2000, Thermo Fisher 
Scientific, UK), and gradually dehydrated in IMS (70%, 90%, 100%), followed by 
immersion in Histoclear (RA Lamb, U.K.), and were embedded with paraffin wax. 
The heads were embedded in a vacuum oven (model 3606-1CE, Labline Instruments 
Incorporated, USA) to ensure entry of wax into cartilagenous tissue. Gonads were 
sectioned longitudinally at 7µM, and each section was mounted on a glass slide. The 
thyroids were sectioned transversally at 5 µM, and two sections were kept every 30 
µM, as recommended by OECD guidelines (unpublished). Specimens from time point 
1 were not analysed as they were too undeveloped for thyroidal or gonadal analysis. 
Morphological  parameters  and thyroid histology was analysed in  specimens taken 
from TP 2, 3, 4, & 5, and gonad histology in specimens from TP 3, 4, & 5. 
2.4.2.3 Histological Analysis
Analysis of all histological sections was undertaken blind, whereby identifying labels 
on slides were covered and coded prior to analysis.
2.4.2.3.1 Thyroidal Analysis
Animals  were  split  into  developmental  stages  prior  to  analysis,  using TK tadpole 
development  table  ,  to  allow  comparison  between  sites.  The  groups  were: 
premetamorphic (pre: TK stage 5-11), prometamorphic (pro: TK stage 12-19), climax 
(clim: TK stage 20-24), and metamorphs (TK stage 25). In most cases, pre, pro, and 
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clim  individuals  were  found  at  TP  2,  and  metamorphs  at  later  TPs.  Since 
developmental  stage  was  the  same  for  all  metamorphs,  they  were  sub-divided 
according to TP (3, 4, or 5) to show changes of the thyroid organ over time. 
2.4.2.3.1 Sex Characterisation
The  sex  of  the  individual  was  characterised  as  female,  male,  intersex,  or 
undifferentiated. Ovaries were characterised by reduction of the medulla, leading to 
formation on an ovarian cavity, and the presence of oogonial cell nests or oocytes. 
Testes  were  characterised  by  a  well  developed  medulla,  and  organisation  of 
spermatogonia  into  early  seminiferous  tubules  .  Intersex  individuals  contained  a 
minimum of one testicular oocyte per teste examined. Undifferentiated individuals 
could not be characterised as female or male due to absence of features described 
above.  
2.4.2.3.2 Cytometric Analysis
Cytometric analysis of BO and gonads was undertaken over several stages. Firstly, the 
number of sections containing the right BO, gonad, or thyroid was counted. Secondly, 
the section containing the largest area of tissue was selected by observing the middle 
section, and the preceding/proceeding 3 sections.  Photographs were then taken for 
further analysis of each tissue type (Olympus BXSI microscope, Micropublisher 5.0 
RTV  camera,  QCapturePro  5.1  software).  One  photograph  was  taken  at  x100 
magnification, which was used for measuring the area of the organ. The size of each 
organ was calculated by multiplication of the area at the largest point by the number 
of  tissue  containing  sections.  BOs,  testes,  and  thyroids  were  ovoid  in  shape,  and 
ovaries lobular, and thus the size of the organs were a relative measure for use within 
this study, not absolute values. Using this photograph of BO or ovary, the number of 
diplotenic  oocytes  with  a  visible  nucleus  was  counted,  and  total  number  was 
calculated by multiplication of counted oocytes by the number of tissue containing 
sections. A further 3 photographs were taken at x 400 or x 1000 magnification of BO 
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and ovary, which were used for measuring the size of second growth phase (SGP) and 
first growth phase (FGP) diplotenic oocytes. To ensure standard oocyte measurements 
between photographs, only oocytes with a visible nucleus were measured (the nucleus 
was generally  found in  only  1 section).  The  larger  oocytes,  which  are  also  more 
centrally located, pertain to the first oogenic wave (FGP oocytes), and the smaller and 
more peripherally located ones pertain to the second oogenic wave (SGP oocytes) . 
Every section containing testicular tissue was checked for the presence of testicular 
oocytes (TOs), and where found, the number was counted. The incidence of testicular 
oocytes  were  calculated  as  number  of  individuals  containing  testicular  oocytes 
divided by total number of females identified at that time point (normal females + 
intersex).  Severity of testicular oocytes was calculated as the number of testicular 
oocytes per intersex individual. The thyroids were analysed using OECD guidelines 
(unpublished). A scoring system (0-5, 0 indicating no perturbation from the normal 
state, and 5 indicating extreme change) was used to assess epithelial cell hypertrophy 
and hyperplasia, and colloid quality and depletion. The epithelial cell hypertrophy and 
hyperplasia values were added together to give a measure of activity of the gland, and 
the colloid quality and depletion values were added together to give a measure of 
colloid perturbation of the gland. The Bidder’s somatic index (BSI), testicular somatic 
index (TSI),  ovarian somatic  index (OSI),  and thyroid somatic  index (ThSI)  were 
calculated by dividing the volume of the organ by the weight of the individual. It is 
possible  that  by calculating the relative size of  the  organ by histological  sections 
instead of weight could introduce an artefact into the data. However, a normalising 
factor  was  necessary  due  to  the  large  differences  in  size  from  laboratory-reared, 
caged, and wild-caught individuals, and organs were too small to dissect from the 
body cavity. 
2.4.2.4 Statistical Analysis
Data were analysed for normality, and where normally distributed, were analysed for 
differences  between groups using ANOVA. Where not  normally distributed,  pairs 
were  analysed  with  Wilcoxon’s  test  and  groups  with  Kruskal  Wallis’s  test.  If 
significant differences were observed at this point, Dunnett’s test was used on both 
parametric  and  non-parametric  data  to  determine  where  these  differences  lay. 
Relationships between multiple variables were analysed using ANCOVA.
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2.4.3 Results
2.4.3.1 Water Quality
There was no difference in water quality between tanks containing laboratory-reared 
individuals  over the exposure period (ANOVA p > 0.05). Values were within the 
range expected for normal tadpole development (Table 2.3). There was no difference 
in temperature, and pH, between laboratory conditions and field sites (ANOVA p > 
0.05). However, DO was significantly higher at YT and 20’ (Dunnett’s p = 0.013 & 
0.008)  compared  to  laboratory  conditions.  Conductivity  also  varied,  and  was 
significantly  higher  at  20’  (Dunnett’s  p  <  0.0001),  and  lower  at  YT  and  PYL 
(Dunnett’s p = 0.018 & < 0.0001), compared to laboratory conditions.
Laboratory YT PYL 20’ LP
T (0C) 15.6 ± 0.02 15.2 ± 1.32 13.9 ± 1.6 15.9 ± 1.6 14.4 ± 1.5
pH 8.03 ± 0.00 8.13 ± 0.14 8 ± 0.1 8 ± 0.2 8.4 ± 0.6
DO (mg/L) 7.6 ± 0.05 11.1 ± 1.3* 8.9 ± 0.5 10.9 ± 0.6* 10.1 ± 1.7
C (µS/cm) 817.4 ± 4.2 500.5 ± 16.3* 212.3 ± 12.5* 2485.2 ± 228* 654 ± 33.6
NH3 (µg/L) 29.7 ± 0.72 N/A N/A N/A N/A
Table 2.3. Water quality in laboratory tanks and from field sites over the larval period, 
values are mean ± SE. For laboratory measurements n = 29, for field measurements n 
= 5. * denotes significant differences in water quality from field sites compared to the 
laboratory conditions
2.4.3.2 Mortality
Mortality  was  high  in  both  laboratory-reared  and  caged  individuals,  but  overall 
survival was lower in the caged individuals (YT = 2%; PYL = 3.5%; 20’ = 8%; LP = 
0%), than the laboratory individuals (YT = 11.5%; PYL = 14.5%; 20’ = 23%; LP = 
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23.5%),  and  was  below  30%  in  all  cases  (Figure  2.17).  In  laboratory-reared 
individuals,  hatching  success  was  fairly  high,  and  larvae  also  had  good  survival, 
however, high mortality was observed between larval and metamorphic stages. In the 
caged individuals, an opposite trend was observed, whereby there was low hatching 
success (except PYL, Figure 2.17, B), but mortality was less pronounced during larval 
and metamorphic periods. In addition, there were significantly more abnormal larvae 
observed in laboratory-reared individuals from LP compared to other sites (Dunnett’s 
p = 0.02, data not shown).
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Figure 2.17. Survivorship of laboratory (pink line) and caged (blue line) individuals 
from YT (Panel A), PYL (Panel B), 20’ (Panel C), and LP (Panel D). Values are 
means from either 5 replicate tanks (laboratory) or 4 replicate cages (caged). 
2.4.3.3 Morphometrics
Individuals from LP were not analysed morphologically due to 100 % mortality in 
caged individuals at  an early stage of the experiment,  and absence of wild-caught 
individuals.  Morphometric  comparisons  between  laboratory-reared  individuals 
showed significant differences in growth and development parameters between YT, 
PYL, and 20’ (Table 2.4). Generally, individuals from YT were bigger (wgt, SVL, 
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wgt/SVL)  than  those  from  PYL  or  20’.  This  difference  persisted  over  the 
experimental period for individuals from 20’, but individuals from PYL were only 
significantly  smaller  than  YT  at  TP  3.  Laboratory-reared  individuals  from  PYL 
developed more slowly (stage, HLL, HLL/SVL) than those from YT or 20’, and this 
difference  also  persisted  over  the  experimental  period.  Percentage  of  FLE  of 
laboratory-reared individuals  (at  TP 2)  was also significantly  lower  in  individuals 
from  PYL compared  to  YT  and  20’.  Significant  differences  between  laboratory-
reared, caged, and wild caught individuals within each site were also observed (Table 
2.4).  Caged  and  wild  caught  individuals  were  smaller  (wgt,  SVL,  wgt/SVL)  and 
developed  more  slowly  (stage,  HLL,  HLL/SVL)  than  their  respective  laboratory-
reared counterparts  at  each site.  These differences persisted over the experimental 
period at PYL and YT (but only until TP4 at 20’), but became less pronounced over 
time.  In addition,  percentage of FLE was significantly  lower in caged individuals 
from PYL and 20’ compared to their laboratory-reared counterparts, but this effect 
was  not  observed  at  YT.  By time  point  5,  differences  between laboratory-reared, 
caged, and wild caught individuals were less pronounced at all sites, and only weight 
(YT), SVL (YT, PYL), and HLL/SVL (20’), were significantly different. At YT and 
20’, few significant differences in growth or development between caged and wild 
caught  individuals  was  observed,  however,  at  PYL wild  caught  individuals  were 
larger and more developed than caged individuals (TP3 – only TP where both caged 
and wild caught individuals were present).
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Yatton Pant-y-Llyn 20’
a/b x/y/z x/y/z x/y/z a/b x/y/z x/y/z x/y/z a/b x/y/z x/y/z x/y/z
Time Point 2 Lab Cage Wild Lab Cage Wild Lab Cage Wild
N 25 13 5 25 10 None 25 16 5
Stage (TK) 19abx 18xy 16y 18ax 7.5y --------------- 20bx 16y 14z
Wgt (mg) 436 (23)ax 189 (10)y 258 (15)y 394 (16)abx 113 (15)y --------------- 351 (7)bx 317 (7)y 371 (3)x
SVL (mm) 13.9 (0.2)ax 10.7 (0.1)y 11.7 (0.4)z 13.6 (0.4)ax 8 (0.4)y --------------- 12.7 (0.1)bx 11.5 (0)y 12.2 (0.3)z
HLL (mm) 12.4 (0.3)ax 8.1 (0.7)y 8.3 (0.7)y 11.4 (0.3)bx 1.3 (0.1)y --------------- 11.8 (0.3)abx 6.2 (0.2)y 4.8 (0.8)z
FLE (%) 44.4a 24.4 --------------- 26.5bx 0y --------------- 62.7cx 0y ---------------
Wgt/SVL 31 (1.2)ax 17.7 (0.9)y 22 (0.7)y 29.2 (1.1)abx 13.8 (1.1)y --------------- 27.7 (0.5)b 27.6 (0.6) 30.4 (1.9)
HLL/SVL 0.9 (0.03)abx 0.76 (0.06)y 0.7 (0.04)y 0.85 (0.03)ax 0.15 (0.02)y --------------- 0.93 (0.02)bx 0.54 (0.02)y 0.39 (0.06)z
Time Point 3 Lab Cage Wild Lab Cage Wild Lab Cage Wild
N 13 4 9 14 10 10 21 13 5
Stage (TK) 25x 25x 24.5y 25x 18.5y 21z 25x 25x 24.5y
Wgt (mg) 271 (15)ax 79 (7)y 71 (4)y 219 (9)bx 139 (13)y 226 (11)x 212 (8)bx 133 (5)y 172 (14)xy
SVL (mm) 14.4 (0.3)ax 8.3 (0.2)y 7.9 (0.1)y 13.6 (0.2)bx 11.1 (0.2)y 13.8 (0.3)x 13.3 (0.2)c 13.3 (0.1) 13.1 (0.5)
HLL (mm) 16.4 (0.5)ax 10.4 (0.3)y 9.8 (0.2)y 14.6 (0.3)bx 6.5 (1.1)y 13.4 (0.5)x 15.1 (0.2)bx 13.9 (0.2)y 13.7 (0.6)y
Wgt/SVL 18.6 (0.8)ax 8.5 (0.6)y 7.8 (0.4)y 16 (0.5)bx 12.4 (1.1)y 16.3 (0.6)x 15.8 (0.4)bx 10 (0.3)y 13 (0.7)z
HLL/SVL 1.13 (0.02)ax 0.99 (0.01)y 0.96 (0.02)y 1.07 (0.02)bx 0.6 (0.11)y 0.97 (0.02)x 1.14 (0.01)ax 1.05 (0.01)y 1.04 (0.02)y
Time Point 4 Lab Cage Wild Lab Cage Wild Lab Cage Wild
N 5 2 5 10 4 None 15 10 1
Stage (TK) 25 25 25 25-x 19-y --------------- 25 25 25
Wgt (mg) 364 (54)a-x 109 (6)-y 107 (29)-y 301 (18)ab-x 62 (16)-y --------------- 277 (16)b 234 (18) 268 (0)
SVL (mm) 15.3 (0.9)-x 10.3 (0.3)-y 10.6 (0.8)-y 14.7 (0.4)-x 8.3 (0.2)-y --------------- 14.0 (0.2)-x 12.7 (0.3)-y 15.8 (0)
HLL (mm) 18.2 (0.5)a-x 13.5 (0)-y 10.7(0.9)-y 17.3 (0.5)ab-x 7.3 (3.1)-y --------------- 16.8 (0.3)b 16.9 (0.4) 16.8 (0)
Wgt/SVL 23.3 (2.6)-x 11.8 (0.2)-y 10.7 (1.9)-y 20.4 (0.7)-x 7.5 (1.8)-y --------------- 19.8 (1.1) 18.2 (1.0) 13 (0.7)
HLL/SVL 1.2 (0.05) 1.21 (0.03) 1.18 (0.03) 1.18 (0.02) 0.89 (0.4) --------------- 1.21 (0.02)-x 1.29 (0.02)-y 1.06 (0)
Time Point 5 Lab Cage Wild Lab Cage Wild Lab Cage Wild
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N 5 2 None 5 None 5 10 9 None
Stage (TK) 25 25 -------------- 25 -------------- 25 25 25 ---------------
Wgt (mg) 575 (55)ax 294 (7)y -------------- 624 (93)a -------------- 523 (69) 386 (36)b 337 (39) ---------------
SVL (mm) 17.6 (0.8)ax 13.9 (0.8)y -------------- 18.5 (0.8)ax -------------- 15.9 (0.7)y 15.7 (0.4)b 14.7 (0.5) ---------------
HLL (mm) 20.6 (0.9) 14.7 (0) -------------- 19.1 (0.2) -------------- 17.5 (0.8) 18.6 (0.4) 19.1 (0.6) ---------------
Wgt/SVL 32 (1.9) 23.7 (1.9) -------------- 33.2 (3.5) -------------- 32.5 (2.9) 24.2 (1.5) 22.4 (1.8) ---------------
HLL/SVL 1.15 (0.02)a 1.15 (0.07) -------------- 1.03 (0.02)bx -------------- 1.1 (0.02)y 1.19 (0.02)ax 1.2 (0.01)y ---------------
Table 2.4. Morphometric parameters measured in laboratory-reared, caged, and wild individuals from each site and time point. Values are means (± se), except for stage & 
FLE, which are median and percentage values respectively. Letters denote significant differences found within each time point for the various endpoints measured. a/b = 
differences between laboratory-reared individuals from each site at each time point. x/y/z = differences between laboratory-reared, caged, and wild individuals within each 
site at each time point. Absence of a letter following a value indicates no significant differences were observed
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2.4.3.4 Thyroidal Analysis
The thyroids are paired glands located in the neck of the amphibian and consist of 
numerous follicles, surrounded by epithelial cells, and filled with colloid (Figure 2.18, 
A-J). A clear distinction can be observed between the thyroids of prometamorphic and 
climax tadpoles taken from time point 2 (Figure 2.18, A-D), and those taken from 
metamorphs (Figure 2.18, E-J). The thyroids of tadpoles are larger, and composed of 
more  follicles  of  different  sizes  (Figure  2.18,  A  &  C),  compared  to  those  from 
metamorphs  (Figure  2.18,  E-J).  The  epithelial  cells  are  elongated  in  tadpoles 
(hypertrophy), indicating stimulation by thyroid stimulating hormone (Figure 2.18, B, 
D), whereas they are cuboidal in metamorphs, indicating reduced stimulation (Figure 
2.18,  F,  H,  J).  In  addition,  in  some specimens there was more than one layer  of 
epithelial  cells  for  each  follicle  (hyperplasia),  also  indicating  increased  glandular 
activity (Figure 2.18,  A-J).  The colloid in these photos is  of good quality and no 
depletion  can  be  observed,  as  would  be  expected  in  un-impacted  individuals. 
However, colloid degeneration was observed in some individuals (Figure 2.19, A, B, 
C, D), which included bubbles near to the epithelial cells in minimal cases (Figure 
2.19,  A),  with those bubbles becoming larger in moderate cases (Figure 2.19,  B), 
leading  to  increased  colloid  depletion  in  severe  cases  (Figure  2.19,  C),  and  and 
complete loss of the colloid from some follicles in very severe cases (Figure 2.19, D). 
These changes to the colloid were not necessarily linked to changes in epithelial cells 
(Figure 2.19,  A & D),  although stimulation of epithelial  cells  in conjunction with 
colloid  depletion  was  also  observed  (Figure  2.19,  B  &  C).  Similarly,  increased 
activity of the thyroid was not always associated with changes in the colloid (Figure 
2.19, E), although in some cases both occurred simultaneously (Figure 2.19, F). In 
some individuals there also appeared to by a high proportion of epithelial cells for 
each follicle (Figure 2.19, G & H). Occasionally, eosinophilic cells were observed in 
the thyroid (Figure 2.19, F), which may be connective tissue , although it is unknown 
why it was found in a few specimens.
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Figure  2.18.  Histological  sections  showing  thyroidal  development  in  Bufo  tadpoles  and 
metamorphs, photos taken at x 100 (Panels A, C, E, G, I) and x 400 (Panels B, D, F, H, I) 
magnification. Panels A & B represent the thyroid of tadpoles in the prometamorphic stage of 
development, and panels C & D tadpoles in the climax stage of development. Panels E & F 
represent metamorphs from time point 3, G & H from time point 4, and I & J from time point 
5. F = follicle, E = epithelial cell, C = colloid.
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Figure  2.19.  Examples  of  thyroidal  abnormalities  in  Bufo  tadpoles  and  metamorphs.  All 
photos taken at x 400 magnification. Panels A-D show colloid degeneration ranging from 
minimal (Panel A) to very severe (Panel D). Panels E & F show hypertrophy, and G & H 
show hyperplasia. Panel F also shows presence of unknown eosinophilic cells in the thyroid. 
Panel A  = caged specimen from PYL (TP 3); Panel B = wild caught specimen from YT (TP 
4); Panel C = caged specimen from 20’ (TP 5); Panel D = laboratory-reared specimen from 
YT (TP 4); Panel E = wild caught specimen from PYL (TP 3); Panel F = laboratory-reared 
specimen from 20’ (TP 3); Panel G = wild caught specimen from PYL (TP 5); Panel H = 
laboratory-reared specimen from 20’ (TP 3). 
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The ThSI increased up to time point 3, and then decreased at TPs 4 & 5, and was 
similar between sites in laboratory-reared individuals (Figure 2.20, A). At all sites, the 
ThSI was smaller in caged and wild caught individuals compared to laboratory-reared 
individuals,  in  at  least  one  time  point.  At  YT  (Figure  2.20,  B),  the  ThSI  of 
prometamorphic tadpoles were significantly smaller in caged (Dunnett’s p = 0.011) 
and  wild  caught  (Dunnett’s  p  =  0.017)  individuals.  The  ThSI  of  wild  caught 
individuals  at  TP  4  was  significantly  greater  than  laboratory-reared  individuals 
(Dunnett’s p = 0.04). A similar trend was observed for the caged individuals at this 
time  point,  but  it  could  not  be  verified  statistically  as  the  thyroid  of  only  one 
individual was analysed (one was lost during processing, Figure 2.20, B). At PYL 
(Figure  2.20,  C),  ThSI  of  caged  prometamorphic  individuals  was  smaller  than 
laboratory-reared  individuals  (Dunnett’s  p  <  0.0001).  Other  comparisons  were 
difficult due to the slow development at this site, which resulted in all cage and wild 
caught individuals to be at climax stage at TP 3. At 20’ (Figure 2.20, D), the ThSI of 
caged  and  wild-caught  individuals  was  always  smaller  than  laboratory-reared 
individuals (Dunnett’s p < 0.001), except at TP 5. At all sites, prometamorphic and 
climax groups from caged and wild caught individuals were represented by tadpoles 
at an earlier stage of developmental stage, than groups comprised of laboratory-reared 
individuals  (data  not  shown).  Therefore,  to  compare  caged  and  wild  caught 
individuals  to their  representative laboratory-reared counterparts,  stage was plotted 
against  ThSI  for  premetamorphic,  prometamorphic,  and  climax  tadpoles,  and 
tadpoles/metamorphs from TP 3 (Figure 2.21). ThSI was not significantly affected by 
treatment (laboratory-reared, caged, or wild caught) at YT (Figure 2.21, A, ANCOVA 
p = 0.33) or PYL (Figure 2.21, B, ANCOVA p = 0.43), but was significantly affected 
at 20’ (Figure 2.21, C, ANCOVA p < 0.0001). In addition, ThSI was significantly 
affected by developmental stage at YT (Figure 2.21, A, ANCOVA p < 0.0001) and 
20’ (Figure 2.21, C, p < 0.0001), but not at PYL (Figure 2.21, B, ANCOVA p = 0.27). 
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Figure  2.20.  ThSI  of  laboratory-reared,  caged  and  wild-caught  individuals  of 
premetamorphic (pre), prometamorphic (pro), and climax (clim) stage tadpoles, and 
metamorphs sampled at  TP 3,  4,  and 5.  Panel  A = laboratory-reared comparison, 
Panel  B  =  individuals  from  YT,  Panel  C  =  individuals  from  PYL,  Panel  D  = 
individuals  from  20’.  *  denotes  significant  differences  of  caged  or  wild-caught 
individuals compared to their laboratory-reared counterparts. Values are mean ± SE, 
for n values see Table 2.4. Missing bars indicate an absence of sampled individuals, 
except PYL (Panel C), where ThSI of clim tadpoles were obtained at TP3, so no 
values for TP3 were available. 
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Figure  2.21.  ThSI  of  laboratory-reared,  caged  and  wild-caught  individuals  plotted  against 
developmental stage (TK = Taylor-Kollros). Premetamorphic, prometamorphic, and climax tadpoles, 
and tadpoles/metamorphs from TP 3 were plotted. Each point represents one individual. Panel A = YT, 
Panel B = PYL, Panel C = 20’. Lines are linear regressions; YT: r2 = 0.68, p < 0.0001 (Lab: r2 = 0.58, p 
= 0.0002; Cage: r2 = 0.62, p = 0.0002; Wild: r2 = 0.82, p < 0.0001); PYL: r2 = 0.52, p < 0.0001 (Lab: r2 
= 0.14, p = 0.07; Cage: r2 = 0.63, p < 0.0001; Wild: r2 = 0.17, p = 0.24); 20’: r2 = 0.67, p < 0.0001 (Lab: 
r2 = 0.16, p = 0.03; Cage: r2 = 0.67, p < 0.0001; Wild: r2 = 0.82, p = 0.0003)
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Activity  of  the  thyroid  gland  was  similar  between  sites  of  laboratory-reared 
individuals from YT, PYL and 20’, and the general trend was a decrease in activity 
over  time  (Figure  2.22,  A).  Activity  was  decreased  in  caged  and  wild  caught 
individuals  from YT in  prometamorphic  tadpoles  (Figure  2.22,  B,  Wilcoxon  p  = 
0.0059), no effects were observed at PYL (Figure 2.22, C), and activity was decreased 
in  caged  individuals  from  20’  at  time  point  3  compared  to  laboratory-reared 
individuals (Figure 2.22, D, Wilcoxon p = 0.0023). 
Figure 2.22. The activity of the thyroid gland in laboratory-reared, caged, and wild-
caught individuals in premetamorphic (pre), prometamorphic (pro), and climax (clim) 
stage tadpoles, and metamorphs sampled at TP 3, 4, and 5. Panel A = laboratory-
reared comparison, Panel B = individuals from YT, Panel C = individuals from PYL, 
Panel D = individuals from 20’. * denotes significant differences between caged or 
wild-caught individuals and their laboratory-reared counterparts. Values are mean ± 
SE, for n values see Table 2.4. 
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The quality  of the colloid was similar  between laboratory-reared individuals  from 
each  site  (Figure  2.23,  A).  The  colloid  quality  was  worse  (high  value)  in 
prometamorphic tadpoles from YT (Figure 2.23, B) and 20’ (Figure 2.23, D) in caged 
and  wild-caught  individuals,  though  this  difference  was  only  significant  at  20’ 
(Wilcoxon p = 0.002). No difference was observed in individuals from PYL (Figure 
2.23, C), or at later TP in any sites.
Figure 2.23. The colloid quality of the thyroid gland in laboratory-reared, caged and 
wild-caught  individuals  during  premetamorphic  (pre),  prometamorphic  (pro),  and 
climax (clim) stage tadpoles, and metamorphs sampled at  TP 3, 4, and 5 (0 = no 
disturbance to colloid, 10 = severely impacted colloid). Panel A = laboratory-reared 
comparison, Panel B = individuals from YT, Panel C = individuals from PYL, Panel 
D = individuals from 20’. * denotes significant differences of caged and wild-caught 
individuals compared to their laboratory-reared counterparts. Values are mean ± SE, 
for n values see Table 2.4. 
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2.4.3.5 Bidderian and Gonadal Development
Morphological differences in the shape of BO and bidderian oocytes, was observed 
between individuals (Figure 2.24, A-F). BOs contained both FGP and SGP oocytes 
(Figure 2.24 C,D), and had a layer of epithelial cells surrounding each oocyte (Figure 
2.24, A-F). Multi-nucleate oocytes were often observed (Figure 2.24 A,B), and atretic 
oocytes were also observed occasionally (Figure 2.24, D).
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Figure 2.24. Features of BO observed in laboratory-reared individuals. Panel’s A, C, 
E & F = x 100 magnification; Panels B & D = x 400 magnification. FB = fat body, 
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FGP = first growth phase oocyte, SGP = second growth phase oocyte, V = oocyte 
containing >1 nuclei, A = atretic oocyte.  
Four sexes were characterised during histological analysis, undifferentiatied (Figure 
2.25),  female  (Figure  2.26,  2.27),  male  (Figure  2.28)  and  intersex  (Figure  2.28). 
Undifferentiated gonads were either, long and thin, but lacking in an ovarian cavity 
(Figure 2.25, A & B), or shorter but lacking testicular features (Figure 2.25 C & D). 
Early ovarian development is characterised by reduction of the medulla, resulting in 
formation of an ovarian cavity (Figure 2.26, A-F).  In some individuals, diplotenic 
oocytes were observed before the ovarian cavity could be well characterised (Figure 
2.26, A,B). In other individuals, a prominent ovarian cavity was observed, but germ 
cells were in oogonial cell nests (Figure 2.26, C-F). Oogonia gradually increase in 
size during development towards becoming oocytes (Figure 2.26, D,F). As the ovary 
develops, the ovarian cavity becomes more pronounced, and oocytes become larger 
(Figure 2.27, A-F). In addition, FGP and SGP oocytes were observed in the older 
metamorphs  (Figure  2.27,  C-F).  Testicular  development  was  more  retarded  than 
ovarian development and development did not proceed past the spermatogonial stage 
(Figure 2.28, A-D), even in individuals 6 weeks post metamorphosis (Figure 2.28, 
C,D). However, they were identified by medullary development, and the presence of 
smaller densely packed germ cells. The shape of the teste changed over time, and 
became  shorter  and  rounder  in  older  metamorphs  (Figure  2.28,  A-D),  TOs  were 
observed in some individuals (intersex), and several were often observed in one teste 
(Figure 2.28, E,F). 
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Figure  2.25.  Undifferentiated  gonads  from young metamorphs,  all  taken  at  x  100 
magnification. Some were long and thin, but lacking an ovarian cavity (Panel A,B) 
and others were shorter, but could not clearly be characterised as testes (Panel C,D). 
G = Gonad, BO = Bidder’s organ, K = Kidney.
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Figure 2.26. Early ovarian development in young metamorphs (all taken from TP 3). 
Panels A, C, & E  = x 100 magnification; Panels B, D, & F = x 400 magnification. BO 
= Bidder’s organ, OC = ovarian cavity, D = diplotenic oocyte, O = oogonial nest. See 
text for details.
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Figure 2.27.  Ovaries from older  metamorphs,  showing ovarian development  (time 
points (TP) 3, 4 & 5). Panel A & B = ovary from TP 3 taken at x 100 & x 400 
magnification, respectively; Panel C & D = ovary from TP 4 taken at x 100 and x 400 
magnification, respectively; Panel E & F = ovary from TP 5 taken at x 100 and x 400 
magnification, respectively. OC = ovarian cavity, FGP = first growth phase oocyte, 
SGP = second growth phase oocyte, O = oogonia.
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Figure 2.28. Testes from metamorphs showing testicular development and testicular 
oocytes from different time points (TP). Panel A = teste from TP 3 (x 100); Panel B = 
teste from TP 4 (x 100); Panel C = teste from TP 5 (x 100); Panel D = teste from TP 5 
(x 400); Panel E = teste showing TO’s (x 400); Panel F = teste showing TO’s (x 400). 
BO = Bidder’s organ, T = teste, TO = testicular oocyte.
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Perturbations from development in laboratory-reared individuals (Figure 2.26-2.28), 
were observed in caged and wild individuals from each site. At YT, retardation of 
gonadal  development  was  observed  (Figure  2.29),  at  PYL  unusual  gonads  were 
observed in wild-caught individuals (desribed below, Figure 2.30), and at 20’ a high 
incidence of intersex individuals were identified (Figure 2.31). Caged and wild-caught 
individuals from YT were undifferentiated at TP4 (Figure 2.29, A & B, respectively), 
which  was  never  observed  at  other  sites.  In  addition,  ovarian  development  was 
retarded  (Figure  2.29,  C-G).  At  TP3,  oogonial  cell  nests  could  be  observed  in 
laboratory-reared individuals (Figure 2.29, C), whereas oogonia were less developed 
in caged individuals, and the only distinguishing feature was an ovarian cavity (Figure 
2.29, D). At TP4, an ovary containing diplotenic oocytes was observed in laboratory-
reared individuals (Figure 2.29, E), whereas only a few small oocytes and oogonial 
cell nests could be observed in caged individuals (Figure 2.29, F). At TP5, ovaries 
from both laboratory-reared and caged individuals were well developed, but ovaries 
and diplotenic oocytes were larger in laboratory-reared individuals (Figure 2.29, H), 
compared with the caged individual (Figure 2.29, G). Males could not be compared at 
YT because they were never observed in caged individuals.  At  PYL, ovarian and 
testicular development in laboratory-reared individuals followed the normal pattern 
(Figure 2.30,  A-F).  All  caged individuals  were undifferentiated at  TP3, and those 
from TP4 were lost, therefore their development could not be compared. However, 
wild-caught individuals were retrieved at TP5, and gonads were unusual (Figure 2.30, 
G & H). The ovary contained small oocytes but no ovarian cavity (Figure 2.28, G), 
and the teste was also underdeveloped compared to laboratory-reared individuals from 
the same time point, and had a dense area of cells in the medulla (Figure 2.30, H). At 
20’, ovarian and testicular development was similar in laboratory-reared (Figure 2.31, 
A & C) and caged individuals (Figure 2.31, B & D), at TP3 (Figure 2.31, A & B) and 
TP4 (Figure  2.31,  C  & D).  However,  a  high  incidence  of  testicular  oocytes  was 
observed in both laboratory-reared and caged individuals (Figure 2.31, E-H). There 
seemed to be more TOs in laboratory-reared (Figure 2.31, E & G) than caged (Figure 
2.31, F &H) individuals. No ovaries were observed at TP5 in caged individuals for 
comparison. 
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Figure  2.29.  Gonadal  development  at  YT  at  different  time  points  (TP).  Panel  A  = 
undifferentiated gonad from caged individual (x 400, TP4); Panel B = undifferentiated gonad 
from wild-caught individual (x 100 TP4); Panel C = immature ovary from laboratory-reared 
individual (x 100 TP3); Panel D = caged individuals (x 100 TP3); Panel E = ovary from 
laboratory-reared individual (x 100 TP4); Panel F = ovary from caged individual (x 100 TP4); 
Panel H = ovary from laboratory-reared individual (x 100 TP5); Panel G = ovary from caged 
individual (x 100 TP5). For list of abbreviations see Figure 2.27.
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Figure 2.30. Gonadal development at PYL at different time points (TP). Panel A  = immature 
ovary  from  laboratory-reared  individual  (TP3);  Panel  B  =  teste  from  laboratory-reared 
individual (TP3); Panel C = ovary from laboratory-reared individual (TP4); Panel D = teste 
from laboratory-reared individual (TP4); Panel E = ovary from laboratory-reared individual 
(TP5); Panel F = teste from laboratory-reared individual (TP5); Panel G = ovary from wild-
caught individual (TP5); Panel H = teste from wild-caught individual (TP5). T = teste, M = 
medullary, for list of other abbreviations see Figure 2.27.
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Figre 2.31.  Gonadal development at 20’ from different time points (TP). Panel A & B = 
immature ovary from laboratory-reared and caged individual (x 100, TP3), respectively; Panel 
C & D = ovary from laboratory-reared and caged individual (x 100, TP4), respectively; Panel 
E  &  F  =  intersex  gonads  from  laboratory-reared  and  caged  individuals  (x  400,  TP4), 
respectively; Panel G & H = intersex gonads from laboratory-reared and caged individuals (x 
400, TP5), respectively. TO = testicular oocyte, for other abbreviations see Figure 2.27.  
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2.4.3.6 Sex Ratios
Using the histological sex characterisations described,  n values of different sexes at 
each time point were determined for YT, PYL, and 20’ (Table 2.5). In laboratory-
reared individuals,  sex ratios  from pooled  time points  were significantly  different 
between sites (Chi2 p = 0.01), more undifferentiated individuals were observed at YT, 
and more intersex at 20’ (Table 2.5). Comparison of sex ratios at YT and PYL from 
laboratory-reared,  caged,  and  wild  caught  caught  individuals  were  not  analysed 
statistically due to the low n values at these sites. However, it can be observed that 
more undifferentiated individuals were observed in caged and wild caught individuals 
from YT and PYL, compared to their laboratory-reared counterparts (Table 2.5). Sex 
ratios changed over time in laboratory-reared individuals (pooled from different sites 
and split into time points, Chi2 p = 0.0001), and the percentage of females remained at 
~40 %, whereas the percentage of  undifferentiated,  intersex,  and male individuals 
differed (data not shown). At 20’, a high proportion of intersex was observed, both in 
laboratory-reared and caged individuals (Table 2.5). No difference in sex ratio was 
observed between laboratory-reared and caged individuals at this site (Chi2 p = 0.5), 
but there was a significant change over time in caged individuals (Figure 2.32, A, Chi2 
p = 0.005), but not in laboratory-reared individuals (Figure 2.32, B, Chi2 p = 0.05). 
The  proportion  of  intersex  and  male  individuals  increased  over  time,  while  the 
proportion of females decreased at both sites, and no females were observed in caged 
individuals at TP 5 (Figure 2.32, B). If intersex individuals were classified as female, 
and undifferentiated individuals as male, the comparison between laboratory-reared 
and caged individuals at 20’ was very similar (Table 2.5, Chi2 p = 0.7). 
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YT PYL 20’
TP F I M U T F I M U T F I M U T
L 3 5 0 1 7 13 6 1 4 2 13 12 2 4 3 21
4 4 0 1 0 5 1 0 8 0 9 5 4 6 0 15
5 1 2 2 0 5 3 0 2 0 5 3 4 3 0 10
Total 10 2 4 7 23 10 1 14 2 27 20 10 13 3 46
Raw % 44 9 17 30 100 37 4 52 7 100 43 22 28 7 100
Adj. % 53 47 100 41 59 100 65 35 100
C 3 2 0 0 2 4 0 0 0 9 9 8 2 1 2 13
4 1 0 0 1 2 0 0 0 0 0 3 4 3 0 10
5 2 0 0 0 2 0 0 0 0 0 0 4 5 0 9
Total 5 0 0 3 8 0 0 0 9 9 11 10 9 2 32
Raw % 63 0 0 37 100 0 0 0 100 100 34 32 28 6 100
Adj. % 63 37 100 0 100 100 66 34 100
W 3 0 0 0 9 9 0 0 1 9 10 3 0 1 1 5
4 0 0 1 4 5 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 1 0 4 0 5 0 0 0 0 0
Total 0 0 1 13 14 1 0 5 9 15 3 0 1 1 5
Raw % 0 0 7 93 100 7 0 33 60 100 60 0 20 20 100
Adj. % 0 100 100 7 93 100 60 40 100
Table 2.5. N values and percentages of each sex at YT, PYL and 20’, in laboratory-reared (L), 
caged (C), and wild-caught (W) individuals, sampled at time points (TP) 3, 4, & 5. Raw % = 
percentage  of  each  sex;  Adj.  %  =  adjusted  percentage  (female  +  intersex  or  male  + 
undifferentiated). T = total number, F = female, M = male, I = intersex, U = undifferentiated. 
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Figure  2.32.  Sex  ratio  of  individuals  from 20’,  at  different  time  points  (3,  4,  or  5),  in 
laboratory-reared (Panel A) and caged (Panel B) individuals. A significant difference over 
time was observed in caged individuals, but not laboratory-reared individuals.  = F,  = I,  
= M,  = U.
2.4.3.7 Cytometric Analysis
2.4.3.7.1 Bidder’s Organ
Sex-specific: There  were  no  sex-specific  differences  in  BSI,  number  of  bidderian 
oocytes,  or  size  of  bidderian  FGP  oocytes  within  sites  in  laboratory-reared 
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individuals,  except  BSI  of  undifferentiated  individuals  were  larger  than  intersex 
individuals  at  20’  (t-test  p  =  0.037).  Due  to  the  minimal  effect  of  sex  on  BSI, 
bidderian  FGP number,  or  bidderian  FGP size  within  sites,  BO data  was  pooled 
between sexes for further analysis (data not shown). 
Laboratory-reared:  In  laboratory-reared  individuals,  there  were  differences  in  BO 
measurements between sites.  The BSI was larger in individuals from PYL & 20’, 
compared to YT (Figure 2.33,  non-significant),  and the number of bidderian FGP 
oocytes was larger in PYL & 20’, compared to YT (ANOVA p = 0.002, Figure 2.35, 
A). In contrast, the size of bidderian FGP oocytes was larger in individuals from YT 
compared to PYL & 20’ (ANOVA p = 0.01, Figure 2.36, A). 
Site  comparison:  At  YT,  BSI  was  significantly  smaller  in  the  caged  individuals, 
compared to their laboratory-reared counterparts (Figure 2.33, Dunnett’s p = 0.001), 
and this difference was observed at all three TP (Figure 2.34, ANOVA p < 0.04), 
however,  this  effect  was  not  observed  in  wild-caught  individuals.  BSI  was  also 
reduced in both caged and wild caught individuals at TP 3 from PYL (ANOVA p < 
0.002), and 20’ (ANOVA p < 0.0001), but no effect was observed at other TPs (data 
not shown. The number of bidderian FGP oocytes from pooled TPs (3, 4, & 5) was 
significantly  higher  in  caged  and  wild-caught  individuals  from  YT  compared  to 
laboratory-reared individuals (Figure 2.35, A, Kruskal-Wallis p = 0.002, Dunnett’s p 
= 0.0008 and 0.0004, respectively), and this difference became less pronounced over 
time (Figure 2.35, B). At PYL (Figure 2.35, C) and 20’ (Figure 2.35, D), significantly 
more bidderian FGP oocytes were observed in caged compared to laboratory-reared 
individuals at TP3 only (Kruskal-Wallis p = 0.03, Dunnett’s p = 0.037 & Kruskal-
Wallis p = 0.005, Dunnett’s p = 0.001). The size of bidderian FGP was smaller in 
caged and wild-caught individuals from YT (Figure 2.36, B, Dunnett’s p < 0.002), 
and in  caged individuals  from 20’ (Figure 2.36,  D, Dunnett’s  p = 0.029),  at  TP3 
compared to their laboratory-reared counterparts. 
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Figure 2.33. Pooled BSI values from each time point (3, 4, & 5) at YT, PYL and 20’. 
Lab = laboratory-reared, Cage = caged, Wild = wild caught. Values are mean ± se, for 
n values,  see Table 2.5. * indicates statistically significant difference compared to 
their laboratory-reared counterpart
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Figure 2.34. Change in BSI over time (TP 3, 4, & 5) at YT. Lab = laboratory-reared, 
Cage = caged, Wild = wild caught. Values are mean ± se, for n values, see Table 2.5. 
*  indicates  statistically  significant  difference  compared  to  their  laboratory-reared 
counterpart. 
118
Site
3L 3C 3W 4L 4C 4W 5L 5C 5W
F
G
P
/m
m2
0
500
1000
1500
2000
2500
Site
3L 3C 3W 4L 4C 4W 5L 5C 5W
F
G
P
/m
m2
0
200
400
600
800
1000
1200
1400
Site
YL YC YW PL PC PW 20L 20C 20W
F
G
P
/m
m2
0
500
1000
1500
2000
2500
Site
3L 3C 3W 4L 4C 4W 5L 5C 5W
F
G
P
/m
m2
0
200
400
600
800
1000
1200
1400
* *
Lab 
Cage 
Wild 
Lab 
Cage 
Wild 
Lab 
Cage 
Wild 
* *
* *
A B
C D
Time Point
Time Point Time Point
F
G
P
/m
m2
F
G
P
/m
m2
F
G
P
/m
m2
F
G
P
/m
m2
F
G
P
/m
m2
F
G
P
/m
m2
F
G
P
/m
m2
F
G
P
/m
m2
F
G
P
/m
m2
F
G
P
/m
m2
F
G
P
/m
m2
F
G
P
/m
m2
F
G
P
/m
m2
F
G
P
/m
m2
F
G
P
/m
m2
F
G
P
/m
m2
Figure 2.35. The number of bidderian FGP oocytes at YT (Y), PYL (P), and 20’ (20), in laboratory-
reared (L), caged (C), and wild caught (W) individuals at different time points (3, 4, or 5). Panel A = 
pooled timepoints; Panel B = YT; Panel C = PYL; Panel D = 20’. Values are medians (line in box), and 
interquartile ranges. For  n values see Table 2.5. * indicates significant difference compared to their 
laboratory-reared counterpart.
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Figure 2.36. The size of bidderian FGP oocytes at YT, PYL, and 20’, in laboratory-reared (L), caged 
(C), and wild caught (W) individuals. Panel A = laboratory-reared comparison (pooled time points 3, 4, 
& 5), Panel B = YT, Panel C = PYL, Panel D = 20’. Values are means ± se. For n values see Table 2.5. 
* indicates significant difference compared to their laboratory-reared counterpart.
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2.4.3.7.2 Ovary
The ovary increased in size compared to the body weight over time at all sites, and 
expecially  between TP 4  & 5  (Figure  2.37).  Sex  was not  differentiated  in  caged 
individuals from PYL, and only one female was observed in wild caught individuals, 
therefore ovarian development at this site could not be analysed. The OSI was not 
affected by the BSI or environmental conditions (i.e. laboratory-reared or caged) at 
YT (ANCOVA p = 0.37 & 0.67), however, both variables affected the OSI at 20’ 
(ANCOVA p = 0.07 & 0.05), and the OSI was smaller  in caged individuals than 
laboratory-reared. The size of ovarian FGP oocytes in caged individuals were also 2-
fold smaller than those from laboratory-reared individuals (Wilcoxon p = 0.016, data 
not shown). 
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Figure 2.37.  OSI at  YT,  PYL, and 20’  from laboratory-reared (L)  and caged (C) 
individuals at TP 3, 4, and 5. Values are mean ± se, for n values see Table 2.5.
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2.4.3.7.3 Teste
No site  specific  differences  were observed in TSI of laboratory-reared individuals 
(Figure 2.38, A). However, the trend differed over time, whereby, at YT, TSI stayed 
the same over time, at PYL, TSI decreased over time, and at 20’, TSI decreased and 
then increased over time (Figure 2.38,  A).  TSI was significantly smaller  in caged 
individuals compared to their laboratory-reared counterparts in pooled TPs (3, 4, & 5) 
from 20’ (Figure 2.38, B, Kruskal-Wallis p = 0.0006, Dunnett’s p < 0.0001). When 
separated by time point, this reduction was observed at time points 3 (non-significant) 
& 5 (ANOVA p = 0.0045), but not at time point 4 (Figure 2.38, C). TSI was affected 
by environmental condititions (i.e caged or laboratory-reared), and BSI (Figure 2.39, 
ANCOVA p = 0.049 & 0.0059), and was also less variable than BSI (Figure 2.39).
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Figure 2.38. TSI at YT, PYL, and 20’ from laboratory (Lab), caged (Cage), and wild-caught 
(Wild) individuals. Panel A = TSI of laboratory-reared individuals from YT, PYL, & 20’ over 
time; Panel B = TSI of laboratory-reared, caged and wild-caught individuals at YT, PYL & 
20’  (pooled  TPs 3,  4,  & 5);  Panel  C = TSI  of  laboratory-reared,  caged  and  wild-caught 
individuals at 20’ over time. Values are mean ± se, for  n values see Table 2.5. * indicates 
significant difference compared to laboratory-reared counterparts.
122
BSI
0 1 2 3 4 5 6
T
S
I
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
3L
4L
5L
3C
4C
5C
Figure 2.39. Relationship between TSI and BSI at 20’, in laboratory-reared (L) and caged 
individuals  (C)  at  TP 3,  4,  and 5.  TSI  was relatively smaller  compared to  BSI  in  caged 
individuals,  than  in  laboratory-reared  individuals.  Each  data  point  represents  mean  ± 
bidirectional error, for n values see Table 2.5.
2.4.3.7.4 Intersexuality
Intersex individuals were rarely observed at YT (2 laboratory-reared individuals) or 
PYL (1 laboratory-reared individual),  but  were  common at  20’,  therefore gonadal 
differentiation of intersex individuals was only analysed from the latter site. BSI and 
TSI values were the same in male or intersex individuals, from laboratory-reared or 
caged  conditions  (data  not  shown).  There  were  no  significant  differences  in  the 
incidence  of  testicular  oocytes  in  laboratory-reared  and  caged  individuals  (i.e. 
percentage  of  intersex  individuals,  see  section  2.4.3.6),  however,  by  TP5 58% of 
laboratory-reared  and  100%  of  caged  females  were  intersex  (Figure  2.40).  The 
severity of TOs appeared to be more pronounced in laboratory-reared individuals, but 
this difference was not statistically significant (Figure 2.40, Wilcoxon p = 0.098). The 
BSI decreased over time in laboratory-reared individuals, but increased over time in 
caged  individuals  (Figure  2.41,  A  &  B).  BSI  was  significantly  affected  by  the 
interaction between site (i.e. laboratory-reared or caged) and TP, though by neither 
parameter alone in both male (Figure 2.41, A, ANCOVA p = 0.016) and intersex 
(Figure 2.41, B, ANCOVA p = 0.0004) individuals. 
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Figure 2.40. Incidence and severity of testicular oocytes observed at each time point, 
in laboratory-reared (red bar) and caged (blue bar) individuals at 20’. Incidence is 
expressed as a percentage of the total number of females observed, and severity as the 
number of testicular oocytes observed per intersex individual. In the latter case, values 
are mean ± se, see Table 2.5 for n values.  
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Figure 2.41. Change in BSI of male (Panel A) and intersex (Panel B) individuals over 
time  (TP  3,  4,  5)  in  individuals  from  20’.   =  laboratory-reared,   =  caged 
individuals). Each data point represents one individual. Lines are linear regressions, 
male:  r2 = 0.42, p = 0.02 (Lab: r2 = 0.58, p = 0.004; Cage: r2 = 0.08, p = 0.46); 
intersex: r2 = 0.57, p = 0.003 (Lab: r2 = 0.63, p = 0.006; Cage: r2 = 0.54, p = 0.016).
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2.4.4 Discussion
2.4.4.1 Mortality and morphology 
Mortality  over  the  experimental  period  was  high  in  laboratory-reared  and  caged 
individuals from all sites, although this is not unusual for toad species. During the 
larval stage, mortality was less than 20 % in laboratory-reared individuals, which was 
lower  than  previous  reports  for  B.bufo (37  %:  Petrini  and  Zaccanti,  1998;  60  % 
Zaccanti  et  al.,  1969),  but  slightly  higher  than  mortality  reported  in   B.vulgaris  
formosus .  Mortality  was very high  during the  post-larval  stage,  and  no  previous 
reports were available for comparison. However, in laboratory-reared individuals, this 
may be an artefact due to drowning, which occurred to greater or lesser extents in 
most  tanks.  In  addition,  many  laboratory-reared  individuals  died  when  placed  in 
compost filled vivariums, prior to changing the compost for sphagnum moss. These 
factors did not cause mortality in caged individuals as they metamorphosed later, and 
therefore, tanks were drained earlier in development to prevent drowning, and by this 
time compost had been replaced with sphagnum moss in the vivariums. In cages, 
larval mortality (typically around 80%) may have been partly due to predation, as 
invertebrates  were  observed  in  cages  at  YT  and  PYL,  and  Cooke   reported  that 
invertebrates can quickly decimate a population of tadpoles in cages. Escapism may 
have also occurred as newt and frog larvae were observed in a cage from PYL. In 
addition,  caged  individuals  were  significantly  smaller  than  laboratory-reared 
individuals, and so mortality may have been caused by food scarcity and subsequent 
cannibalism by remaining tadpoles.  Previous studies have reported loss of tadpole 
populations from field deployment of cages. In one case tadpole samples could not be 
retrieved  from  one  third  of  the  cages  deployed  ,  and  in  another  mortality  was 
generally low (exposure period over larval stage only), but all tadpoles disappeared 
from a few cages . There were also animals that ‘disappeared’ from the vivariums, 
which may have been due to cannibalism  or escapism, as bodies were not observed. 
Under natural conditions, it is thought that a small proportion of the 1000’s of eggs 
laid  survive to  adulthood,  so perhaps  it  is  not  surprising that  mortality  was high. 
However,  changes  in  the  experimental  design,  such  as  ensuring  removal  of 
invertebrates and supplementing cages with food, may have increased survival rates. 
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On the other hand, it could be argued that cages mimicked natural conditions, where 
pressures of competition and predation ensure only the fittest individuals survive. 
2.4.4.4.1 Embryogenesis
Hatching and embryogenesis are very sensitive stages of development, and the Frog 
Embryo Teratogenesis Assay-Xenopus (FETAX) is an established in vitro technique 
for assessing toxicity using these endpoints . In caged individuals, hatching success 
was very high at PYL (84 %), compared to YT, 20’, and LP (~20 %), suggesting that 
early life stage toxicity was lower at the ‘reference’ site compared to the ‘polluted’ 
sites.  A  negative  correlation  between  hatching  success  and  increasing  industrial 
contaminant exposure in caged Rana pipiens and Rana clamitans-melanota has also 
been  reported  .  Overall  mortality  in  laboratory-reared  individuals  from  LP  was 
comparable  to  other  sites,  however,  it  had  the  lowest  hatching  rate  and  also 
significantly higher larval abnormalities than other sites. In addition, no larvae were 
observed in cages or in the wild at this site after hatching, suggesting that lethal toxic 
effects may have occurred. It is not known what contaminants were present at LP, 
however, the pond was bordered by pasture on one side and arable land on the other. 
Toadspawn was reasonably abundant at  this site, and according to the landowners 
toads were a common sight, although tadpoles were also not observed at breeding 
season  two.  Due  to  the  high  fidelity  of  toads  to  their  breeding  site,  the  toxicity 
observed  may  be  a  relatively  recent  phenomenon.  The  pesticide  azinphos-methyl 
(active ingredient of Guthion ®) decreased hatching and increased abnormalities in 
FETAX at mg/L levels , but is unlikely to be causing effects observed here as its 
concentration  range  in  the  U.K.  is  0.01-0.18  µg/L  (see  Appendix  1).  The  more 
commonly used herbicides glyphosate , atrazine and 2,4,-D  have also been found to 
cause malformations  in  the FETAX assay.  Morgan  et al.  (1996) reported that  the 
EC50’s for atrazine and 2,4-D were close to their maximum solubility values in water 
(33 mg/L and 245 mg/L,  respectively),  and much higher  than levels  found in the 
environment  (maximum  detected  in  2004/2005:  1.96  µg/L  and  18.6  mg/L, 
respectively).  In  the  case  of  glyphosate,  Perkins  et  al. (2000)  reported  that  the 
surfactant  POEA,  which  is  found  in  the  commercial  formulation  of  glyphosate 
Roundup ®, was the toxic component rather than the glyphosate itself (LC50’s of 
5,407 mg/L for glyphosate, compared to 9.4 mg/L for POEA). Roundup ® is the most 
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common formulation of glyphosate, but glyphosate was still only detected up to 1.6 
mg/L in  the  UK. Therefore,  none of  these pesticides  are  likely to  be causing the 
effects observed here alone. However, equimolar mixtures of pesticides have been 
reported to cause mortality (35 %) compared to each pesticide alone (0-7.8 %) in 
Rana pipiens larvae . In addition, pesticide loading near to LP was higher than other 
sites  (Appendix  2  pp  297-319),  and  the  pesticides  detected  at  the  highest 
concentrations included 2,4-D (max: 236 ng/L, percentage of times detected: 13%), 
atrazine (163 ng/L, 18%), diuron (840 ng/L, 50%), isoproturon (1980 ng/L, 20%), 
MCPA (221 ng/L, 40%), mecoprop (563 ng/L, 53%), and PCP (2740 ng/L, 30%). 
Atrazine was the only pesticide that was detected near to LP and formed part of the 
mix tested by Hayes et al. (2006), however, the concentration of pesticides used in his 
mix was lower than measured levels here (0.1 µg/L). In addition, PCP was found at 
high concentrations nearby, and is highly toxic to fish, with LC50 values of between 
32 µg/L – 205 µg/L . Therefore, although the toxic effects on tadpoles are unknown in 
response  to  PCP,  or  the  other  pesticides  detected  nearby,  mixtures  of  these 
compounds, and the cause of toxicity at this site, warrant further investigation. Since 
no caged or wild individuals could be collected from LP for comparison to laboratory-
reared individuals, samples were not analysed further.
2.4.4.4.2 Larval Stage
Between hatching and metamorphosis  (larval  stage),  mortality  rates  in  laboratory-
reared individuals were low. The same was true in caged individuals from YT and 
20’, despite high initial mortality rates at hatching. The opposite trend was observed at 
PYL, whereby the highest mortality was observed during larval stages compared to 
other  stages.  In  addition,  caged  metamorphs  from  PYL  were  extremely  small 
compared to laboratory-reared and wild-caught individuals, and despite abundant food 
provided in the vivariums post TP 3, they decreased in weight between TP 3 and 4, 
and none were left by time point 5. The reason for this is unclear, but may suggest 
starvation of the metamorphs (despite food availability),  caused by a lack of food 
availability during larval stages. Poor tadpole growth and small size at metamorphosis 
are  correlated  with  decreased  survival  of  metamorphs  ,  which  may  explain  the 
continuing  mortality  despite  food  availability  at  TPs  3,  4,  &  5.  Wild  caught 
individuals from TP 3 and 5 (they were not observed at other TP) were the same size 
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as laboratory-reared individuals, suggesting a specific effect of the caged environment 
on larval growth and development. Cooke  reported that clear water containing little 
algal growth (conditions similar to those of PYL) resulted in poor tadpole growth, 
which was presumably due to the lack of food. It is a turlough, so is not linked to 
surface or ground water inflow, except via run-off, and may therefore have a lower 
mineral and nutrient input. Indeed, the ambient water at PYL had low conductivity, 
hardness, nitrate, and phosphate values compared to other sites in breeding season two 
(April-May,  2005).  A  contributing  factor  to  the  slow  growth  and  small  size  at 
metamorphosis observed may have been increased tadpole competition at this site, 
due  to  the high  hatching  rate  ,  which then  exacerbated the  low food availability. 
Indeed, Karasov  et al. (2005) reported that final size of metamorphs was inversely 
proportional to caged tadpole density. Interestingly, survivorship of caged individuals 
was similar at all sites (except LP) at the end of the larval period (15-20 %), perhaps 
suggesting that cages were initially overstocked, and mortality occurred until enough 
resources were available for the remaining tadpoles. In the present study 100 eggs 
were placed in a cage of 35 x 35 x 25 cm size, in contrast, Karasov  et al. (2005) 
placed 100 eggs in a field enclosure of 102 cm height and 61 cm diameter (~ 10x 
larger). In the latter study, enclosures were also supplemented with food, and although 
one third of the cages they deployed were lost, survivorship in the remaining cages 
was  much  higher  than  observed  here  (55  %  for  green  frogs  (Rana  clamitans 
melanota) and 80 % for leopard frogs (Rana pipiens)). In addition, Cooke  put 40 
tadpoles in a cage with 30 x 30 x 45 cm dimensions (~ 3x larger) and no mortality 
was observed  over  the  14  day  period,  although this  study was  of  short  duration. 
Therefore, the morphological effects at PYL were likely related to the experimental 
design rather than any toxic effect at the site. 
Wild-caught individuals were found at PYL at TP 3 & 5 only, whereas they were 
found at TPs 2-4 at YT and 20’. Time point 5 was approximately 2 months post-
metamorphosis, therefore, it may be expected that metamorphs would have left the 
area immediately adjacent to the pond at this stage, and thus would be difficult to find. 
However, it was surprising that no wild individuals could be found at PYL at time 
point 2,  as  they are  tadpoles at  this  stage,  or  time point  4,  when they are  young 
metamorphs. It  is a large deep pond surrounded by woodland, and so this finding 
could be an artefact of the environmental conditions, however, it was reported that 
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since 2000 there has been a drastic decrease in toad populations at PYL (Barney Gill 
pers. comm.), to the extent that there is no longer a toad crossing organised for this 
site by Froglife. Since minimal toxicity was observed at this site and it is known that 
tadpoles  need  salts  for  healthy  development  ,  it  was  hypothesised  that  the  low 
conductivity of this site may have contributed to tadpole mortality. However, Fort et 
al.  reported that conductivity values of 42-1790 µS/cm had no effect on hatching 
success or abnormality  rates in  a  FETAX assay (212 µS/cm measured at  PYL in 
2005).  Since  the  experimental  design  may  have  been  largely  responsible  for 
morphological effects observed here, and hatching success was high, the reason for 
the apparent population decline at this site warrants further investigation.
2.4.4.4.3 Growth
Laboratory-reared individuals were significantly larger than caged and wild-caught 
individuals  at  all  sites.  Caged  tadpoles  were  also  often  smaller  than  wild-caught 
individuals, however, this difference was only significant at PYL (discussed above). 
Therefore, although the cage had a negative impact on growth of individuals, it was 
less pronounced than the positive effect of feeding on laboratory-reared individuals 
from YT and 20’. Furthermore, the snout-vent length of all individuals was higher 
than  those  reported  for  B.bufo metamorphs  sacrificed  immediately  following 
completion of metamorphosis (Petrini and Zaccanti, 1998). Interestingly, there were 
significant  differences in size of  laboratory-reared individuals  from different  sites, 
whereby those from YT were the largest, 20’ were the smallest, and those from PYL 
were in between. Moreover, these differences persisted until TP 4. The reason for this 
is unknown, however it may be a function of distinct genetic groups, or a result of 
maternal transfer of compounds that affected growth. Interestingly, hatching success 
and developmental abnormalities of narrow-mouth toad (Gastrophyrne carolinensis) 
embryos were correlated with levels of trace metals (associated with coal combustion 
waste) in adults . Although similar studies using pesticides have not been reported in 
amphibians, in ovo exposure to the pesticides atrazine (0.2 µg/L) or endosulfan (2 or 
20 µg/L) reduced hatchling size of  Caiman latirostris  , and Karasov  et al. (2005) 
reported that tadpole growth was negatively correlated with contaminant loading of 
sediment by industrial pollutants. At YT, laboratory-reared individuals were 2 to 4-
fold bigger than caged (and wild caught) individuals, and this difference persisted for 
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the  duration  of  the  experimental  period,  despite  the  same  feeding  regime  for 
approximately half of this time. This did not occur at 20’, where caged, but not wild-
caught, individuals were only slightly smaller than laboratory-reared individuals, and 
this difference did not persist after TP 3. Since hatching rate and larval survival were 
similar  at  the two sites,  this  suggests  that  environmental  factors  at  YT may have 
affected tadpole growth, which could not be overcome by approximately 8 weeks of 
feeding in the laboratory. A smaller size at metamorphosis may have population level 
consequences, as it is believed to result in a higher risk of predation, and reduced 
fecundity due to a smaller size at first reproduction .
2.4.4.2 Thyroidal Development
As  discussed  above,  there  were  large  differences  in  general  growth  between 
experimental  groups,  and  these  are  likely  to  affect  thyroidal  endpoints. 
Metamorphosis can be affected by temperature, pond drying, predation, and nutrition 
(Rose, 2005). Temperature did not differ between experimental conditions, and there 
was no evidence of decreased water levels during the experimental period. Predation 
may have occurred, as invertebrates were observed in some cages (YT & PYL), which 
have  been  reported  to  decimate  populations  of  caged  tadpoles  .  Differences  in 
nutrition are also thought to have occurred (see above). No data were available on the 
effect  of  food  availability  on  the  growth  and  development  of  the  thyroid  gland 
specifically,  however,  nutrition  has  been  reported  to  be  an  important  factor  in 
determining timing of metamorphosis (for review see Rose, 2005). For the developing 
tadpole, there is a trade-off between capitalising on an abundant food supply to attain 
a  large  size  at  metamorphosis,  and the risk  of  staying  in  a  potentially  dangerous 
habitat.  Therefore,  good  nutrition  results  in  larger  metamorphs,  which  complete 
metamorphosis at a younger age . In contrast, Laugen et al. (2002) reported that food 
affected  size  but  not  age  at  metamorphosis,  perhaps  due  to  sufficient  food  for 
complete metamorphosis in both low and high food groups in this study. Therefore, 
due  to  possible  nutritional  differences  in  experimental  groups,  the  differences 
observed in thyroid sensitive endpoints in larvae and metamorphs must be treated 
with caution. 
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Metamorphosis  was  inhibited  in  laboratory-reared  individuals  from  PYL  (earlier 
developmental  stage at  time point  2,  smaller  HLL at  TP 2 & 3,  decreased FLE), 
compared to laboratory-reared individuals from YT or 20’, and this appeared to be 
independent  of  growth,  as  weight  and  SVL  were  lowest  at  20’.  As  in  growth 
endpoints,  differences  in  thyroidal  endpoints  in  laboratory-reared individuals  were 
unexpected, as they developed under the same feeding, temperature, and water quality 
regime. Interestingly, a similar pattern of development was observed in all individuals 
from PYL, whereby laboratory-reared, caged, and wild caught individuals from PYL 
developed  very  slowly  compared  to  laboratory-reared,  caged,  or  wild  caught 
individuals from other sites. This suggests inherent developmental rates of distinct 
groups of tadpoles, or a latent effect of the pond environment. It has been reported 
that  different  races  of  Rana  temporaria display  different  age  and  size  at 
metamorphosis  in  the laboratory,  depending on latitude  of  the parent  frogspawn , 
although the range of sampling sites in the latter study was ~ 140N (or ~1500 km) 
compared to 1-20N latitude (240 km) here. Maternal and genetic input have also been 
shown to affect age and size at metamorphosis . Only the male origin had a significant 
effect on the age at metamorphosis, whereas there was a lot more plasticity in the size 
at metamorphosis, and female origin, male origin, and food abundance all affected 
this parameter. If the same were true in B.bufo, it may be expected that the possible 
lack of food at PYL did not delay metamorphosis, but contributed to the small size 
observed  at  metamorphosis,  and  therefore,  a  non-nutrient  factor  may  have  also 
affected  metamorphosis.  As  mentioned,  the  only  reported  study  to  test  maternal 
transfer was in relation to coal combustion waste,  and thyroid sensitive endpoints 
were not reported 
Despite  significant  differences  in  thyroid  sensitive  morphological  endpoints  in 
laboratory-reared  individuals  between  sites,  the  ThSI,  thyroid  gland  activity  and 
colloid quality were very similar between sites, suggesting the thyroid gland is less 
susceptible  to  perturbation than morphological  endpoints.  Effects  observed  on the 
thyroid histology were minimal in caged and wild-caught individuals, suggesting that 
the morphological effects on thyroid sensitive endpoints observed were largely caused 
by  external  factors  rather  than  thyroid  disruption  per  se.  Characteristic  effects  of 
thyroid  disruption  are  increased  thyroid  gland size,  accompanied  by  an  increased 
activity (hyperplasia and hypertrophy), and in severe cases, decreased colloid . This is 
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caused by decreased thyroid hormone production, leading to increased stimulation of 
epithelial cells by thyroid stimulating hormone. At the same time, thyroglobulin is 
released  from the  colloid,  which  in  turn  decreases  colloid  due  to  the  inability  of 
epithelial cells to replenish the thyroglobulin. In contrast, the most common effect 
observed in caged and wild-caught individuals in the present study was a decrease in 
ThSI, accompanied by a decrease in activity and decreased colloid quality. Effects 
were most often observed in prometamorphic tadpoles, which is not surprising as this 
is a stage of intense thyroid system stimulation.  The mechanism responsible for a 
decrease  in  the  ThSI  is  unknown,  but  it  was  observed  in  caged  and  wild-caught 
prometamorphic tadpoles at  all  sites,  suggesting it  may be a function of nutrition. 
Alternatively,  it  may have been an artefact of the earlier  stage of caged and wild 
caught tadpoles compared to laboratory-reared individuals within groups. Indeed, in a 
regression analysis, only individuals at 20’ were different from their laboratory-reared 
counterparts,  and this was also the only site where reduced ThSI was observed at 
other TPs. In addition, colloid degeneration was severe in prometamorphic tadpoles, 
and  no  forelimb  emergence  was  observed  in  caged individuals  at  TP 2  in  caged 
individuals (compared to 24% at YT, and 0 % at PYL). The effects of nutrition were 
less  marked  at  20’  than  the  other  sites,  and  FLE  was  high  in  laboratory-reared 
individuals (64 %), suggesting additional environmental factors may have contributed 
to specific thyroidal effects observed. Pesticides identified in the highest levels near to 
20’ (Appendix 2, pp 288-297) included, 2,4-D (max: 60 ng/L, percentage of times 
detected: 14%), atrazine (45 ng/L, 86%), bentazone (200 ng/L, 14%), chloropropham 
(2140 ng/L, 100%), diuron (1008 ng/L, 100%), mecoprop (120 ng/L, 43%), simazine 
(235 ng/L,  100%),  however  no data  on  the  effects  of  these  pesticides  on  thyroid 
function were available, therefore, it is difficult to hypothesise what may have been 
causing these effects. However, similarly to effects of pesticide mixtures on growth, 
Hayes  et  al. (2006)  reported  increased  time  to  FLE  in  response  to  the  mixture 
compared to each compound alone. At YT/PYL little effect was observed on thyroid 
histology, suggesting that the inhibition of development at these sites were largely due 
to nutrition, competition, and/or other factors.
2.4.4.3 Bidderian and Gonadal Differentiation
Bidderian  and  gonadal  development  were  similar  to  that  previously  reported  for 
B.bufo , except the previously reported mesogonad in males  was rarely observed in 
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this study. In addition, sex specific differences in size of BO, number of FGP oocytes, 
and size of FGP oocytes in the BO were previously reported (Petrini and Zaccanti, 
1998), but no such effect was observed here. As previously reported for Bufonidae 
species,  in  the  present  study  sex  differentiation  appeared  to  be  of  the  semi-
differentiated  type  (all  develop  as  females  first),  as  the  percentage  of  females 
remained constant  over time (~40 %),  but  the ratio of undifferentiated,  male,  and 
intersex differed. However, since the first samples were taken post-metamorphosis, it 
is  not  known  if  all  gonads  were  originally  female,  therefore  perhaps  it  is  more 
accurate to say that ovaries developed at an earlier stage than the testes (also reported 
by  Petrini  and  Zaccanti,  1998).  Various  investigators  have  reported  that  the 
relationship between gonadal development and somatic growth in amphibians to be 
weak.  For  example,  in  an  early  publication, B.lentiginosus tadpoles  were  starved 
throughout development, and no effect on sex ratio was observed . More recently, 
Ogielska & Kotusz  reported that ovarian development was only slightly affected by 
somatic growth in Rana lessonae and Rana temporaria tadpoles, and that age was a 
more  important  determining  factor  in  development.  Similarly,  Gruca  and 
Michalowski  investigated the rate of gonadal development in Xenopus laevis tadpoles 
kept under various feeding conditions, and reported that feeding conditions influenced 
somatic  growth  considerably  more  strongly  that  gonad  differentiation,  although 
decreased  food  availability  also  contributed  to  the  inhibitory  effect  on  gonadal 
development. Lastly, Chang and Hsu  reported a strong correlation between age and 
ovarian differentiation, but no correlation to size in Rana catesbeiana tadpoles. In the 
present study, the presence of the fat body, which reflects the nutritional status of the 
animal  ,  did  not  appear  to  be  associated  with  gonadal  differentiation  (personal 
observation). Therefore, histological differences observed in gonadal development are 
likely  to  be  largely  independent  of  nutritional  status.  However,  due  to  the  high 
mortality in caged individuals, it cannot be discounted that skewed sex ratios were a 
function of sex-specific mortality.
2.4.4.3.1 Laboratory-reared Individuals
Sample sizes were often too small to determine statistical differences in sex ratios 
between laboratory-reared,  caged,  and wild-caught  individuals  within each site.  If 
gonadal  development  is  largely  determined  by  age  in  this  species,  it  would  be 
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expected that  similar  patterns  of  gonadal  development  would occur  in  laboratory-
reared, caged, and wild caught individuals. However, similarly to effects observed in 
morphological endpoints, there were significant differences in sex ratio of laboratory-
reared  individuals  between  sites,  and  these  differences  followed  similar  trends  in 
caged  and  wild  caught  individuals.  This  could  be  observed  in  the  ratio  of 
undifferentiated individuals, as more were observed in laboratory-reared, caged, and 
wild caught individuals from YT compared to corresponding individuals from other 
sites. In addition to inhibited gonadal differentiation at YT, the BSI was smaller, the 
number of bidderian FGP oocytes was greater,  and the size of FGP oocytes were 
smaller, compared to laboratory-reared individuals from PYL or 20’. More intersex 
individuals were also observed in laboratory-reared individuals from 20’ compared to 
other sites (YT – 9 %, PYL – 4 %, 20’ – 22 %), and this was mirrored in caged 
individuals  (YT – 0 %, PYL – 0 %, 20’ – 32 %). These findings suggest that in 
addition to possible effects of the ambient water, genetic, maternal, and/or a latent 
effect  of  the  pond  environment  may  have  contributed  to  differences  observed  in 
gonadal differentiation. The differences between laboratory-reared individuals, both 
in growth and development, and in gonadal differentiation, highlight differences that 
may be observed in the ‘control’ group in laboratory exposures. Furthermore, these 
findings may partially explain differences reported in the literature, where the same 
compounds are tested using the same species, and experimental setup, but different 
responses are reported. 
2.4.4.3.2 Retarded Differentiation
All caged individuals from PYL were undifferentiated at TPs 3 & 4, although since 
growth  contributes  slightly  to  gonadal  differentiation,  the  retarded  gonadal 
development  at  PYL  may  have  been  partially  caused  by  starvation  of  these 
individuals.  However,  wild-caught  individuals  from PYL (TP3)  were  of  a  similar 
developmental stage and weight to laboratory-reared individuals, but only 10 % were 
differentiated, compared to 76 % differentiated in the laboratory. In addition, in wild 
caught  individuals  from PYL (TP5),  the  singly  ovary  was  immature,  with  small 
oocytes and no ovarian cavity, and the testes of one of the males had a dense patch of 
cells in the medulla, which may be indicative of recent colonisation of this area . This 
suggests there may have been an endocrine disrupting effect on the gonads at this site. 
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However, little activity was observed in PADs in breeding season two, and only TBT 
(0.03 µg/L) was detected near to this site (Appendix 2 pp 281-288). Therefore, the 
reason for this effect is unknown, but due to the reported population decline at this 
site, warrants further investigation.
 
Undifferentiated gonads were often observed in individuals from YT, and the effects 
were more marked in field collected individuals than those raised in the laboratory. 
The n values for caged individuals (n = 8) and wild caught individuals (n = 14) was 
low, nevertheless, retarded development was observed in histological sections and it 
was the only site where an undifferentiated individual were observed at TP4. B.bufo 
tadpoles treated with an aromatase inhibitor (OHA: 0.1 & 1 mg/L), testosterone (1 
mg/L),  or  DHT  (1  mg/L)  displayed  retarded  gonadal  differentiation  (Petrini  and 
Zaccanti, 1998), and a similar effect was observed in larval B.americanus exposed to 
estradiol (1 mg/L) or methyltestosterone (500 µg/L) (Chang, 1955). In contrast, the 
anti-androgenic  compounds  cyproterone  acetate  (receptor  mediated)  and  a  5α-R 
inhibitor (17βC), stimulated gonadal development in both sexes (Petrini and Zaccanti, 
1998).  Using  this  rationale,  it  may  be  expected  that  compounds  that  increased 
androgen  or  estrogen  levels  may  lead  to  an  increase  in  undifferentiated  gonads. 
Interestingly, another consequence of increased androgen levels in toads is a decrease 
in BO size (see section 2.3.1), which was observed in caged, but not wild-caught, 
individuals at YT. In addition, FGP bidderian oocytes were smaller in caged and wild-
caught individuals, compared to laboratory reared individuals from YT, and exposure 
of B.bufo tadpoles to OHA (0.1 or 1 mg/L), estradiol (0.1 mg), testosterone (1 mg/L) 
or dihydrotestosterone (1 mg/L), was previously reported to reduce the diameter of 
diplotenic oocytes (Petrini and Zaccanti, 1998). Since both estrogens and androgens 
seem  to  have  a  similar  effect  on  BO,  perhaps  a  central  control  mechanism  is 
implicated. Extracts from YT at breeding season two were strongly anti-estrogenic 
and  anti-androgenic,  and  the  model  anti-androgens  flutamide  (0.5  µM)  and 
cyproterone acetate (CPA: 0.5 µM) feminised larval  Rana rugosa ,  whereas CPA 
(0.24 µM) had no effect on sex ratios in larval B.bufo (Petrini and Zaccanti, 1998). In 
addition, the anti-estrogen ICI182780 (0.017 µM) significantly affected the sex ratio 
in larval  Rana pipiens, indicated by an decrease in the proportion of males, and an 
increase in proportion of intersex . Therefore, it is not known what caused retarded 
differentiation, and extracts were not tested for other properties (such as effects on 
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steroidogenesis), but despite the low n value at this site, these findings warrant further 
investigation. 
2.4.4.3.3 Masculinisation
A high proportion of intersex individuals were observed at 20’ in laboratory-reared 
and caged individuals.  Despite estrogenic activity of water extracts  from breeding 
season one and two,  intersex individuals  were classified as masculinised females; 
rather than feminised males. This was primarily due to the change in sex ratios over 
time, which was indicative of masculinisation (TP5: laboratory-reared: M – 30 %, F – 
30 %, I – 40 %; caged: M – 55 %, I – 45 %), as well as the increased severity of 
testicular  oocytes  in  laboratory-reared  individuals.  In  addition,  treatment  of  mink 
(Rana septentrionalis) or green (Rana clamitans) frogs with the potent estrogen EE2 
(3.3 to 9.1 ng/L) resulted in maximum intersex levels of 28 % , which is much lower 
than levels observed here. Since ovarian development occurred earlier than testicular 
development, undifferentiated individuals from TP 3 were classified as genetic males. 
If intersex are classified as female and undifferentiated as male, presumed genetic sex 
ratios in laboratory-reared and caged individuals were almost identical (Female = 64 
or 65 %, respectively), indicating the higher percentage of females in both cases may 
be of genetic origin. Interestingly, in Bufonidae species the female is thought to be the 
heterogametic sex , and it has been reported that breeding of a masculinised female 
(zw) with a normal female (zw) in Ambystoma mexicanum and A.tigrinum  results in 
25 % male (zz) and 75 % female (zw & ww) offspring . Therefore, in order to test this 
hypothesis, it would be interesting to test the genetic sex ratio of toads from this site. 
Masculinisation  was  more  marked  in  caged  than  laboratory-reared  individuals, 
possibly  suggesting  an  additional  effect  of  the  ambient  pond environment  on  sex 
differentiation.  Masculinisation  in  response  to  xenobiotics  has  been  linked  with 
compounds  that  inhibit  aromatase  activity  such  as  the  effects  of  fadrozole  (a 
pharmaceutical aromatase inhibitor) on fish , and TBT on marine gastropods . TBT 
has also been shown to cause masculinisation in Zebrafish and to damage sperm at 
concentrations  between  0.1-100  ng/L  ,  and  to  inhibit  steroidogenesis  in  Xenopus 
ovarian explants at the lowest concentration tested . Surprisingly, TBT was detected 
115 times over the range of 10-7900 ng/L in 2004/2005 in U.K. freshwaters (see 
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Appendix 1) and was detected once (0.02 µg/L) at a site close to 20’ (Appendix 2, pp 
287-296).  Therefore,  TBT may have  contributed  to  the  effects  observed.  Another 
pesticides that inhibits aromatase  in vitro and is found in the UK is cypermethrin , 
which was found 11 times over a concentration range of 12-93 ng/L (see Appendix 1), 
however, it was not found in this area (Appendix 2). To the author’s knowledge, no 
exposure studies of  effects  of  aromatase inhibiting pesticides  on amphibians have 
been reported, however, aromatase is thought to be important for sex differentiation in 
vertebrates  (see Chapter  1,  section 1.3.3).  Furthermore,  it  was  reported in  a  newt 
species (Pleurodeles waltl), that aromatase expression was down regulated during sex 
reversal of females to males, as a result of incubating individuals at a masculinising 
temperature . Similarly, fadrozole (500 µg/g in food) decreased aromatase expression, 
and caused complete masculinisation of developing zebrafish, which persisted after 90 
days of control conditions . However, treatment of larval  B.bufo with an OHA (an 
aromatase  inhibitor)  resulted  in  development  of  female  (F),  male  (M)  and 
undifferentiated (U) individuals, (1 mg/L = F0:M3:U4; 0.1 mg/L = F4:M1:U7; Petrini 
and Zaccanti, 1998), and results were inconclusive, perhaps due to the low n values in 
this  study.  Therefore,  the  role  of  aromatase  inhibiting  compounds  in  gonadal 
differentiation in amphibians, and the effect of pesticides on aromatase activity, both 
warrant further investigation. 
In addition to effects  on steroidogenesis,  there  may have also been effects on the 
hypothalamo-pituitary-gonadal  axis.  Androgenic  and  estrogenic  hormones  affect 
gonadotropin  release  via  the  negative  feedback  mechanism  of  the  hypothalamo-
pituitary-gonadal  axis  (see  Chapter  1,  section  1.3.3).  Removal  of  the  pituitary 
inhibited  testicular  development  of  B.americanus,  but  had  no  effect  on  ovarian 
development (Chang, 1955), suggesting gonadotropins are less important in ovarian 
growth (see Chapter 1, section 1.3.3 for details).  Therefore, it  is hypothesised that 
females develop first due to immaturity of the hypothalamo-pituitary-gonadal system 
in the developing tadpole, and at a later stage of development, genetic males develop 
testes  as  levels  of  gonadotropins  increase.  Therefore,  any  EDs  that  decrease 
circulating androgens or estrogens may therefore cause an increase in gonadotropin 
levels, leading to normal testicular development in genetic males, and masculinisation 
of genetic females. Conversely, any EDs that increased circulating levels of androgens 
or  estrogens,  and  thereby  decreased  gonadotropin  levels,  may  result  in 
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undifferentiated individuals.  In agreement with this  hypothesis,  treatment of larval 
B.vulgaris with  FSH  caused  masculinisation  ,  and  no  masculinising  effect  was 
observed  after  treatment  of  larval  B.bufo with  testosterone  (1  mg/L),  or  DHT (1 
mg/L), but instead, the incidence of undifferentiated gonads increased (Petrini and 
Zaccanti  1998).  This  effect  was  especially  potent  with  DHT  treatment  (88% 
undifferentiated,  n =  8),  which  also  dramatically  inhibited  the  growth  of  the 
undifferentiated  gonad  (8-fold  compared  to  control  ovary,  &  4-fold  compared  to 
control teste), and DHT is known to be a potent inhibitor of gonadotropin release in 
larval  and  adult  Rana  esculenta .  A  similar  explanation  could  be  applied  to  the 
paradoxical  effect  of  the  receptor  mediated  anti-androgen  CPA,  which  causes 
masculinisation in developing amphibians, and may be due to its inhibitory effect on 
3β-HSD activity . This would presumably decrease hormone production by the gonad, 
leading to increased gonadotropin levels, and subsequent masculinisation. In addition 
to altered sex ratios, the BSI increased in size over time in caged male and intersex 
individuals,  but  decreased  over  time  in  laboratory-reared  individuals.  In  addition, 
ovarian and testicular growth was inhibited in relation to BSI (OSI and TSI were 
smaller  compared to the BSI),  in caged individuals  compared to laboratory-reared 
individuals. It is not known why gonadal growth was inhibited, but there is a dynamic 
relationship between teste size and BO size in adults (Calisi, 2005), whereby presence 
of  the teste  inhibits  BO growth independently of  gonadotropin levels  .  Therefore, 
perhaps the increasing size of BO inhibited both ovarian and testicular growth. 
In addition to possible causes of masculinisation discussed above, many other factors 
could have contributed to the effects  observed.  For example,  corticosterone levels 
were higher in B.boreas raised at a greater tadpole density , and cortisone was shown 
to  cause  masculinisation  in  Rana  sylvatica tadpoles  (Witschi  and  Chang,  1950); 
therefore  the  results  should  be  treated  with  caution.  Nevertheless,  to  the  author’s 
knowledge,  in situ masculinisation of an aquatic species has only previously been 
reported in fish, in relation to paper and pulp mill effluent . Lastly, extracts from 20’ 
from breeding season two were moderately estrogenic, weakly anti-estrogenic, and 
only  slightly  anti-androgenic.  According  to  present  understanding  described  here, 
these  properties  would  not  be  expected  to  cause  masculinisation  in  amphibians. 
However, due to the uncertainty of the cause(s) of masculinisation, unknown possible 
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additional  properties  of  the  extracts,  and  the  time  lapse  of  1  year,  perhaps  this 
discrepancy is not surprising. 
2.5 Conclusions
Interpretation of results obtained in the field work was difficult due to various factors. 
Firstly,  due  to  endocrine  activity  in  field  blanks,  and  unknown  uptake  rates,  the 
reliability of activity observed from the PADs is uncertain;  secondly, very little is 
known about the endocrine activity of commonly used pesticides, and nothing about 
mixture  effects  of  these  pesticides;  thirdly,  growth  and  development  were  more 
advanced  in  laboratory-reared  individuals  compared  to  cage  individuals;  fourthly, 
mortality was very high,  leading to low  n values,  reducing reliability of observed 
effects;  and  finally,  the  mechanism of  gonadal  differentiation  in  toads  is  largely 
unknown. It is also not known how these factors interact with each other, or their 
environmental importance. However, in spite of these limitations, preliminary results 
observed were interesting, and warrant further investigation.
Extracts from every site tested in breeding season two were active in at  least one 
screen, and toads collected from all sites in breeding season three were affected in 
different ways. YT had very high anti-estrogenic and anti-androgenic activity, and 
inhibited gonadal  development,  little endocrine activity was observed at  PYL, but 
populations are apparently decreasing. At 20’, estrogenic and weak anti-estrogenic 
and anti-androgenic effects were observed, as well as various effects on gonadal and 
thyroid histology. Finally, at LP, high anti-estrogenic and anti-androgenic activity was 
observed and 100 % mortality occurred in field specimens. In addition, the activity 
observed at each site did not seem to have any bearing on the effects observed in the 
toads. This was especially true in the fens, where estrogenic activity was observed at 
breeding season one & two, but toads were masculinised. Interestingly, more males 
are consistently reported by Froglife volunteers as part of the Toads on Roads scheme. 
Although  this  is  probably  due  to  the  discrepancy  in  the  age  of  sexual  maturity 
between males (2-3 years) and females (3-6 years), it may be prudent to monitor sex 
ratios  in  sites  run  by  Froglife,  to  try  and  establish  long term trends.  Finally,  the 
suitability of toads as a test species is questionable due to the high mortality observed. 
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However,  they  also  have  potential  as  biomonitoring  species  in  the  agricultural 
environment, due to their presence in agricultural ponds and ditches, high site fidelity, 
and  presence  of  the  BO,  which  may  assist  in  elucidating  gonadal  effects.  In 
conclusion, further investigation at each site is warranted, as well as wild sex ratios of 
amphibians, and effects of environmentally relevant pesticides.
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Chapter 3
Assay Optimisation
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3.1 Overview
There  are  few  reported  effects  of  endocrine  disrupting  compounds  on  amphibian 
tissue in vitro, and extrapolation from mammalian tissue may not be representative of 
effects in amphibians. Therefore, in this study, 3 endocrine sensitive assays based on 
amphibian tissue were investigated for suitability as ED screens. It was proposed that 
the hepatocyte assay, which was used for samples collected in breeding season one, 
could be used for PAD extracts; and comparison to effects observed in YES would 
assist in elucidating relative effects of parent compounds and metabolites. However, 
despite successful use in Towa-Kagaku (Japan), it could not be optimised for use at 
Brunel University. The germinal vesicle breakdown assay (GVBD) was developed to 
identify  receptor-mediated  anti-androgenic  activity,  and  it  was  proposed  that 
comparison to the YAS would assist in comparison of the human AR and the receptor 
of the oocyte. It was successfully developed for use with the relevant positive and 
negative  control,  but  testing  of  pesticides  resulted  in  unreliable  results  that  were 
highly  variable.  The  ovulation  assay  was  developed  to  test  for  inhibition  or 
stimulation of ovarian steroidogenic enzymes through measuring tissue production of 
progesterone,  testosterone,  and  estradiol.  In  addition,  the  ovulatory  response  is 
ecologically  relevant  as  inhibition  or  stimulation  of  ovulation  could  affect 
reproductive  fitness.  This  test  was  successfully  developed,  and  proved  to  be  a 
sensitive and informative test for pesticides (see Chapter 4). 
3.2 Introduction
3.2.1. Liver Cell Preparations 
Details  of  the  basis  and  rationale  for  using  the  hepatocyte  monolayer  assay  were 
described in Chapter 2 (section 2.2.1.1), as this assay was used to test water extracts in 
Japan (Towa-Kagaku, Japan) as part of the field work aspect of this project. Training 
in the experimental procedure was also completed at this time. However, attempts to 
establish the same procedure in the UK were unsuccessful due to poor viability of the 
hepatocytes,  and  lack  of  VTG  production  when  stimulated  with  E2.  Therefore, 
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changes  to  the  original  hepatocyte  monolayer  assay  protocol  were  implemented, 
including culture of whole liver slices .
3.2.2. Germinal Vesicle Breakdown (GVBD)
In the female reproductive system, the maturation of oocytes is arrested in prophase of 
the first meiotic division, where development is suspended (immature oocytes) until 
stimulated to re-enter the meiotic cycle and complete the first meiotic division (Rugh, 
1951). Maturation normally occurs just before the spring breeding period , and causes 
morphological changes in the oocytes including breakdown of the germinal vesicle, 
which is characterised by swelling of the oocyte and the presence of a white spot near 
the centre of the animal pole, which can be observed using a dissecting microscope 
(Figure 3.1, Rugh, 1951). 
M
M
M
M
I
I
I
Figure 3.1 Cultured oocytes of Xenopus laevis, showing mature (M) and immature (I) 
oocytes. Mature oocytes have undergone GVBD (white spot) and detached from the 
connective tissue of the ovary (ovulation). Immature oocytes remain attached to the 
ovary tissue, and no white spot can be observed. Photo taken at x 10 magnification.
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The immature oocyte is surrounded by a layer of follicle cells that synthesise steroid 
hormones  in  response  to  gonadotropins,  resulting  in  maturation  of  the  oocyte  . 
Progesterone was thought to be the initiating factor produced by follicle cells , as it 
was shown to be one of the most potent inducers of GVBD , and in vivo treatment of 
Xenopus with  gonadotropins  stimulated  ovarian  production  of  progesterone  . 
However, later researchers reported that testosterone was produced at much higher 
concentrations  than  progesterone  if  ovarian  fragments  were  incubated  with  frog 
pituitary  homogenate  or  HCG .  In  addition,  in  spite  of  research  in  this  area,  the 
progesterone  receptor  (PR)  has  not  been  identified  in  the  oocyte  .  The  receptor-
initiated response is distinct from other steroid receptors in a number of ways. Firstly, 
steroid receptors normally induce effects via a transcription mediated response, but 
actinomycin D (a RNA synthesis inhibitor) does not inhibit maturation, indicating it 
occurs independently of transcription . Secondly, the receptor is thought to be on the 
cell surface rather than located nuclearly, as steroids covalently bound to polymers 
(and thus unable to enter the oocyte) still induced maturation . Finally, the EC50 for 
GVBD is much higher than that required for transcriptional activation by the nuclear 
receptor (200nM compared with 1nM). In addition the PR receptor antagonist RU486 
does not block GVBD induction by progesterone, but instead acts as a weak agonist 
(Maller,  2001).  It  has been suggested that the conventional  (intracellular)  receptor 
may be located on the cell membrane of amphibian oocytes, and exert its effect via a 
novel mechanism of action . However, although an increase in PR expression was 
accompanied with an increase in GVBD, the PR could not be identified at the cell 
membrane  where  the  progesterone  was  present,  so  direct  interaction  between 
progesterone and the PR may not have occurred (Bayaa et al., 2000). 
In  addition  to  progesterone,  androgens  have  also  long  been  recognised  as  potent 
inducers of maturation . It was suggested that they could be the primary inducers of 
maturation in vivo as they were found in much higher levels than progesterone (>10-
fold) in amphibian ovaries in vitro . In addition, Lutz et al.  reported that progesterone 
may be converted to androstenedione (testosterone precursor) and testosterone within 
the oocyte, as androgen levels in the Xenopus oocyte in vitro and in vivo were much 
higher  compared  to  progesterone.  Furthermore,  Lutz  et  al.  (2001;  2003)  have 
provided evidence for the presence of the classical AR, and it has been shown both 
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biochemically  and  immuno-histochemically  to  be  associated  with  the  plasma 
membrane of Xenopus oocytes. 
Other steroid hormones are also able to induce maturation (Table 3.1), indicating that 
the  nature  of  the  receptor  is  not  hormone  specific.  Indeed,  flutamide,  and  its 
hydroxylated metabolite 2-hydroxyflutamide, bind with high affinity to the classical 
androgen receptor  in vitro , and also inhibit androgen mediated maturation  in vitro 
and  in  vivo .  The  known  agonist  of  AR-mediated  transcription  methyltrienolone 
(R1881), which is one of the most potent activators of AR-mediated transcription, was 
unable to promote nongenomic signalling and maturation in oocytes when incubated 
at 1 µM alone (Lutz et al., 2001). Instead, it inhibited testosterone-induced maturation 
(co-incubation of  R1881 and testosterone),  presumably by binding to  the receptor 
without stimulating the cascade of events leading to maturation (Lutz et al., 2003). In 
contrast,  androstenediol  was  a  poor  promoter  of  AR-mediated  transcription,  but  a 
strong mediator  of  maturation  and nongenomic  signalling in  oocytes  (Lutz  et  al., 
2003). Interestingly, most of the steroids which were able to induce maturation by 
incubation have a ketone group in the 23 position, and those that were not effective 
have a hydroxyl group in the same position (Jacobelli  et al., 1974). The absence of 
any enhanced activity of the more water soluble sulphated steroids suggests that the 
differential effectiveness of the steroids is not due to their solubility characteristics . 
In  addition,  injected testosterone and hydrocortisone both induced maturation,  but 
progesterone  and aldosterone (Jacobelli et al., 1974) did not (Table 3.1). 
Incubation - % maturation Injection
Reference 
Source
Schorderet-
Slatkine, 1972
Jacobelli et al., 1974 Smith  and 
Ecker, 1971
Schuetz, 
1967
Jacobelli  et  
al., 1974
Hormone (ug/L) 0.01 0.1 1 0.01 0.1 1 5 0.01 0.1 0.67 6.7 0.013
Progesterone 100 97 94 14 93 97 100 87 - 100 100 0
Pregnenolone - 27 100 0 100 100 100 - 85 0 50 -
Testosterone - - - 38 100 100 100 - 100 0 83 72 (0.003)
Aldosterone - - - 100 100 100 77 - 5 0 0 0
Hydrocortisone 19 100 89 0 0 100 100 - 100 0 50 100
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Deoxycortic* - - - - - - - - - 100 100 -
Cortisone 38 100 90 - - - - - - - - -
Estrogen - - - 0 0 0 0 - 0 0 0 0
Table 3.1 – The effects of various hormones on ooctye maturation in Xenopus laevis.
*Deoxycortic. = deoxycorticosterone
In conclusion, the relative roles of androgens and progesterone in oocyte maturation, 
and the nature of their corresponding receptors, remain unclear, as they do not induce 
gene  transcription  like  conventional  nuclear  receptors,  and  can  be  stimulated  by 
diverse hormones. However, testosterone induces maturation, and this response can be 
inhibited with AR binding compounds (flutamide and R1881), and therefore GVBD 
has  potential  for  development  as  an  amphibian  specific  anti-androgenic  screen. 
Exposure to progesterone for as little as 5 minutes, followed by washing, initiates the 
cascade of events that lead to maturation (Schuetz, 1967). Therefore, both flutamide 
and  R1881  were  tested  for  their  effectiveness  as  anti-androgens,  both  with  and 
without  pre-incubation  periods,  to  elucidate  the  optimum  conditions  for  testing 
unknown compounds for inhibitory activity on GVBD. 
3.2.3. Ovulation Assay
Oocyte  maturation  (GVBD)  and  ovulation  occurs  more  or  less  synchronously  in 
response to gonadotropin stimulation  in vivo and  in vitro,  and the two events  are 
closely linked to each other . Induction of maturation and ovulation can be stimulated 
by crude pituitary homogenates ,  and purified gonadotropins .  Removal of follicle 
cells from the oocyte results in inhibition of this response (Masui, 1967; Smith, 1968), 
but it can be ameliorated by co-incubation with follicle cells that have been excised 
from the oocyte (Masui, 1967). This is due to simulation of steroid production , which 
in turn causes maturation and ovulation of the oocyte . Steroidogenic enzymes are 
responsible for the biosynthesis of various steroid hormones, including progesterone, 
testosterone,  and  estradiol  (Figure  3.2).  Enzymes  involved  in  ovulation  include 
specific  cytochrome  P450  enzymes,  hydroxysteroid  dehydrogenases,  and  steroid 
reductases  .  Steroid  synthesis  begins  with  the  conversion  of  cholesterol  to 
pregnenolone by CYP450scc, and subsequent conversion to progesterone by 3β-HSD, 
which together are the precursors of all other steroid hormones .
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Figure 3.2. Proposed steroidogenic pathways in the amphibian oocyte, see text for 
details. Taken (modified) from Lutz et al.  and Yang et al.  CYP = cytochrome P450 
enzyme;  17OH  Preg.  =  17-hydroxypregnenolone;  17OH  Prog.  =  17-
hydroxyprogesterone.
In vitro, stimulation of frog ovarian follicles with gonadotropin results in production 
of  progestins  and  androgens,  and  maturation  of  the  oocyte  .  Progesterone  and 
testosterone concentrations increased markedly after stimulation with LH, and then 
decreased  after  approximately  10  hours,  and  ovulation  only  occured  when 
concentrations  of  both  were  elevated  (El-Zein  et  al.,  1988).  In  contrast,  estradiol 
levels increased more slowly and then remained stable over the experimental period 
(El-Zein  et al., 1988), and estradiol has been shown to have an inhibitory effect on 
ovulation . In addition, simultaneous treatment of Xenopus ovarian explants with frog 
pituitary homogenate and cyanoketone (3β-HSD inhibitor) inhibited the conversion of 
pregnenolone to progesterone, and also inhibited ovulation . Similarly, co-treatment 
of  Indian Major  Carp oocytes with LH and the  3β-HSD inhibitor  epostane ,  also 
inhibited  ovulation  ,  though  hormone  levels  were  not  measured.  Therefore,  it  is 
anticipated  that  inhibition or  stimulation of  enzymes involved in  steroid hormone 
production, resulting in corresponding changes in hormone levels, will in turn affect 
maturation and ovulation of the oocyte. Therefore, the ovulation assay was designed 
to  measure  effects  of  xenobiotics  on  steroidogenesis  by  measuring  the  ovulatory 
response  (i.e.  release  of  eggs  from  ovarian  connective  tissue),  and  hormone 
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production by the follicles. In addition, co-administration with epostane inhibited the 
ovulatory response, and thus acted as the positive control for inhibition of ovulation. 
3.3 Methods & Results
The methods and results sections are grouped due to the nature of assay optimisation, 
whereby methods were altered by results obtained from each experiment. 
3.3.1 Liver Cell Preparations
Initially,  methods  were  followed  as  described  previously  (see  Chapter  2,  section 
2.2.2.2),  however,  despite  a  total  of 13  attempts,  hepatocytes  did  not  form  a 
monolayer  and  remain  viable.  Therefore,  liver  cells  were  later  cultured  as  tissue 
fragments, instead of dissociated cells (see below).
3.3.1.1 Hepatocyte Monolayer 
The first four times, the original protocol was followed, but the cells did not survive, 
and this was not due to contamination of the cell culture. The fifth time, cells were 
incubated at 220C and 270C, however, cells were not viable. The ELISA protocol was 
verified using VTG and ALB standards,  and response to standards was similar to 
those obtained in Japan.  Therefore,  the lack of VTG and ALB production by the 
hepatocytes was not due to a fault in the ELISA. In the sixth experiment, a small 
amount of VTG (~ 9 ng/ml) was produced in hepatocytes exposed to 1.2-9.4 nM E2, 
but was slightly below the detection limit of the ELISA (detection range 11-300 ng/ml 
VTG). For comparison, hepatocytes cultured in Japan produced around 1000 ng/ml of 
VTG when exposed to 1.11 nM E2.
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It was discovered that the cell culture plates used in Japan were of a different brand 
than the ones used in the UK, therefore a comparison between the two different types 
was  made.  In  addition,  media  was  supplemented  with  varying  concentrations  of 
HEPES (a buffer) as it was observed that the media was becoming acidic during the 
cell  culture.  Therefore,  cells  were  incubated  in  NUNC (UK)  or  Sumiton  (Japan) 
plates, and with 0, 5, or 10 mM HEPES, and exposed to E2. No VTG was produced in 
cells cultured in either plastic plate, but ALB was produced by cells cultured in 5 and 
10  mM  HEPES,  with  higher  cell  viability  (i.e.  ALB  production)  at  the  highest 
concentration of HEPES (Figure 3.3), and no difference in plate type was observed. 
However, even under our best condition, the levels of ALB in the media were still 
approximately 10-fold lower than those observed in Japan (1000 ng/ml compared to 
10000  ng/ml).  Due  to  the  results  of  this  experiment,  NUNC  plates,  and  media 
supplemented with 10 mM HEPES, were used in following experiments.  
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Figure  3.3.  Albumin  produced  by  hepatocytes  exposed  to  a  range  of  estradiol  (E2) 
concentrations (1-8 nM), in either NUNC or Sumiton (SUM) 96 well plates, and in media 
without  HEPES,  or  containing  5 or  10  mM HEPES.  Values  are  mean ±  SE based on  3 
replicate wells.
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Due to previous experiments, the viability of the hepatocytes was slightly improved, 
however, VTG production was still very low or absent. Therefore, the effects of cell 
composition  and  seeding  density  were  assessed.  Cell  preparations  derived  from 
centrifugation of  liver  cells  at  20g (original),  50g & 80g were seeded at  1  x  105 
cells/ml (original), 0.5 x 105 cells/ml, and 2 x 105 cells/ml. The cells were exposed to a 
range of estradiol concentrations (0.125, 0.25, 0.5, 1, 2 nM), or a control (control, 
ethanol control). VTG was produced in low concentrations (15-21 ng/ml) under four 
conditions (20g 1 x 105 cells/ml, 50g 1 x 105 cells/ml, 50g 2 x 105 cells/ml, & 80g 2 x 
105 cells/ml), but not in a dose-dependant manner, indeed control cells also produced 
VTG at a similar level. Therefore, data from all conditions were pooled (Figure 3.4). 
ALB  production  by  cells  was  also  measured,  which  was  different  between 
experimental  conditions  (Figure  3.5),  but  lower  than  in  the  previous  experiment. 
Neither the spin speed nor the cell density clearly resulted in healthier hepatocytes, 
however when combined with the VTG data, it was decided that 50g, 1 x 105 cells/ml 
was the optimum condition for the hepatocytes. 
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Figure 3.4. VTG produced by hepatocytes exposed to 0.125, 0.5, 1 or 2 nM E2 (pooled). Cells 
centrifuged at different speeds (20g, 50g or 80g), and inoculated at different densities (1 & 2 x 
105 cells/ml). Mean ± SE based on 12 replicate wells (2 wells from each E2 concentration). 
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Figure 3.5. Albumin produced by hepatocytes exposed to 0.125, 0.5, 1 or 2 nM E2, or a 
control (pooled). Cells centrifuged at different speeds (20g, 50g or 80g), and inoculated at 
different densities (0.5, 1 & 2 x 105 cells/ml). Mean ± SE based on 12 replicate wells (2 wells 
from each E2 concentration, control, and EtOH).
As  a  result  of  these  experiments,  the  experimental  protocol  was  modified  as 
described.  However,  despite  5  more  attempts,  the  cells  never  produced  VTG  in 
appreciable concentrations. Therefore, it  was decided that using whole liver tissue, 
instead of isolated hepatocytes, may result in better survival and responsiveness of 
hepatocytes.
3.3.1.2 Liver Slice 
Adult male Xenopus were immersed in MS-222 until reflexes ceased. The body cavity 
was  opened,  the  liver  removed  and  placed  in  ice  cold  media.  It  was  cut  into 
approximately  50  mg  pieces,  and  each  was  placed  into  a  well  (24-well  plate) 
containing 500 μl media. The media was changed on day 3, by removal of 400 µl, and 
replacement with fresh media. On day 6, the media was removed, and VTG and ALB 
were measured. The liver slice assay was performed a total of 6 times. The first time 
VTG was produced in response to estradiol (Figure 3.6). However, the second time, 
only 11 wells (out of 48) produced detectable levels of VTG, and even then only in 
very low concentrations (max. – 16 ng/ml, data not shown).
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Figure  3.6.  VTG  production  by  liver  slices  when  exposed  to  a  range  of  estradiol 
concentrations (2.34-600 nM) or a control (control, ethanol control). Mean ± SE based on 3 
replicate wells per experimental condition.
The third time, VTG was produced in a dose-dependant manner, although the control 
and ethanol wells also produced high levels of VTG (Figure 3.7, A). Normalisation of 
VTG by ALB (Figure 3.7, B) or by weight (Figure 3.7, C), did not reduce variability 
of the data. The relationship between the amount of albumin produced and the weight 
of the tissue was also weak (Figure 3.7, D). Due to the positive response caused by the 
control and ethanol control,  glassware was solvent rinsed, and the experiment was 
repeated. In this case VTG produced in the control and ethanol wells was minimal, 
and dose-response curve was observed (Figure 3.8).  
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Figure 3.7. VTG production by liver slices when exposed to a range of estradiol (E2) 
concentrations (0.3, 195, 1250 nM) or a control (control,  ethanol (EtOH) control). 
Values  are  mean ±  SE based  on  6  replicate  wells.  Panel  A =  VTG produced in 
response to estradiol; Panel B = VTG produced per ng/ml of albumin (ALB); Panel C 
= VTG produced per mg tissue; Panel D = relationship between ALB (ng/ml) and 
tissue weight (mg), each point represents one value.
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Figure 3.8.  VTG production by liver  slices  when exposed to  a  range of  estradiol 
concentrations (9.78-5000 nM) or a control (control, EtOH control) for 6 days. Values 
are mean ± SE, based on 4 replicate wells per treatment.
As a result of limited success in the optimisation experiments, environmental samples 
were tested three times, however, VTG was only produced at very low levels (< 6 
ng/ml) in response to E2 in each experiment.  Therefore, no further tests with this 
assay were undertaken.  
3.3.2 GVBD
There were two distinct phases of optimisation; firstly, different media, collagenase, 
and  methods  were  tested  for  increasing  oocyte  responsiveness  and  viability,  and 
secondly, anti-androgenic compounds were tested for their effectiveness in inhibiting 
maturation both with and without pre-incubation steps. 
3.3.2.1 Reagents
• Calcium Free Hanks O Medium (Hanks O: D.Pickford):
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o Ca2+ -free,  phenol  red-free  Hanks  balanced salts  solution  diluted  in 
1.3L  distilled  water,  buffered  with  HEPES  10  mM,  pH  7.6  and 
supplemented  with  Polyvinylpyrolidone  (1g/L)  and 
Penicillin/streptomycin solution (5000 U/50 mg per ml). Sterilised by 
filtration (0.22 μm) 
• Calcium Free Ringers Solution (RO: Jane Kirk, Cancer Research Institute, U.K.):
o 825 mM NaCl, 2 mM KCl, 1 mM MgCl2,  buffered 10 mM HEPES, 
pH  7.6,  penicillin/streptomycin  solution  (5000  U/50  mg  per  ml), 
sterilised by filtration (0.22 μm).
• Collagenase Solution:
o Hanks O or RO supplemented with 0.2% collagenase (Type A, Roche 
Diagnostics,  or  Type  II,  Worthington  Biochemical  Corporation), 
sterilised by filtration (0.22 μm)
• Modified Barths Culture Medium (MBS: Jane Kirk, Cancer Research, UK):
o 88 mM NaCl, 1 mM KCl, 0.41 mM CaCl2, 2.5 mM NaHCO3, 0.82 mM 
MgSO4,  0.33  mM  Ca  (NO3)2,  buffered  10  mM  HEPES,  pH  7.6, 
Penicillin/Streptomycin (5000 U/50 mg per ml), sterilised by filtration 
(0.22 μm) 
• Defined Nutrient Oocyte Media :
o Amino Acids: 
 L-tryptophan  (20  mg/L),  L-lysine.HCl  (280  mg/L),  L-
histidine.HCl (60 mg/L), L-arginine.HCl (140 mg/L), L-aspartic 
acid (Mg salt, 450 mg/L), L-threonine (70 mg/L), L-serine (240 
mg/L), L-glutamic acid.HCl (1200 mg/L), L-proline (60 mg/L), 
glycine (60 mg/L) L-alanine (130 mg/L), L-valine (60 mg/L), 
L-methionine (50 mg/L), L-isoleucine (50 mg/L), L-leucine (80 
mg/L), L-phenylalanine (50 mg/L), L-cysteine.HCl hydrate (20 
mg/L), L-tyrosine (40 mg/L), L-cystine (10 mg/L), L-glutamine 
(80 mg/L).
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o Salts:
 NaCl  (2820 mg/L),  KCl  (186  mg/L),  Na2HPO4 (142  mg/L), 
CaCl2 (111 mg/L), MgCl2.6 H20 (203 mg/L)
o Others:
 Pyruvic  acid  (110  mg/L),  oxaloacetic  acid  (152  mg/L), 
polyvinylpyrrolidone  (500  mg/L),  phenol  red  (10  mg/L), 
gentamicin (100 mg/L), D-Ca pantothenate (1 mg/L), choline 
chloride  (1  mg/L),  folic  acid  (1  mg/L),  i-Inositol  (2  mg/L), 
nicotinamide (1 mg/L), pyridoxal.HCl (1 mg/L), riboflavin (1 
mg/L), thiamine.HCl (1 mg/L).
o Sterilised by filtration (0.22 µM), pH 7.6.
• Trichloroacetic Acid (TCA):
o TCA – 5% in water.
• Methyl Green solution:
o 0.4 % methyl green, 6 % Acetic Acid, 2 mM CaCl2, in water
• Ethyl 3-aminobenzoate sulfonate salt (MS222):
o MS222 (2g/L), buffered with NaHCO3 (0.5 M), pH 7.4
3.3.2.2 Phase 1
3.3.2.2.1. Oocyte Preparation
Sexually mature female Xenopus laevis (Blades Biological, UK) were anaesthetised 
by submersion in MS222 until reflexes ceased, and were then sacrificed by pithing. 
The body cavity was opened, the ovaries were removed, and were placed in Hanks O 
or  RO.  They  were  cut  into  thin  strips,  rinsed  several  times,  and  placed  into  a 
collagenase  solution  for  digestion of  follicle  cells.  Follicle  cells  were  removed to 
avoid confounding effects due to steroidogenic activity of follicle cells. The ovarian 
tissue was incubated on a gentle shaker at 220C, until follicle cells were no longer 
present (60-120 mins). The presence of follicle cells was tested with methyl green 
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solution, which stains the follicle cells but not the oocyte surface epithelium. Large, 
banded, preovulatory, stage VI oocytes, were then selected by hand, using a sterile 
Pasteur  pipette,  under  a  stereo  dissecting  microscope.  After  selection,  they  were 
placed in sterile 24-well polystyrene culture plates (20 oocytes per well) containing 
DNOM. Oocytes were incubated for in the presence or absence of steroids and/or 
antagonists for 20 hours. At the end of the incubation period, oocytes were fixed with 
TCA for  observation  of  maturation  and  abnormality,  which  were  calculated  as  a 
percentage of the total number of oocytes for each well.
3.3.2.2.2 Standard Curve
Oocytes were exposed to progesterone or testosterone (10, 100, 320, 1000 nM), media 
only, or an EtOH control. Therefore, hormone stocks were prepared in ethanol at a 
concentration of: 0.022 mM for 10 nM, 0.22 mM for 100 nM, 0.71 mM for 320 nM, 
and 2.22 mM for 1000 nM, and they were diluted 1000-fold in DNOM/MBS. 900 μl 
of this dilution was added to each well, along with 900 μl of DNOM/MBS, to make 
1.8 ml per well, and a further 0.2 ml was added to the wells, along with oocytes from 
the petri dish, resulting in a final volume of 2 mls. This resulted in a final dilution of 
x2222 of each hormone stock, and 0.05 % EtOH in each well. Four frogs were tested 
at these concentrations of progesterone or testosterone (Figure 3.9). Testosterone was 
always  a  more  potent  initiator  of  maturation  than  progesterone  within  each  frog. 
According  to  published  literature,  close  to  100  %  GVBD  would  be  expected  in 
response to 1000 nM of testosterone or progesterone (see Table 3.1), therefore, even 
at the highest concentration of hormone, only a sub-maximal response was observed 
(testosterone = 55%, progesterone = 40%).
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Figure 3.9. GVBD response of oocytes exposed to testosterone (T) or progesterone 
(P) over a range of concentrations (10, 100, 320 or 1000 nM), or a media only/EtOH 
control. Four frogs were used in four separate experiments, indicated by the number 
following either T or P (1, 2, 3 or 4). Values are mean ± SE, n = 6.
3.3.2.2.3 Assay Optimisation
Due to submaximal response, and in some cases, low viability (data not shown), the 
incubation temperature,  and the type of collagenase (A, B, D & dispase – Roche 
Diagnostics, U.K.), used for digestion was altered. Dispase did not digest the ovary 
tissue sufficiently to remove follicle cells, even after 4 hours, so these oocytes were 
discarded. There was little difference in the percent maturation using collagenase A, B 
or D, but the percentage of abnormal oocytes differed (Figure 3.10). Based on these 
results, collagenase D was used in further experiments. Initially the digestion step was 
conducted at 180C, but it was observed that digestion occurred more quickly when the 
temperature was increased to room temperature (230C), and no adverse effects on the 
oocytes was observed (data not shown). 
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Figure  3.10.  Effect  of  different  collagenase  (Coll)  treatments  (A,  B,  or  D)  on 
incidence of GVBD and abnormality in cultured Xenopus oocytes. GVBD response to 
progesterone (Prog) or testosterone (Test) at 1000 nM, and pooled abnormality values 
over  a  range  of  progesterone/testosterone  concentrations  (control,  EtOH,  and 
progesterone/testosterone at: 10, 100, 320 & 1000 nM). Values are mean ± SE, n = 6 
for hormone treatments, n = 60 for abnormality values.
Due to low maturation and high abnormality, I contacted an expert on Xenopus oocyte 
maturation (Dr. Jane Kirk, Cancer Research U.K. (CRUK), Clare Hall Laboratories), 
and  visited  her  laboratory  to  resolve  experimental  difficulties.  A  comparison  of 
methods and reagents using oocytes from the same frog resulted in higher abnormality 
and  lower  maturation  in  original  conditions  compared  to  those  used  at  CRUK 
(abnormality: ~50% compared to ~5%; GVBD: ~40% compared to ~90%). Various 
differences in methods were observed.  Firstly,  the preparation of  the oocytes was 
distinct. At CRUK, glass petri dishes and rounded glass pasteur pipettes were used for 
tissue preparation, whereas in the original experimental design, plastic was used in 
both cases, which may have damaged the oocytes. Secondly, to reduce time spent in 
preparation of the oocytes for digestion with collagenase, a method of tearing ovarian 
lobes  with forceps  was employed at  CRUK, whereas in  the original  experimental 
design, lobes were cut with microscissors, which resulted in more handling time, and 
possibly damage to the oocyte with the scissors. Lastly, at CRUK, the collagenase 
solution was replaced every hour, reducing possible impact of cell debris, whereas in 
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the original design they were left in the same solution for the entire incubation period. 
These aspects of the experimental design were altered in favour of methods used at 
CRUK, and reagents were then compared. The Ca2+-free media (collagenase media) 
used at CRUK was RO, and that used originally was Hanks O solution. The type of 
collagenase  was  also  distinct  (CRUK – Type  II;  original  –  Type  D),  as  was  the 
incubating media (CRUK – MBS; original – DNOM). The experimental design for 
testing anti-androgenic effects involved maintaining viability of oocytes over 2 days, 
therefore the various media, and collagenase were tested on day 1 and day 2 (Table 
3.2). The Ca2+-free media Hanks O caused high abnormality in the oocytes and low 
maturation (Table 3.2), and collagenase Type D also caused higher abnormality than 
collagenase type II (Table 3.2). However, the effects of the incubation media were 
similar.  Under optimal conditions (collagenase type II,  RO, and MBS or DNOM), 
there was little difference in viability (abnormality) or maturation on different days. 
DNOM is a media designed for the long-term maintenance of Xenopus oocytes, which 
is not necessary in this case, therefore, it was decided that type II collagenase, RO, 
and MBS would be used in further experiments with Xenopus oocytes.  
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Day Coll. Ca+ -Free  Incubating T. Conc. Ab. (%) GVBD (%)
1
D
Hanks
DNOM
0 6 0
100 5 0
1000 8 5.4
MBS
0 8 0
100 14 1.8
1000 9 17.3
II Ringers
DNOM
0 0 0
100 0 2.5
1000 1 69.6
MBS
0 0 0
100 3 24.6
1000 7 69.6
2
D Hanks
DNOM
0 24 0
100 27 0
1000 19 14.0
MBS
0 47 0
100 49 9.1
1000 46 28.2
D Ringers MBS
0 0 0
100 12 29.9
1000 6 53.0
½ D
Hanks DNOM
0 1 0
100 6 60.8
1000 14 62.8
Ringers MBS
0 1 0
100 1 23.2
1000 5 65.4
II
Ringers
DNOM
0 0 0
100 2 2.6
1000 1 76.2
MBS
0 2 0
100 2 9.1
1000 2 63.9
Hanks DNOM
0 37 0
100 43 3.6
1000 44 0
Table 3.2. Comparison between reagents used for Xenopus oocyte culture on 2 days.  
Coll. = collagenase; T Conc. = testosterone concentration; Ab. = abnormality.
3.3.2.3 Phase 2
3.3.2.3.1 Anti-Androgen Treatments
The experimental design was based on first testing the responsiveness and viability of 
the oocytes by exposing them to a range of testosterone concentrations (10, 100, 320, 
1000 nM), or a control (control, EtOH control) on day 1. Providing the abnormality 
observed was less than 5%, a submaximal concentration of testosterone was chosen to 
raise the background of GVBD, so that anti-androgenic effects could be observed. 
Two  anti-androgens  were  possible  candidates  to  be  used  as  the  positive  control; 
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flutamide and R1881. In order to elucidate the optimal anti-androgen and testosterone 
concentrations,  two R1881 and flutamide concentrations (0.5 and 1 µM) were co-
incubated with a range of testosterone concentrations (10, 100, 320, & 1000 nM). 
Two pre-incubation times were tested for each concentration of anti-androgen, 1 hour 
(Figure 3.11) and 24 hours (Figure 3.12). After 1 hour pre-incubation, inhibition was 
observed when co-incubated with 100 µM of testosterone, but this effect was largely 
lost at higher concentrations. However, after pre-incubation for 24 hours, all the anti-
androgenic treatments caused inhibition of GVBD at all testosterone concentrations. 
Flutamide was the strongest inhibitor of GVBD at 1 µM, and therefore was used as 
the positive control for GVBD inhibition in further experiments.
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Figure 3.11. Pre-incubation with anti-androgens (R1881 (R) or flutamide (F)) for 1 
hour, prior to co-incubation with testosterone (T: 100, 320 or 1000 nM). Test. only = 
testosterone only. Values are mean ± SE based on 4 replicate wells.
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Figure 3.12. Pre-incubation with anti-androgens (R1881 (R) or flutamide (F)) for 24 
hours, prior to co-incubation with testosterone (T: 100, 320 or 1000 nM). Test. only = 
testosterone only. Values are mean ± SE based on 4 replicate wells.
3.3.2.3.2 Flutamide Inhibition
Oocytes were exposed to a range of testosterone concentrations (10, 100, 320, & 1000 
nM) for 20 hours on day 1. GVBD was observed in a dose-dependant manner (Figure 
3.13),  and  abnormality  was  below  5%  (data  not  shown).  Therefore,  unexposed 
oocytes of the same batch were exposed to a range of flutamide concentrations (5, 1, 
0.1, 0.01 µM) on day 2, and were incubated for 24 hours. Since 100 nM (54% of full 
response) and 320 nM (90% of full response) both displayed submaximal responses, 
they were tested by co-incubation with each flutamide concentration on day 3. The 
background GVBD was higher in oocytes exposed to 320 nM testosterone, than 100 
nM, and this resulted in a larger dynamic range of the flutamide dose-response curve 
(Figure 3.14). 
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Figure  3.13.  GVBD  response  of  oocytes  exposed  to  a  range  of  testosterone 
concentrations (0, 10, 100, 320 & 1000 nM) for 20 hours (on day 1). Values are mean 
± SE based on 4 replicate wells.
Figure 3.14. GVBD response of oocytes to a range of flutamide (Flut) concentrations 
(0.01, 0.1, 1, & 5 µM), pre-incubated for 24 hours on day 2, and co-incubated with 
either 100 or 320 nM testosterone (T) on day 3. Oocytes were also pre-incubated in 
media  only,  followed by  addition  of  testosterone  on  day  3  for  maximal  response 
values (100 or 320 nM T). Values are mean ± SE based on 4 replicate wells.
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3.3.3 Ovulation
3.3.3.1 Oocyte Preparation
Sexually mature female Xenopus laevis (Blades Biological, U.K) were anaesthetised 
by submersion in MS222 until reflexes ceased, and were then sacrificed by pithing. 
The ovaries were removed and placed in a glass petri dish containing MBS and cut 
into pieces, the size of which was altered during the optimisation process. Ovarian 
tissue was incubated with human chorionic gonadotropin (HCG: 6.25, 12.5, 25, 50 
I.U.), or media only, for 20 hours. At the end of incubation, media was extracted, 
frozen on dry ice,  and stored at  -80 until  hormone analysis by radioimmunoassay 
(RIA:  for  description  of  methods  see  Chapter  4,  section  4.2.5).  In  addition,  the 
oocytes were tested for viability with Trypan blue (0.2%), fixed with TCA, and the 
number of ovulated oocytes were counted (i.e. the number of oocytes released from 
ovarian tissue). Ovulated oocytes were checked for GVBD to ensure that released 
oocytes had undergone maturation.
3.3.3.2 Optimisation
The proposed experimental  design comprised of  two steps:  1.  a  sensitivity-test  of 
ovarian  tissue;  and  2.  co-incubation  with  HCG  and  the  test  compound.  The 
optimisation procedure comprised to 3 phases,  the viability and responsiveness of 
ovarian  tissue  was  tested  over  2  days  (phase  1),  the  optimal  size  of  the  tissue 
fragments was determined (phase 2),  and the proposed positive control agent  was 
tested (phase 3). In addition, the effectiveness of weight as a normalising factor on 
incidence of ovulation by tissue fragments was tested.
3.3.3.2.1 Phase 1
Ovarian fragments were exposed to a range of HCG concentrations (6.25, 12.5, 25, & 
20 I.U.), or a media only control, for 20 hours, on day 1 or 2. Oocytes remained viable 
during the exposure time, as measured with Trypan Blue solution, and the ovulatory 
response was similar on days 1 & 2, although, it was slightly less on day 2 (Figure 
165
3.15,  A).  In  addition,  weight  was not  effective at  reducing variability  of  the data 
(Figure 3.15, B).
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Figure 3.15. Ovulation of oocytes following exposure to HCG (6.25, 12.5, 25, or 50 
I.U.) in MBS media for 20 hours, beginning exposure on day 1 or 2. Either ovulation 
values alone (Panel A), or per mg of tissue (Panel B). Tissue fragment size was 40-60 
mg. Values are mean ± SE based on 6 replicate wells.  = day 1,  = day 2.
3.3.3.2.2 Phase 2
The  optimal  tissue  size,  for  hormone  production  and  decreased  variability,  was 
assessed by identifying the straight portion of dose response curves of ovulation and 
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hormone production. The ovary was cut into pieces of tissue ranging from 10-113 mg, 
incubated with 3 concentrations of  HCG (12.5,  25,  and 50 I.U.)  or a  media only 
control, and ovulation (Figure 3.16) and hormone production (Figure 3.17-3.19), were 
measured. Ovulation (released oocytes) per mg of tissue decreased with increasing 
tissue size, irrespective of the HCG concentration used, as did testosterone (Figure 
3.17) and progesterone (Figure 3.18) production. However, hormone production of 
the smallest tissue fragments was near the detection limit of the RIA. Ovulation was 
never observed in unstimulated wells, and hormone levels were not detectable. The 
straight portion of the dose-response curve occurred in tissue sizes < 60 mg in the 
ovulation (Figure 3.16), and testosterone (Figure 3.18) production, when oocytes were 
exposed to 12.5 or 25 I.U. HCG (but not 50 I.U.). For progesterone, the dose-response 
relationship was linear over the range of tissue sizes tested at all concentrations of 
HCG. The production of estradiol (Figure 3.19) followed the opposite pattern to the 
other parameters measured whereby estradiol production increased per mg of tissue as 
the size of the tissue increased. However, the straight portion of the dose-response 
curve also occurred in tissue size < 60 mg. Due to these results, two pieces of tissue of 
30-40 mg per well were cultured in 62.5, 12.5, or 25 I.U. HCG, or in media only. The 
ovulatory response was measured, and progesterone, testosterone, and estradiol were 
measured in the culture media. Variability was decreased in ovulation, progesterone 
and testosterone, but not estradiol production (Figure 3.20). Hormone production was 
also sufficiently elevated for detection in the RIA, and values fell in the mid-range of 
the standard curve.
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Figure 3.16. Ovulation (oocytes) per mg ovarian tissue in different tissue fragment 
sizes, exposed to a range of HCG concentrations (12.5, 25 or 50). Each data point 
represents one tissue fragment, 8 tissue fragments of ascending size were used per 
HCG concentration, and lines’ are polynominal regressions. ♦ = 12.5 I.U., ■ = 25 I.U., 
▲ = 50 I.U., of HCG
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Figure  3.17.  Testosterone  production  per  mg  ovarian  tissue  in  different  tissue 
fragment sizes, exposed to a range of HCG concentrations (12.5, 25 or 50). Each data 
point represents one tissue fragment, 8 tissue fragments of ascending size were used 
per HCG concentration, and lines’ are polynominal regressions. ♦ = 12.5 I.U., ■ = 25 
I.U., ▲ = 50 I.U., of HCG.
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Figure  3.18.  Progesterone  production  per  mg  ovarian  tissue  in  different  tissue 
fragment sizes, exposed to a range of HCG concentrations (12.5, 25 or 50). Each data 
point represents one tissue fragment, 8 tissue fragments of ascending size were used 
per HCG concentration, and lines’ are polynominal regressions. ♦ = 12.5 I.U., ■ = 25 
I.U., ▲ = 50 I.U., of HCG
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Figure 3.19. Estradiol production per mg ovarian tissue in different tissue fragment 
sizes, exposed to a range of HCG concentrations (12.5, 25 or 50). Each data point 
represents one tissue fragment, 8 tissue fragments of ascending size were used per 
HCG concentration, lines’ are polynominal regressions. ♦ = 12.5 I.U., ■ = 25 I.U., ▲ 
= 50 I.U., of HCG.
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Figure 3.20. Ovulatory response (Panel A), and progesterone (Panel B), testosterone 
(Panel C), and estradiol (Panel D) production, by ovarian tissue (two fragments of 30-
40 mg each) exposed to HCG (6.25, 12.5, 25, or 50) or a media only control (20 
hours). NB: Progesterone production in response to 50 I.U. samples was lost. Values 
are mean ± SE based on 6 replicate wells.  
3.3.3.2.3 Phase 3
The effectiveness of epostane as an ovulatory inhibitor was tested to determine it’s 
applicability as a positive control for inhibition of ovulation. Two pieces of ovarian 
tissue (30-50 mg) were co-incubated with HCG, to induce ovulation, and a range of 
epostane concentrations (0.1, 1, 10, 100, 1000 and 5000 nM), to inhibit ovulation. A 
full dose-response curve was observed when exposed to 12.5 and 25 I.U., and a partial 
dose-response curve when exposed to 6.25 I.U. In addition, complete inhibition of 
ovulation was observed when tissue was exposed to  5000 and 1000 nM epostane 
(Figure 3.21). Variability was not reduced by normalisation with weight values, and 
therefore, these were not used in further experiments.
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Figure 3.21. Ovulatory response of ovarian Xenopus tissue incubated with HCG alone 
(6.25,  12.5,  or  25  I.U.),  or  co-incubated  with  a  range  of  epostane  (EPO) 
concentrations (1, 0, 100, 1000, or 5000 nM). Data was expressed as the number of 
oocytes ovulated (Panel A), or the number ovulated per mg ovarian tissue (Panel B). 
Values are mean ± SE, based on 6 replicate wells.
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3.4 Discussion
Two  novel  assays  for  testing  ED  based  on  amphibian  tissues  were  successfully 
developed and optimised for use (GVBD and ovulation), however, optimisation of 
liver cell preparations for use at Brunel University was not successful. In addition, 
despite successful optimisation of the GVBD assay as described here, when used for 
measuring  effects  of  pesticides,  results  were  highly  variable  and  unreliable  (2 
replicate assays). Therefore, GVBD was not used for further analysis of compounds.  
3.4.1 Optimisation Procedure
The problems encountered in use of the hepatocyte assay were not anticipated, as the 
author had performed this assay successfully during training with N.Mitsui (Towa-
Kagaku, Japan). The reasons for failure of hepatocyte culture are unknown, but short 
initial training and a lack of on-hand expertise impeded the problem solving process. 
Indeed, frequent and detailed communication between myself and N.Mitsui did not 
isolate the cause of failure, and it became clear that it was not possible to problem-
solve effectively without further training in the laboratory environment. In retrospect, 
it would have been better to take the test compounds to Japan for testing, where the 
assay  was  already  set  up  for  testing  estrogenic  and  anti-estrogenic  compounds. 
Alternatively,  an  expert  at  Brunel  University,  or  longer  initial  training,  may have 
resulted in successful hepatocyte culture. The rationale for addition of HEPES was to 
prevent acidosis of the incubating media, which did improve viability of hepatocytes. 
However, acidosis did not occur during training, indicating that an essential part of the 
hepatocyte  preparation  procedure  was  altered  in  some way.  In  addition,  different 
centrifugation speeds were implemented, resulting in different cell compositions, as 
co-incubation of rat hepatocytes with parenchymal cells increased their viability . In 
addition, cells were seeded at different densities, as contact between cells is necessary 
to  form a  monolayer  (N.Mitsui  pers  comm),  but  there  is  also  a  finite  amount  of 
nutrients and oxygen available to cells in culture. However, neither of these changes 
to the protocol appreciably altered the sensitivity of the hepatocytes to E2. The liver 
slice  assay was based on methods used by Hurter  et al.,  ,  and was initially more 
successful, but it was not reliable; and no results from the water extracts could be 
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obtained.  Similar  problems  occurred  initially  when  optimising  the  GVBD  assay, 
whereby  viability  and  responsiveness  of  oocytes  was  low.  However,  due  to  the 
experience  with the  liver  cell  preparations,  laboratory training in  the method was 
obtained, and this resulted in effective problem-solving. The cell culture conditions of 
ovarian fragments (for the ovulation assay) was based on findings from the GVBD 
optimisation procedure, and resulted in viable and responsive cells; and therefore no 
further optimisation of basic cell culture conditions was necessary. The assays are 
presented here in chronological order, and therefore, there was probably an influence 
of the authors’ laboratory experience and training, on the success of the optimisation 
procedure. Although it is also true that the assays decreased in complexity over time, 
and it may have been prudent to begin with the assay requiring the least laboratory 
skill (ovulation), and proceeding to the GVBD assay, and finally the hepatocyte assay. 
3.4.2 GVBD Optimisation  
After initial optimisation, which was concerned with basic cell culture conditions, the 
assay  was  optimised  for  detecting  anti-androgenic  activity.  Two  anti-androgenic 
compounds were  tested for  suitability  as the inhibitory control,  and different  pre-
incubation  exposure  periods  were  investigated.  Both  R1881  and  flutamide  were 
previously shown to inhibit testosterone induced GVBD (Lutz et al., 2003), and were 
tested at two concentrations. Testosterone has higher affinity for the AR than R1881 
or  flutamide  (Lutz  et  al.,  2003),  and  once  maturation  has  been  initiated,  steroid 
stimulation is no longer necessary, which can be achieved in as little as five minutes 
incubation with the initiator (Schuetz, 1967). Therefore, it was decided that incubation 
with  the  anti-androgen  prior  to  addition  of  testosterone  would  result  in  a  more 
effective inhibition of GVBD, and therefore make the assay more sensitive. Both the 
anti-androgens were more potent inhibitors of GVBD after 24 hours than 1 hour, but 
flutamide was more effective than R1881. The increased potency of flutamide after 24 
hours pre-incubation was likely due to testosterone binding with higher affinity than 
flutamide to the receptor, and effectively out-competing flutamide when only 1 hour 
pre-incubation occurred (Ankley et al., 2004). In addition, the anti-androgen was most 
effective if the background GVBD was raised to 80% (320 nM testosterone) of the 
maximal response (1000 nM testosterone). Therefore, to ensure a sufficient dynamic 
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range of the assay,  and to maintain it’s sensitivity to weak anti-androgens,  it  was 
decided that a concentration of 70% of the maximal response on day 1 would be 
optimal  for  testing  xenobiotics.  Unfortunately,  as  mentioned  above,  testing  of 
pesticide resulted in highly variable and unreliable results. Perhaps repeating assays at 
an earlier stage of optimisation would have identified this problem prior to testing 
pesticides
3.4.3 Ovulation Optimisation
Due to optimisation of  culture  conditions for  GVBD, no alteration to  cell  culture 
conditions  was  necessary  for  the  ovulation  assay.  However,  response  of  ovarian 
fragments was highly variable. Although this would be expected between individuals 
due to the endogenous hormone environment , high variability was observed between 
wells from the same frog. In an attempt to reduce this variability, data were initially 
normalised using the weight of each individual fragment; however, no difference in 
variability could be observed. Therefore, the effect of fragment size on ovulation and 
hormone production was investigated.  The original  fragment  size (50-60 mg) was 
discovered to reside in the curved section of the dose response curve. That may have 
led to variable results, as marginally different fragment sizes would have resulted in 
different fragments falling on different standard curves. Therefore, fragments were 
sized to lie on the first half of the graph (30-40 mg), as this was the steeper slope, and 
more hormone was being produced per mg of tissue. Two fragments were also placed 
in each well, to ensure sufficient hormone levels were produced to allow detection if 
inhibition  of  steroidogenesis  occurred.  This  resulted  in  substantially  decreased 
variability. In addition, the 3β-HSD inhibitor, epostane, was shown to be an effective 
inhibitor of ovulation and was used as the inhibitory control. 
3.4.4 The role of Androgens in the Ovary
Data presented here provides supporting evidence of a prominent role of testosterone 
in GVBD and ovulation of the amphibian oocyte. Firstly, testosterone was always a 
more potent initiator of GVBD than progesterone. Secondly, flutamide and R1881 
effectively inhibited testosterone induced GVBD (as previously reported in Lutz  et 
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al.,  2003),  indicating  that  testosterone  binds  to  a  receptor  on  the  oocyte,  which 
initiates  ovulation.  Thirdly,  patterns  of  ovulation  and  testosterone  production  by 
ovarian fragments were similar over two different experiments (see Figures 3.16/3.17 
& 3.20). The pattern of production was also suggestive of conversion of progesterone 
to testosterone, as progesterone levels were low when testosterone was increasing, and 
increased  sharply  when  testosterone  levels  reached  a  plateau  (see  Figure  3.20). 
Interestingly, it was previously reported that stimulation of ovarian tissue with frog 
pituitary homogenate increased metabolism of progesterone to other products (Snyder 
and Schuetz, 1973), although the authors did not identify these compounds. Finally, 
testosterone  production  was  approximately  10-fold  higher  than  progesterone 
production (as previously reported in El-Zein et al., 1998), and Jacobelli et al. (1974). 
Furthermore, Masui and Mackert  reported that injected progesterone did not induce 
maturation, whereas testosterone injection did (Jacobelli  et al., 1974). Interestingly, 
exposure of ovarian fragments to 12.5 I.U. HCG resulted in production of 10 nM 
testosterone,  0.5  nM progesterone,  and  ovulation/GVBD of  oocytes.  The  level  of 
testosterone produced was approximately 10-fold lower than levels required to initiate 
GVBD  in  denuded  oocytes  by  exogenous  administration  (100  nM  testosterone), 
indicating that  other  factors  may be  involved.  Both progesterone  and testosterone 
levels are elevated after stimulation and El-Zein  et al. (1988) reported that it  was 
necessary for both progesterone and testosterone to be elevated to stimulate ovulation. 
Therefore, since various steroid hormones are capable of initiating maturation at high 
concentrations, and progesterone is a precursor of testosterone, the optimal condition 
for GVBD and ovulation may be a combination of these hormones. 
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Chapter 4
Pesticide-induced Endocrine 
Disruption
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4.1 Overview
The potential for agricultural chemicals to cause ED is an increasing concern, both in 
humans   and  in  wildlife  .  The  organochlorine  DDT was  the  first  pesticide  to  be 
identified as an ED , and to date, the majority of published research on pesticides and 
ED  concerns  organochlorine  pesticides.  However,  although  these  chemicals  are 
environmentally important because of their persistence and ability to bioaccumulate, 
their use has been largely superseded by less persistent pesticides (see Appendix 1), of 
which much less is known. Indeed, plant growth regulators/herbicides form the largest 
group of pesticides, and made up 44 % of the world market in agricultural pesticide 
use in 2000 and 2001. In comparison, 28 % were insecticides, 19% were fungicides, 
and 9 % were other pesticides . To reflect this pattern of usage, eleven herbicides 
(MCPA  (4-chloro-2-methylphenoxy  acetic  acid),  mecoprop,  2,4,-D  (2,4-
dichlorophenoxy  acetic  acid),  bentazone,  isoproturon,  diuron,  linuron,  simazine, 
atrazine, trifluralin, chlorpropham), two insecticides (sulcofuron and flucofuron), one 
fungicide (tecnazene), and one general use biocide (PCP: pentachlorophenol) were 
tested  for  endocrine  disrupting  activity.  EDs  have  many  potential  targets  in  the 
organism (see Chapter 1, section 1.3), however, current evidence primarily supports 
agonism/ antagonism of nuclear hormone binding to receptors, and to a lesser extent 
stimulation/inhibition  of  enzymes  involved  in  steroidogenesis.  Therefore, 
estrogenic/androgenic  and  anti-estrogenic/  androgenic  activity  was  tested  in  a 
recombinant yeast assay, and disruption of the steroidogenic pathway was tested using 
cultured Xenopus oocytes. Although in vitro tests are limited in predicting effects  in 
vivo, they can be useful for  indicating which compounds require further testing, and 
can also assist in elucidating mechanism of action . Therefore, the predictive ability of 
these screens was tested with the most active pesticide identified  in vitro (PCP), by 
means of a short in vivo test using adult Xenopus.
4.2 Introduction
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To  date,  most  in  vitro tests  for  endocrine  disruption  have  focused  on 
agonism/antagonism  of  hormone  receptors,  with  estrogen  receptor  agonism  and 
androgen  receptor  antagonism  being  the  most  common  (Ashby,  2000),  and 
agrochemicals  and industrial  chemicals  are often demonstrated to possess receptor 
mediated estrogenic and/or anti-estrogenic and/or anti-androgenic activity . Some of 
the pesticides used here have previously been tested for these activities (see Chapter 
1, section 1.5), however, for the majority it is the first time they have been tested for 
androgenic and anti-estrogenic activity. The recombinant yeast used here have been 
transfected with the human estrogen receptor or the human androgen receptor, and the 
screen is  highly sensitive,  reproducible  and rapid (Routledge and Sumpter,  1996). 
Disruption  of  the  steroidogenic  pathway  is  a  less  well  researched  area,  but  is 
increasingly  gaining  attention  as  an  important  target  for  EDs  .  Ovulation  is  an 
environmentally relevant endpoint, and has the potential to have direct effects on the 
reproductive  capability  of  individuals.  It  has  also  previously  been  shown to  be  a 
sensitive  endpoint  to  pesticide  exposure  .  Many  steroid  hormones  can  induce 
ovulation in amphibians, but progesterone and testosterone are generally recognised 
as being the most potent (Jacobelli  et al.,  1974; Smith and Ecker, 1971), whereas 
estradiol inhibits maturation . Therefore, it is expected that alterations in steroidogenic 
enzyme activity and the corresponding changes in hormone levels, will in turn affect 
maturation and ovulation of the oocyte (Masui,  1967; Snyder and Schuetz, 1973). 
Furthermore,  measurement of hormone levels  in the ovulation media can assist  in 
identifying which enzymes are being affected by the treatment (e.g. Ahn et al., 2007). 
In  the  UK,  herbicides  were  widely  used  and  were  found  frequently  at  low 
concentrations in the environment,  whereas other types of pesticides tended to  be 
found less frequently, but at higher concentrations (see Appendix 1). The phenoxy 
herbicides MCPA, 2,4,-D, and mecoprop, and the substituted-urea herbicides diuron, 
linuron and isoproturon, were the highest ranked pesticides in the U.K. (Mecoprop-1st, 
MCPA-4th,  2,4,-D-5th,  diuron-2nd;  linuron-24th;  isoproturon-3rd).  In  addition,  2,4,-D 
was the  5th most  commonly used  pesticide  in  the  U.S.  in  2001 .  The former  are 
synthetic  auxins,  which  are  used  for  post-emergence  control  of  weeds  in  a  wide 
variety of applications, including in cereals, maize, grassland, under fruit trees, on 
roadside verges and in the aquatic environment (Tomlin, 2006). The latter function by 
inhibiting photosynthetic electron transport and are used for pre- and post- emergence 
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control in vegetable and wheat crops (Tomlin, 2006). Despite the widespread use of 
these pesticides, information pertaining to their endocrine effects, if any, is scarce. 
MCPA caused a loss of maturing spermatids, and slight testicular degeneration in the 
seminiferous tubules of rats dosed with 112 mg/kg/day . In addition, newts exposed to 
800 mg/L displayed increased hepatic  enzyme activity in  females but  not  males , 
although, these exposure levels and concentrations are much higher than those found 
in the environment. Mecoprop had a slightly toxic effect on murine embryos exposed 
to 0.5 µg/L , but was not reported to have estrogenic or anti-estrogenic activity in a 
reporter cell line . 2,4,-D was reported to decrease circulating thyroxine levels in ewes 
exposed to 30 mg/kg/week for 5 weeks, although estradiol,  cortisol and LH levels 
were unaffected . In addition, rats exposed to a chemical formulation containing 2,4,-
D (Tordon 75D®) displayed testicular germ cell depletion, shrunken tubules, and a 
decrease in teste weight, but only in animals exposed to the highest dose (150 mg/kg 
body weight) for 9 weeks . Circulating testosterone levels were not depleted, possibly 
suggesting  a  direct  toxic  effect  on  the  teste,  rather  than  interference  with  the 
hypothalamo-pituitary-gonadal  axis.  In  vitro,  Xenopus oocyte  maturation  was 
irreversibly inhibited by exposure to 10 mM 2,4,-D , although this is an extremely 
high concentration (corresponds to 2.2 g/L). Diuron had no effect on fish testicular or 
ovarian steroidogenesis in vitro at 0.1 or 1 mM . In addition, no effect was observed 
on prostate 5α-R activity up to 100 µM , or placental aromatase activity up to 50 µM , 
in human tissue homogenates. It also did not interact with the estrogen receptor , but 
was weakly anti-androgenic in a reporter gene assay (8.7 µM caused 20 % inhibition 
of  the  maximal  androgenic  response;  Kojima  et  al.,  2004).  Considering  its 
weak/absent endocrine effects  in vitro,  perhaps it  is not surprising that diuron had 
minimal  effects  on  reproductive  parameters  in  rats  exposed  in  vivo .  At  similar 
concentrations, linuron also did not interact with the estrogen receptor (Vingaard  et 
al.,  1999;  Kojima  et  al.,  2004),  and  did  not  inhibit  placental  aromatase  acitivity 
(Vingaard  et  al.,  2000).  However,  linuron  was  approximately  3  times  more  anti-
androgenic than diuron , and inhibited prostate 5α-R activity by 50% at 86 µM (Lo et 
al.,  2007).  Several  studies  have  shown  anti-androgenic  activity  of  linuron  on 
reproductive parameters in rats in vivo, and the mechanism of action is hypothesised 
to be at least partly via antagonism of the androgen receptor . Anti-androgenic activity 
has  also  been  demonstrated  in  an  aquatic  exposure  study,  whereby  inhibition  of 
spiggin  production  in  female  Stickleback  co-exposed  to  150  µg/L  linuron  and 
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methyltestosterone was reported . However, in the latter study, no effect was observed 
at 15 µg/L nominal levels, although measured values were lower (3.4-12 µg/L), they 
were still higher than the maximum detected concentration in the UK in 2004/2005 
(1.4 µg/L). Isoproturon is the least well studied of the phenoxy herbicides, and to the 
author’s  knowledge,  in  just  one  publication  has  this  chemical  been  tested  for 
endocrine effects in vitro. In this study, no estrogenic or anti-estrogenic activity was 
observed in a reporter cell line up to 30 µM . Isoproturon has been reported to inhibit 
spermatogenesis  at  400-800  mg/kg  ,  and  to  reduce  activity  of  testicular  3α-HSD 
(Sarkar et al., 1997), and liver detoxification enzymes  in rats. Moreover, in Bombina 
bombina (fire-bellied toad) tadpoles exposed to 0.1-100 µg/L isoproturon, it has been 
shown to cause mortality and developmental deformities .
The triazine  herbicides,  atrazine  and simazine,  were  the  next  most  highly  ranked 
pesticides in the U.K. (simazine-6th, atrazine-7th), and atrazine was the second most 
commonly used pesticide in the US in 2001 (Kiely, 2004). They also function by 
inhibiting photosynthetic electron transport and are used for pre- and post- emergence 
control in maize, sugar cane, pineapples, grassland and for industrial weed control 
(Tomlin, 2006). Atrazine and simazine do not interact with the estrogen or androgen 
receptor  ,  but  they  have  been  shown  to  affect  steroidogenesis  .  Aromatase 
upregulation  was  observed  in  human  adrenocortical  carcinoma,  and  placental 
choriocarcinoma cells at between 0.3-30 µM . However, upregulation could not be 
detected in amphibians or reptiles in vivo . Atrazine also significantly inhibited 5α-R, 
3αHSD, and 17βHSD activity in cultured rat pituitary cells when they were exposed 
to 0.92 µM, and a similar effect was observed in the hypothalamus of rats exposed in 
vivo (12mg/100g b.w./day for 7 days, Babic-Gojmerac et al., 1989). Furthermore, 5α-
R activity was inhibited in fish testicular homogenate exposed to 100 µM atrazine 
(Thibaut  and  Porte,  2004),  and  atrazine  inhibited  adrenocorticotropin  hormone 
(ACTH)  stimulated  cortisol  secretion  in  adrenocortical  cells  of  Onchorhynchus 
mykiss at 0.005-5 µM (Bisson and Hontela, 2003) and  Rana catesbeiana at 10-100 
µM (but  not  Xenopus  laevis, Goulet  and  Hontela,  2003).  Atrazine  has  also  been 
reported to cause endocrine disruption in amphibians via analysis of gonadal histology 
at environmentally relevant concentrations . The diazinone herbicide bentazone also 
inhibits  photosynthetic  electron transport,  and is  used on cereals,  maize,  and peas 
(Tomlin, 2006). It was ranked 15th in the UK (see Appendix 1), and was the pesticide 
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most  commonly  found  above  0.1  µg/L  in  groundwater  in  2005  .  However,  no 
information related to its EDg potential was available.
The dinitroaniline herbicide trifluralin and the carbamate herbicide chlorpropham both 
function  by  inhibiting  cellular  microtubule  assembly.  Trifluralin  is  used  for  pre-
emergence weed control in many vegetables, and is often used in combination with 
linuron  or  isoproturon  in  winter  cereals  (Tomlin,  2006).  It  was  the  12th  most 
commonly used pesticide in the US in 2001 (Kiely, 2004), and was ranked 28th in the 
UK  (see  Appendix  1).  Trifluralin  decreased  thyroxine,  increased  estradiol,  and 
decreased  LH  concentrations  in  ewes  exposed  to  35  mg/kg/week  for  5  weeks 
(Rawlings  et al., 1998). However, it did not interact with the estrogen or androgen 
receptor  in  vitro ,  therefore,  the  mechanism of  action  is  unknown.  Chlorpropham 
constituted 91% of the total tonnage used to prevent sprouting in stored potatoes in 
2002 , and was ranked 16th in the U.K. (see Appendix 1).  Chlorpropham was not 
active on the estrogen or androgen receptor ,  and had little effect on reproductive 
parameters in rats . The fungicide tecnazene inhibits lipid peroxidation and is also 
used as a sprout suppressant on stored potatoes (Tomlin, 2006). It was found rarely (4 
times), but at up to 0.21 µg/L, which was the highest concentration of the fungicides 
(see Appendix 1). To the author’s knowledge, no information pertaining to its ED 
effects have been published.
The urea insecticides sulcofuron and flucofuron (mitins) inhibit digestion in wool-
feeding insect larvae, and are used as mothproofing agents (Tomlin, 2006). Discharge 
of mothproofing chemicals from the textile industry are frequently the cause of water 
quality failures in the UK , and although the mitins are reportedly not used in moth-
proofing at present, they were detected in freshwaters. Indeed, they were among the 
highest ranked insecticides (33rd & 41th), and although detected rarely (4 & 6 times in 
2004/2005), they had the highest median concentration of all insecticides (0.545 & 
0.255 µg/L). To the author’s knowledge, no reports pertaining to ED activity of these 
insecticides was available. 
The general use biocide PCP functions by uncoupling oxidative phosphorylation. It 
was the most potent pesticide tested in vitro, and therefore, was also tested in vivo. It 
is  used  as  an  insecticide,  fungicide,  and  herbicide  and thus  has  a  wide  range  of 
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applications, agriculturally, and industrially, but its primary use is to protect timber 
from wood-boring insects and fungal rots (Tomlin, 2006). In spite of it’s restricted use 
in Europe since 1991 , it was ranked 12th in the U.K., and was detected 93 times at a 
median concentration of 0.16 µg/L, and the maximum detected concentration was 
2.74 µg/L. Assuming use of PCP is minimal, it’s high ranking may have been partly 
due to metabolism of hexachlorobenzene and hexachlorocyclohexane isomers (e.g. 
lindane),  resulting  in  environmental  PCP  .  Alternatively,  it  may  have  been  via 
improper disposal of left-over stocks. PCP has previously been reported to have anti-
estrogenic  activity  in  vitro (50%  inhibition  at  1.6  µM-Jung  et  al.,  2004,  80% 
inhibition at 3 µM-Lemaire  et al., 2006), although estrogenic  and anti-androgenic 
activity were not observed , and it had no effect on aromatase activity (Vinggaard et 
al., 2000). In a series of publications, Beard and Rawlings have demonstrated various 
reproductive effects  in  mammals,  for  example,  decreased whelping rate  in  mink , 
increased severity of oviductal intraepithelial cysts in adult ewes , and seminiferous 
tubule atrophy in rams . Interestingly, serum hormone and gonadotropin levels were 
unaffected in these studies, suggesting a direct toxic effect on reproductive tissues. 
Indeed PCP has been shown to inhibit ovulation of Zebrafish oocytes in vitro at > 0.6 
µM (Tokumoto et al., 2005), and to cause toxicity in rat sertoli cells at 10 nM, which 
was the lowest concentration tested . Furthermore, PCP reduced the number of eggs 
laid, and their subsequent hatching rates in Japanese medaka, and induced formation 
of  testis-ova  .  Finally,  a  link  between  PCP concentration  and follicle  stimulating 
hormone in women with gynaecological dysfunction has been reported . 
4.2 Methods
4.2.1 Chemicals
17β-estradiol (> 98% pure), testosterone (> 98% pure), progesterone (> 99% pure), 
flutamide (98% pure), 4-hydroxytamoxifen (> 98% pure), and all pesticides (> 97% 
pure)  except  sulcofuron  and  flucofuron  were  obtained  from  Sigma  Chemical 
Company Ltd. (Dorset, UK). Sulcofuron (> 99% pure) and flucofuron (> 97% pure) 
were obtained from Greyhound Chromatography and Allied Chemicals (Wirral, UK). 
Cell  culture media components, radioimmunoassay buffer components,  and human 
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chorionic gonadotropin (HCG) were purchased from Sigma (Dorset, UK). Epostane 
was  gifted  from  V.  Luu-Thé  (Oncology  and  Molecular  Endocrinology  Research 
Center, CHUQ pavillon CHUL, 2705 Laurier Boulevard, Ste-Foy, Quebec, G1V 4G2, 
Canada). Hormones and epostane were dissolved in ethanol to make a stock solution 
of 10 mM. Pesticides were dissolved in ethanol to make a stock solution of 20 mM, 
except simazine, which was dissolved in methanol at a concentration of 2 mM. 
4.2.2 Yeast screen
The  methods  for  (anti-)  YES  and  (anti-)  YAS  assays  were  described  previously 
(Chapter  2,  section  2.3.2.4),  therefore,  only  specific  methods  related  to  pesticide 
exposure will  be described here.  Initially,  pesticides were added to wells over the 
range of 1000 – 0.49 µM, but turbidity readings were unacceptably low for some 
pesticides,  indicating  a  toxic  effect  on  the  yeast  cells.  Therefore,  isoproturon, 
flucofuron, and trifluralin were subsequently tested over the range of 125-0.06 µM, 
diuron,  linuron,  chlorpropham,  sulcofuron,  and  tecnazene  over  the  range  of  15.6-
0.008  µM,  PCP over  the  range  of  7.8-0.004  µM,  and MCPA,  mecoprop,  2,4,-D, 
atrazine, simazine, and bentazone were re-tested at the same concentrations. Where 
cell turbidity was significantly reduced compared to the EtOH or media only controls, 
data  was  omitted  from statistical  analysis.  After  evaporation,  200  µL of  medium 
containing CPRG and yeast (8 X 105 cells/ml) were added to each well. For the anti-
estrogenic/androgenic screens, 0.25 nM of estradiol, or 2.5 nM of testosterone, was 
added to the media prior to addition to the wells. Ethanol and media only controls 
were also run in each assay. Pesticides were tested in triplicate over three plates, and 
over two experiments. Absorbance was measured after 2-5 days, depending on the 
assay. 
4.2.3 Ovulation
Sexually  mature  female Xenopus  laevis (gifted  by  Jane  Kirk,  Cancer  Research 
Institute, UK) were anaesthetised by submersion in MS222 until reflexes ceased, and 
were then sacrificed by pithing. The ovaries were removed and placed in a glass Petri 
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dish containing MBS (see Chapter 3, section 3.3.2.1). They were cut into ~ 30 mg 
tissue fragments (~ 10 stage VI oocytes), and two sections were cultured per well in 
24-well plates. After 20 hours incubation, media was extracted, frozen on dry ice, and 
stored at -80 until hormone analysis (by RIA). In addition, the oocytes were tested for 
viability with Trypan blue (0.2%), fixed with TCA (5%), and the number of ovulated 
oocytes were counted. Oocytes were initially incubated with 50, 25, 12.5, 6.25 I.U. 
HCG or control media, for 20 hours. On day two a submaximal concentration of HCG 
(~  60%  of  maximum  ovulatory  response)  was  chosen  for  co-incubation  with 
pesticides, and oocytes were cultured in control media, HCG alone, or co-incubated 
with a pesticide, in sextuplicate wells. The ovulation assay was repeated three times 
with modifications to pesticide concentrations. Initially, all pesticides were tested at 
62.5 and 6.25 µM, and pesticides that had no effect or only an effect at 62.5 µM, were 
re-tested at the same concentrations. Those that had an effect at 62.5 & 6.25 µM were 
additionally tested at 0.625, 0.0625, & 0.00625 µM (PCP, sulcofuron, chlorpropham, 
atrazine). The complete range was then repeated for each pesticide, therefore, each 
concentration of each pesticide was tested twice or three times. Exceptions were PCP 
and sulcofuran, which were only tested at the top concentration once, due to complete 
inhibition at this concentration. In addition, the 3β-HSD inhibitor epostane was tested 
at 1, 0.1, 0.01, and 0.001 µM, to verify inhibition of ovulation via inhibition of steroid 
hormone  synthesis  .  The  GVBD  assay  was  also  used  to  test  selected  pesticides, 
however, flutamide was not an effective inhibitor over two assays, and data was very 
variable (data not shown).  
4.2.4 In vivo Exposure
Fifty-four adult female  Xenopus laevis (4 years old) were taken from the breeding 
stock  of  the  Leibniz-Institute  of  Freshwater  Ecology  and  Inland  Fisheries  (IGB, 
Berlin). The frogs were fed twice per week prior to exposure and the light:dark cycle 
was  12:12  hours.  They  were  placed  in  9  x  12  L  glass  aquaria  containing  10  L 
reconstituted tap water (distilled water supplemented with 2.5 g marine salt, Tropic 
Marin Meersalz, Tagis, Dreieich, Germany), at a loading density of 6 animals/tank, 
and were not fed during the exposure period. PCP has a log Kow of 5.18 and has been 
shown to bioaccumulate . Thus, it was tested for effects  in vivo at environmentally 
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relevant concentrations (1 & 0.1 µg/L = 0.375 nM & 3.75 nM), with the assumption 
that  it  would be bioaccumulated to higher  levels  within the animal.  A PCP stock 
solution of 1 mg/L was prepared in distilled water at the beginning of exposure, and 
was stored at 40C during the exposure period. This stock was diluted x 10000 for the 
0.1 µg/L treatment, and x 1000 for the 1 µg/L treatment, and tanks were re-dosed 
every  48  hours  during  water  change  (100  %).  Temperature  and  pH  were  also 
measured prior to and following each water change, and water samples were taken 
from each tank at  the same time for chemical analysis of PCP. At the end of the 
exposure period, animals were bled, and total weight, liver weight and ovary weight 
were  recorded.  Blood  was  centrifuged  at  6000  g  for  1  minute,  and  plasma  was 
removed and snap frozen in liquid nitrogen. The liver and ovary were removed and 
weighed, and ovarian follicles were cultered in MBS supplemented with 20 I.U. HCG 
in sextuplicate wells. Media was removed after 20 hours, frozen, and stored at -200C. 
4.2.5 Radioimmunoassays
4.2.5.1 Media 
Unextracted media samples were tested for progesterone, testosterone, and estradiol 
concentration. Assay tubes contained 300 µL test media (for testosterone, 200 µL of 
test media was diluted with 100 µL of culture media), 100 µL of antibody, and 100 
µL of radiolabelled steroid, for a total  assay volume of 500 µL. Antibodies (AbD 
Serotec, Morphosys AG, Germany) were added at final concentrations of 1:500 for 
progesterone (cross reactivity: 0.02% cortisone only), 1:4000 for testosterone (cross 
reactivity:  11β-hydroxy  testosterone  3.3%,  5α  di-hydroxy  testosterone  2%),  and 
1:2000  for  estradiol  (cross  reactivity:  oestrone  14%,  oestriol  5%).  Radiolabelled 
steroids,  [1,2,6,7-3H]  progesterone,  [1,2,6,7-3H]  testosterone,  and  [2,4,6,7-3H] 
estradiol  (Perkin  Elmer,  Massachusetts,  USA),  were  added  at  120000  counts/ml. 
Antibodies  and  radiolabel  were  diluted  in  0.2  M  phosphate  buffered  saline, 
supplemented  with  0.02% sodium azide  and  0.5% bovine  serum albumin  (sPBS) 
(Sigma,  Dorset,  UK).  After  addition  of  all  components,  tubes  were  vortexed  and 
incubated overnight at  40C. To separate bound-free hormone, 500 µL of activated 
charcoal slurry (0.5% charcoal and 0.05% dextran in sPBS), was added to each tube. 
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Tubes were incubated on ice (10 minutes) and centrifuged (2000 g, 15 minutes), the 
supernatant was added to scintillation vials. Scintillation cocktail (5 ml) was added to 
the vials,  they  were  vortexed,  and  radioactivity  was  measured  (Tri-Carb,  Packard 
Instrument  Company,  CT,  USA).  Samples  were  tested  singly  over  two  assays, 
therefore they were frozen and thawed twice. In order to minimise error, standards 
were diluted in culture media at the time of test media extraction, and freeze-thawed 
for use in the two assays. The detection range for estradiol and progesterone was 
109–3500 pM, and for testosterone was 875–7000 pM, and the interassay coefficients 
of variance were 22% for progesterone, 8% for testosterone, and 17% for estradiol for 
in vitro pesticide testing. Media samples from the  in vivo exposure were run in one 
assay, so no interassay variability values were available.
4.2.5.2 Plasma
The same reagents used for the media RIA were also used for the plasma RIA. For 
hormone extraction of plasma, ethyl acetate was added (~ 3:1 ratio of ethyl acetate to 
plasma),  and  tubes  were  shaken  vigorously  for  10  minutes.  Tubes  were  then 
centrifuged at 2000 g for 2 minutes to separate the aqueous and solvent phases, and 
the top layer (ethyl acetate) was removed. This step was repeated, and combined ethyl 
acetate was then dried with purified nitrogen gas. 650 µL MBS was then added to 
each dry tube, and they were vortexed vigorously. 100 µL of extracted sample was 
added to each assay tube in duplicate (progesterone, testosterone & estradiol), and 100 
µL of antibody and radiolabel were also added (total = 300 µL). Tubes were incubated 
overnight at 40C, and charcoal dextran slurry was used to separate the bound from the 
unbound fraction, as described above. Samples were run in one assay, and intrassay 
variability was 22 % for progesterone, 18 % for testosterone, and 12 % for estradiol. 
Extraction efficiencies were 68 % for progesterone, 86 % for testosterone, and 73 % 
for estradiol.   
4.2.6 Statistics
Data was tested for normality using the Shapiro-Wilk W test. For normally distributed 
data, ANOVA was used to find differences between groups. For non-parametric data, 
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Kruskal-Wallis test was used to find differences between groups. Dunnett’s test was 
used as a post-hoc test in both cases, to test differences from the control. Yeast data 
and ovulation data were converted into percentages of the control value to allow for 
variation between experiments prior to statistical  analysis.  Data were pooled from 
different experiments, resulting in  n values of 3 or 6 for yeast data, 6, 12, or 18 for 
ovulation. Media hormone data were analysed without conversion, and correlations 
between  hormone  levels  and  ovulatory  response  were  calculated  using  Pearson’s 
correlation  co-efficient.  For  the  in  vivo exposure,  liver  and  ovary  weight  were 
converted  to  hepatic  somatic  index  (HSI)  and  gonadal  somatic  index  (GSI),  by 
dividing values by the total weight of the individual, and these values were analysed 
statistically.  Plasma hormone data,  ovulation  data,  and abnormality  data  were  log 
transformed for normalisation, prior to statistical analysis.
4.3 Results
4.3.1 Yeast Screen
All yeast screen data was analysed parametrically. None of the pesticides tested were 
agonistic in the estrogen or androgen screen, however, seven pesticides were anti-
estrogenic,  and  eleven  were  anti-androgenic.  Cytotoxicity  was  often  observed. 
Therefore, the top concentrations reported below refer to the highest concentration 
eliciting  an  effect  on  the  receptor,  without  affecting  turbidity  readings  (pesticides 
were cytotoxic above these concentrations unless otherwise stated). 
PCP was the most potent compound tested and was anti-estrogenic from 0.015-7.8 
µM (p < 0.004). Anti-estrogenic activity was also observed from 0.9-31.5 µM for 
diuron (p < 0.004), from 1.9-31.5 µM for linuron (p < 0.02), and from 15.3-250 µM 
for isoproturon (p < 0.02) (Figure 4.1, A). Atrazine, and flucofuron were also weakly 
anti-estrogenic  (1000-125  &  1000-500  µM,  respectively,  Figure  4.1  A  &  B). 
Flucofuron also displayed agonistic activity from 62.5-3.9 µM (p < 0.04), although no 
agonistic  response  was  observed  in  the  estrogen  screen  (Figure  4.1,  B).  Lastly, 
sulcofuron  was  antagonistic  from  15-3.9  µM  (p  <  0.02),  though  no  effect  was 
observed at other concentrations (Figure 4.1, B). 
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PCP was also a potent anti-androgen, and displayed activity from 0.015-3.9 µM (p < 
0.02, Figure 4.1, D). Anti-androgenic activity was also observed from 15.6-31.25 µM 
for diuron (p < 0.04), from 0.97-62.5 µM for linuron (p < 0.03), and from 125-250 
µM for isoproturon (p < 0.02) (Figure 4.1, C). Flucofuron was anti-androgenic from 
0.5-1000 µM (p < 0.01), and sulcofuron from 0.9-62.5 µM (p < 0.03) (Figure 4.1, E). 
In  addition,  trifluralin  was  anti  androgenic  from  15.6-1000  µM  (p  =  0.03),  and 
chlorpropham from 0.5-15.6 µM (p < 0.02) (Figure 4.1, D). Bentazone was a very 
weak anti-androgen, and only exerted an effect at 500 & 1000 µM (data not shown). 
Agonistic and antagonistic activity was observed in response to atrazine (androgenic: 
3.9 – 31.25 µM, p < 0.03; anti-androgenic: 125-1000 µM, p < 0.04), and androgenic 
activity was observed in response to simazine (125 µM, p < 0.03) when co-incubated 
with testosterone (Figure 4.1, F). Indeed, no agonistic response was observed with 
atrazine or simazine in the androgen screen (data not shown). 
188
Figure 4.1. Activity of standards (grey line) and pesticides in the yeast anti-estrogen (A & B) 
and anti-androgen screen (C-F). Values are mean ± SE, n = 3 or 6 for the pesticides, and 4 for 
the standards. Cont = ethanol control, OHT = hydroxy-tamoxifen, Flut = flutamide, Diu = 
diuron,  Lin  =  linuron,  Iso  =  isoproturon,  Atr  =  atrazine,  Sim  =  simazine,  PCP  = 
pentachlorophenol,  Flu  =  flucofuron,  Sul  =  sulcofuron,  Cprop  =  chlorpropham,  Tri  = 
trifluralin.
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4.3.2 Ovulation
Ovulation  data  were  analysed  non-parametrically.  The  negative  control  epostane 
effectively inhibited ovulation in a dose-dependant manner (Figure 4.2,  A).  Seven 
pesticides tested had a  significant  effect  on ovulation (Figure 4.2,  B,  C, D).  PCP 
(Figure  4.2,  C)  and  sulcofuron  (Figure  4.2,  D)  were  the  strongest  inhibitors  of 
ovulation,  and  inhibition  was  observed  at  62.5,  6.25,  and  0.625  µM.  Isoproturon 
(Figure 4.2, B), diuron (Figure 4.2, B), chlorpropham (Figure 4.2, C), and flucofuron 
(Figure 4.2, D) inhibited ovulation at 62.5 µM, but not at 6.25 µM. Atrazine had both 
a stimulatory and inhibitory effect on ovulation at  different concentrations (Figure 
4.2, D), with stimulation observed at 6.2 µM and inhibition at 0.0625 µM.
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Figure  4.2.  Effects  of  pesticides  on  in vitro ovulation.  Values are  medians (line  in  box), 
interquartile ranges (box) and 25th & 75th percentiles (‘whiskers’), and n vlaues were 6, 12, or 
18. * = p <0.05, ** = p < 0.01, *** = p < 0.001. HCG = human chorionic gonadotropin, EPO 
= epostane, TEC = tecnazene, BZONE = bentazone, see Figure 4.1 for other abbreviations.
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4.3.2.1 Hormone concentrations.
Hormone data were analysed non-parametrically. Nine pesticides tested had an efffect 
on  progesterone,  testosterone,  and/or  estradiol  concentrations  (Table  4.1),  and 
epostane  inhibited  testosterone  and  estradiol  concentrations  in  a  dose-dependant 
manner. Testosterone concentrations were the most sensitive to perturbation, estradiol 
was  the  least,  and  the  most  common  effect  was  elevation  of  progesterone  and 
depression  of  testosterone.  Progesterone  concentrations  were  elevated  by  linuron 
(62.5 µM, p = 0.0005), atrazine (62.5 µM, p < 0.0001; 6.25 µM, p = 0.0002,), and 
chlorpropham (0.00625  µM,  p  =  0.002),  and  were  depressed  by  PCP (62.5,  p  = 
0.009), and sulcofuron (62.5, p = 0.018). Testosterone concentrations were elevated 
by MCPA (62.5, p = 0.01), mecoprop (62.5, p = 0.036), atrazine (6.25, p = 0.003), 
and simazine (62.5, p = 0.004). Testosterone concentrations were depressed by diuron 
(62.5, p < 0.0001), PCP (62.5, not detectable, 6.25, p < 0.001), chlorpropham (62.5, p 
= 0.008), sulcofuron (62.5 and 6.25, p < 0.001), and flucofuron (62.5, p < 0.001). 
Estradiol concentrations were elevated by mecoprop (6.25, p < 0.001), and depressed 
by PCP (62.5, p = 0.003, 6.25, p = 0.02) and sulcofuron (62.5, p < 0.0001).
4.3.2.2. Correlations
Using Pearson’s correlation co-efficient,  all  combinations of  percentage ovulation, 
progesterone, testosterone, and estradiol were statistically significant (p < 0.0002). 
Percentage  ovulation  was  most  closely  correlated  with  testosterone  (R2 =  0.63, 
correlation co-efficient = 0.79), followed by progesterone (R2 = 0.45, correlation co-
efficient  =  0.67),  and  estradiol  (R2 =  0.32,  correlation  co-efficient  =  0.57).  In 
comparison of hormone concentrations,  estradiol was most closely correlated with 
testosterone (R2 = 0.54,  correlation co-efficient  = 0.73),  followed by progesterone 
with testosterone (R2 = 0.41, correlation co-efficient = 0.64), and progesterone with 
estradiol (R2 = 0.27, correlation co-efficient = 0.52). 
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Treatment Conc. (µM) Prog. (pM) Test. (pM) E2 (pM)
HCG N/A 374 ± 28 7646 ± 443 819 ± 61
EPO 1 531 ± 32 ↑ 2325 ± 108 ↓↓↓ 377 ± 19 ↓↓↓
0.1 400 ± 30 2934 ± 371 ↓↓↓ 382 ± 41 ↓↓
0.01 355 ± 23 2819 ± 368 ↓↓↓ 491 ± 41 ↓
0.001 472 ± 61 7585 ± 556 556 ± 75
ISO 62 394 ± 37 7567 ± 619 592 ± 46
6.2 515 ± 93 7927 ± 619 800 ± 65
DIU 62 372 ± 30 4102 ± 522 ↓↓↓ 728 ± 65
6.2 416 ± 64 7021 ± 648 933 ± 73
LIN 62 634 ± 58 ↑↑↑ 6715 ± 400 751 ± 94
6.2 396 ± 43 7657 ± 717 921 ± 94
MCPA 62 493 ± 48 9966 ± 583 ↑ 937 ± 79
6.2 399 ± 38 9410 ± 398 946 ± 85
MPROP 62 363 ± 41 10047 ± 322 ↑ 985 ± 103
6.2 430 ± 53 9685 ± 334 1296 ± 115 ↑↑↑
2,4,-D 62 424 ± 47 7417 ± 610 759 ± 55
6.2 451 ± 50 8447 ± 703 918 ± 64
ATR 62 762 ± 68 ↑↑↑ 9103 ± 505 795 ± 50
6.2 609 ± 58 ↑↑↑ 9514 ± 353 ↑↑ 939 ± 71
0.62 419 ± 50 7118 ± 711 657 ± 67
0.062 389 ± 13 6616 ± 443 953 ± 71
SIM 62 398 ± 22 9835 ± 341 ↑ 779 ± 93
6.2 512 ± 87 9121 ± 653 923 ± 155
PCP 62 < 109 ↓↓↓ < 875 ↓↓↓ 267 ± 59 ↓↓
6.2 351 ± 30 2701 ± 117 ↓↓↓ 483 ± 43 ↓
0.62 387 ± 56 5960 ± 570 714 ± 65
0.062 335 ± 18 8096 ± 621 846 ± 100
0.0062 341 ± 25 7743 ± 728 775 ± 63
FLUC 62 253 ± 28 3640 ± 431 ↓↓↓ 692 ± 51
6.2 386 ± 46 6036 ± 459 809 ± 62
SULC 62 115 ± 3 ↓ 2320 ± 64 ↓↓↓ 225 ± 20 ↓↓↓
6.2 248 ± 26 5198 ± 534 ↓↓↓ 812 ± 98
0.62 430 ± 36 7581 ± 675 1007 ± 103
0.062 468 ± 48 9283 ± 607 890 ±103
0.0062 486 ± 32 8093 ± 678 845 ± 94
TRI 62 342 ± 25 8098 ± 563 770 ± 97
6.2 343 ± 35 7760 ± 455 1007 ± 101
CPROP 62 246 ± 22 4192 ± 448 ↓↓ 583 ± 54
6.2 375 ± 27 7335 ± 428 784 ± 74
0.62 397 ± 28 6538 ± 555 799 ± 58
0.062 414 ± 32 6372 ± 821 735 ± 99
0.0062 634 ± 92 ↑↑ 8844 ± 862 968 ± 93
BZONE 62 349 ± 39 8383 ± 573 721 ± 91
6.2 498 ± 101 9354 ± 608 857 ± 71
TEC 62 339 ± 19 8050 ± 641 813 ± 119
6.2 376 ± 54 9158 ± 583 673 ± 97
Table 4.1. Hormone concentrations in oocyte incubation media after incubation with 
pesticides or epostane. Values are mean ± SE, and n values were 6, 12, or 18. Arrows 
(↑  =  elevation  compared  to  HCG,  ↓  =  depression  compared  to  HCG)  indicate 
significant differences from HCG only treated oocytes (↑↑↑/↓↓↓ = p < 0.001, ↑↑/↓↓ = p < 
0.01, ↑/↓ = p < 0.05). Prog = progesterone, Test = testosterone, E2 = estradiol, N/A = Not 
Applicable, for list of other abbreviations see Figure 4.2.
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4.3.4 In vivo Exposure
Water temperature was 18.90C ± 0.11 and pH was 6.13 ± 0.08 over the exposure 
period, and there were no differences between tanks. PCP concentration was similar 
to nominal values in the high treatment after each water change (0.89 ± 0.08 µg/L), 
however, had decreased markedly after 48 hours (0.29 ± 0.06 µg/L). No PCP was 
found in the control tanks (detection limit 0.2 µg/L), and water from the low treatment 
group was not analysed. No difference in total weight, HSI, or GSI was observed 
between treatments, however, morphological differences were observed (Figure 4.3). 
Normal ovarian sacs are filled with large, banded stage VI oocytes (Panel A), which 
undergo maturation upon stimulation with HCG (Panel B). One individual from the 
low treatment contained a large fluid-filled cyst in place of the ovary (Panel C), which 
contained just a few oocytes (Panel D). Another individual from the low treatment 
group had an ovary containing very few stage VI oocytes, and instead had many stage 
I/II oocytes (Panel E & F). One individual from the high treatment had an almost 
empty ovarian sac (Panel G), and others contained many abnormal oocytes post HCG 
treatment (Panel H). Abnormal oocytes were also observed in control individuals after 
HCG treatment,  however  the degenerative effects  observed in  the whole ovary of 
treated individuals were never observed.  In addition, more abnormal oocytes were 
observed in low (log transformed value, mean ± SE: 1.19 ± 0.08), and high (1.24 ± 
0.07) treatments, compared to control (1.06 ± 0.07), though this difference was not 
statistically significant (Dunnett’s: control & low p = 0.37, control & high p = 0.16). 
There  was  no  difference  in  plasma  testosterone  (ANOVA  p  =  0.97)  or  estradiol 
(ANOVA  p  =  0.4)  between  treatments,  however  progesterone  concentrations 
approached significance (ANOVA p = 0.09). They were elevated in individuals from 
the low treatment (log transformed value, mean ± SE: 3.2 ± 0.03; Dunnett’s p = 0.06), 
and the high treatment (3.16 ± 0.05; Dunnett’s p = 0.21), compared to the control 
(3.05 ± 0.06). If progesterone values from low and high treatment values were pooled 
(i.e. ‘treated’), they were significantly different from the control (ANOVA p = 0.036). 
Progesterone and testosterone production by cultured ovarian tissue differed between 
treatments (p = 0.06 & 0.04 Kruskal Wallis, respectively), and both were depressed in 
the low treatment compared to the high treatment (progesterone: Dunnett’s p = 0.04; 
testosterone: Dunnett’s p = 0.14), but neither were different from the control (p > 0.7).
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Figure 4.3.  Ovaries taken from experimental  treatments.  Panel  A & B show a control  ovary,  both 
before (A) and after (B) treatment with HCG. Note that oocytes with a visible white spot on the animal 
pole are matured. Panel C & D show a cyst found in a low dose treated individual (C), and the oocytes 
it contained (D). Panels E & F show an undeveloped ovary (E) containing few oocytes (F), from the 
high dose treatment. Panel G shows an almost empty ovarian sac from a high dose treated individual, 
and Panel H shows many abnormal oocytes (marbled appearance) observed in HCG treated oocytes 
taken from a high dose exposure individual. Note there are also a few normally matured oocytes.
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Figure 4.4. Hormone concentrations in plasma from control, low dose, and high dose 
individuals. Values are mean ± SE, n = 18. Prog = progesterone, Test = testosterone, 
and E2 = 17β-estradiol. * denotes significant difference from control.
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Figure 4.5.  Hormone concentrations  in  ovulation media from control  (green),  low 
dose (pink), and high dose (red) individuals. Values are medians (line in box) and 
interquartile ranges (box) and 25th & 75th percentiles (‘whiskers’),  n = 18 (oocytes 
plated in sextuplicate wells for each individual).
*
195
4.4 Discussion
None of  the pesticides were  estrogenic  at  any concentration tested.  In  agreement, 
Nishihara  et al., (2000) tested 118 pesticides (including linuron, atrazine, simazine, 
chlorpropham,  PCP,  &  trifluralin),  and  found  that  none  were  estrogenic.  Indeed, 
pesticides  reported  as  having  estrogenic  activity  are  mainly  organochlorines  and 
organophosphates  (Kojima  et  al.,  2004),  which  are  generally  not  environmentally 
relevant to the UK. Twelve out of fifteen pesticides tested were active in at least one 
assay (2,4,-D, bentazone, & tecnazene had no effect) and classes of pesticides tended 
to  behave  similarly,  especially  in  the  yeast  screen.  There  did  not  appear  to  be  a 
correlation between mode of action of the pesticide and ED activity in either screen. 
More pesticides were anti-androgenic (10) than anti-estrogenic (7),  which may be 
partially  due to  the higher  specificity  of  the estrogen receptor  compared with the 
androgen receptor (Sohoni and Sumpter, 1998). In addition, many of the pesticides 
had an effect on either ovulation or media hormone levels (11). Receptor-mediated 
anti-androgenic activity and decreased testosterone levels appeared to be linked to 
inhibited ovulation. There is some evidence that androgens, rather than progesterone, 
are the physiological initiators of ovulation  in vivo . In agreement, testosterone was 
more  closely  correlated  to  ovulation  than  progesterone,  and  was  found  at 
approximately 23x higher levels. 
4.4.1. In vitro effects
Isoproturon, diuron, and linuron had similar effects in the yeast screen, all were anti-
estrogenic and anti-androgenic, although isoproturon was less potent than diuron and 
linuron. In addition, isoproturon and diuron inhibited ovulation, whereas no effect was 
observed in response to linuron. Progesterone and testosterone are known inducers of 
ovulation  (Jacobelli  et  al.,  1974;  Smith  and  Ecker,  1971),  and  anti-androgenic 
compounds are known to inhibit testosterone induced maturation of the oocyte (Lutz 
et  al.,  2001).  Therefore,  perhaps  the  anti-ovulatory  response  was  caused  by  anti-
androgenic activity at the receptor on the oocyte. In the case of linuron, progesterone 
concentrations  in  the  media  were  double  control  values,  so  perhaps  the  receptor-
mediated  anti-androgenic  effect  was  ameliorated  by  increased  progesterone 
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concentrations. In addition, atrazine had a similar effect in the anti-androgen screen 
and  on  the  ovulatory  response,  and  testosterone  levels,  whereby,  it  had  both 
stimulatory and inhibitory effects over the concentration range tested. Furthermore, 
sulcofuron,  flucofuron,  chlorpropham, and PCP were all  anti-androgenic,  and also 
inhibited  ovulation  (although  trifluralin  was  anti-androgenic,  without  affecting 
ovulation), suggesting that the testosterone produced by ovarian tissue  in vitro may 
have an important role in initiating ovulation (see Chapter 3, section 3.4.4). 
Diuron and linuron were previously shown to possess anti-androgenic activity in vitro 
(Kojima  et  al.,  2004;  linuron  –  Lambright  et  al.,  2000), and  in  vivo (Linuron  – 
Lambright et al., 2000), but this is the first time their anti-estrogenic activity has been 
reported.  In  fact,  both were more potent  anti-estrogens  than anti-androgens in the 
yeast assays (LOEC’s were 0.98 µM and 31.25 µM for diuron, and 0.98 µM and 7.8 
µM for linuron). Linuron has previously been identified as a more potent endocrine 
disruptor than diuron, however, the LOEC for anti-estrogenic activity of diuron was 
close to environmental levels (maximum detected concentrations: 28 µg/L (0.12µM)), 
whereas this was not the case for linuron (maximum detected concentration: 1.4 µg/L 
(0.0056 µM)). In addition to effects at the receptor, diuron also inhibited ovulation 
and  testosterone  concentration  at  62.5  µM,  indicating  disruption  of  steroidogenic 
pathways. Diuron has previously been reported to have no effect on 17β-HSD activity 
in fish ovarian microsomes at 0.1 or 1 mM (Thibaut and Porte, 2004), or placental 
aromatase  activity  up  to  50  µM in  human  tissue  homogenates  (Vinggaard  et  al., 
2000),  or  rats  exposed  in  vivo (Fernandes  et  al.,  2007).  However,  its  effects  on 
amphibians have not been tested, and it is ubiquitous in the UK environment (detected 
> 0.01 µg/L 785 times). Linuron caused an increase in progesterone concentration at 
62.5  µM,  and  a  corresponding  decrease  in  testosterone  concentrations  (non-
significant). It was previously reported to inhibit 5α-R activity (50% inhibition, 86 
µM) in human prostate tissue homogenate (Lo et al., 2007). Therefore, it may also be 
inhibiting  enzymes  involved  in  the  conversion  of  progesterone  to  testosterone. 
Isoproturon caused a decrease in ovulation without changing hormone levels, but was 
anti-androgenic, indicating it may have competed at the receptor site but did not affect 
steroidogenic  enzymes.  It  is  the  first  time  it  has  been  tested  for  anti-androgenic 
activity  in vitro, but was shown to cause testicular degeneration and retardation of 
spermatogenesis  in  rats  (Sarkar  et al.,  1995).  However,  reprotoxic effects  were in 
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conjunction with hepatic and renal toxicity, and effective levels were close to the LC50 
for rats (800 mg/kg compared with 1826 mg/kg), suggesting they were possibly a by-
product of general toxicity. Isoproturon was also weakly anti-estrogenic (LOEC 15 
µM), but had previously been reported to have no anti-estrogenic activity in a reporter 
cell line (HELN) at 10 µM (Lemaire et al., 2006). The effects observed here occurred 
at  concentrations  higher  than  those  found in  the  environment  (maximum detected 
concentration – 29.5 µg/L (0.14 µM); LOEC’s: anti-YES – 15 µM, anti-YAS – 125 
µM; ovulation assay – 62.5 µM), however, it has been shown to bioaccumulate in 
tadpoles , and freshwater macrophytes . Therefore, in addition to aquatic exposure, 
isoproturon may enter the tadpole through diet, and has been shown to be toxic to 
embryos and young tadpoles at  levels  as low as 0.1 µg/L (Greulich  et al.,  2002). 
Furthermore,  it  is  persistent  in  the  aquatic  environment,  with  only  9  %  of  the 
isoproturon removed from an aquatic microcosm in 21 days (Bottcher and Schroll, 
2007), and is ubiquitous in the UK environment (found above 0.01 µg/L 635 times). 
Therefore, although diuron and isoproturon were not as potent as linuron, their effects 
may be greater, and more research is needed to elucidate risk to amphibians.
Mecoprop  and  MCPA  were  not  active  in  receptor  binding  assays,  which  has 
previously been reported (Kojima et al., 2004, Lemaire  et al., 2006), however, they 
had a stimulatory effect on steroidogenesis. Both increased testosterone and estradiol 
levels, and were the only compounds to have this effect. Indeed, mecoprop was the 
only compound to significantly increase estradiol concentration (at 6.25 µM only), 
and both significantly increased testosterone concentration (at 62.5 µM only). Since 
both testosterone and estradiol were affected, but progesterone was not, it seems that 
stimulation  occurred  at  some  point  in  the  steroidogenic  pathway  between 
progesterone  and  testosterone.  No  information  could  be  found  on  the  endocrine 
effects of these two compounds, but they are ubiquitous in the environment (detected 
> 0.01 µg/L 1444 & 615 times, respectively) and are found at high concentrations 
(maximum measured concentrations: 6180 µg/L (28.8 µM) & 4700 µg/L (23.4 µM), 
respectively). 2,4,-D, bentazone (except for very weak anti-androgenic activity), and 
tecnazene were not active in any of the assays. Kojima  et al. (2004) also found no 
estrogenic  or  anti-androgenic  activity  in  a  receptor  binding  assay  for  2,4,-D,  and 
bentazone. 2,4,-D was previously demonstrated to block maturation of defolliculated 
Xenopus oocytes  (LaChapelle  et  al.,  2007),  and  thus  was  expected  to  inhibit 
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maturation and ovulation in this study. Ovulation was depressed, but not significantly 
(p = 0.07), which may be explained by the higher concentrations used previously (10 
mM compared to 62.5 µM), or by limited entry into the oocyte due to the presence of 
follicle cells in this study.
Atrazine was weakly anti-estrogenic, which has previously been reported  , but was 
not  anti-androgenic,  which  has  also  previously  been  reported  for  atrazine  and 
simazine . However, both atrazine and simazine stimulated androgenic activity in the 
anti-androgen  screen,  but  were  not  agonists  in  the  androgen  screen.  In  addition, 
atrazine  was  weakly  anti-androgenic  at  higher  concentrations  (250-1000  µM). 
Atrazine  affected  ovulation  in  a  similar  way,  and  caused  stimulation  at  an 
intermediate concentration (6.25 µM), but inhibition at a lower concentration (0.0625 
µM). The  mechanism  of  action  of  triazines  is  unknown,  but  this  effect  could 
potentially  be  explained  by  upregulation  of  the  AR  receptor,  leading  to  higher 
sensitivity to testosterone. Xenoestrogens are known to upregulate the ERβ in vitro , 
and  research  into  prostate  cancer  treatment  has  shown  that  anti-androgens  can 
upregulate the androgen receptor .  This is a relatively untested route of endocrine 
disruption, and may explain the effects observed on ovulation. However, it is unlikely 
to be causing the observed effect in the yeast screen as the AR is upregulated by a 
copper-dependant promoter in this test system, and therefore upregulation would have 
to  affect  this  promoter  (E.Routledge,  pers.  comm.).  Alternatively,  atrazine  and 
simazine  may  have  altered  the  behaviour  of  the  ligand  bound  receptor  (i.e.  AR-
testosterone)  on  the  promoter  of  the  reporter  gene.  Stimulated  ovulation  was 
accompanied  by  increased  progesterone  and testosterone  levels,  but  no  change in 
hormone levels were observed when ovulation was inhibited,  and it  was not  anti-
androgenic at the receptor at the lowest concentration tested (0.9 µM). In addition, 
Kojima  et  al.,  (2004)  reported  no  anti-androgenic  activity  of  atrazine  at  any 
concentration  (0.01-10  µM).  Therefore,  the  mechanism  by  which  ovulation  was 
inhibited is unknown, but occurred at environmentally relevant concentrations (0.0625 
µM = 1.29  µg/L). It  is  also unclear  whether  the  potency of  atrazine  would  have 
increased  as  concentrations  decreased,  and  at  what  point  inhibition  would  have 
ceased. Atrazine was the only compound to exert such an effect, but this pattern has 
previously been reported in cortisol secretion by adrenocortical cells in response to 
atrazine  .  Furthermore,  Hayes  et al.  (2003)  reported  higher  levels  of 
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hermaphoroditism in frogs exposed to 0.1 µg/L than 25 µg/L atrazine. The ‘inverted-
U’ dose-response curve has recently gained wider recognition  and clearly requires 
further investigation. An increase in steroid concentrations in response to atrazine is in 
contrast  to previous reports  of atrazine inhibition of 17β-HSD and 3α-HSD in rat 
pituitary homogenate (Babic-Gojmerac et al., 1989), which would result in decreased 
hormone  levels  in  the  ovulation  assay  (as  occurred  with  the  3β-HSD  inhibitor 
epostane). However, perhaps this is due to the test system used as atrazine had no 
effect on 17β-HSD levels in carp testicular microsomes (Thibaut and Porte, 2004). 
Finally, atrazine upregulates aromatase in the human adrenocorticocarcinoma cell line 
H295R ,  and  the  mechanism of  action  is  thought  to  be  via  the  “orphan”  steroid 
receptor, steroidogenic factor-1 . Amphibians are known to possess this receptor , but 
there  was  no  evidence  of  stimulatory  effects  on  aromatase,  as  estradiol  did  not 
increase, and testosterone did not decrease. 
Trifluralin was moderately anti-androgenic (LOEC: 15.6 µM), and chlorpropham was 
strongly anti-androgenic (LOEC: 0.5 µM), but both had previously been found to 
have  no  activity  in  an  anti-androgen  screen  over  a  similar  concentration  range 
(Kojima  et  al.,  2004).  This  discrepancy  was  unusual,  as  all  the  other  receptor-
mediated effects reported here were generally in agreement with previously published 
data. In addition, trifluralin was also the only anti-androgenic compound that did not 
affect ovulation. Both compounds act by inhibiting cell division, and therefore it is 
possible  that  anti-androgenic  responses  could  have  been  artefacts  of  cell  growth. 
However,  since  results  with  decreased  turbidity  readings  were  omitted  from  the 
statistical analysis, it is unlikely that this would have affected the result. Therefore, 
the anti-androgenic nature of these compounds should be treated with caution, and 
further testing in a different system is needed to verify their anti-androgenic nature. 
Levels  eliciting a  response for  trifluralin  were 4 orders  of  magnitude higher  than 
levels found in the environment (maximum measured concentration: 3.06 µg/L (0.009 
µM)), so it may not be environmentally relevant alone, whereas, effective levels were 
similar to levels found in the environment  for chlorpropham (maximum measured 
concentration: 269 µg/L (1.26 µM)). Chlorpropham also inhibited ovulation at 62.5 
µM, and an accompanying decrease in testosterone concentrations was also observed, 
however, it was previously reported to have no effect on reproductive parameters in 
rats  ,  though,  specific  anti-androgenic  parameters,  such  as  reduction  in  male 
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anogenital distance and male sex gland reduction , were not measured. It also had an 
unexpected  effect  of  increasing  progesterone  concentrations  as  its  concentration 
decreased, and this effect was significant at 0.000625 µM. It is found fairly frequently 
in the U.K. environment (104 times), and more research is warranted on its effects in 
aquatic organisms. 
No  previous  information  on  effects  to  the  endocrine  system  of  sulcofuron  and 
flucofuron could be found. They were strongly anti-androgenic (LOEC’s: 0.9 & 0.5 
µM), and had variable effects in the anti-estrogen screen. Sulcofuron was a potent 
inhibitor  of  ovulation  (>  0.625  µM),  and  also  inhibited  progesterone  (62.5  µM), 
testosterone (62.5 & 6.25 µM), and estradiol (62.5 µM) concentrations. Flucofuron 
had a similar effect, but was less potent than sulcofuron. They exert their toxic effect 
through enzyme inhibition in moth larvae (Tomlin, 2006), therefore it is not surprising 
that they caused enzyme inhibition in this experiment. Although they are not often 
found in the environment, aquatic point-source levels from industrial discharge can be 
relatively high (maximum observed concentration: 0.75 µg/L (0.0014 µM) & 0.52 
µg/L (0.0012 µM)), and therefore more research into their effect in vivo is warranted.
4.4.2. Pentachlorophenol
PCP was the strongest inhibitor tested across all assays, it was anti-estrogenic and 
anti-androgenic  at  concentrations  as  low  as  0.01  µM.  In  addition,  it  completely 
abolished the ovulatory response and decreased hormone levels at 62.5 and 6.25 µM, 
and partially  inhibited  ovulation at  0.625 µM.  The concentrations  that  elicited  an 
effect  in  vitro approached  those  found  in  the  environment  (maximum  measured 
concentration: 2.74 µg/L (0.01 µM)). Anti-estrogenic activity has previously reported 
in response to PCP , though it was previously reported to have no anti-androgenic 
activity  at  0.1-10  µM (Hamster  ovary  cells:  Kojima  et  al.,  2004)  or  0.01-10 µM 
(monkey kidney CV-1 cell line: Sun et al., 2006), in reporter gene assays in . It was 
shown to inhibit DHT binding to the AR by 30 % at 100 µM . In addition, inhibition 
of ovulation has also previously been reported in zebrafish oocytes  in vitro, over a 
similar  concentration  range,  which  persisted  after  washout  and  re-stimulation 
(Tokumoto et al., 2005). The inhibition of ovulation observed here was accompanied 
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by  a  decrease  in  hormone  concentrations,  and  testosterone  concentrations  were 
particularly sensitive.  In vivo,  it  has previously been shown to cause seminiferous 
tubule atrophy and a decrease in sperm density in rams , which are characteristic of 
anti-androgenic activity (Gray  et al.,  2001), and could potentially be explained by 
both antagonistic effects at the receptor and inhibition of steroidogenesis as reported 
here. Furthermore, although testosterone concentrations were not affected  in vivo in 
the  present  study,  plasma  progesterone  levels  were  increased  in  the  treated 
individuals. This could be explained by inhibition of conversion to testosterone in the 
ovary, as testosterone levels were inhibited at 62.5, 6.25, and 0.625 µM in vitro. A 
reprotoxic effect on the ovary was also observed  in vivo, which has also previously 
been reported in relation to (testicular) sertoli cells  in vitro at 10 nM . Furthermore, 
dose-dependant inhibition of testicular development, and degeneration of the ovary, 
was observed in medaka exposed to 20-200 µg/L (Zha  et al., 2006), and increased 
severity of oviductal intraepithelial cysts was observed in adult ewes (Rawlings et al., 
1998). Although PCP levels in the frogs were not measured, it was greatly decreased 
in the water after 48 hours. It is known to have considerable ability to bioaccumulate , 
and when Goldfish were exposed to 5 µg/L PCP for 96 hours at pH 7, it was rapidly 
bioaccumulated by the fish, as it was removed from the water (the bioconcentration 
factor was 607; Stehly and Hayton, 1990). This may also explain effects observed in 
cultured oocytes, where progesterone and testosterone levels were decreased in the 
low treated  individuals  (only  in  relation  to  high  dose  animals,  and  neither  were 
different than the control), as a latent effect of  in vivo exposure. Although, it is not 
known why only low dose animals were affected by in vivo treatment.   
4.5 Conclusions
The  ovulation  assay  has  been  shown  to  be  a  sensitive,  informative,  and 
environmentally relevant test for steroidogenic endocrine disruption. Although it was 
not possible to elucidate specific enzyme inhibition/stimulation in the present study, 
this has recently been achieved by measuring additional steroids in the media (Ahn et 
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al., 2007). In addition, the majority of research concerned with steroidogenic enzymes 
has focused on aromatase, and to a lesser extent 5α-R. DHT levels in the media were 
not tested, therefore effects on 5α-R are unknown, however, there were no obvious 
effects  on  aromatase  in  response  to  any  pesticides.  Instead  it  appeared  that  the 
hydroxy  steroid  dehydrogenases  were  affected,  as  the  most  common  effect  was 
decreased testosterone levels in relation to progesterone levels. The effect of PCP in 
vitro was broadly indicative of endocrine disruption in vivo, and although the effects 
in  vivo were  weak,  considering  the  low concentration  (0.1  &  1  µg/L)  and  short 
exposure duration (6 days), the presence of this compound in the environment is a 
cause for concern. 
Approximately half of the pesticides tested disrupted endocrinological endpoints at or 
near  to  levels  observed  in  the  environment,  and  if  possible  bioaccumulation  and 
mixture effects are taken into consideration, the effects of these pesticides are a cause 
for  concern  for  wildlife,  and  specifically  amphibians,  which  inhabit  agricultural 
ponds. Furthermore, information pertaining to the effects of these pesticides is sparse, 
and there is continuing focus of resources on pesticides about which much is known, 
and  use  is  restricted  (e.g.  DDT),  despite  the  dearth  of  information  about 
environmentally relevant pesticides. 
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Chapter 5
Discussion
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The aim of this study was to assess whether there is evidence for alteration in thyroid 
function and reproductive parameters in native amphibian populations, specifically in 
relation to agrochemicals. To achieve this objective, in vitro tests and population data 
were used to select suitable field sites, and toad specimens from a subsample of these 
sites were used to compare morphology, thyroidal, and gonadal development of caged 
and  wild-caught  tadpoles/metamorphs  to  their  laboratory-raised  counterparts. In 
addition, the endocrine disrupting potential of environmentally relevant pesticides was 
assessed in vitro, and a short-term in vivo exposure was used to assess the predictive 
ability of the in vitro screens. Biological activities of water sample extracts, together 
with indications of delayed metamorphosis, skewed sex ratios, and altered gonadal 
differentiation suggest there may be endocrine disrupting effects in native amphibians 
in the agricultural landscape. Further investigation is needed to confirm these findings 
due to limitations in the field work. Interpretation of results was hindered by various 
factors, including: unknown contaminants present at field sites; unknown effects of 
mixtures of environmentally relevant pesticides in amphibians; high mortality of toad 
specimens; unknown impact of genetics and maternal transfer on measured endpoints; 
and lastly, lack of reliable baseline data concerning the effects of model endocrine 
disrupting  compounds  in  toads,  for  comparison  to  effects  observed.  However, 
findings reported in this study also filled previous gaps in knowledge, primarily in 
relation to in vitro effects of environmentally relevant pesticides. In addition, during 
the project, major gaps in the literature were identified, which must be addressed if 
the risk of the agricultural environment to amphibians, and indeed other wildlife, can 
be assessed.
5.1 Assays
The assay development aspect of this project highlighted the difficulties involved in 
optimising experimental procedures. In total five assays were used, 4 in vitro screens 
(yeast  screen,  GVBD,  hepatocyte,  ovulation),  and  1  short-term  in  vivo screen 
(transgenic assay). The yeast screen was previously optimised for use, however, the 
other screens were developed in this study with varying success,  indeed,  only the 
ovulation assay proved to be useful for detecting EDg compounds. It was shown to be 
sensitive,  informative,  and of  ecological  relevance due to  the role  of  ovulation in 
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reproduction,  and  could  be  modified  to  elucidate  specific  enzyme  inhibition/ 
stimulation by testing additional steroids, and their intermediate compounds, in the 
culture  media  (Ahn  et  al.,  2007).  The  majority  of  published  reports  concerning 
perturbations to steroidogenesis have focused on aromatase and 5α-R, due to their 
importance  in  catalyzing production  of  the highly  active hormones E2 and DHT. 
Despite the important role of these enzymes in vivo, there were no obvious effects on 
aromatase in response to any pesticides, although the effect of the pesticides on 5α-R 
is not known as DHT was not measured. Instead it appeared that the hydroxy steroid 
dehydrogenases (HSDs) were affected, as testosterone levels were often decreased in 
relation to progesterone levels. Therefore, in addition to testing aromatase and 5α-R, 
my research suggests that the effects of pesticides and water contaminants on HSDs 
warrant further investigation. Furthermore, considering that many pesticides function 
by inhibiting active processes in the target organism, such as electron transport or 
enzyme activity, this route of ED is underrepresented in the literature. Data presented 
here have partially filled this gap in the literature, and demonstrated the importance of 
enzymatic endpoints  on a  physiological  response (ovulation).  Although activity  of 
liver biotransformation has been measured in field-collected reptiles , it would also be 
interesting to measure gonadal enzyme expression in amphibians in situ. Since short-
term  in vivo exposure to environmentally relevant concentrations of PCP (slightly) 
affected hormone production of stimulated ovarian tissue in vitro, perhaps culture of 
ovarian  tissue  of  collected  individuals  would  be  informative.  Lastly,  in  the  fens, 
estrogenicity  was  observed  in  hepatocytes  exposed  to  C18 and  OASIS  extracts 
(breeding  season  one)  and  in  YES  in  response  to  PADs  (breeding  season  two), 
suggesting that these extraction methods and assays were comparable. 
5.2 Pesticides
During this investigation, it became clear that very little is known about the effects of 
pesticides that  are  currently used in  the UK and the USA, and thus probably the 
western  world  in  general,  on  the  endocrine  system  of  wildlife.  Paradoxically,  in 
relative terms, much more is known about pesticides that are banned or have restricted 
use (e.g.  DDT),  and there is  a negative correlation between published data of the 
effects  of  pesticides,  and  their  presence  in  the  UK  environment.  It  precludes 
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explanation  that  banned  pesticides  have  been  found  to  have  adverse  effects  on 
wildlife.  These compounds may still  be affecting wildlife,  however,  if  the aim of 
environmental research is to protect the environment by assessing risk to wildlife and 
humans,  it  is  essential  that  such  research  is  environmentally  relevant.  Therefore, 
testing of compounds that are present in the environment and which have continued 
use,  should  have  a  higher  priority  than  elucidating  fine  details,  such  as  precise 
mechanisms  of  action,  of  redundant  compounds.  Furthermore,  although  many 
pesticides that have now been banned in the western world due to their EDg nature 
(e.g.  DDT)  are  still  used  in  developing  countries,  the  issue  is  arguably  one  of  a 
cultural nature, rather than a scientific one. On the other hand, since the majority of 
pesticides that were detected here (Appendix 1) are not new compounds, perhaps the 
fact that highly toxic effects have not been reported in recent history indicates that 
they are not having a large impact on wildlife. However, it is arguable that dramatic 
declines in amphibians (and other species) are indeed occurring, and these may be at 
least partially related to pesticides. Therefore, in contrast to the extreme toxic effects 
of pesticides reported in the 1960’s, the effects we see presently are more subtle due 
to improved environmental quality, which are characteristic effects of ED. 
The  question  of  the  effects  of  environmentally  relevant  pesticides  was  partially 
addressed in this study, and it was surprising to find that 80 % of the pesticides tested 
had  a  measurable  response  in  at  least  one  test,  and  approximately  half  at 
concentrations close to those found in the environment. In addition, effects of PCP 
observed in vitro were partially corroborated by effects observed in vivo, suggesting 
that other pesticides active in the yeast screen and ovulation assay may also affect 
endocrine endpoints in vivo. Furthermore, since pesticide mixtures have been reported 
to have an increased effect compared to single compounds (Hayes  et al., 2006), it 
would be informative to test the other pesticides that were active in vitro in exposure 
studies,  both  singly  and  in  combination.  Chemical  analysis  of  the  water  extracts 
would have also assisted in interpretation of endocrine effects in relation to pesticides 
present in the extract. Nevertheless, it was interesting that the predominant receptor-
mediated  effects  in  response  to  water  extracts  were  anti-estrogenic  and  anti-
androgenic  activity,  which  were  also  the  effects  observed  in  response  to 
environmentally relevant pesticides, which were purchased and tested separately. In 
contrast, none of the pesticides tested were estrogenic, and estrogenic activity of water 
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extracts was only observed from one site, which may have been related to sewage 
treatment  works  effluent.  Very  little  is  known  about  the  effects  of  model  anti-
estrogens/anti-androgens, or anti-estrogenic/anti-androgenic pesticides on amphibians. 
Therefore,  in  light  of  data  presented  here,  the  importance  of  anti-estrogenic/anti-
androgenic pesticides and model compounds on amphibians in vivo warrants further 
investigation. Furthermore, comparison of these findings to in vitro data would assist 
in  assessing  the  predictive  value  of  the  ovulation  and  yeast  screen  assays,  on 
endocrinological  effects  in  vivo.  Finally,  in  vitro and  in  vivo tests  could  also  be 
modified to increase environmental relevance by testing mixtures as well as single 
compounds. 
5.3 Toads
Extracts from every field site tested were active in the yeast screens, and effects were 
observed in  amphibians  from a  subsample  of  these  sites,  however,  no  correlation 
between ED effects of extracts and on toads  in vivo could be observed. This was 
especially true at 20’, which was highly estrogenic, but apparent masculinisation in 
toads  occurred.  However  the  low  n values  of  specimens  at  all  sites  hindered  the 
interpretation of results. Indeed, the field work aspect of this study highlighted the 
difficulties in doing field studies with amphibians. Due to previous reports of high 
mortality during larval stages, it could be argued that toads are not a good test species. 
However,  toads  are  widespread  in  agricultural  water  bodies,  and  they  may  be 
declining in  the UK .  Furthermore,  the presence of  BO may assist  to  elucidating 
effects. Therefore, if the problems of mortality could be overcome by draining tanks 
earlier to prevent drowning, increasing cage area, as well as supplementing cages with 
food, they may be a useful test species in further experiments.  
An  unexpected  finding  from  the  field  work  was  the  substantial  and  prolonged 
differences in the laboratory-reared individuals collected at the various sites, in spite 
of  the  same rearing conditions.  The  eggs  collected  were  of  a  very early  stage  in 
development, so whatever the cause of these effects, they occurred early in the life of 
the individual. Possible candidates include: a latent effect of the pond environment, 
genetic  factors,  or  maternal  transfer  of  contaminants.  To the  author’s  knowledge, 
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there are no reports in relation to latent effects of the pond environment. This could 
perhaps  be  studied by exposure of  cloned embryos to  test  substances  for  varying 
periods  (e.g.  48,  72,  96 hrs)  and observing morphological  and/or  thyroidal  and/or 
gonadal  development.  Maternal  transfer  of  TCDD  (2,3,7,8-tetrachlorodibenzo-p-
dioxin) administered to adult Zebrafish via the food, has been reported to cause early 
life stage toxicity of eggs . In this study, TCDD levels in the eggs were approximately 
100-fold lower than the levels present in the food (40 or 100 ng/g) except  at  the 
lowest  concentration  (10  ng/g)  after  20  days.  In  contrast,  in  a  frog  species 
(Gastrophryne carolinensis), approximately 50 % of the maternal burden of selenium, 
was transferred to the eggs, and levels were correlated with tadpole abnormalities in 
the FETAX assay . Therefore, it seems that adult exposure can affect offspring (e.g. 
DES in humans), and this may help to explain the high incidence of intersex observed 
in  both  laboratory-reared  and  caged  individuals  from  20’.  Using  this  rationale, 
perhaps  a  combination  of  early  life  exposure  and  maternal  transfer  affected  the 
individuals in this study. In contrast, it has been shown in Rana temporaria that there 
are effects of nutritional status of the female on size of eggs laid and corresponding 
tadpole and metamorph size. In addition, genetic factors such as male origin, affected 
the age at metamorphosis , indicating that differences observed in the lab may not 
have been related to contaminants. Furthermore, larval survival rate was correlated 
with genetic diversity and was lower in smaller, isolated urban, habitats in comparison 
to larger rural habitats . Therefore, care must be taken with interpretation of results of 
the field study, and the factors outlined above need to be taken into account. Finally, 
whatever the cause, this finding has implications for comparison of laboratory studies, 
where  different  effects  have  sometimes  been  reported  in  response  to  the  same 
compounds under similar experimental conditions.  
5.4 Conclusions & Further Direction
There is preliminary evidence that native amphibians may be affected by agricultural 
compounds, however, this requires further investigation. Furthermore, data presented 
here  suggests  that  previously  untested  pesticides  are  EDs  in  vitro,  but  that  the 
interactions  between pesticides  and  amphibians  are  complex.  Due to  the  work  of 
Froglife, the UK is in a unique situation concerning long-term qualitative population 
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data,  however,  sex  ratios  are  rarely  recorded.  Although,  males  are  always  more 
prevalent than females at crossing sites, it would be interesting to see if the sex ratio 
changes over time. In addition, it would be relatively easy to obtain these data by 
requesting that current toads on roads groups note the sex of individuals at the time of 
carrying  across  the  road.  In  relation  to  specific  sites  and  pesticides,  in  the  first 
instance it would be beneficial to repeat the caged study (breeding season three) with 
modifications to try and decrease mortality, to see if results were reproducible. Water 
samples could be collected at these sites by grab samplings and PADs to verify anti-
estrogenic/anti-androgenic/estrogenic  results  observed  previously.  Furthermore, 
analysis of genetic sex ratio  and fitness (Hitchings and Beebee, 1998) could be tested 
in  caged  and  laboratory-reared  individuals  at  euthanisation.  If  necessary,  further 
samples  of  adults  from the  populations  could  also  be  taken  for  genetic  analysis, 
without  killing  the  animals.  In  relation  to  the  effects  of  pesticides,  it  would  be 
informative  to  test  the  active  pesticides  reported  in  this  study,  in  vivo,  including 
various  mixtures  of  these  pesticides.  These  pesticides  and  mixtures  could also  be 
tested in relation to maternal transfer of compounds and their effects on offspring after 
short-term egg exposure. Finally, it may be informative to transplant and cage spawn 
from a relatively unpolluted site  (e.g.  PYL) as a  ‘reference’  to  other  sites,  which 
would provide a baseline of development, against which caged spawn from the native 
sites could be tested. 
In conclusion, data reported here are preliminary in nature, but effects were observed 
in  every  endpoint  tested,  suggesting  pesticides  may  be  affecting  amphibian 
populations, but further research is needed to substantiate reported effects.
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Appendix 1
Levels of agrochemicals measured in U.K. freshwaters in 2004/2005 (Environment Agency Copyright 2007), and expenditure in the U.S.A. in 
2001 (Kiely, 2004).
Herbicides/Plant Growth Regulators 
Mode of Action Type Compound Mean 
(µg/L)
Range 
(µg/L)
Median 
(µg/L)
Incidence
(> 0.01 µg/L)
Median x 
Incidence
Rank
UK      US
Synthetic auxin Phenoxy- acids Mecoprop 6.593 0.028-6180 0.1 1444 144.4 1
MCPA 12.052 0.04-4700 0.152 615 93.48 4
2,4-D 40.348 0.04-18600 0.140 488 68.32 5 5
Dichlorprop 5.112 0.04-561 0.200 120 24 9
2,4-DB 0.315 0.04-1.4 0.200 35 7 17
MCPB 0.296 0.04-1.81 0.1 65 6.5 19
2,4,5-T 0.077 0.02-0.352 0.059 24 1.416 44
4-CPA 0.165 0.04-0.995 0.075 12 0.9 49
Benzoic Acid Dicamba 89.617 0.035-5090 0.1 57 5.7 21 24
2,3,6-TBA 0.814 0.01-4.4 0.21 19 3.99 26
Pyridinecarboxylic acid Fluroxypyr 0.315 0.044-4.54 0.084 26 2.184 32
Triclopyr 0.097 0.03-0.34 0.061 27 1.647 39
Clopyralid 0.093 0.04-0.37 0.05 12 0.6 53
Unknown Benazolin 0.908 0.05-4.150 0.585 21 12.285 14
Photosynthetic electron 
transport inhibitor Urea Diuron 0.652 0.016-28 0.131 785 102.835 2
Isoproturon 0.443 0.02-29.5 0.150 635 95.25 3
Chlorotoluron 0.271 0.021-5.87 0.077 217 16.709 10
Linuron 0.123 0.2-1.4 0.057 74 4.218 24
Monuron 0.346 0.04-0.94 0.196 9 1.764 36
Fenuron 0.129 0.07-0.213 0.124 10 1.24 46
Neburon 0.055 0.04-0.089 0.053 7 0.371 54
Triazine Simazine 0.067 0.01-2.24 0.038 1444 54.872 6 23
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Atrazine 0.053 0.01-1.96 0.024 1464 35.136 7 2
Trietazine 1.559 0.01-5.91 0.925 18 16.65 11
Terbutryn 0.134 0.01-4 0.027 148 3.996 25
Propazine 1.075 0.5-2.76 0.567 5 2.835 30
Benzothiadiazinone Bentazone 0.121 0.04-1.75 0.07 137 9.59 15
Hydroxybenzonitrile Bromoxynil 0.838 0.04-6.5 0.35 18 6.3 20
Pyridazinone Chloridazon 0.573 0.04-1.73 0.32 7 2.24 31
Uncoupler of oxidative 
phosphorylation Dinitrophenol DNOC (insecticide)  0.274 0.04-1.8 0.1 17 1.7 38
Unknown
Pentachlorophenol 
(biocide) 0.304 0.016-2.74 0.163 93 15.159 12
Inhibits cell division (blocks 
microtubule function) Carbamate Chlorpropham 4.816 0.01-269.6 0.089 103 9.167 16
Carbetamide 0.264 0.05-0.744 0.297 17 5.049 23
Benzamide Propyzamide 2.55 0.01-310 0.042 124 5.208 22
Dinitroaniline Trifluralin 0.038 0.01-3.06 0.018 183 3.294 28 12
Inhibits cell division (blocks 
protein synthesis) Chloroacetamide Metazochlor 0.048 0.01-0.588 0.019 82 1.558 40
Inhibts cell division (blocks 
sterol synthesis) Triazole Paclobutrazol 0.021 0.01-0.038 0.02 9 0.18 62
Inhibiton of cell wall 
synthesis Benzonitrile Dichlobenil 0.168 0.01-10.6 0.026 122 3.172 29
Chitin synthesis inhibitor Benzoylurea Diflubenzuron 0.11 0.04-0.87 0.058 21 1.218 47
Inhibits lipid synthesis Benzofuron Ethofunesate 0.573 0.01-13.3 0.023 76 1.748 37
Thiocarbamate Tri-allate 0.016 0.01-0.035 0.012 13 0.156 63
Inhibits synthesis of 
essential amino acids Glycine Derivative Glyphosate 27.95 0.11-1600 0.229 149 34.121 8 1
Insecticides & Fungicides (f)
Mode of Action Type Compound Mean 
(µg/L)
Range   
(µg/L)
Median 
(µg/L)
Incidence
(> 0.01 µg/L)
Median x 
Incidence
Rank
UK      US
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Nerve Poison (affects 
sodium balance in nerves) Organochlorine DDT 0.025 0.01-0.094 0.02 21 0.42 53
TDE (DDD) 0.027 0.014-0.11 0.018 11 0.198 61
Antagonist of the GABA 
receptor Cyclodiene organochlorine Dieldrin 5.647 0.01-153.4 0.096 69 6.624 18
Aldrin 0.05 0.011-0.312 0.024 15 0.36 55
HCH 0.019 0.01-0.055 0.017 14 0.238 60
Cholinestersae inhibition Organophosphate Diazinon 0.046 0.01-0.535 0.03 451 13.53 13
Parathion 0.754 0.012-3 0.085 17 1.445 43
Mevinphos 0.33 0.01-2.53 0.03 29 0.87 50
Dimethoate 0.055 0.011-0.367 0.024 29 0.696 51
Azinphos-methyl 0.053 0.01-0.178 0.032 11 0.352 56
Malathion 0.03 0.01-0.109 0.019 17 0.323 57 6
Fenitrothion 0.068 0.013-0.137 0.06 4 0.24 59
Propetamphos 0.019 0.01-0.034 0.016 7 0.112 64
Chlorfenvinphos 0.032 0.015-0.073 0.023 4 0.092 66
Triazophos 0.013 0.01-0.02 0.01 6 0.06 67
Carbamate Pirimicarb 0.328 0.011-8.86 0.085 46 3.91 27
Nerve poison (blocks 
sodium transport in nerves) Pyrethroid Permethrin 1166.8 0.01-26400 0.029 30 0.87 50
Cypermethrin 0.033 0.012-0.093 0.024 11 0.264 58
Inhibition of digestive 
enzymes Mitin Sulcofuron 0.523 0.25-0.75 0.545 4 2.18 33
Flucofuron 0.293 0.18-0.52 0.255 6 1.53 41
Unknown Eulan 0.107 0.02-0.7 0.07 14 0.98 48
Uncoupler of oxidative 
phosphorylation Organotin Tributyltin 0.089 0.01-7.9 0.016 115 1.84 34
Dibutyltin 0.034 0.01-0.4 0.017 87         1.479   42
Inhibition of beta-tubulin 
synthesis Benzimadazole Carbendazim (f) 0.11 0.023-0.516 0.069 20 1.38 45
Inhibtion of ergosterol 
synthesis Triazole Flutriafol (f) 0.072 0.012-0.162 0.068 26 1.768 35
Morpholine Fenpropimorph (f) 0.03 0.018-0.064 0.02 5 0.1 65
Lipid peroxidation Chlorphenyl/nitroaniline Tecnazene (f) 0.013 0.01-0.21 0.011 4 0.044 68
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(f) refers to fungicide
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Appendix 2 
Detected Pesticides at Sampling Sites 
(Environment Agency)
2.1 Yatton:
• Co-ordinates: x,y = 342549, 175219
Date Pesticide
Less 
than
Conc. 
(ng/L) x y
15/08/2005
(2,4,5-TRICHLOROPHENOXY)ETHANOIC 
ACID < 10 347815 195172
25/07/2005
(2,4,5-TRICHLOROPHENOXY)ETHANOIC 
ACID < 10 347815 195172
19/09/2005
(2,4,5-TRICHLOROPHENOXY)ETHANOIC 
ACID < 1 347815 195172
10/10/2005
(2,4,5-TRICHLOROPHENOXY)ETHANOIC 
ACID < 40 347815 195172
17/10/2005
(2,4,5-TRICHLOROPHENOXY)ETHANOIC 
ACID < 40 347815 195172
13/06/2005
(2,4,5-TRICHLOROPHENOXY)ETHANOIC 
ACID < 10 347815 195172
24/05/2005
(2,4,5-TRICHLOROPHENOXY)ETHANOIC 
ACID < 10 347815 195172
12/12/2005
(2,4,5-TRICHLOROPHENOXY)ETHANOIC 
ACID < 40 347815 195172
07/11/2005
(2,4,5-TRICHLOROPHENOXY)ETHANOIC 
ACID < 40 347815 195172
10/02/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 366163 169000
17/03/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 366163 169000
13/05/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 366163 169000
17/06/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 366163 169000
15/04/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 60 366163 169000
15/08/2005
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347815 195172
25/07/2005
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347815 195172
10/10/2005
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347815 195172
19/09/2005
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347815 195172
17/10/2005
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347815 195172
21/03/2005
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347815 195172
18/01/2005 (2,4-DICHLOROPHENOXY)ETHANOIC < 50 347815 195172
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ACID
21/02/2005
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347815 195172
24/05/2005
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347815 195172
13/06/2005
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347815 195172
18/04/2005
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347815 195172
12/12/2005
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347815 195172
07/11/2005
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347815 195172
17/08/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347820 195220
11/10/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347820 195220
21/09/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347820 195220
22/11/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347820 195220
25/10/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347820 195220
08/11/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347820 195220
09/03/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347820 195220
13/04/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347820 195220
20/01/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347820 195220
24/02/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347820 195220
21/06/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347820 195220
19/07/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347820 195220
18/05/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 347820 195220
21/03/2005 2,4,5-TRICHLOROPHENOL < 10 347815 195172
18/01/2005 2,4,5-TRICHLOROPHENOL < 10 347815 195172
21/02/2005 2,4,5-TRICHLOROPHENOL < 10 347815 195172
18/04/2005 2,4,5-TRICHLOROPHENOL < 10 347815 195172
11/10/2004 2,4,5-TRICHLOROPHENOL < 10 347820 195220
17/08/2004 2,4,5-TRICHLOROPHENOL < 10 347820 195220
21/09/2004 2,4,5-TRICHLOROPHENOL < 10 347820 195220
22/11/2004 2,4,5-TRICHLOROPHENOL < 10 347820 195220
25/10/2004 2,4,5-TRICHLOROPHENOL < 10 347820 195220
08/11/2004 2,4,5-TRICHLOROPHENOL < 10 347820 195220
20/01/2004 2,4,5-TRICHLOROPHENOL < 10 347820 195220
09/03/2004 2,4,5-TRICHLOROPHENOL < 10 347820 195220
13/04/2004 2,4,5-TRICHLOROPHENOL < 10 347820 195220
24/02/2004 2,4,5-TRICHLOROPHENOL < 10 347820 195220
21/06/2004 2,4,5-TRICHLOROPHENOL < 10 347820 195220
19/07/2004 2,4,5-TRICHLOROPHENOL < 10 347820 195220
18/05/2004 2,4,5-TRICHLOROPHENOL < 10 347820 195220
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15/08/2005 2,4-DB < 100 347815 195172
25/07/2005 2,4-DB < 100 347815 195172
19/09/2005 2,4-DB < 100 347815 195172
17/10/2005 2,4-DB < 40 347815 195172
10/10/2005 2,4-DB < 40 347815 195172
21/03/2005 2,4-DB < 100 347815 195172
18/01/2005 2,4-DB < 100 347815 195172
21/02/2005 2,4-DB < 100 347815 195172
24/05/2005 2,4-DB < 100 347815 195172
13/06/2005 2,4-DB < 100 347815 195172
18/04/2005 2,4-DB < 100 347815 195172
12/12/2005 2,4-DB < 40 347815 195172
07/11/2005 2,4-DB < 40 347815 195172
11/10/2004 2,4-DB < 100 347820 195220
17/08/2004 2,4-DB < 100 347820 195220
21/09/2004 2,4-DB < 100 347820 195220
22/11/2004 2,4-DB < 100 347820 195220
25/10/2004 2,4-DB < 100 347820 195220
08/11/2004 2,4-DB < 100 347820 195220
09/03/2004 2,4-DB < 100 347820 195220
13/04/2004 2,4-DB < 100 347820 195220
20/01/2004 2,4-DB < 100 347820 195220
24/02/2004 2,4-DB < 100 347820 195220
21/06/2004 2,4-DB < 100 347820 195220
19/07/2004 2,4-DB < 100 347820 195220
18/05/2004 2,4-DB < 100 347820 195220
17/03/2004 ALDRIN < 1 366163 169000
17/06/2004 ALDRIN < 1 366163 169000
12/08/2004 ALDRIN < 1 366163 169000
15/02/2005 ALDRIN < 1 366163 169000
17/03/2005 ALDRIN < 1 366163 169000
14/04/2005 ALDRIN < 1 366163 169000
13/05/2005 ALDRIN < 1 366163 169000
14/06/2005 ALDRIN < 1 366163 169000
16/08/2005 ALDRIN < 1 366163 169000
11/07/2005 ALDRIN < 2 366163 169000
10/02/2004 ATRAZINE < 3 366163 169000
17/03/2005 ATRAZINE < 3 366163 169000
14/04/2005 ATRAZINE  8 366163 169000
15/02/2005 ATRAZINE  9 366163 169000
17/03/2004 ATRAZINE  11 366163 169000
15/04/2004 ATRAZINE  12 366163 169000
13/05/2004 ATRAZINE  16 366163 169000
17/06/2004 ATRAZINE < 18 366163 169000
16/08/2005 ATRAZINE  19 366163 169000
13/05/2005 ATRAZINE  23 366163 169000
12/08/2004 ATRAZINE  36 366163 169000
14/06/2005 ATRAZINE  86 366163 169000
15/07/2004 ATRAZINE  129 366163 169000
11/07/2005 ATRAZINE  148 366163 169000
15/08/2005 ATRAZINE < 10 347815 195172
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25/07/2005 ATRAZINE < 10 347815 195172
17/10/2005 ATRAZINE < 10 347815 195172
19/09/2005 ATRAZINE < 10 347815 195172
10/10/2005 ATRAZINE < 10 347815 195172
21/03/2005 ATRAZINE < 10 347815 195172
18/01/2005 ATRAZINE < 10 347815 195172
21/02/2005 ATRAZINE < 10 347815 195172
24/05/2005 ATRAZINE < 10 347815 195172
13/06/2005 ATRAZINE < 10 347815 195172
18/04/2005 ATRAZINE < 10 347815 195172
12/12/2005 ATRAZINE < 10 347815 195172
07/11/2005 ATRAZINE < 10 347815 195172
11/10/2004 ATRAZINE < 10 347820 195220
17/08/2004 ATRAZINE < 10 347820 195220
21/09/2004 ATRAZINE < 10 347820 195220
22/11/2004 ATRAZINE < 10 347820 195220
25/10/2004 ATRAZINE < 10 347820 195220
08/11/2004 ATRAZINE < 10 347820 195220
09/03/2004 ATRAZINE < 10 347820 195220
13/04/2004 ATRAZINE < 10 347820 195220
20/01/2004 ATRAZINE < 10 347820 195220
24/02/2004 ATRAZINE < 10 347820 195220
21/06/2004 ATRAZINE < 10 347820 195220
19/07/2004 ATRAZINE < 10 347820 195220
18/05/2004 ATRAZINE < 10 347820 195220
10/02/2004 AZINPHOS-ETHYL < 6 366163 169000
17/03/2004 AZINPHOS-ETHYL < 6 366163 169000
15/04/2004 AZINPHOS-ETHYL < 6 366163 169000
13/05/2004 AZINPHOS-ETHYL < 6 366163 169000
17/06/2004 AZINPHOS-ETHYL < 6 366163 169000
15/07/2004 AZINPHOS-ETHYL < 6 366163 169000
12/08/2004 AZINPHOS-ETHYL < 6 366163 169000
15/02/2005 AZINPHOS-ETHYL < 6 366163 169000
17/03/2005 AZINPHOS-ETHYL < 6 366163 169000
14/04/2005 AZINPHOS-ETHYL < 6 366163 169000
14/06/2005 AZINPHOS-ETHYL < 6 366163 169000
11/07/2005 AZINPHOS-ETHYL < 6 366163 169000
13/05/2005 AZINPHOS-ETHYL < 7 366163 169000
16/08/2005 AZINPHOS-ETHYL < 7 366163 169000
10/02/2004 AZINPHOS-METHYL < 3 366163 169000
17/03/2004 AZINPHOS-METHYL < 3 366163 169000
15/04/2004 AZINPHOS-METHYL < 3 366163 169000
13/05/2004 AZINPHOS-METHYL < 3 366163 169000
17/06/2004 AZINPHOS-METHYL < 3 366163 169000
15/07/2004 AZINPHOS-METHYL < 3 366163 169000
12/08/2004 AZINPHOS-METHYL < 3 366163 169000
15/02/2005 AZINPHOS-METHYL < 3 366163 169000
17/03/2005 AZINPHOS-METHYL < 3 366163 169000
14/04/2005 AZINPHOS-METHYL < 3 366163 169000
13/05/2005 AZINPHOS-METHYL < 3 366163 169000
14/06/2005 AZINPHOS-METHYL < 3 366163 169000
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11/07/2005 AZINPHOS-METHYL < 3 366163 169000
16/08/2005 AZINPHOS-METHYL < 3 366163 169000
15/08/2005 BENAZOLIN < 25 347815 195172
25/07/2005 BENAZOLIN < 25 347815 195172
19/09/2005 BENAZOLIN < 25 347815 195172
17/10/2005 BENAZOLIN < 40 347815 195172
10/10/2005 BENAZOLIN < 40 347815 195172
21/03/2005 BENAZOLIN < 25 347815 195172
18/01/2005 BENAZOLIN < 25 347815 195172
21/02/2005 BENAZOLIN < 25 347815 195172
24/05/2005 BENAZOLIN < 25 347815 195172
13/06/2005 BENAZOLIN < 25 347815 195172
18/04/2005 BENAZOLIN < 25 347815 195172
12/12/2005 BENAZOLIN < 40 347815 195172
07/11/2005 BENAZOLIN < 40 347815 195172
21/09/2004 BENAZOLIN < 25 347820 195220
11/10/2004 BENAZOLIN < 25 347820 195220
17/08/2004 BENAZOLIN < 25 347820 195220
22/11/2004 BENAZOLIN < 25 347820 195220
25/10/2004 BENAZOLIN < 25 347820 195220
08/11/2004 BENAZOLIN < 25 347820 195220
13/04/2004 BENAZOLIN < 25 347820 195220
09/03/2004 BENAZOLIN < 25 347820 195220
20/01/2004 BENAZOLIN < 25 347820 195220
24/02/2004 BENAZOLIN < 25 347820 195220
21/06/2004 BENAZOLIN < 25 347820 195220
19/07/2004 BENAZOLIN < 25 347820 195220
18/05/2004 BENAZOLIN < 25 347820 195220
10/02/2004 BENTAZONE < 40 366163 169000
17/03/2004 BENTAZONE < 40 366163 169000
13/05/2004 BENTAZONE < 40 366163 169000
17/06/2004 BENTAZONE < 40 366163 169000
15/04/2004 BENTAZONE < 50 366163 169000
15/08/2005 BENTAZONE < 100 347815 195172
25/07/2005 BENTAZONE < 100 347815 195172
17/10/2005 BENTAZONE < 40 347815 195172
19/09/2005 BENTAZONE < 100 347815 195172
10/10/2005 BENTAZONE < 40 347815 195172
21/02/2005 BENTAZONE < 100 347815 195172
21/03/2005 BENTAZONE < 100 347815 195172
18/01/2005 BENTAZONE < 100 347815 195172
24/05/2005 BENTAZONE < 100 347815 195172
18/04/2005 BENTAZONE < 100 347815 195172
13/06/2005 BENTAZONE < 100 347815 195172
12/12/2005 BENTAZONE < 40 347815 195172
07/11/2005 BENTAZONE < 40 347815 195172
21/09/2004 BENTAZONE < 100 347820 195220
11/10/2004 BENTAZONE < 100 347820 195220
17/08/2004 BENTAZONE < 100 347820 195220
22/11/2004 BENTAZONE < 100 347820 195220
25/10/2004 BENTAZONE < 100 347820 195220
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08/11/2004 BENTAZONE < 100 347820 195220
09/03/2004 BENTAZONE < 100 347820 195220
20/01/2004 BENTAZONE < 100 347820 195220
24/02/2004 BENTAZONE < 100 347820 195220
21/06/2004 BENTAZONE < 100 347820 195220
13/04/2004 BENTAZONE < 100 347820 195220
19/07/2004 BENTAZONE < 100 347820 195220
18/05/2004 BENTAZONE < 100 347820 195220
17/10/2005 CHLORFENVINPHOS < 1 347815 195172
15/08/2005 CHLORFENVINPHOS < 1 347815 195172
25/07/2005 CHLORFENVINPHOS < 1 347815 195172
13/06/2005 CHLORFENVINPHOS < 1 347815 195172
19/09/2005 CHLORFENVINPHOS < 1 347815 195172
10/10/2005 CHLORFENVINPHOS < 1 347815 195172
21/02/2005 CHLORFENVINPHOS < 1 347815 195172
21/03/2005 CHLORFENVINPHOS < 1 347815 195172
18/01/2005 CHLORFENVINPHOS < 1 347815 195172
24/05/2005 CHLORFENVINPHOS < 1 347815 195172
18/04/2005 CHLORFENVINPHOS < 1 347815 195172
12/12/2005 CHLORFENVINPHOS < 1 347815 195172
07/11/2005 CHLORFENVINPHOS < 1 347815 195172
21/09/2004 CHLORFENVINPHOS < 1 347820 195220
11/10/2004 CHLORFENVINPHOS < 1 347820 195220
17/08/2004 CHLORFENVINPHOS < 1 347820 195220
22/11/2004 CHLORFENVINPHOS < 1 347820 195220
19/07/2004 CHLORFENVINPHOS < 1 347820 195220
25/10/2004 CHLORFENVINPHOS < 1 347820 195220
08/11/2004 CHLORFENVINPHOS < 1 347820 195220
09/03/2004 CHLORFENVINPHOS < 1 347820 195220
20/01/2004 CHLORFENVINPHOS < 1 347820 195220
24/02/2004 CHLORFENVINPHOS < 1 347820 195220
21/06/2004 CHLORFENVINPHOS < 1 347820 195220
13/04/2004 CHLORFENVINPHOS < 1 347820 195220
18/05/2004 CHLORFENVINPHOS < 1 347820 195220
17/03/2004 CYFLUTHRIN < 1 366163 169000
17/06/2004 CYFLUTHRIN < 1 366163 169000
12/08/2004 CYFLUTHRIN < 1 366163 169000
17/03/2005 CYFLUTHRIN < 1 366163 169000
17/10/2005 CYPERMETHRIN < 1 347815 195172
15/08/2005 CYPERMETHRIN < 1 347815 195172
13/06/2005 CYPERMETHRIN < 1 347815 195172
25/07/2005 CYPERMETHRIN < 1 347815 195172
19/09/2005 CYPERMETHRIN < 1 347815 195172
10/10/2005 CYPERMETHRIN < 1 347815 195172
21/03/2005 CYPERMETHRIN < 1 347815 195172
18/01/2005 CYPERMETHRIN < 1 347815 195172
21/02/2005 CYPERMETHRIN < 1 347815 195172
24/05/2005 CYPERMETHRIN < 1 347815 195172
18/04/2005 CYPERMETHRIN < 1 347815 195172
12/12/2005 CYPERMETHRIN < 1 347815 195172
07/11/2005 CYPERMETHRIN < 1 347815 195172
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21/09/2004 CYPERMETHRIN < 1 347820 195220
11/10/2004 CYPERMETHRIN < 1 347820 195220
17/08/2004 CYPERMETHRIN < 1 347820 195220
22/11/2004 CYPERMETHRIN < 1 347820 195220
25/10/2004 CYPERMETHRIN < 1 347820 195220
08/11/2004 CYPERMETHRIN < 1 347820 195220
09/03/2004 CYPERMETHRIN < 1 347820 195220
20/01/2004 CYPERMETHRIN < 1 347820 195220
24/02/2004 CYPERMETHRIN < 1 347820 195220
21/06/2004 CYPERMETHRIN < 1 347820 195220
19/07/2004 CYPERMETHRIN < 1 347820 195220
13/04/2004 CYPERMETHRIN < 1 347820 195220
18/05/2004 CYPERMETHRIN < 1 347820 195220
17/03/2004 DDE (PP) < 1 366163 169000
17/06/2004 DDE (PP) < 1 366163 169000
12/08/2004 DDE (PP) < 1 366163 169000
15/02/2005 DDE (PP) < 1 366163 169000
17/03/2005 DDE (PP) < 1 366163 169000
14/04/2005 DDE (PP) < 1 366163 169000
13/05/2005 DDE (PP) < 1 366163 169000
14/06/2005 DDE (PP) < 1 366163 169000
16/08/2005 DDE (PP) < 1 366163 169000
11/07/2005 DDE (PP) < 2 366163 169000
17/03/2004 DDT (OP) < 3 366163 169000
17/06/2004 DDT (OP) < 3 366163 169000
15/02/2005 DDT (OP) < 3 366163 169000
17/03/2005 DDT (OP) < 3 366163 169000
14/04/2005 DDT (OP) < 3 366163 169000
13/05/2005 DDT (OP) < 3 366163 169000
16/08/2005 DDT (OP) < 3 366163 169000
14/06/2005 DDT (OP) < 4 366163 169000
11/07/2005 DDT (OP) < 5 366163 169000
17/03/2004 DDT (PP) < 1 366163 169000
17/06/2004 DDT (PP) < 1 366163 169000
12/08/2004 DDT (PP) < 1 366163 169000
15/02/2005 DDT (PP) < 1 366163 169000
17/03/2005 DDT (PP) < 1 366163 169000
14/04/2005 DDT (PP) < 1 366163 169000
13/05/2005 DDT (PP) < 1 366163 169000
14/06/2005 DDT (PP) < 1 366163 169000
16/08/2005 DDT (PP) < 1 366163 169000
11/07/2005 DDT (PP) < 2 366163 169000
15/08/2005 DIAZINON < 1 347815 195172
13/06/2005 DIAZINON < 1 347815 195172
25/07/2005 DIAZINON < 1 347815 195172
19/09/2005 DIAZINON < 1 347815 195172
10/10/2005 DIAZINON < 1 347815 195172
21/02/2005 DIAZINON < 1 347815 195172
21/03/2005 DIAZINON < 1 347815 195172
18/01/2005 DIAZINON < 1 347815 195172
24/05/2005 DIAZINON < 1 347815 195172
18/04/2005 DIAZINON < 1 347815 195172
17/10/2005 DIAZINON < 1 347815 195172
12/12/2005 DIAZINON < 1 347815 195172
07/11/2005 DIAZINON < 1 347815 195172
21/09/2004 DIAZINON < 1 347820 195220
11/10/2004 DIAZINON < 1 347820 195220
17/08/2004 DIAZINON < 1 347820 195220
08/11/2004 DIAZINON < 1 347820 195220
22/11/2004 DIAZINON < 1 347820 195220
25/10/2004 DIAZINON  17.3 347820 195220
09/03/2004 DIAZINON < 1 347820 195220
20/01/2004 DIAZINON < 1 347820 195220
19/07/2004 DIAZINON < 1 347820 195220
24/02/2004 DIAZINON < 1 347820 195220
21/06/2004 DIAZINON < 1 347820 195220
13/04/2004 DIAZINON < 1 347820 195220
18/05/2004 DIAZINON < 1 347820 195220
15/08/2005
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347815 195172
13/06/2005
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347815 195172
25/07/2005
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347815 195172
19/09/2005
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347815 195172
10/10/2005
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 40 347815 195172
21/02/2005
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347815 195172
21/03/2005
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347815 195172
18/01/2005
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347815 195172
24/05/2005
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347815 195172
18/04/2005
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347815 195172
12/12/2005
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 40 347815 195172
17/10/2005
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 40 347815 195172
07/11/2005
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 40 347815 195172
11/10/2004
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347820 195220
21/09/2004
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347820 195220
17/08/2004
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347820 195220
08/11/2004
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347820 195220
22/11/2004
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347820 195220
25/10/2004
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347820 195220
09/03/2004 DICAMBA {3,6-DICHLORO(O- < 25 347820 195220
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METHOXYBENZOIC ACID)}
20/01/2004
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347820 195220
24/02/2004
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347820 195220
21/06/2004
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347820 195220
19/07/2004
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347820 195220
13/04/2004
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347820 195220
18/05/2004
DICAMBA {3,6-DICHLORO(O-
METHOXYBENZOIC ACID)} < 25 347820 195220
10/02/2004 DICHLORVOS < 4 366163 169000
17/03/2004 DICHLORVOS < 4 366163 169000
15/04/2004 DICHLORVOS < 4 366163 169000
13/05/2004 DICHLORVOS < 4 366163 169000
17/06/2004 DICHLORVOS < 4 366163 169000
15/07/2004 DICHLORVOS < 4 366163 169000
12/08/2004 DICHLORVOS < 4 366163 169000
15/02/2005 DICHLORVOS < 4 366163 169000
17/03/2005 DICHLORVOS < 4 366163 169000
14/04/2005 DICHLORVOS < 4 366163 169000
14/06/2005 DICHLORVOS < 4 366163 169000
11/07/2005 DICHLORVOS < 4 366163 169000
16/08/2005 DICHLORVOS < 4 366163 169000
13/05/2005 DICHLORVOS < 5 366163 169000
10/02/2004 DIELDRIN < 1 366163 169000
17/03/2004 DIELDRIN < 1 366163 169000
15/04/2004 DIELDRIN < 1 366163 169000
17/06/2004 DIELDRIN < 1 366163 169000
15/07/2004 DIELDRIN < 1 366163 169000
12/08/2004 DIELDRIN < 1 366163 169000
15/02/2005 DIELDRIN < 1 366163 169000
17/03/2005 DIELDRIN < 1 366163 169000
14/04/2005 DIELDRIN < 1 366163 169000
13/05/2005 DIELDRIN < 1 366163 169000
14/06/2005 DIELDRIN < 1 366163 169000
16/08/2005 DIELDRIN < 1 366163 169000
11/07/2005 DIELDRIN < 2 366163 169000
13/05/2004 DIELDRIN < 10 366163 169000
10/02/2004 DIMETHOATE < 6 366163 169000
17/03/2004 DIMETHOATE < 6 366163 169000
15/04/2004 DIMETHOATE < 6 366163 169000
13/05/2004 DIMETHOATE < 6 366163 169000
17/06/2004 DIMETHOATE < 6 366163 169000
15/07/2004 DIMETHOATE < 6 366163 169000
14/06/2005 DRINS TOTAL (AL-, DIEL-, EN- & ISO-) < 6 366163 169000
16/08/2005 DRINS TOTAL (AL-, DIEL-, EN- & ISO-) < 6 366163 169000
11/07/2005 DRINS TOTAL (AL-, DIEL-, EN- & ISO-) < 11 366163 169000
10/02/2004 ENDOSULPHAN ALPHA < 1 366163 169000
17/03/2004 ENDOSULPHAN ALPHA < 1 366163 169000
15/04/2004 ENDOSULPHAN ALPHA < 1 366163 169000
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17/06/2004 ENDOSULPHAN ALPHA < 1 366163 169000
15/07/2004 ENDOSULPHAN ALPHA < 1 366163 169000
13/05/2004 ENDOSULPHAN ALPHA < 10 366163 169000
10/02/2004 ENDOSULPHAN BETA < 2 366163 169000
17/03/2004 ENDOSULPHAN BETA < 2 366163 169000
15/04/2004 ENDOSULPHAN BETA < 2 366163 169000
17/06/2004 ENDOSULPHAN BETA < 2 366163 169000
15/07/2004 ENDOSULPHAN BETA < 2 366163 169000
12/08/2004 ENDOSULPHAN BETA < 2 366163 169000
15/02/2005 ENDOSULPHAN BETA < 2 366163 169000
17/03/2005 ENDOSULPHAN BETA < 2 366163 169000
14/04/2005 ENDOSULPHAN BETA < 2 366163 169000
13/05/2005 ENDOSULPHAN BETA < 2 366163 169000
14/06/2005 ENDOSULPHAN BETA < 2 366163 169000
16/08/2005 ENDOSULPHAN BETA < 2 366163 169000
11/07/2005 ENDOSULPHAN BETA < 4 366163 169000
13/05/2004 ENDOSULPHAN BETA < 20 366163 169000
17/03/2004 ENDRIN < 1 366163 169000
17/06/2004 ENDRIN < 1 366163 169000
12/08/2004 ENDRIN < 1 366163 169000
15/02/2005 ENDRIN < 1 366163 169000
17/03/2005 ENDRIN < 1 366163 169000
14/04/2005 ENDRIN < 1 366163 169000
13/05/2005 ENDRIN < 3 366163 169000
14/06/2005 ENDRIN < 3 366163 169000
16/08/2005 ENDRIN < 3 366163 169000
11/07/2005 ENDRIN < 5 366163 169000
10/02/2004 FENITROTHION < 1 366163 169000
17/03/2004 FENITROTHION < 1 366163 169000
15/04/2004 FENITROTHION < 1 366163 169000
13/05/2004 FENITROTHION < 1 366163 169000
17/06/2004 FENITROTHION < 1 366163 169000
15/07/2004 FENITROTHION < 1 366163 169000
12/08/2004 FENITROTHION < 1 366163 169000
15/02/2005 FENITROTHION < 1 366163 169000
17/03/2005 FENITROTHION < 1 366163 169000
14/04/2005 FENITROTHION < 1 366163 169000
13/05/2005 FENITROTHION < 1 366163 169000
14/06/2005 FENITROTHION < 1 366163 169000
11/07/2005 FENITROTHION < 1 366163 169000
16/08/2005 FENITROTHION < 1 366163 169000
25/07/2005 FENPROPIMORPH < 10 347815 195172
15/08/2005 FENPROPIMORPH < 10 347815 195172
13/06/2005 FENPROPIMORPH < 10 347815 195172
19/09/2005 FENPROPIMORPH < 10 347815 195172
10/10/2005 FENPROPIMORPH < 10 347815 195172
21/02/2005 FENPROPIMORPH < 10 347815 195172
21/03/2005 FENPROPIMORPH < 10 347815 195172
18/01/2005 FENPROPIMORPH < 10 347815 195172
24/05/2005 FENPROPIMORPH < 10 347815 195172
18/04/2005 FENPROPIMORPH < 10 347815 195172
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12/12/2005 FENPROPIMORPH < 10 347815 195172
17/10/2005 FENPROPIMORPH < 10 347815 195172
07/11/2005 FENPROPIMORPH < 10 347815 195172
21/09/2004 FENPROPIMORPH < 10 347820 195220
11/10/2004 FENPROPIMORPH < 10 347820 195220
17/08/2004 FENPROPIMORPH < 10 347820 195220
22/11/2004 FENPROPIMORPH < 10 347820 195220
08/11/2004 FENPROPIMORPH < 10 347820 195220
25/10/2004 FENPROPIMORPH < 10 347820 195220
24/02/2004 FENPROPIMORPH < 10 347820 195220
09/03/2004 FENPROPIMORPH < 10 347820 195220
20/01/2004 FENPROPIMORPH < 10 347820 195220
21/06/2004 FENPROPIMORPH < 10 347820 195220
19/07/2004 FENPROPIMORPH < 10 347820 195220
13/04/2004 FENPROPIMORPH < 10 347820 195220
18/05/2004 FENPROPIMORPH < 10 347820 195220
10/02/2004 FENTHION < 1 366163 169000
17/03/2004 FENTHION < 1 366163 169000
15/04/2004 FENTHION < 8 366163 169000
13/05/2004 FENTHION < 8 366163 169000
17/06/2004 FENTHION < 8 366163 169000
15/07/2004 FENTHION < 8 366163 169000
15/02/2005 FENTHION < 8 366163 169000
14/04/2005 FENTHION < 8 366163 169000
14/06/2005 FENTHION < 8 366163 169000
11/07/2005 FENTHION < 8 366163 169000
13/05/2005 FENTHION < 9 366163 169000
16/08/2005 FENTHION < 9 366163 169000
17/03/2004 FLUCOFURON < 100 366163 169000
17/06/2004 FLUCOFURON < 100 366163 169000
12/08/2004 FLUCOFURON < 100 366163 169000
17/03/2005 FLUCOFURON < 100 366163 169000
15/08/2005 FLUMETHRIN < 1 347815 195172
13/06/2005 FLUMETHRIN < 1 347815 195172
25/07/2005 FLUMETHRIN < 1 347815 195172
19/09/2005 FLUMETHRIN < 1 347815 195172
10/10/2005 FLUMETHRIN < 1 347815 195172
21/02/2005 FLUMETHRIN < 1 347815 195172
21/03/2005 FLUMETHRIN < 1 347815 195172
18/01/2005 FLUMETHRIN < 1 347815 195172
24/05/2005 FLUMETHRIN < 1 347815 195172
18/04/2005 FLUMETHRIN < 1 347815 195172
12/12/2005 FLUMETHRIN < 1 347815 195172
17/10/2005 FLUMETHRIN < 1 347815 195172
07/11/2005 FLUMETHRIN < 1 347815 195172
21/09/2004 FLUMETHRIN < 1 347820 195220
11/10/2004 FLUMETHRIN < 1 347820 195220
17/08/2004 FLUMETHRIN < 1 347820 195220
08/11/2004 FLUMETHRIN < 1 347820 195220
22/11/2004 FLUMETHRIN < 1 347820 195220
25/10/2004 FLUMETHRIN < 1 347820 195220
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09/03/2004 FLUMETHRIN < 1 347820 195220
20/01/2004 FLUMETHRIN < 1 347820 195220
19/07/2004 FLUMETHRIN < 1 347820 195220
24/02/2004 FLUMETHRIN < 1 347820 195220
21/06/2004 FLUMETHRIN < 1 347820 195220
13/04/2004 FLUMETHRIN < 1 347820 195220
18/05/2004 FLUMETHRIN < 1 347820 195220
15/08/2005 FLUROXYPYR < 25 347815 195172
13/06/2005 FLUROXYPYR < 25 347815 195172
25/07/2005 FLUROXYPYR < 25 347815 195172
19/09/2005 FLUROXYPYR < 25 347815 195172
10/10/2005 FLUROXYPYR < 50 347815 195172
21/02/2005 FLUROXYPYR < 25 347815 195172
18/01/2005 FLUROXYPYR < 25 347815 195172
21/03/2005 FLUROXYPYR < 25 347815 195172
24/05/2005 FLUROXYPYR < 25 347815 195172
18/04/2005 FLUROXYPYR < 25 347815 195172
12/12/2005 FLUROXYPYR < 50 347815 195172
17/10/2005 FLUROXYPYR  57 347815 195172
07/11/2005 FLUROXYPYR < 50 347815 195172
21/09/2004 FLUROXYPYR < 25 347820 195220
11/10/2004 FLUROXYPYR < 25 347820 195220
17/08/2004 FLUROXYPYR < 25 347820 195220
08/11/2004 FLUROXYPYR < 25 347820 195220
19/07/2004 FLUROXYPYR < 25 347820 195220
22/11/2004 FLUROXYPYR < 25 347820 195220
25/10/2004 FLUROXYPYR < 25 347820 195220
09/03/2004 FLUROXYPYR < 25 347820 195220
20/01/2004 FLUROXYPYR < 25 347820 195220
24/02/2004 FLUROXYPYR < 25 347820 195220
21/06/2004 FLUROXYPYR < 25 347820 195220
13/04/2004 FLUROXYPYR < 25 347820 195220
18/05/2004 FLUROXYPYR < 25 347820 195220
17/03/2004 HCH ALPHA < 2 366163 169000
17/06/2004 HCH ALPHA < 2 366163 169000
12/08/2004 HCH ALPHA < 2 366163 169000
15/02/2005 HCH ALPHA < 2 366163 169000
17/03/2005 HCH ALPHA < 2.1 366163 169000
14/04/2005 HCH ALPHA < 2.1 366163 169000
13/05/2005 HCH ALPHA < 2.1 366163 169000
16/08/2005 HCH ALPHA < 2.1 366163 169000
14/06/2005 HCH ALPHA < 3 366163 169000
11/07/2005 HCH ALPHA < 4 366163 169000
17/03/2004 HCH BETA < 2 366163 169000
17/06/2004 HCH BETA < 2 366163 169000
12/08/2004 HCH BETA < 2 366163 169000
15/02/2005 HCH BETA < 2 366163 169000
17/03/2005 HCH BETA < 2.1 366163 169000
14/04/2005 HCH BETA < 2.1 366163 169000
13/05/2005 HCH BETA < 2.1 366163 169000
16/08/2005 HCH BETA < 2.1 366163 169000
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14/06/2005 HCH BETA < 3 366163 169000
11/07/2005 HCH BETA < 4 366163 169000
17/03/2004 HCH GAMMA < 2 366163 169000
17/06/2004 HCH GAMMA < 2 366163 169000
12/08/2004 HCH GAMMA < 2 366163 169000
15/02/2005 HCH GAMMA < 2 366163 169000
17/03/2005 HCH GAMMA < 2.2 366163 169000
14/04/2005 HCH GAMMA < 2.2 366163 169000
13/05/2005 HCH GAMMA < 2.2 366163 169000
16/08/2005 HCH GAMMA < 2.2 366163 169000
14/06/2005 HCH GAMMA < 3 366163 169000
11/07/2005 HCH GAMMA < 4 366163 169000
16/08/2005 HCH TOTAL (ALPHA, BETA & GAMMA) < 6.4 366163 169000
14/06/2005 HCH TOTAL (ALPHA, BETA & GAMMA) < 9 366163 169000
11/07/2005 HCH TOTAL (ALPHA, BETA & GAMMA) < 12 366163 169000
17/03/2004 HEXACHLOROBENZENE < 1 366163 169000
17/06/2004 HEXACHLOROBENZENE < 1 366163 169000
12/08/2004 HEXACHLOROBENZENE < 1 366163 169000
15/02/2005 HEXACHLOROBENZENE < 1 366163 169000
17/03/2005 HEXACHLOROBENZENE < 1 366163 169000
13/05/2005 HEXACHLOROBENZENE < 1 366163 169000
14/06/2005 HEXACHLOROBENZENE < 1 366163 169000
16/08/2005 HEXACHLOROBENZENE < 1 366163 169000
11/07/2005 HEXACHLOROBENZENE < 2 366163 169000
17/03/2004 ISODRIN < 1 366163 169000
17/06/2004 ISODRIN < 1 366163 169000
12/08/2004 ISODRIN < 1 366163 169000
15/02/2005 ISODRIN < 1 366163 169000
17/03/2005 ISODRIN < 1 366163 169000
14/04/2005 ISODRIN < 1 366163 169000
13/05/2005 ISODRIN < 1 366163 169000
14/06/2005 ISODRIN < 1 366163 169000
16/08/2005 ISODRIN < 1 366163 169000
11/07/2005 ISODRIN < 2 366163 169000
10/02/2004 LINURON < 50 366163 169000
17/03/2004 LINURON < 50 366163 169000
15/04/2004 LINURON < 50 366163 169000
13/05/2004 LINURON < 50 366163 169000
17/06/2004 LINURON < 50 366163 169000
15/07/2004 LINURON < 50 366163 169000
10/02/2004 MALATHION < 2 366163 169000
17/03/2004 MALATHION < 2 366163 169000
15/04/2004 MALATHION < 2 366163 169000
13/05/2004 MALATHION < 2 366163 169000
17/06/2004 MALATHION < 2 366163 169000
15/07/2004 MALATHION < 2 366163 169000
12/08/2004 MALATHION < 2 366163 169000
15/02/2005 MALATHION < 2 366163 169000
17/03/2005 MALATHION < 2 366163 169000
14/04/2005 MALATHION < 2 366163 169000
13/05/2005 MALATHION < 2 366163 169000
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14/06/2005 MALATHION < 2 366163 169000
11/07/2005 MALATHION < 2 366163 169000
16/08/2005 MALATHION < 2 366163 169000
10/02/2004 MCPA < 40 366163 169000
17/03/2004 MCPA < 40 366163 169000
17/06/2004 MCPA < 40 366163 169000
15/04/2004 MCPA < 50 366163 169000
13/05/2004 MCPA  80 366163 169000
15/08/2005 MCPA < 25 347815 195172
13/06/2005 MCPA < 25 347815 195172
25/07/2005 MCPA < 25 347815 195172
19/09/2005 MCPA < 25 347815 195172
10/10/2005 MCPA < 40 347815 195172
24/05/2005 MCPA < 25 347815 195172
12/12/2005 MCPA < 40 347815 195172
17/10/2005 MCPA < 40 347815 195172
07/11/2005 MCPA < 40 347815 195172
25/07/2005 MCPB < 100 347815 195172
13/06/2005 MCPB < 100 347815 195172
15/08/2005 MCPB < 100 347815 195172
19/09/2005 MCPB < 100 347815 195172
10/10/2005 MCPB < 60 347815 195172
21/02/2005 MCPB < 100 347815 195172
18/01/2005 MCPB < 100 347815 195172
24/05/2005 MCPB < 100 347815 195172
21/03/2005 MCPB < 100 347815 195172
18/04/2005 MCPB < 100 347815 195172
12/12/2005 MCPB < 60 347815 195172
17/10/2005 MCPB < 60 347815 195172
07/11/2005 MCPB < 60 347815 195172
21/09/2004 MCPB < 100 347820 195220
11/10/2004 MCPB < 100 347820 195220
19/07/2004 MCPB < 100 347820 195220
17/08/2004 MCPB < 100 347820 195220
08/11/2004 MCPB < 100 347820 195220
22/11/2004 MCPB < 100 347820 195220
25/10/2004 MCPB < 100 347820 195220
24/02/2004 MCPB < 100 347820 195220
09/03/2004 MCPB < 100 347820 195220
20/01/2004 MCPB < 100 347820 195220
21/06/2004 MCPB < 100 347820 195220
13/04/2004 MCPB < 100 347820 195220
18/05/2004 MCPB < 100 347820 195220
10/02/2004 MECOPROP < 40 366163 169000
13/05/2004 MECOPROP < 40 366163 169000
17/06/2004 MECOPROP < 40 366163 169000
15/04/2004 MECOPROP < 50 366163 169000
17/03/2004 MECOPROP  80 366163 169000
25/07/2005 MECOPROP < 25 347815 195172
13/06/2005 MECOPROP < 25 347815 195172
19/09/2005 MECOPROP < 25 347815 195172
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10/10/2005 MECOPROP < 40 347815 195172
15/08/2005 MECOPROP < 25 347815 195172
21/02/2005 MECOPROP < 25 347815 195172
18/01/2005 MECOPROP < 25 347815 195172
24/05/2005 MECOPROP < 25 347815 195172
21/03/2005 MECOPROP < 25 347815 195172
18/04/2005 MECOPROP  1025 347815 195172
12/12/2005 MECOPROP < 40 347815 195172
07/11/2005 MECOPROP < 40 347815 195172
17/10/2005 MECOPROP < 40 347815 195172
21/09/2004 MECOPROP < 25 347820 195220
11/10/2004 MECOPROP < 25 347820 195220
19/07/2004 MECOPROP < 25 347820 195220
17/08/2004 MECOPROP < 25 347820 195220
08/11/2004 MECOPROP < 25 347820 195220
22/11/2004 MECOPROP < 25 347820 195220
25/10/2004 MECOPROP < 25 347820 195220
24/02/2004 MECOPROP < 25 347820 195220
09/03/2004 MECOPROP < 25 347820 195220
20/01/2004 MECOPROP < 25 347820 195220
21/06/2004 MECOPROP < 25 347820 195220
13/04/2004 MECOPROP < 25 347820 195220
18/05/2004 MECOPROP < 25 347820 195220
10/02/2004 MEVINPHOS < 2 366163 169000
17/03/2004 MEVINPHOS < 2 366163 169000
15/04/2004 MEVINPHOS < 8 366163 169000
13/05/2004 MEVINPHOS < 8 366163 169000
17/06/2004 MEVINPHOS < 8 366163 169000
15/07/2004 MEVINPHOS < 8 366163 169000
10/02/2004 PARATHION {PARATHION ETHYL} < 4 366163 169000
17/03/2004 PARATHION {PARATHION ETHYL} < 4 366163 169000
15/04/2004 PARATHION {PARATHION ETHYL} < 4 366163 169000
13/05/2004 PARATHION {PARATHION ETHYL} < 4 366163 169000
17/06/2004 PARATHION {PARATHION ETHYL} < 4 366163 169000
15/07/2004 PARATHION {PARATHION ETHYL} < 4 366163 169000
12/08/2004 PARATHION {PARATHION ETHYL} < 4 366163 169000
15/02/2005 PARATHION {PARATHION ETHYL} < 4 366163 169000
17/03/2005 PARATHION {PARATHION ETHYL} < 4 366163 169000
14/04/2005 PARATHION {PARATHION ETHYL} < 4 366163 169000
14/06/2005 PARATHION {PARATHION ETHYL} < 4 366163 169000
11/07/2005 PARATHION {PARATHION ETHYL} < 4 366163 169000
16/08/2005 PARATHION {PARATHION ETHYL} < 4 366163 169000
13/05/2005 PARATHION {PARATHION ETHYL} < 5 366163 169000
25/07/2005 PARATHION {PARATHION ETHYL} < 5 347815 195172
13/06/2005 PARATHION {PARATHION ETHYL} < 5 347815 195172
18/04/2005 PARATHION {PARATHION ETHYL} < 5 347815 195172
19/09/2005 PARATHION {PARATHION ETHYL} < 5 347815 195172
15/08/2005 PARATHION {PARATHION ETHYL} < 5 347815 195172
10/10/2005 PARATHION {PARATHION ETHYL} < 5 347815 195172
21/02/2005 PARATHION {PARATHION ETHYL} < 5 347815 195172
18/01/2005 PARATHION {PARATHION ETHYL} < 5 347815 195172
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24/05/2005 PARATHION {PARATHION ETHYL} < 5 347815 195172
21/03/2005 PARATHION {PARATHION ETHYL} < 5 347815 195172
07/11/2005 PARATHION {PARATHION ETHYL} < 5 347815 195172
17/10/2005 PARATHION {PARATHION ETHYL} < 5 347815 195172
12/12/2005 PARATHION {PARATHION ETHYL} < 5 347815 195172
21/09/2004 PARATHION {PARATHION ETHYL} < 5 347820 195220
11/10/2004 PARATHION {PARATHION ETHYL} < 5 347820 195220
19/07/2004 PARATHION {PARATHION ETHYL} < 5 347820 195220
17/08/2004 PARATHION {PARATHION ETHYL} < 5 347820 195220
08/11/2004 PARATHION {PARATHION ETHYL} < 5 347820 195220
22/11/2004 PARATHION {PARATHION ETHYL} < 5 347820 195220
25/10/2004 PARATHION {PARATHION ETHYL} < 5 347820 195220
24/02/2004 PARATHION {PARATHION ETHYL} < 5 347820 195220
09/03/2004 PARATHION {PARATHION ETHYL} < 5 347820 195220
20/01/2004 PARATHION {PARATHION ETHYL} < 5 347820 195220
21/06/2004 PARATHION {PARATHION ETHYL} < 5 347820 195220
13/04/2004 PARATHION {PARATHION ETHYL} < 5 347820 195220
18/05/2004 PARATHION {PARATHION ETHYL} < 5 347820 195220
10/02/2004 PARATHION-METHYL < 3 366163 169000
17/03/2004 PARATHION-METHYL < 3 366163 169000
15/04/2004 PARATHION-METHYL < 3 366163 169000
13/05/2004 PARATHION-METHYL < 3 366163 169000
17/06/2004 PARATHION-METHYL < 3 366163 169000
15/07/2004 PARATHION-METHYL < 3 366163 169000
12/08/2004 PARATHION-METHYL < 3 366163 169000
15/02/2005 PARATHION-METHYL < 3 366163 169000
17/03/2005 PARATHION-METHYL < 3 366163 169000
14/04/2005 PARATHION-METHYL < 3 366163 169000
13/05/2005 PARATHION-METHYL < 3 366163 169000
14/06/2005 PARATHION-METHYL < 3 366163 169000
11/07/2005 PARATHION-METHYL < 3 366163 169000
16/08/2005 PARATHION-METHYL < 3 366163 169000
17/03/2004 PCSD'S (CHLORPHENYLID) < 2 366163 169000
17/06/2004 PCSD'S (CHLORPHENYLID) < 2 366163 169000
12/08/2004 PCSD'S (CHLORPHENYLID) < 4 366163 169000
17/03/2005 PENTACHLOROPHENOL < 20 366163 169000
14/04/2005 PENTACHLOROPHENOL < 20 366163 169000
13/05/2005 PENTACHLOROPHENOL < 20 366163 169000
14/06/2005 PENTACHLOROPHENOL < 20 366163 169000
11/07/2005 PENTACHLOROPHENOL < 20 366163 169000
17/03/2004 PENTACHLOROPHENOL < 40 366163 169000
17/06/2004 PENTACHLOROPHENOL < 40 366163 169000
12/08/2004 PENTACHLOROPHENOL < 40 366163 169000
16/08/2005 PENTACHLOROPHENOL < 125 366163 169000
17/03/2004 PERMETHRIN, CIS < 1 366163 169000
17/06/2004 PERMETHRIN, CIS < 1 366163 169000
12/08/2004 PERMETHRIN, CIS < 1 366163 169000
17/03/2005 PERMETHRIN, CIS < 2 366163 169000
17/03/2004 PERMETHRIN, TRANS < 1 366163 169000
17/06/2004 PERMETHRIN, TRANS < 1 366163 169000
12/08/2004 PERMETHRIN, TRANS < 1 366163 169000
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17/03/2005 PERMETHRIN, TRANS < 2 366163 169000
25/07/2005 PROCHLORAZ < 29 347815 195172
13/06/2005 PROCHLORAZ < 29 347815 195172
19/09/2005 PROCHLORAZ < 29 347815 195172
15/08/2005 PROCHLORAZ < 29 347815 195172
10/10/2005 PROCHLORAZ < 29 347815 195172
21/02/2005 PROCHLORAZ < 29 347815 195172
18/01/2005 PROCHLORAZ < 29 347815 195172
24/05/2005 PROCHLORAZ < 29 347815 195172
21/03/2005 PROCHLORAZ < 29 347815 195172
18/04/2005 PROCHLORAZ < 29 347815 195172
07/11/2005 PROCHLORAZ < 29 347815 195172
12/12/2005 PROCHLORAZ < 29 347815 195172
17/10/2005 PROCHLORAZ < 29 347815 195172
21/09/2004 PROCHLORAZ < 29 347820 195220
19/07/2004 PROCHLORAZ < 29 347820 195220
11/10/2004 PROCHLORAZ < 29 347820 195220
17/08/2004 PROCHLORAZ < 29 347820 195220
08/11/2004 PROCHLORAZ < 29 347820 195220
22/11/2004 PROCHLORAZ < 29 347820 195220
25/10/2004 PROCHLORAZ < 29 347820 195220
24/02/2004 PROCHLORAZ < 29 347820 195220
09/03/2004 PROCHLORAZ < 29 347820 195220
20/01/2004 PROCHLORAZ < 29 347820 195220
21/06/2004 PROCHLORAZ < 29 347820 195220
13/04/2004 PROCHLORAZ < 29 347820 195220
18/05/2004 PROCHLORAZ < 29 347820 195220
25/07/2005 PROPETAMPHOS < 1 347815 195172
13/06/2005 PROPETAMPHOS < 1 347815 195172
19/09/2005 PROPETAMPHOS < 1 347815 195172
15/08/2005 PROPETAMPHOS < 1 347815 195172
10/10/2005 PROPETAMPHOS < 1 347815 195172
18/04/2005 PROPETAMPHOS < 1 347815 195172
21/02/2005 PROPETAMPHOS < 1 347815 195172
18/01/2005 PROPETAMPHOS < 1 347815 195172
24/05/2005 PROPETAMPHOS < 1 347815 195172
21/03/2005 PROPETAMPHOS < 1 347815 195172
07/11/2005 PROPETAMPHOS < 1 347815 195172
12/12/2005 PROPETAMPHOS < 1 347815 195172
17/10/2005 PROPETAMPHOS < 1 347815 195172
21/09/2004 PROPETAMPHOS < 1 347820 195220
19/07/2004 PROPETAMPHOS < 1 347820 195220
17/08/2004 PROPETAMPHOS < 1 347820 195220
08/11/2004 PROPETAMPHOS < 1 347820 195220
22/11/2004 PROPETAMPHOS < 1 347820 195220
11/10/2004 PROPETAMPHOS < 1 347820 195220
25/10/2004 PROPETAMPHOS < 1 347820 195220
09/03/2004 PROPETAMPHOS < 1 347820 195220
20/01/2004 PROPETAMPHOS < 1 347820 195220
24/02/2004 PROPETAMPHOS < 1 347820 195220
21/06/2004 PROPETAMPHOS < 1 347820 195220
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13/04/2004 PROPETAMPHOS < 1 347820 195220
18/05/2004 PROPETAMPHOS < 1 347820 195220
25/07/2005 PROPICONAZOLE < 10 347815 195172
13/06/2005 PROPICONAZOLE < 10 347815 195172
19/09/2005 PROPICONAZOLE < 10 347815 195172
15/08/2005 PROPICONAZOLE < 10 347815 195172
10/10/2005 PROPICONAZOLE < 10 347815 195172
21/02/2005 PROPICONAZOLE < 10 347815 195172
18/01/2005 PROPICONAZOLE < 10 347815 195172
24/05/2005 PROPICONAZOLE < 10 347815 195172
21/03/2005 PROPICONAZOLE < 10 347815 195172
18/04/2005 PROPICONAZOLE < 10 347815 195172
07/11/2005 PROPICONAZOLE < 10 347815 195172
12/12/2005 PROPICONAZOLE < 10 347815 195172
17/10/2005 PROPICONAZOLE < 10 347815 195172
21/09/2004 PROPICONAZOLE < 10 347820 195220
19/07/2004 PROPICONAZOLE < 10 347820 195220
17/08/2004 PROPICONAZOLE < 10 347820 195220
08/11/2004 PROPICONAZOLE < 10 347820 195220
22/11/2004 PROPICONAZOLE < 10 347820 195220
11/10/2004 PROPICONAZOLE < 10 347820 195220
25/10/2004 PROPICONAZOLE < 10 347820 195220
24/02/2004 PROPICONAZOLE < 10 347820 195220
09/03/2004 PROPICONAZOLE < 10 347820 195220
20/01/2004 PROPICONAZOLE < 10 347820 195220
18/05/2004 PROPICONAZOLE < 10 347820 195220
21/06/2004 PROPICONAZOLE < 10 347820 195220
13/04/2004 PROPICONAZOLE < 10 347820 195220
15/07/2004 SIMAZINE < 3 366163 169000
17/03/2005 SIMAZINE < 3 366163 169000
15/04/2004 SIMAZINE  10 366163 169000
17/06/2004 SIMAZINE  10 366163 169000
10/02/2004 SIMAZINE  11 366163 169000
11/07/2005 SIMAZINE  12 366163 169000
13/05/2004 SIMAZINE  13 366163 169000
14/06/2005 SIMAZINE  14 366163 169000
12/08/2004 SIMAZINE  19 366163 169000
15/02/2005 SIMAZINE  23 366163 169000
13/05/2005 SIMAZINE  23 366163 169000
17/03/2004 SIMAZINE  31 366163 169000
16/08/2005 SIMAZINE  32 366163 169000
14/04/2005 SIMAZINE  59 366163 169000
25/07/2005 SIMAZINE < 10 347815 195172
13/06/2005 SIMAZINE < 10 347815 195172
19/09/2005 SIMAZINE < 10 347815 195172
15/08/2005 SIMAZINE < 10 347815 195172
21/02/2005 SIMAZINE < 10 347815 195172
18/01/2005 SIMAZINE < 10 347815 195172
18/04/2005 SIMAZINE  35.3 347815 195172
24/05/2005 SIMAZINE < 10 347815 195172
21/03/2005 SIMAZINE < 10 347815 195172
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07/11/2005 SIMAZINE < 10 347815 195172
12/12/2005 SIMAZINE < 10 347815 195172
10/10/2005 SIMAZINE < 10 347815 195172
17/10/2005 SIMAZINE < 10 347815 195172
21/09/2004 SIMAZINE < 10 347820 195220
19/07/2004 SIMAZINE < 10 347820 195220
17/08/2004 SIMAZINE < 10 347820 195220
08/11/2004 SIMAZINE < 10 347820 195220
22/11/2004 SIMAZINE < 10 347820 195220
11/10/2004 SIMAZINE < 10 347820 195220
25/10/2004 SIMAZINE < 10 347820 195220
09/03/2004 SIMAZINE < 10 347820 195220
24/02/2004 SIMAZINE < 10 347820 195220
20/01/2004 SIMAZINE < 10 347820 195220
18/05/2004 SIMAZINE < 10 347820 195220
21/06/2004 SIMAZINE < 10 347820 195220
13/04/2004 SIMAZINE < 10 347820 195220
10/02/2004 SULCOFURON < 2500 366163 169000
17/03/2004 SULCOFURON < 2500 366163 169000
15/04/2004 SULCOFURON < 2500 366163 169000
13/05/2004 SULCOFURON < 2500 366163 169000
17/06/2004 SULCOFURON < 2500 366163 169000
15/07/2004 SULCOFURON < 2500 366163 169000
12/08/2004 SULCOFURON < 2500 366163 169000
17/03/2005 SULCOFURON < 2500 366163 169000
17/03/2004 TDE (PP) < 1 366163 169000
17/06/2004 TDE (PP) < 1 366163 169000
12/08/2004 TDE (PP) < 1 366163 169000
15/02/2005 TDE (PP) < 1 366163 169000
17/03/2005 TDE (PP) < 1 366163 169000
14/04/2005 TDE (PP) < 1 366163 169000
13/05/2005 TDE (PP) < 1 366163 169000
14/06/2005 TDE (PP) < 1 366163 169000
16/08/2005 TDE (PP) < 1 366163 169000
11/07/2005 TDE (PP) < 2 366163 169000
25/07/2005 TERBUTRYN < 2 347815 195172
13/06/2005 TERBUTRYN < 2 347815 195172
19/09/2005 TERBUTRYN < 2 347815 195172
15/08/2005 TERBUTRYN < 2 347815 195172
10/10/2005 TERBUTRYN < 2 347815 195172
21/02/2005 TERBUTRYN < 2 347815 195172
18/01/2005 TERBUTRYN < 2 347815 195172
24/05/2005 TERBUTRYN < 2 347815 195172
21/03/2005 TERBUTRYN < 2 347815 195172
18/04/2005 TERBUTRYN < 2 347815 195172
07/11/2005 TERBUTRYN < 2 347815 195172
12/12/2005 TERBUTRYN < 2 347815 195172
17/10/2005 TERBUTRYN < 2 347815 195172
21/09/2004 TERBUTRYN < 2 347820 195220
19/07/2004 TERBUTRYN < 2 347820 195220
17/08/2004 TERBUTRYN < 2 347820 195220
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08/11/2004 TERBUTRYN < 2 347820 195220
22/11/2004 TERBUTRYN < 2 347820 195220
11/10/2004 TERBUTRYN < 2 347820 195220
25/10/2004 TERBUTRYN < 2 347820 195220
24/02/2004 TERBUTRYN < 2 347820 195220
09/03/2004 TERBUTRYN < 2 347820 195220
20/01/2004 TERBUTRYN < 2 347820 195220
18/05/2004 TERBUTRYN < 2 347820 195220
21/06/2004 TERBUTRYN < 2 347820 195220
13/04/2004 TERBUTRYN < 2 347820 195220
10/02/2004 TRIAZOPHOS < 4 366163 169000
17/03/2004 TRIAZOPHOS < 4 366163 169000
13/05/2004 TRIAZOPHOS < 4 366163 169000
17/06/2004 TRIAZOPHOS < 4 366163 169000
15/07/2004 TRIAZOPHOS < 4 366163 169000
10/02/2004 TRIBUTYL TIN < 2 366163 169000
17/03/2004 TRIBUTYL TIN < 2 366163 169000
15/04/2004 TRIBUTYL TIN < 2 366163 169000
13/05/2004 TRIBUTYL TIN < 2 366163 169000
17/06/2004 TRIBUTYL TIN < 2 366163 169000
15/07/2004 TRIBUTYL TIN < 2 366163 169000
10/02/2004 TRIFLURALIN < 11 366163 169000
17/03/2004 TRIFLURALIN < 11 366163 169000
15/04/2004 TRIFLURALIN < 11 366163 169000
17/06/2004 TRIFLURALIN < 11 366163 169000
15/07/2004 TRIFLURALIN < 11 366163 169000
12/08/2004 TRIFLURALIN < 11 366163 169000
15/02/2005 TRIFLURALIN < 11 366163 169000
14/04/2005 TRIFLURALIN < 11 366163 169000
13/05/2005 TRIFLURALIN < 11 366163 169000
17/03/2005 TRIFLURALIN < 12 366163 169000
16/08/2005 TRIFLURALIN < 13 366163 169000
14/06/2005 TRIFLURALIN < 14 366163 169000
11/07/2005 TRIFLURALIN < 21 366163 169000
13/05/2004 TRIFLURALIN < 114 366163 169000
2.2 Pant-y-Llyn:
• Co-ordinates: x,y = 260654,216617
Date Pesticide
Less 
than
Conc. 
(ng/L) x y
15/03/2005 TRIAZOPHOS < 1 261461 208764
14/06/2005
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 261461 208764
15/03/2005
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 261461 208764
06/12/2005
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 261461 208764
13/09/2005 (2,4-DICHLOROPHENOXY)ETHANOIC < 50 261461 208764
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ACID
15/06/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 261461 208764
09/03/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 261461 208764
17/02/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 261461 208764
11/05/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 261461 208764
13/01/2004
(2,4-DICHLOROPHENOXY)ETHANOIC 
ACID < 50 261461 208764
24/05/2005 ALDRIN < 2.5 261461 208764
14/04/2005 ALDRIN < 2.5 261461 208764
14/06/2005 ALDRIN < 2.5 261461 208764
11/01/2005 ALDRIN < 2.5 261461 208764
15/02/2005 ALDRIN < 2.5 261461 208764
15/03/2005 ALDRIN < 2.5 261461 208764
08/11/2005 ALDRIN < 2.5 261461 208764
11/10/2005 ALDRIN < 2.5 261461 208764
06/12/2005 ALDRIN < 2.5 261461 208764
09/08/2005 ALDRIN < 2.5 261461 208764
12/07/2005 ALDRIN < 2.5 261461 208764
13/09/2005 ALDRIN < 2.5 261461 208764
10/08/2004 ALDRIN < 2.5 261461 208764
13/07/2004 ALDRIN < 2.5 261461 208764
15/06/2004 ALDRIN < 2.5 261461 208764
17/02/2004 ALDRIN < 2.5 261461 208764
09/03/2004 ALDRIN < 2.5 261461 208764
13/01/2004 ALDRIN < 2.5 261461 208764
11/05/2004 ALDRIN < 2.5 261461 208764
15/04/2004 ALDRIN < 2.5 261461 208764
14/06/2005 ATRAZINE < 10 261461 208764
15/03/2005 ATRAZINE < 10 261461 208764
06/12/2005 ATRAZINE < 10 261461 208764
13/09/2005 ATRAZINE < 10 261461 208764
15/06/2004 ATRAZINE < 10 261461 208764
17/02/2004 ATRAZINE < 10 261461 208764
13/01/2004 ATRAZINE < 10 261461 208764
09/03/2004 ATRAZINE < 10 261461 208764
11/05/2004 ATRAZINE < 10 261461 208764
15/04/2004 ATRAZINE < 10 261461 208764
14/06/2005 AZINPHOS-METHYL < 1 261461 208764
15/03/2005 AZINPHOS-METHYL < 1 261461 208764
06/12/2005 AZINPHOS-METHYL < 1 261461 208764
13/09/2005 AZINPHOS-METHYL < 1 261461 208764
15/06/2004 AZINPHOS-METHYL < 1 261461 208764
09/03/2004 AZINPHOS-METHYL < 1 261461 208764
17/02/2004 AZINPHOS-METHYL < 1 261461 208764
13/01/2004 AZINPHOS-METHYL < 1 261461 208764
11/05/2004 AZINPHOS-METHYL < 1 261461 208764
15/04/2004 AZINPHOS-METHYL < 1 261461 208764
06/12/2005 BENTAZONE < 40 261461 208764
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14/06/2005 BENTAZONE < 100 261461 208764
15/03/2005 BENTAZONE < 100 261461 208764
13/09/2005 BENTAZONE < 100 261461 208764
15/06/2004 BENTAZONE < 100 261461 208764
17/02/2004 BENTAZONE < 100 261461 208764
13/01/2004 BENTAZONE < 100 261461 208764
11/05/2004 BENTAZONE < 100 261461 208764
14/04/2005 DDE (PP) < 1.5 261461 208764
24/05/2005 DDE (PP) < 1.5 261461 208764
14/06/2005 DDE (PP) < 1.5 261461 208764
15/02/2005 DDE (PP) < 1.5 261461 208764
11/01/2005 DDE (PP) < 1.5 261461 208764
15/03/2005 DDE (PP) < 1.5 261461 208764
08/11/2005 DDE (PP) < 1.5 261461 208764
11/10/2005 DDE (PP) < 1.5 261461 208764
06/12/2005 DDE (PP) < 1.5 261461 208764
09/08/2005 DDE (PP) < 1.5 261461 208764
12/07/2005 DDE (PP) < 1.5 261461 208764
13/09/2005 DDE (PP) < 1.5 261461 208764
13/07/2004 DDE (PP) < 1.5 261461 208764
10/08/2004 DDE (PP) < 1.5 261461 208764
15/06/2004 DDE (PP) < 1.5 261461 208764
17/02/2004 DDE (PP) < 1.5 261461 208764
13/01/2004 DDE (PP) < 1.5 261461 208764
11/05/2004 DDE (PP) < 1.5 261461 208764
09/03/2004 DDE (PP) < 1.5 261461 208764
15/04/2004 DDE (PP) < 1.5 261461 208764
24/05/2005 DDT (PP) < 1 261461 208764
14/04/2005 DDT (PP) < 1 261461 208764
14/06/2005 DDT (PP) < 1 261461 208764
15/02/2005 DDT (PP) < 1 261461 208764
11/01/2005 DDT (PP) < 1 261461 208764
15/03/2005 DDT (PP) < 1 261461 208764
08/11/2005 DDT (PP) < 1 261461 208764
11/10/2005 DDT (PP) < 1 261461 208764
06/12/2005 DDT (PP) < 1 261461 208764
09/08/2005 DDT (PP) < 1 261461 208764
12/07/2005 DDT (PP) < 1 261461 208764
13/09/2005 DDT (PP) < 1 261461 208764
13/07/2004 DDT (PP) < 1 261461 208764
10/08/2004 DDT (PP) < 1 261461 208764
15/06/2004 DDT (PP) < 1 261461 208764
17/02/2004 DDT (PP) < 1 261461 208764
13/01/2004 DDT (PP) < 1 261461 208764
11/05/2004 DDT (PP) < 1 261461 208764
09/03/2004 DDT (PP) < 1 261461 208764
15/04/2004 DDT (PP) < 1 261461 208764
14/06/2005 DICHLORVOS < 1 261461 208764
15/03/2005 DICHLORVOS < 1 261461 208764
06/12/2005 DICHLORVOS < 1 261461 208764
13/09/2005 DICHLORVOS < 1 261461 208764
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15/06/2004 DICHLORVOS < 1 261461 208764
17/02/2004 DICHLORVOS < 1 261461 208764
13/01/2004 DICHLORVOS < 1 261461 208764
11/05/2004 DICHLORVOS < 1 261461 208764
15/04/2004 DICHLORVOS < 1 261461 208764
09/03/2004 DICHLORVOS < 1 261461 208764
24/05/2005 DIELDRIN < 2.5 261461 208764
14/04/2005 DIELDRIN < 2.5 261461 208764
14/06/2005 DIELDRIN < 2.5 261461 208764
15/02/2005 DIELDRIN < 2.5 261461 208764
11/01/2005 DIELDRIN < 2.5 261461 208764
15/03/2005 DIELDRIN < 2.5 261461 208764
08/11/2005 DIELDRIN < 2.5 261461 208764
11/10/2005 DIELDRIN < 2.5 261461 208764
06/12/2005 DIELDRIN < 2.5 261461 208764
09/08/2005 DIELDRIN < 2.5 261461 208764
12/07/2005 DIELDRIN < 2.5 261461 208764
13/09/2005 DIELDRIN < 2.5 261461 208764
13/07/2004 DIELDRIN < 2.5 261461 208764
10/08/2004 DIELDRIN < 2.5 261461 208764
15/06/2004 DIELDRIN < 2.5 261461 208764
17/02/2004 DIELDRIN < 2.5 261461 208764
13/01/2004 DIELDRIN < 2.5 261461 208764
15/04/2004 DIELDRIN < 2.5 261461 208764
11/05/2004 DIELDRIN < 2.5 261461 208764
09/03/2004 DIELDRIN < 2.5 261461 208764
14/06/2005 DIMETHOATE < 5 261461 208764
15/03/2005 DIMETHOATE < 5 261461 208764
06/12/2005 DIMETHOATE < 5 261461 208764
13/09/2005 DIMETHOATE < 5 261461 208764
15/06/2004 DIMETHOATE < 5 261461 208764
17/02/2004 DIMETHOATE < 5 261461 208764
13/01/2004 DIMETHOATE < 5 261461 208764
11/05/2004 DIMETHOATE < 5 261461 208764
15/04/2004 DIMETHOATE < 5 261461 208764
09/03/2004 DIMETHOATE < 5 261461 208764
14/06/2005 ENDOSULPHAN ALPHA < 1 261461 208764
15/03/2005 ENDOSULPHAN ALPHA < 1 261461 208764
06/12/2005 ENDOSULPHAN ALPHA < 1 261461 208764
13/09/2005 ENDOSULPHAN ALPHA < 1 261461 208764
15/06/2004 ENDOSULPHAN ALPHA < 1 261461 208764
17/02/2004 ENDOSULPHAN ALPHA < 1 261461 208764
13/01/2004 ENDOSULPHAN ALPHA < 1 261461 208764
15/04/2004 ENDOSULPHAN ALPHA < 1 261461 208764
11/05/2004 ENDOSULPHAN ALPHA < 1 261461 208764
09/03/2004 ENDOSULPHAN ALPHA < 1 261461 208764
14/06/2005 ENDOSULPHAN BETA < 1 261461 208764
15/03/2005 ENDOSULPHAN BETA < 1 261461 208764
06/12/2005 ENDOSULPHAN BETA < 1 261461 208764
13/09/2005 ENDOSULPHAN BETA < 1 261461 208764
15/06/2004 ENDOSULPHAN BETA < 1 261461 208764
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17/02/2004 ENDOSULPHAN BETA < 1 261461 208764
15/04/2004 ENDOSULPHAN BETA < 1 261461 208764
11/05/2004 ENDOSULPHAN BETA < 1 261461 208764
09/03/2004 ENDOSULPHAN BETA < 1 261461 208764
24/05/2005 ENDRIN < 2.5 261461 208764
14/04/2005 ENDRIN < 2.5 261461 208764
14/06/2005 ENDRIN < 2.5 261461 208764
15/02/2005 ENDRIN < 2.5 261461 208764
11/01/2005 ENDRIN < 2.5 261461 208764
15/03/2005 ENDRIN < 2.5 261461 208764
08/11/2005 ENDRIN < 2.5 261461 208764
11/10/2005 ENDRIN < 2.5 261461 208764
06/12/2005 ENDRIN < 2.5 261461 208764
09/08/2005 ENDRIN < 2.5 261461 208764
12/07/2005 ENDRIN < 2.5 261461 208764
13/09/2005 ENDRIN < 2.5 261461 208764
13/07/2004 ENDRIN < 2.5 261461 208764
10/08/2004 ENDRIN < 2.5 261461 208764
15/06/2004 ENDRIN < 2.5 261461 208764
17/02/2004 ENDRIN < 2.5 261461 208764
15/04/2004 ENDRIN < 2.5 261461 208764
11/05/2004 ENDRIN < 2.5 261461 208764
09/03/2004 ENDRIN < 2.5 261461 208764
14/06/2005 FENITROTHION < 1 261461 208764
15/03/2005 FENITROTHION < 1 261461 208764
06/12/2005 FENITROTHION < 1 261461 208764
13/09/2005 FENITROTHION < 1 261461 208764
15/06/2004 FENITROTHION < 1 261461 208764
17/02/2004 FENITROTHION < 1 261461 208764
15/04/2004 FENITROTHION < 1 261461 208764
11/05/2004 FENITROTHION < 1 261461 208764
09/03/2004 FENITROTHION < 1 261461 208764
24/05/2005 HCH GAMMA < 1 261461 208764
14/04/2005 HCH GAMMA < 1 261461 208764
14/06/2005 HCH GAMMA < 1 261461 208764
15/02/2005 HCH GAMMA < 1 261461 208764
11/01/2005 HCH GAMMA < 1 261461 208764
15/03/2005 HCH GAMMA < 1 261461 208764
08/11/2005 HCH GAMMA < 1 261461 208764
11/10/2005 HCH GAMMA < 1 261461 208764
06/12/2005 HCH GAMMA < 1 261461 208764
09/08/2005 HCH GAMMA < 1 261461 208764
12/07/2005 HCH GAMMA < 1 261461 208764
13/09/2005 HCH GAMMA < 1 261461 208764
13/07/2004 HCH GAMMA < 1 261461 208764
10/08/2004 HCH GAMMA < 1 261461 208764
15/06/2004 HCH GAMMA < 1 261461 208764
17/02/2004 HCH GAMMA < 1 261461 208764
15/04/2004 HCH GAMMA < 1 261461 208764
09/03/2004 HCH GAMMA < 1 261461 208764
15/03/2005 LINURON < 20 261461 208764
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06/12/2005 LINURON < 20 261461 208764
15/06/2004 LINURON < 20 261461 208764
17/02/2004 LINURON < 20 261461 208764
11/05/2004 LINURON < 20 261461 208764
15/04/2004 LINURON < 20 261461 208764
09/03/2004 LINURON < 20 261461 208764
14/06/2005 LINURON < 23 261461 208764
13/09/2005 LINURON < 24 261461 208764
14/06/2005 MALATHION < 5 261461 208764
15/03/2005 MALATHION < 5 261461 208764
06/12/2005 MALATHION < 5 261461 208764
13/09/2005 MALATHION < 5 261461 208764
11/05/2004 MALATHION < 5 261461 208764
15/06/2004 MALATHION < 5 261461 208764
17/02/2004 MALATHION < 5 261461 208764
15/04/2004 MALATHION < 5 261461 208764
09/03/2004 MALATHION < 5 261461 208764
14/06/2005 MECOPROP < 25 261461 208764
15/03/2005 MECOPROP < 25 261461 208764
13/09/2005 MECOPROP < 25 261461 208764
11/05/2004 MECOPROP < 25 261461 208764
15/06/2004 MECOPROP < 25 261461 208764
17/02/2004 MECOPROP < 25 261461 208764
09/03/2004 MECOPROP < 25 261461 208764
06/12/2005 MECOPROP < 40 261461 208764
14/06/2005 MEVINPHOS < 1 261461 208764
15/03/2005 MEVINPHOS < 1 261461 208764
06/12/2005 MEVINPHOS < 1 261461 208764
13/09/2005 MEVINPHOS < 1 261461 208764
11/05/2004 MEVINPHOS < 1 261461 208764
15/06/2004 MEVINPHOS < 1 261461 208764
17/02/2004 MEVINPHOS < 1 261461 208764
15/04/2004 MEVINPHOS < 1 261461 208764
09/03/2004 MEVINPHOS < 1 261461 208764
11/05/2004 OMETHOATE < 10 261461 208764
15/06/2004 OMETHOATE < 10 261461 208764
17/02/2004 OMETHOATE < 10 261461 208764
15/04/2004 OMETHOATE < 10 261461 208764
09/03/2004 OMETHOATE < 10 261461 208764
15/03/2005 SIMAZINE < 10 261461 208764
14/06/2005 SIMAZINE < 10 261461 208764
06/12/2005 SIMAZINE < 10 261461 208764
13/09/2005 SIMAZINE < 10 261461 208764
15/06/2004 SIMAZINE < 10 261461 208764
11/05/2004 SIMAZINE < 10 261461 208764
17/02/2004 SIMAZINE < 10 261461 208764
15/04/2004 SIMAZINE < 10 261461 208764
09/03/2004 SIMAZINE < 10 261461 208764
14/04/2005 TDE (PP) < 1.5 261461 208764
24/05/2005 TDE (PP) < 1.5 261461 208764
15/02/2005 TDE (PP) < 1.5 261461 208764
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11/01/2005 TDE (PP) < 1.5 261461 208764
15/03/2005 TDE (PP) < 1.5 261461 208764
11/10/2005 TDE (PP) < 1.5 261461 208764
08/11/2005 TDE (PP) < 1.5 261461 208764
13/09/2005 TDE (PP) < 1.5 261461 208764
06/12/2005 TDE (PP) < 1.5 261461 208764
09/08/2005 TDE (PP) < 1.5 261461 208764
14/06/2005 TDE (PP) < 1.5 261461 208764
12/07/2005 TDE (PP) < 1.5 261461 208764
13/07/2004 TDE (PP) < 1.5 261461 208764
10/08/2004 TDE (PP) < 1.5 261461 208764
11/05/2004 TDE (PP) < 1.5 261461 208764
15/06/2004 TDE (PP) < 1.5 261461 208764
17/02/2004 TDE (PP) < 1.5 261461 208764
15/04/2004 TDE (PP) < 1.5 261461 208764
09/03/2004 TDE (PP) < 1.5 261461 208764
13/09/2005 TRIAZOPHOS < 1 261461 208764
06/12/2005 TRIAZOPHOS < 1 261461 208764
14/06/2005 TRIAZOPHOS < 1 261461 208764
15/06/2004 TRIAZOPHOS < 1 261461 208764
11/05/2004 TRIAZOPHOS < 1 261461 208764
17/02/2004 TRIAZOPHOS < 1 261461 208764
15/04/2004 TRIAZOPHOS < 1 261461 208764
09/03/2004 TRIAZOPHOS < 1 261461 208764
24/05/2005 TRIBUTYL TIN < 2 261461 208764
14/04/2005 TRIBUTYL TIN < 2 261461 208764
15/03/2005 TRIBUTYL TIN < 2 261461 208764
15/02/2005 TRIBUTYL TIN < 2 261461 208764
13/07/2004 TRIBUTYL TIN < 2 261461 208764
15/06/2004 TRIBUTYL TIN < 2 261461 208764
10/08/2004 TRIBUTYL TIN < 2 261461 208764
11/05/2004 TRIBUTYL TIN < 2 261461 208764
17/02/2004 TRIBUTYL TIN < 2 261461 208764
15/04/2004 TRIBUTYL TIN < 2 261461 208764
09/03/2004 TRIBUTYL TIN < 2 261461 208764
11/01/2005 TRIBUTYL TIN  3.2 261461 208764
15/03/2005 TRIFLURALIN < 5 261461 208764
13/09/2005 TRIFLURALIN < 5 261461 208764
06/12/2005 TRIFLURALIN < 5 261461 208764
14/06/2005 TRIFLURALIN < 5 261461 208764
15/06/2004 TRIFLURALIN < 5 261461 208764
11/05/2004 TRIFLURALIN < 5 261461 208764
17/02/2004 TRIFLURALIN < 5 261461 208764
13/01/2004 TRIFLURALIN < 5 261461 208764
15/04/2004 TRIFLURALIN < 5 261461 208764
09/03/2004 TRIFLURALIN < 5 261461 208764
14/04/2005 TRIPHENYLTIN COMPOUNDS < 2 261461 208764
15/03/2005 TRIPHENYLTIN COMPOUNDS < 2 261461 208764
24/05/2005 TRIPHENYLTIN COMPOUNDS < 2 261461 208764
11/01/2005 TRIPHENYLTIN COMPOUNDS < 2 261461 208764
15/02/2005 TRIPHENYLTIN COMPOUNDS < 2 261461 208764
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13/07/2004 TRIPHENYLTIN COMPOUNDS < 2 261461 208764
15/06/2004 TRIPHENYLTIN COMPOUNDS < 2 261461 208764
10/08/2004 TRIPHENYLTIN COMPOUNDS < 2 261461 208764
11/05/2004 TRIPHENYLTIN COMPOUNDS < 2 261461 208764
17/02/2004 TRIPHENYLTIN COMPOUNDS < 2 261461 208764
13/01/2004 TRIPHENYLTIN COMPOUNDS < 2 261461 208764
15/04/2004 TRIPHENYLTIN COMPOUNDS < 2 261461 208764
09/03/2004 TRIPHENYLTIN COMPOUNDS < 2 261461 208764
2.3 20’ River/Ibberson’s Pump:
• 20’ River co-ordinates: x,y = 532215, 297208
• Ibberson’s Pump co-ordinates: x,y = 535900, 288000
Date Pesticide
Less 
than
Conc. 
(ng/L) x y
04/03/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 50 539400 274700
14/04/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 50 539400 274700
12/05/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 50 539400 274700
04/06/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 50 539400 274700
11/08/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 50 539400 274700
14/04/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID 60 539400 274700
14/07/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 60 539400 274700
19/04/2004 2,3,5,6-TETRACHLOROAMINOBENZENE 
{2,...ANILINE}
< 1 539400 274700
14/07/2004 2,3,5,6-TETRACHLOROAMINOBENZENE 
{2,...ANILINE}
< 1 539400 274700
11/04/2005 2,3,5,6-TETRACHLOROAMINOBENZENE 
{2,...ANILINE}
< 1 539400 274700
05/05/2005 2,3,5,6-TETRACHLOROAMINOBENZENE 
{2,...ANILINE}
< 1 535664 293648
02/06/2005 2,3,5,6-TETRACHLOROAMINOBENZENE 
{2,...ANILINE}
< 1 535664 293648
03/08/2005 2,3,5,6-TETRACHLOROAMINOBENZENE 
{2,...ANILINE}
< 1 535664 293648
11/02/2005 2,3,5,6-TETRACHLOROAMINOBENZENE 
{2,...ANILINE}
< 5 535664 293648
14/03/2005 2,3,5,6-TETRACHLOROAMINOBENZENE 
{2,...ANILINE}
< 5 535664 293648
07/04/2005 2,3,5,6-TETRACHLOROAMINOBENZENE 
{2,...ANILINE}
< 10 535664 293648
05/05/2005 2,3,5,6-TETRACHLOROTHIOANISOLE < 1 535664 293648
02/06/2005 2,3,5,6-TETRACHLOROTHIOANISOLE < 1 535664 293648
03/08/2005 2,3,5,6-TETRACHLOROTHIOANISOLE < 1 535664 293648
11/02/2005 2,3,5,6-TETRACHLOROTHIOANISOLE < 5 535664 293648
14/03/2005 2,3,5,6-TETRACHLOROTHIOANISOLE < 5 535664 293648
07/04/2005 2,3,5,6-TETRACHLOROTHIOANISOLE < 10 535664 293648
04/03/2004 ALDRIN < 1 539400 274700
14/04/2004 ALDRIN < 1 539400 274700
14/04/2004 ALDRIN < 1 539400 274700
12/05/2004 ALDRIN < 1 539400 274700
04/06/2004 ALDRIN < 1 539400 274700
14/07/2004 ALDRIN < 1 539400 274700
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14/07/2004 ALDRIN < 1 539400 274700
11/08/2004 ALDRIN < 1 539400 274700
10/02/2005 ALDRIN < 1 539400 274700
10/03/2005 ALDRIN < 1 539400 274700
11/04/2005 ALDRIN < 1 539400 274700
10/05/2005 ALDRIN < 1 539400 274700
06/06/2005 ALDRIN < 1 539400 274700
01/08/2005 ALDRIN < 1 539400 274700
18/02/2004 ALDRIN < 1 544200 299200
14/04/2004 ALDRIN < 1 544200 299200
05/05/2004 ALDRIN < 1 544200 299200
25/05/2004 ALDRIN < 1 544200 299200
28/07/2004 ALDRIN < 1 544200 299200
10/08/2004 ALDRIN < 1 544200 299200
15/02/2005 ALDRIN < 1 544200 299200
14/03/2005 ALDRIN < 1 544200 299200
08/04/2005 ALDRIN < 1 544200 299200
02/06/2005 ALDRIN < 1 544200 299200
03/08/2005 ALDRIN < 1 544200 299200
05/05/2005 ALDRIN 2 544200 299200
11/04/2005 ATRAZINE < 3 539400 274700
10/02/2005 ATRAZINE 6 539400 274700
10/03/2005 ATRAZINE 7 539400 274700
14/04/2004 ATRAZINE 12 539400 274700
14/04/2004 ATRAZINE < 13 539400 274700
06/06/2005 ATRAZINE 15 539400 274700
04/06/2004 ATRAZINE 16 539400 274700
11/08/2004 ATRAZINE 18 539400 274700
10/05/2005 ATRAZINE 20 539400 274700
14/07/2004 ATRAZINE 23 539400 274700
12/05/2004 ATRAZINE 25 539400 274700
14/07/2004 ATRAZINE 26 539400 274700
18/07/2005 ATRAZINE 38 539400 274700
01/08/2005 ATRAZINE 45 539400 274700
14/04/2004 AZINPHOS-METHYL < 3 539400 274700
14/04/2004 AZINPHOS-METHYL < 3 539400 274700
12/05/2004 AZINPHOS-METHYL < 3 539400 274700
04/06/2004 AZINPHOS-METHYL < 3 539400 274700
14/07/2004 AZINPHOS-METHYL < 3 539400 274700
11/08/2004 AZINPHOS-METHYL < 3 539400 274700
04/03/2004 BENTAZONE < 40 539400 274700
14/04/2004 BENTAZONE < 40 539400 274700
14/04/2004 BENTAZONE < 40 539400 274700
04/06/2004 BENTAZONE < 40 539400 274700
14/07/2004 BENTAZONE < 40 539400 274700
11/08/2004 BENTAZONE < 40 539400 274700
12/05/2004 BENTAZONE 200 539400 274700
02/06/2005 CHLOROPROPHAM 8 535664 293648
03/08/2005 CHLOROPROPHAM 10 535664 293648
05/05/2005 CHLOROPROPHAM 17 535664 293648
07/04/2005 CHLOROPROPHAM 419 535664 293648
11/02/2005 CHLOROPROPHAM 601 535664 293648
14/03/2005 CHLOROPROPHAM 2140 535664 293648
14/07/2004 CHLOROTHALONIL < 10 539400 274700
18/07/2005 CHLOROTHALONIL < 40 539400 274700
11/04/2005 CIS-HEPTACHLOR EPOXIDE < 2.3 539400 274700
19/04/2004 DDE (OP) < 1 539400 274700
14/07/2004 DDE (OP) < 1 539400 274700
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11/04/2005 DDE (OP) < 1 539400 274700
04/03/2004 DDE (PP) < 1 539400 274700
14/04/2004 DDE (PP) < 1 539400 274700
14/04/2004 DDE (PP) < 1 539400 274700
12/05/2004 DDE (PP) < 1 539400 274700
04/06/2004 DDE (PP) < 1 539400 274700
14/07/2004 DDE (PP) < 1 539400 274700
14/07/2004 DDE (PP) < 1 539400 274700
11/08/2004 DDE (PP) < 1 539400 274700
10/02/2005 DDE (PP) < 1 539400 274700
10/03/2005 DDE (PP) < 1 539400 274700
11/04/2005 DDE (PP) < 1 539400 274700
10/05/2005 DDE (PP) < 1 539400 274700
06/06/2005 DDE (PP) < 1 539400 274700
01/08/2005 DDE (PP) < 1 539400 274700
19/04/2004 DDT (OP) < 3 539400 274700
14/07/2004 DDT (OP) < 3 539400 274700
11/04/2005 DDT (OP) < 3 539400 274700
04/03/2004 DDT (PP) < 1 539400 274700
14/04/2004 DDT (PP) < 1 539400 274700
14/04/2004 DDT (PP) < 1 539400 274700
12/05/2004 DDT (PP) < 1 539400 274700
04/06/2004 DDT (PP) < 1 539400 274700
14/07/2004 DDT (PP) < 1 539400 274700
14/07/2004 DDT (PP) < 1 539400 274700
11/08/2004 DDT (PP) < 1 539400 274700
10/02/2005 DDT (PP) < 1 539400 274700
10/03/2005 DDT (PP) < 1 539400 274700
11/04/2005 DDT (PP) < 1 539400 274700
10/05/2005 DDT (PP) < 1 539400 274700
06/06/2005 DDT (PP) < 1 539400 274700
01/08/2005 DDT (PP) < 1 539400 274700
14/04/2004 DICHLORVOS < 4 539400 274700
14/04/2004 DICHLORVOS < 4 539400 274700
12/05/2004 DICHLORVOS < 4 539400 274700
04/06/2004 DICHLORVOS < 4 539400 274700
14/07/2004 DICHLORVOS < 4 539400 274700
11/08/2004 DICHLORVOS < 4 539400 274700
04/03/2004 DIELDRIN < 1 539400 274700
14/04/2004 DIELDRIN < 1 539400 274700
14/04/2004 DIELDRIN < 1 539400 274700
12/05/2004 DIELDRIN < 1 539400 274700
04/06/2004 DIELDRIN < 1 539400 274700
14/07/2004 DIELDRIN < 1 539400 274700
14/07/2004 DIELDRIN < 1 539400 274700
11/08/2004 DIELDRIN < 1 539400 274700
10/02/2005 DIELDRIN < 1 539400 274700
10/03/2005 DIELDRIN < 1 539400 274700
11/04/2005 DIELDRIN < 1 539400 274700
10/05/2005 DIELDRIN < 1 539400 274700
06/06/2005 DIELDRIN < 1 539400 274700
01/08/2005 DIELDRIN < 1 539400 274700
18/02/2004 DIELDRIN < 1 544200 299200
14/04/2004 DIELDRIN < 1 544200 299200
05/05/2004 DIELDRIN < 1 544200 299200
25/05/2004 DIELDRIN < 1 544200 299200
28/07/2004 DIELDRIN < 1 544200 299200
10/08/2004 DIELDRIN < 1 544200 299200
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15/02/2005 DIELDRIN < 1 544200 299200
14/03/2005 DIELDRIN < 1 544200 299200
08/04/2005 DIELDRIN < 1 544200 299200
02/06/2005 DIELDRIN < 1 544200 299200
03/08/2005 DIELDRIN < 1 544200 299200
05/05/2005 DIELDRIN 3 544200 299200
14/04/2004 DIMETHOATE < 6 539400 274700
14/04/2004 DIMETHOATE < 6 539400 274700
12/05/2004 DIMETHOATE < 6 539400 274700
04/06/2004 DIMETHOATE < 6 539400 274700
14/07/2004 DIMETHOATE < 6 539400 274700
11/08/2004 DIMETHOATE < 6 539400 274700
14/04/2004 DIURON 914 539400 274700
14/04/2004 DIURON 1008 539400 274700
11/04/2005 DRINS TOTAL (AL-, DIEL-, EN- & ISO-) < 4 539400 274700
18/02/2004 DRINS TOTAL (AL-, DIEL-, EN- & ISO-) < 4 544200 299200
14/04/2004 DRINS TOTAL (AL-, DIEL-, EN- & ISO-) < 4 544200 299200
05/05/2004 DRINS TOTAL (AL-, DIEL-, EN- & ISO-) < 4 544200 299200
25/05/2004 DRINS TOTAL (AL-, DIEL-, EN- & ISO-) < 4 544200 299200
28/07/2004 DRINS TOTAL (AL-, DIEL-, EN- & ISO-) < 4 544200 299200
10/08/2004 DRINS TOTAL (AL-, DIEL-, EN- & ISO-) < 4 544200 299200
15/02/2005 DRINS TOTAL (AL-, DIEL-, EN- & ISO-) < 4 544200 299200
14/03/2005 DRINS TOTAL (AL-, DIEL-, EN- & ISO-) < 4 544200 299200
08/04/2005 DRINS TOTAL (AL-, DIEL-, EN- & ISO-) < 4 544200 299200
02/06/2005 DRINS TOTAL (AL-, DIEL-, EN- & ISO-) < 6 544200 299200
03/08/2005 DRINS TOTAL (AL-, DIEL-, EN- & ISO-) < 6 544200 299200
05/05/2005 DRINS TOTAL (AL-, DIEL-, EN- & ISO-) 9 544200 299200
04/03/2004 ENDOSULPHAN ALPHA < 1 539400 274700
14/04/2004 ENDOSULPHAN ALPHA < 1 539400 274700
14/04/2004 ENDOSULPHAN ALPHA < 1 539400 274700
19/04/2004 ENDOSULPHAN ALPHA < 1 539400 274700
12/05/2004 ENDOSULPHAN ALPHA < 1 539400 274700
04/06/2004 ENDOSULPHAN ALPHA < 1 539400 274700
14/07/2004 ENDOSULPHAN ALPHA < 1 539400 274700
14/07/2004 ENDOSULPHAN ALPHA < 1 539400 274700
11/08/2004 ENDOSULPHAN ALPHA < 1 539400 274700
11/04/2005 ENDOSULPHAN ALPHA < 1 539400 274700
04/03/2004 ENDOSULPHAN BETA < 2 539400 274700
14/04/2004 ENDOSULPHAN BETA < 2 539400 274700
14/04/2004 ENDOSULPHAN BETA < 2 539400 274700
19/04/2004 ENDOSULPHAN BETA < 2 539400 274700
12/05/2004 ENDOSULPHAN BETA < 2 539400 274700
04/06/2004 ENDOSULPHAN BETA < 2 539400 274700
14/07/2004 ENDOSULPHAN BETA < 2 539400 274700
14/07/2004 ENDOSULPHAN BETA < 2 539400 274700
11/08/2004 ENDOSULPHAN BETA < 2 539400 274700
11/04/2005 ENDOSULPHAN BETA < 2 539400 274700
04/03/2004 ENDRIN < 1 539400 274700
14/04/2004 ENDRIN < 1 539400 274700
14/04/2004 ENDRIN < 1 539400 274700
12/05/2004 ENDRIN < 1 539400 274700
04/06/2004 ENDRIN < 1 539400 274700
14/07/2004 ENDRIN < 1 539400 274700
14/07/2004 ENDRIN < 1 539400 274700
11/08/2004 ENDRIN < 1 539400 274700
10/02/2005 ENDRIN < 1 539400 274700
10/03/2005 ENDRIN < 1 539400 274700
11/04/2005 ENDRIN < 1 539400 274700
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10/05/2005 ENDRIN < 3 539400 274700
06/06/2005 ENDRIN < 3 539400 274700
01/08/2005 ENDRIN < 3 539400 274700
18/02/2004 ENDRIN < 1 544200 299200
14/04/2004 ENDRIN < 1 544200 299200
05/05/2004 ENDRIN < 1 544200 299200
25/05/2004 ENDRIN < 1 544200 299200
28/07/2004 ENDRIN < 1 544200 299200
10/08/2004 ENDRIN < 1 544200 299200
15/02/2005 ENDRIN < 1 544200 299200
14/03/2005 ENDRIN < 1 544200 299200
08/04/2005 ENDRIN < 1 544200 299200
05/05/2005 ENDRIN < 3 544200 299200
02/06/2005 ENDRIN < 3 544200 299200
03/08/2005 ENDRIN < 3 544200 299200
14/04/2004 FENITROTHION < 1 539400 274700
14/04/2004 FENITROTHION < 1 539400 274700
12/05/2004 FENITROTHION < 1 539400 274700
04/06/2004 FENITROTHION < 1 539400 274700
14/07/2004 FENITROTHION < 1 539400 274700
11/08/2004 FENITROTHION < 1 539400 274700
04/03/2004 HCH ALPHA < 2 539400 274700
14/04/2004 HCH ALPHA < 2 539400 274700
14/04/2004 HCH ALPHA < 2 539400 274700
19/04/2004 HCH ALPHA < 2 539400 274700
12/05/2004 HCH ALPHA < 2 539400 274700
04/06/2004 HCH ALPHA < 2 539400 274700
14/07/2004 HCH ALPHA < 2 539400 274700
14/07/2004 HCH ALPHA < 2 539400 274700
11/08/2004 HCH ALPHA < 2 539400 274700
10/02/2005 HCH ALPHA < 2 539400 274700
10/03/2005 HCH ALPHA < 2.1 539400 274700
11/04/2005 HCH ALPHA < 2.1 539400 274700
10/05/2005 HCH ALPHA < 2.1 539400 274700
06/06/2005 HCH ALPHA < 2.1 539400 274700
01/08/2005 HCH ALPHA < 2.1 539400 274700
18/02/2004 HCH ALPHA < 2 544200 299200
14/04/2004 HCH ALPHA < 2 544200 299200
05/05/2004 HCH ALPHA < 2 544200 299200
25/05/2004 HCH ALPHA < 2 544200 299200
28/07/2004 HCH ALPHA < 2 544200 299200
10/08/2004 HCH ALPHA < 2 544200 299200
15/02/2005 HCH ALPHA < 2 544200 299200
14/03/2005 HCH ALPHA < 2.1 544200 299200
08/04/2005 HCH ALPHA < 2.1 544200 299200
02/06/2005 HCH ALPHA < 2.1 544200 299200
03/08/2005 HCH ALPHA < 2.1 544200 299200
05/05/2005 HCH ALPHA 3 544200 299200
04/03/2004 HCH BETA < 2 539400 274700
14/04/2004 HCH BETA < 2 539400 274700
14/04/2004 HCH BETA < 2 539400 274700
19/04/2004 HCH BETA < 2 539400 274700
12/05/2004 HCH BETA < 2 539400 274700
04/06/2004 HCH BETA < 2 539400 274700
14/07/2004 HCH BETA < 2 539400 274700
14/07/2004 HCH BETA < 2 539400 274700
11/08/2004 HCH BETA < 2 539400 274700
10/02/2005 HCH BETA < 2 539400 274700
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10/03/2005 HCH BETA < 2.1 539400 274700
11/04/2005 HCH BETA < 2.1 539400 274700
10/05/2005 HCH BETA < 2.1 539400 274700
06/06/2005 HCH BETA < 2.1 539400 274700
01/08/2005 HCH BETA < 2.1 539400 274700
18/02/2004 HCH BETA < 2 544200 299200
14/04/2004 HCH BETA < 2 544200 299200
05/05/2004 HCH BETA < 2 544200 299200
25/05/2004 HCH BETA < 2 544200 299200
28/07/2004 HCH BETA < 2 544200 299200
10/08/2004 HCH BETA < 2 544200 299200
15/02/2005 HCH BETA < 2 544200 299200
14/03/2005 HCH BETA < 2.1 544200 299200
08/04/2005 HCH BETA < 2.1 544200 299200
05/05/2005 HCH BETA < 2.1 544200 299200
02/06/2005 HCH BETA < 2.1 544200 299200
03/08/2005 HCH BETA < 2.1 544200 299200
04/03/2004 HCH DELTA < 1 539400 274700
14/04/2004 HCH DELTA < 1 539400 274700
14/04/2004 HCH DELTA < 1 539400 274700
19/04/2004 HCH DELTA < 1 539400 274700
12/05/2004 HCH DELTA < 1 539400 274700
04/06/2004 HCH DELTA < 1 539400 274700
14/07/2004 HCH DELTA < 1 539400 274700
14/07/2004 HCH DELTA < 1 539400 274700
11/08/2004 HCH DELTA < 1 539400 274700
10/02/2005 HCH DELTA < 1 539400 274700
10/03/2005 HCH DELTA < 1 539400 274700
11/04/2005 HCH DELTA < 1 539400 274700
10/05/2005 HCH DELTA < 1 539400 274700
06/06/2005 HCH DELTA < 1 539400 274700
01/08/2005 HCH DELTA < 1 539400 274700
18/02/2004 HCH DELTA < 1 544200 299200
14/04/2004 HCH DELTA < 1 544200 299200
05/05/2004 HCH DELTA < 1 544200 299200
25/05/2004 HCH DELTA < 1 544200 299200
28/07/2004 HCH DELTA < 1 544200 299200
10/08/2004 HCH DELTA < 1 544200 299200
15/02/2005 HCH DELTA < 1 544200 299200
14/03/2005 HCH DELTA < 1 544200 299200
08/04/2005 HCH DELTA < 1 544200 299200
05/05/2005 HCH DELTA < 1 544200 299200
02/06/2005 HCH DELTA < 1 544200 299200
03/08/2005 HCH DELTA < 1 544200 299200
04/03/2004 HCH GAMMA < 2 539400 274700
14/04/2004 HCH GAMMA < 2 539400 274700
14/04/2004 HCH GAMMA < 2 539400 274700
12/05/2004 HCH GAMMA < 2 539400 274700
04/06/2004 HCH GAMMA < 2 539400 274700
14/07/2004 HCH GAMMA < 2 539400 274700
14/07/2004 HCH GAMMA < 2 539400 274700
11/08/2004 HCH GAMMA < 2 539400 274700
10/02/2005 HCH GAMMA < 2 539400 274700
10/03/2005 HCH GAMMA < 2.2 539400 274700
11/04/2005 HCH GAMMA < 2.2 539400 274700
10/05/2005 HCH GAMMA < 2.2 539400 274700
06/06/2005 HCH GAMMA < 2.2 539400 274700
01/08/2005 HCH GAMMA < 2.2 539400 274700
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18/02/2004 HCH GAMMA < 2 544200 299200
14/04/2004 HCH GAMMA < 2 544200 299200
05/05/2004 HCH GAMMA < 2 544200 299200
25/05/2004 HCH GAMMA < 2 544200 299200
28/07/2004 HCH GAMMA < 2 544200 299200
10/08/2004 HCH GAMMA < 2 544200 299200
15/02/2005 HCH GAMMA < 2 544200 299200
14/03/2005 HCH GAMMA < 2.2 544200 299200
08/04/2005 HCH GAMMA < 2.2 544200 299200
02/06/2005 HCH GAMMA < 2.2 544200 299200
03/08/2005 HCH GAMMA < 2.2 544200 299200
14/10/2005 HCH GAMMA < 2.2 544200 299200
05/05/2005 HCH GAMMA 4 544200 299200
11/04/2005 HCH TOTAL (ALPHA, BETA & GAMMA) < 6.4 539400 274700
18/02/2004 HCH TOTAL (ALPHA, BETA & GAMMA) < 6 544200 299200
14/04/2004 HCH TOTAL (ALPHA, BETA & GAMMA) < 6 544200 299200
05/05/2004 HCH TOTAL (ALPHA, BETA & GAMMA) < 6 544200 299200
25/05/2004 HCH TOTAL (ALPHA, BETA & GAMMA) < 6 544200 299200
28/07/2004 HCH TOTAL (ALPHA, BETA & GAMMA) < 6 544200 299200
10/08/2004 HCH TOTAL (ALPHA, BETA & GAMMA) < 6 544200 299200
15/02/2005 HCH TOTAL (ALPHA, BETA & GAMMA) < 6 544200 299200
14/03/2005 HCH TOTAL (ALPHA, BETA & GAMMA) < 6.4 544200 299200
08/04/2005 HCH TOTAL (ALPHA, BETA & GAMMA) < 6.4 544200 299200
02/06/2005 HCH TOTAL (ALPHA, BETA & GAMMA) < 6.4 544200 299200
03/08/2005 HCH TOTAL (ALPHA, BETA & GAMMA) < 6.4 544200 299200
05/05/2005 HCH TOTAL (ALPHA, BETA & GAMMA) 9.1 544200 299200
19/04/2004 HEPTACHLOR < 1 539400 274700
14/07/2004 HEPTACHLOR < 1 539400 274700
11/04/2005 HEPTACHLOR < 1 539400 274700
19/04/2004 HEXACHLOROBENZENE < 1 539400 274700
14/07/2004 HEXACHLOROBENZENE < 1 539400 274700
11/04/2005 HEXACHLOROBENZENE < 1 539400 274700
19/04/2004 ISODRIN < 1 539400 274700
14/07/2004 ISODRIN < 1 539400 274700
11/04/2005 ISODRIN < 1 539400 274700
18/02/2004 ISODRIN < 1 544200 299200
14/04/2004 ISODRIN < 1 544200 299200
05/05/2004 ISODRIN < 1 544200 299200
25/05/2004 ISODRIN < 1 544200 299200
28/07/2004 ISODRIN < 1 544200 299200
10/08/2004 ISODRIN < 1 544200 299200
15/02/2005 ISODRIN < 1 544200 299200
14/03/2005 ISODRIN < 1 544200 299200
08/04/2005 ISODRIN < 1 544200 299200
05/05/2005 ISODRIN < 1 544200 299200
02/06/2005 ISODRIN < 1 544200 299200
03/08/2005 ISODRIN < 1 544200 299200
04/03/2004 LINURON < 50 539400 274700
14/04/2004 LINURON < 50 539400 274700
14/04/2004 LINURON < 50 539400 274700
12/05/2004 LINURON < 50 539400 274700
14/07/2004 LINURON < 50 539400 274700
11/08/2004 LINURON < 50 539400 274700
04/06/2004 LINURON < 60 539400 274700
14/04/2004 MALATHION < 2 539400 274700
14/04/2004 MALATHION < 2 539400 274700
12/05/2004 MALATHION < 2 539400 274700
04/06/2004 MALATHION < 2 539400 274700
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14/07/2004 MALATHION < 2 539400 274700
11/08/2004 MALATHION < 2 539400 274700
04/03/2004 MECOPROP < 40 539400 274700
14/04/2004 MECOPROP < 40 539400 274700
14/04/2004 MECOPROP < 40 539400 274700
11/08/2004 MECOPROP < 40 539400 274700
14/07/2004 MECOPROP 50 539400 274700
04/06/2004 MECOPROP 100 539400 274700
12/05/2004 MECOPROP 120 539400 274700
14/04/2004 MEVINPHOS < 2 539400 274700
14/04/2004 MEVINPHOS < 8 539400 274700
12/05/2004 MEVINPHOS < 8 539400 274700
04/06/2004 MEVINPHOS < 8 539400 274700
14/07/2004 MEVINPHOS < 8 539400 274700
11/08/2004 MEVINPHOS < 8 539400 274700
10/03/2005 PENTACHLOROPHENOL < 20 539400 274700
11/04/2005 PENTACHLOROPHENOL < 20 539400 274700
10/05/2005 PENTACHLOROPHENOL < 20 539400 274700
06/06/2005 PENTACHLOROPHENOL < 20 539400 274700
18/07/2005 PENTACHLOROPHENOL < 20 539400 274700
04/03/2004 PENTACHLOROPHENOL < 40 539400 274700
12/05/2004 PENTACHLOROPHENOL < 40 539400 274700
04/06/2004 PENTACHLOROPHENOL < 40 539400 274700
14/07/2004 PENTACHLOROPHENOL < 40 539400 274700
14/07/2004 PENTACHLOROPHENOL < 40 539400 274700
11/08/2004 PENTACHLOROPHENOL < 40 539400 274700
04/03/2004 PERMETHRIN, CIS < 1 539400 274700
14/04/2004 PERMETHRIN, CIS < 1 539400 274700
14/04/2004 PERMETHRIN, CIS < 1 539400 274700
12/05/2004 PERMETHRIN, CIS < 1 539400 274700
04/06/2004 PERMETHRIN, CIS < 1 539400 274700
14/07/2004 PERMETHRIN, CIS < 1 539400 274700
11/08/2004 PERMETHRIN, CIS < 1 539400 274700
04/03/2004 PERMETHRIN, TRANS < 1 539400 274700
14/04/2004 PERMETHRIN, TRANS < 1 539400 274700
14/04/2004 PERMETHRIN, TRANS < 1 539400 274700
12/05/2004 PERMETHRIN, TRANS < 1 539400 274700
04/06/2004 PERMETHRIN, TRANS < 1 539400 274700
14/07/2004 PERMETHRIN, TRANS < 1 539400 274700
11/08/2004 PERMETHRIN, TRANS < 1 539400 274700
11/08/2004 SIMAZINE 29 539400 274700
10/03/2005 SIMAZINE 34 539400 274700
14/07/2004 SIMAZINE 37 539400 274700
14/07/2004 SIMAZINE 40 539400 274700
01/08/2005 SIMAZINE 41 539400 274700
04/06/2004 SIMAZINE 49 539400 274700
10/05/2005 SIMAZINE 69 539400 274700
18/07/2005 SIMAZINE 72 539400 274700
14/04/2004 SIMAZINE 74 539400 274700
14/04/2004 SIMAZINE 80 539400 274700
06/06/2005 SIMAZINE 83 539400 274700
10/02/2005 SIMAZINE 132 539400 274700
12/05/2004 SIMAZINE 226 539400 274700
11/04/2005 SIMAZINE 235 539400 274700
19/04/2004 TDE (OP) < 1 539400 274700
14/07/2004 TDE (OP) < 1 539400 274700
11/04/2005 TDE (OP) < 1 539400 274700
04/03/2004 TDE (PP) < 1 539400 274700
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14/04/2004 TDE (PP) < 1 539400 274700
14/04/2004 TDE (PP) < 1 539400 274700
12/05/2004 TDE (PP) < 1 539400 274700
04/06/2004 TDE (PP) < 1 539400 274700
14/07/2004 TDE (PP) < 1 539400 274700
14/07/2004 TDE (PP) < 1 539400 274700
11/08/2004 TDE (PP) < 1 539400 274700
10/02/2005 TDE (PP) < 1 539400 274700
10/03/2005 TDE (PP) < 1 539400 274700
11/04/2005 TDE (PP) < 1 539400 274700
10/05/2005 TDE (PP) < 1 539400 274700
06/06/2005 TDE (PP) < 1 539400 274700
01/08/2005 TDE (PP) < 1 539400 274700
19/04/2004 TECNAZENE < 10 539400 274700
11/04/2005 TECNAZENE < 10 539400 274700
14/07/2004 TECNAZENE < 11 539400 274700
05/05/2005 TECNAZENE < 10 535664 293648
02/06/2005 TECNAZENE < 10 535664 293648
03/08/2005 TECNAZENE < 10 535664 293648
11/02/2005 TECNAZENE < 50 535664 293648
14/03/2005 TECNAZENE < 50 535664 293648
07/04/2005 TECNAZENE < 100 535664 293648
19/04/2004 TRANS-HEPTACHLOR EPOXIDE < 3 539400 274700
14/07/2004 TRANS-HEPTACHLOR EPOXIDE < 3 539400 274700
11/04/2005 TRANS-HEPTACHLOR EPOXIDE < 3 539400 274700
14/04/2004 TRIAZOPHOS < 4 539400 274700
14/04/2004 TRIAZOPHOS < 4 539400 274700
12/05/2004 TRIAZOPHOS < 4 539400 274700
04/06/2004 TRIAZOPHOS < 4 539400 274700
14/07/2004 TRIAZOPHOS < 4 539400 274700
11/08/2004 TRIAZOPHOS < 4 539400 274700
04/03/2004 TRIBUTYL TIN < 2 539400 274700
14/04/2004 TRIBUTYL TIN < 2 539400 274700
14/04/2004 TRIBUTYL TIN < 2 539400 274700
19/04/2004 TRIBUTYL TIN < 2 539400 274700
12/05/2004 TRIBUTYL TIN < 2 539400 274700
04/06/2004 TRIBUTYL TIN < 2 539400 274700
14/07/2004 TRIBUTYL TIN < 2 539400 274700
14/07/2004 TRIBUTYL TIN < 2 539400 274700
11/08/2004 TRIBUTYL TIN < 2 539400 274700
10/02/2005 TRIBUTYL TIN < 2 539400 274700
10/03/2005 TRIBUTYL TIN < 2 539400 274700
11/04/2005 TRIBUTYL TIN < 2 539400 274700
10/05/2005 TRIBUTYL TIN 2 539400 274700
06/06/2005 TRIBUTYL TIN < 2 539400 274700
18/07/2005 TRIBUTYL TIN < 2 539400 274700
01/08/2005 TRIBUTYL TIN < 2 539400 274700
14/04/2004 TRIFLURALIN < 11 539400 274700
14/04/2004 TRIFLURALIN < 11 539400 274700
19/04/2004 TRIFLURALIN < 11 539400 274700
12/05/2004 TRIFLURALIN < 11 539400 274700
04/06/2004 TRIFLURALIN < 11 539400 274700
14/07/2004 TRIFLURALIN < 11 539400 274700
11/08/2004 TRIFLURALIN < 11 539400 274700
11/04/2005 TRIFLURALIN < 11 539400 274700
14/07/2004 TRIFLURALIN < 12 539400 274700
04/03/2004 TRIFLURALIN < 19 539400 274700
04/03/2004 TRIPHENYLTIN COMPOUNDS < 2 539400 274700
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14/04/2004 TRIPHENYLTIN COMPOUNDS < 2 539400 274700
14/04/2004 TRIPHENYLTIN COMPOUNDS < 2 539400 274700
19/04/2004 TRIPHENYLTIN COMPOUNDS < 2 539400 274700
12/05/2004 TRIPHENYLTIN COMPOUNDS < 2 539400 274700
04/06/2004 TRIPHENYLTIN COMPOUNDS < 2 539400 274700
14/07/2004 TRIPHENYLTIN COMPOUNDS < 2 539400 274700
14/07/2004 TRIPHENYLTIN COMPOUNDS < 2 539400 274700
11/08/2004 TRIPHENYLTIN COMPOUNDS < 2 539400 274700
10/02/2005 TRIPHENYLTIN COMPOUNDS < 2 539400 274700
10/03/2005 TRIPHENYLTIN COMPOUNDS < 2 539400 274700
11/04/2005 TRIPHENYLTIN COMPOUNDS < 2 539400 274700
10/05/2005 TRIPHENYLTIN COMPOUNDS < 2 539400 274700
06/06/2005 TRIPHENYLTIN COMPOUNDS < 2 539400 274700
18/07/2005 TRIPHENYLTIN COMPOUNDS < 2 539400 274700
01/08/2005 TRIPHENYLTIN COMPOUNDS < 2 539400 274700
2.4 Layes Pool:
• Co-ordinates: x,y = 380253, 265808
Date Pesticide
Less 
than
Conc. 
(ng/L) x y
15/08/2005 DICHLORVOS < 0.5 381350 270950
15/07/2005 (2,4,5-TRICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
24/05/2005 (2,4,5-TRICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
16/03/2005 (2,4,5-TRICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
09/02/2005 (2,4,5-TRICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
10/08/2004 (2,4,5-TRICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
02/07/2004 (2,4,5-TRICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
25/06/2004 (2,4,5-TRICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
03/06/2004 (2,4,5-TRICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
22/04/2004 (2,4,5-TRICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
15/03/2004 (2,4,5-TRICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
16/03/2005 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
09/02/2005 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
10/08/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
12/07/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
02/07/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
25/06/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
25/06/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
03/06/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
03/06/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
22/04/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
22/04/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
15/03/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
15/03/2004 (2,4-DICHLOROPHENOXY)ETHANOIC ACID < 40 381350 270950
24/05/2005 (2,4-DICHLOROPHENOXY)ETHANOIC ACID  52 381350 270950
15/07/2005 (2,4-DICHLOROPHENOXY)ETHANOIC ACID  236 381350 270950
15/07/2005 2,4-DB < 40 381350 270950
24/05/2005 2,4-DB < 40 381350 270950
16/03/2005 2,4-DB < 40 381350 270950
09/02/2005 2,4-DB < 40 381350 270950
10/08/2004 2,4-DB < 40 381350 270950
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02/07/2004 2,4-DB < 40 381350 270950
25/06/2004 2,4-DB < 40 381350 270950
03/06/2004 2,4-DB < 40 381350 270950
22/04/2004 2,4-DB < 40 381350 270950
15/03/2004 2,4-DB < 40 381350 270950
14/07/2005 ALDRIN < 2.5 381350 270950
14/04/2005 ALDRIN < 2.5 381350 270950
13/04/2005 ALDRIN < 2.5 381350 270950
15/08/2005 ALDRIN < 5 381350 270950
15/07/2005 ALDRIN < 5 381350 270950
10/06/2005 ALDRIN < 5 381350 270950
24/05/2005 ALDRIN < 5 381350 270950
16/03/2005 ALDRIN < 5 381350 270950
09/02/2005 ALDRIN < 5 381350 270950
10/08/2004 ALDRIN < 5 381350 270950
12/07/2004 ALDRIN < 5 381350 270950
25/06/2004 ALDRIN < 5 381350 270950
03/06/2004 ALDRIN < 5 381350 270950
22/04/2004 ALDRIN < 5 381350 270950
15/03/2004 ALDRIN < 5 381350 270950
15/08/2005 ATRAZINE < 30 381350 270950
15/07/2005 ATRAZINE < 30 381350 270950
15/07/2005 ATRAZINE < 30 381350 270950
14/07/2005 ATRAZINE < 30 381350 270950
10/06/2005 ATRAZINE < 30 381350 270950
24/05/2005 ATRAZINE < 30 381350 270950
14/04/2005 ATRAZINE < 30 381350 270950
13/04/2005 ATRAZINE < 30 381350 270950
16/03/2005 ATRAZINE < 30 381350 270950
16/03/2005 ATRAZINE < 30 381350 270950
09/02/2005 ATRAZINE < 30 381350 270950
09/02/2005 ATRAZINE < 30 381350 270950
10/08/2004 ATRAZINE < 30 381350 270950
12/07/2004 ATRAZINE < 30 381350 270950
01/07/2004 ATRAZINE < 30 381350 270950
25/06/2004 ATRAZINE < 30 381350 270950
15/03/2004 ATRAZINE < 30 381350 270950
15/03/2004 ATRAZINE < 30 381350 270950
03/06/2004 ATRAZINE  52.3 381350 270950
02/07/2004 ATRAZINE  52.6 381350 270950
03/06/2004 ATRAZINE  57.7 381350 270950
25/06/2004 ATRAZINE  163 381350 270950
15/08/2005 AZINPHOS-ETHYL < 20 381350 270950
15/07/2005 AZINPHOS-ETHYL < 20 381350 270950
15/07/2005 AZINPHOS-ETHYL < 20 381350 270950
14/07/2005 AZINPHOS-ETHYL < 20 381350 270950
10/06/2005 AZINPHOS-ETHYL < 20 381350 270950
24/05/2005 AZINPHOS-ETHYL < 20 381350 270950
24/05/2005 AZINPHOS-ETHYL < 20 381350 270950
14/04/2005 AZINPHOS-ETHYL < 20 381350 270950
13/04/2005 AZINPHOS-ETHYL < 20 381350 270950
16/03/2005 AZINPHOS-ETHYL < 20 381350 270950
16/03/2005 AZINPHOS-ETHYL < 20 381350 270950
09/02/2005 AZINPHOS-ETHYL < 20 381350 270950
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09/02/2005 AZINPHOS-ETHYL < 20 381350 270950
10/08/2004 AZINPHOS-ETHYL < 20 381350 270950
10/08/2004 AZINPHOS-ETHYL < 20 381350 270950
12/07/2004 AZINPHOS-ETHYL < 20 381350 270950
02/07/2004 AZINPHOS-ETHYL < 20 381350 270950
01/07/2004 AZINPHOS-ETHYL < 20 381350 270950
25/06/2004 AZINPHOS-ETHYL < 20 381350 270950
25/06/2004 AZINPHOS-ETHYL < 20 381350 270950
03/06/2004 AZINPHOS-ETHYL < 20 381350 270950
03/06/2004 AZINPHOS-ETHYL < 20 381350 270950
15/03/2004 AZINPHOS-ETHYL < 20 381350 270950
15/03/2004 AZINPHOS-ETHYL < 20 381350 270950
15/08/2005 AZINPHOS-METHYL < 1 381350 270950
15/07/2005 AZINPHOS-METHYL < 1 381350 270950
15/07/2005 AZINPHOS-METHYL < 1 381350 270950
14/07/2005 AZINPHOS-METHYL < 1 381350 270950
10/06/2005 AZINPHOS-METHYL < 1 381350 270950
14/04/2005 AZINPHOS-METHYL < 1 381350 270950
13/04/2005 AZINPHOS-METHYL < 1 381350 270950
16/03/2005 AZINPHOS-METHYL < 1 381350 270950
16/03/2005 AZINPHOS-METHYL < 1 381350 270950
09/02/2005 AZINPHOS-METHYL < 1 381350 270950
09/02/2005 AZINPHOS-METHYL < 1 381350 270950
10/08/2004 AZINPHOS-METHYL < 1 381350 270950
10/08/2004 AZINPHOS-METHYL < 1 381350 270950
12/07/2004 AZINPHOS-METHYL < 1 381350 270950
02/07/2004 AZINPHOS-METHYL < 1 381350 270950
01/07/2004 AZINPHOS-METHYL < 1 381350 270950
25/06/2004 AZINPHOS-METHYL < 1 381350 270950
25/06/2004 AZINPHOS-METHYL < 1 381350 270950
03/06/2004 AZINPHOS-METHYL < 1 381350 270950
03/06/2004 AZINPHOS-METHYL < 1 381350 270950
15/03/2004 AZINPHOS-METHYL < 1 381350 270950
15/03/2004 AZINPHOS-METHYL < 1 381350 270950
15/08/2005 CARBOPHENOTHION < 10 381350 270950
15/07/2005 CARBOPHENOTHION < 10 381350 270950
15/07/2005 CARBOPHENOTHION < 10 381350 270950
14/07/2005 CARBOPHENOTHION < 10 381350 270950
10/06/2005 CARBOPHENOTHION < 10 381350 270950
24/05/2005 CARBOPHENOTHION < 10 381350 270950
24/05/2005 CARBOPHENOTHION < 10 381350 270950
14/04/2005 CARBOPHENOTHION < 10 381350 270950
13/04/2005 CARBOPHENOTHION < 10 381350 270950
16/03/2005 CARBOPHENOTHION < 10 381350 270950
16/03/2005 CARBOPHENOTHION < 10 381350 270950
10/08/2004 CARBOPHENOTHION < 10 381350 270950
10/08/2004 CARBOPHENOTHION < 10 381350 270950
12/07/2004 CARBOPHENOTHION < 10 381350 270950
02/07/2004 CARBOPHENOTHION < 10 381350 270950
01/07/2004 CARBOPHENOTHION < 10 381350 270950
25/06/2004 CARBOPHENOTHION < 10 381350 270950
25/06/2004 CARBOPHENOTHION < 10 381350 270950
03/06/2004 CARBOPHENOTHION < 10 381350 270950
03/06/2004 CARBOPHENOTHION < 10 381350 270950
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15/03/2004 CARBOPHENOTHION < 10 381350 270950
15/03/2004 CARBOPHENOTHION < 10 381350 270950
15/08/2005 CHLORFENVINPHOS < 1 381350 270950
15/07/2005 CHLORFENVINPHOS < 1 381350 270950
15/07/2005 CHLORFENVINPHOS < 1 381350 270950
14/07/2005 CHLORFENVINPHOS < 1 381350 270950
10/06/2005 CHLORFENVINPHOS < 1 381350 270950
24/05/2005 CHLORFENVINPHOS < 1 381350 270950
24/05/2005 CHLORFENVINPHOS < 1 381350 270950
14/04/2005 CHLORFENVINPHOS < 1 381350 270950
13/04/2005 CHLORFENVINPHOS < 1 381350 270950
16/03/2005 CHLORFENVINPHOS < 1 381350 270950
16/03/2005 CHLORFENVINPHOS < 1 381350 270950
09/02/2005 CHLORFENVINPHOS < 1 381350 270950
09/02/2005 CHLORFENVINPHOS < 1 381350 270950
10/08/2004 CHLORFENVINPHOS < 1 381350 270950
10/08/2004 CHLORFENVINPHOS < 1 381350 270950
12/07/2004 CHLORFENVINPHOS < 1 381350 270950
02/07/2004 CHLORFENVINPHOS < 1 381350 270950
01/07/2004 CHLORFENVINPHOS < 1 381350 270950
25/06/2004 CHLORFENVINPHOS < 1 381350 270950
25/06/2004 CHLORFENVINPHOS < 1 381350 270950
03/06/2004 CHLORFENVINPHOS < 1 381350 270950
03/06/2004 CHLORFENVINPHOS < 1 381350 270950
15/03/2004 CHLORFENVINPHOS < 1 381350 270950
15/03/2004 CHLORFENVINPHOS < 1 381350 270950
15/07/2005 CHLORTOLURON < 40 381350 270950
24/05/2005 CHLORTOLURON < 40 381350 270950
16/03/2005 CHLORTOLURON < 40 381350 270950
09/02/2005 CHLORTOLURON < 40 381350 270950
10/08/2004 CHLORTOLURON < 40 381350 270950
02/07/2004 CHLORTOLURON < 40 381350 270950
03/06/2004 CHLORTOLURON < 40 381350 270950
22/04/2004 CHLORTOLURON < 40 381350 270950
15/03/2004 CHLORTOLURON < 40 381350 270950
25/06/2004 CHLORTOLURON  140 381350 270950
15/09/2005 COUMAPHOS < 1 381350 270950
15/08/2005 COUMAPHOS < 1 381350 270950
15/07/2005 COUMAPHOS < 1 381350 270950
15/07/2005 COUMAPHOS < 1 381350 270950
14/07/2005 COUMAPHOS < 1 381350 270950
10/06/2005 COUMAPHOS < 1 381350 270950
24/05/2005 COUMAPHOS < 1 381350 270950
24/05/2005 COUMAPHOS < 1 381350 270950
14/04/2005 COUMAPHOS < 1 381350 270950
13/04/2005 COUMAPHOS < 1 381350 270950
16/03/2005 COUMAPHOS < 1 381350 270950
16/03/2005 COUMAPHOS < 1 381350 270950
09/02/2005 COUMAPHOS < 1 381350 270950
09/02/2005 COUMAPHOS < 1 381350 270950
10/08/2004 COUMAPHOS < 1 381350 270950
10/08/2004 COUMAPHOS < 1 381350 270950
12/07/2004 COUMAPHOS < 1 381350 270950
02/07/2004 COUMAPHOS < 1 381350 270950
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01/07/2004 COUMAPHOS < 1 381350 270950
25/06/2004 COUMAPHOS < 1 381350 270950
25/06/2004 COUMAPHOS < 1 381350 270950
03/06/2004 COUMAPHOS < 1 381350 270950
03/06/2004 COUMAPHOS < 1 381350 270950
15/03/2004 COUMAPHOS < 1 381350 270950
15/03/2004 COUMAPHOS < 1 381350 270950
15/08/2005 CYFLUTHRIN < 10 381350 270950
15/07/2005 CYFLUTHRIN < 10 381350 270950
14/07/2005 CYFLUTHRIN < 10 381350 270950
10/06/2005 CYFLUTHRIN  10 381350 270950
24/05/2005 CYFLUTHRIN < 10 381350 270950
14/04/2005 CYFLUTHRIN < 10 381350 270950
13/04/2005 CYFLUTHRIN < 10 381350 270950
09/02/2005 CYFLUTHRIN < 10 381350 270950
10/08/2004 CYFLUTHRIN < 10 381350 270950
12/07/2004 CYFLUTHRIN < 10 381350 270950
25/06/2004 CYFLUTHRIN < 10 381350 270950
03/06/2004 CYFLUTHRIN < 10 381350 270950
22/04/2004 CYFLUTHRIN < 10 381350 270950
15/03/2004 CYFLUTHRIN < 10 381350 270950
14/07/2005 CYPERMETHRIN < 10 381350 270950
14/04/2005 CYPERMETHRIN < 10 381350 270950
14/07/2005 DDE (OP) < 2 381350 270950
14/04/2005 DDE (OP) < 2 381350 270950
13/04/2005 DDE (OP) < 2 381350 270950
15/08/2005 DDE (OP) < 5 381350 270950
15/07/2005 DDE (OP) < 5 381350 270950
10/06/2005 DDE (OP) < 5 381350 270950
24/05/2005 DDE (OP) < 5 381350 270950
16/03/2005 DDE (OP) < 5 381350 270950
09/02/2005 DDE (OP) < 5 381350 270950
10/08/2004 DDE (OP) < 5 381350 270950
12/07/2004 DDE (OP) < 5 381350 270950
25/06/2004 DDE (OP) < 5 381350 270950
03/06/2004 DDE (OP) < 5 381350 270950
22/04/2004 DDE (OP) < 5 381350 270950
15/03/2004 DDE (OP) < 5 381350 270950
14/07/2005 DDE (PP) < 1.5 381350 270950
14/04/2005 DDE (PP) < 1.5 381350 270950
13/04/2005 DDE (PP) < 1.5 381350 270950
15/08/2005 DDE (PP) < 5 381350 270950
15/07/2005 DDE (PP) < 5 381350 270950
10/06/2005 DDE (PP) < 5 381350 270950
24/05/2005 DDE (PP) < 5 381350 270950
16/03/2005 DDE (PP) < 5 381350 270950
09/02/2005 DDE (PP) < 5 381350 270950
10/08/2004 DDE (PP) < 5 381350 270950
12/07/2004 DDE (PP) < 5 381350 270950
25/06/2004 DDE (PP) < 5 381350 270950
03/06/2004 DDE (PP) < 5 381350 270950
22/04/2004 DDE (PP) < 5 381350 270950
15/03/2004 DDE (PP) < 5 381350 270950
14/07/2005 DDT (OP) < 1.5 381350 270950
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14/04/2005 DDT (OP) < 1.5 381350 270950
13/04/2005 DDT (OP) < 1.5 381350 270950
15/08/2005 DDT (OP) < 5 381350 270950
15/07/2005 DDT (OP) < 5 381350 270950
10/06/2005 DDT (OP) < 5 381350 270950
24/05/2005 DDT (OP) < 5 381350 270950
16/03/2005 DDT (OP) < 5 381350 270950
09/02/2005 DDT (OP) < 5 381350 270950
10/08/2004 DDT (OP) < 5 381350 270950
12/07/2004 DDT (OP) < 5 381350 270950
25/06/2004 DDT (OP) < 5 381350 270950
03/06/2004 DDT (OP) < 5 381350 270950
22/04/2004 DDT (OP) < 5 381350 270950
15/03/2004 DDT (OP) < 5 381350 270950
14/07/2005 DDT (PP) < 1.5 381350 270950
14/04/2005 DDT (PP) < 1.5 381350 270950
13/04/2005 DDT (PP) < 1.5 381350 270950
15/08/2005 DDT (PP) < 5 381350 270950
15/07/2005 DDT (PP) < 5 381350 270950
10/06/2005 DDT (PP) < 5 381350 270950
24/05/2005 DDT (PP) < 5 381350 270950
16/03/2005 DDT (PP) < 5 381350 270950
09/02/2005 DDT (PP) < 5 381350 270950
10/08/2004 DDT (PP) < 5 381350 270950
12/07/2004 DDT (PP) < 5 381350 270950
25/06/2004 DDT (PP) < 5 381350 270950
03/06/2004 DDT (PP) < 5 381350 270950
22/04/2004 DDT (PP) < 5 381350 270950
15/03/2004 DDT (PP) < 5 381350 270950
15/07/2005 DEMETON-S-METHYL < 50 381350 270950
14/07/2005 DEMETON-S-METHYL < 50 381350 270950
14/04/2005 DEMETON-S-METHYL < 50 381350 270950
16/03/2005 DEMETON-S-METHYL < 50 381350 270950
10/08/2004 DEMETON-S-METHYL < 50 381350 270950
12/07/2004 DEMETON-S-METHYL < 50 381350 270950
02/07/2004 DEMETON-S-METHYL < 50 381350 270950
01/07/2004 DEMETON-S-METHYL < 50 381350 270950
25/06/2004 DEMETON-S-METHYL < 50 381350 270950
25/06/2004 DEMETON-S-METHYL < 50 381350 270950
03/06/2004 DEMETON-S-METHYL < 50 381350 270950
03/06/2004 DEMETON-S-METHYL < 50 381350 270950
15/03/2004 DEMETON-S-METHYL < 50 381350 270950
15/03/2004 DEMETON-S-METHYL < 50 381350 270950
15/09/2005 DIAZINON < 1 381350 270950
15/08/2005 DIAZINON < 1 381350 270950
15/07/2005 DIAZINON < 1 381350 270950
15/07/2005 DIAZINON < 1 381350 270950
14/07/2005 DIAZINON < 1 381350 270950
10/06/2005 DIAZINON < 1 381350 270950
24/05/2005 DIAZINON < 1 381350 270950
24/05/2005 DIAZINON < 1 381350 270950
14/04/2005 DIAZINON < 1 381350 270950
13/04/2005 DIAZINON < 1 381350 270950
16/03/2005 DIAZINON < 1 381350 270950
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16/03/2005 DIAZINON < 1 381350 270950
09/02/2005 DIAZINON < 1 381350 270950
09/02/2005 DIAZINON < 1 381350 270950
10/08/2004 DIAZINON < 1 381350 270950
10/08/2004 DIAZINON < 1 381350 270950
12/07/2004 DIAZINON < 1 381350 270950
02/07/2004 DIAZINON < 1 381350 270950
01/07/2004 DIAZINON < 1 381350 270950
25/06/2004 DIAZINON < 1 381350 270950
25/06/2004 DIAZINON < 1 381350 270950
03/06/2004 DIAZINON < 1 381350 270950
03/06/2004 DIAZINON < 1 381350 270950
15/03/2004 DIAZINON < 1 381350 270950
15/03/2004 DIAZINON < 1 381350 270950
13/07/2005 DIBUTYL TIN < 1 381350 270950
15/07/2005
DICAMBA {3,6-DICHLORO(O-METHOXYBENZOIC 
ACID)} < 40 381350 270950
24/05/2005
DICAMBA {3,6-DICHLORO(O-METHOXYBENZOIC 
ACID)} < 40 381350 270950
16/03/2005
DICAMBA {3,6-DICHLORO(O-METHOXYBENZOIC 
ACID)} < 40 381350 270950
09/02/2005
DICAMBA {3,6-DICHLORO(O-METHOXYBENZOIC 
ACID)} < 40 381350 270950
02/07/2004
DICAMBA {3,6-DICHLORO(O-METHOXYBENZOIC 
ACID)} < 40 381350 270950
25/06/2004
DICAMBA {3,6-DICHLORO(O-METHOXYBENZOIC 
ACID)} < 40 381350 270950
03/06/2004
DICAMBA {3,6-DICHLORO(O-METHOXYBENZOIC 
ACID)} < 40 381350 270950
22/04/2004
DICAMBA {3,6-DICHLORO(O-METHOXYBENZOIC 
ACID)} < 40 381350 270950
15/03/2004
DICAMBA {3,6-DICHLORO(O-METHOXYBENZOIC 
ACID)} < 40 381350 270950
10/08/2004
DICAMBA {3,6-DICHLORO(O-METHOXYBENZOIC 
ACID)}  42.4 381350 270950
15/07/2005 DICHLOBENIL < 20 381350 270950
14/07/2005 DICHLOBENIL < 20 381350 270950
24/05/2005 DICHLOBENIL < 20 381350 270950
14/04/2005 DICHLOBENIL < 20 381350 270950
16/03/2005 DICHLOBENIL < 20 381350 270950
09/02/2005 DICHLOBENIL < 20 381350 270950
10/08/2004 DICHLOBENIL < 20 381350 270950
02/07/2004 DICHLOBENIL < 20 381350 270950
01/07/2004 DICHLOBENIL < 20 381350 270950
25/06/2004 DICHLOBENIL < 20 381350 270950
03/06/2004 DICHLOBENIL < 20 381350 270950
15/03/2004 DICHLOBENIL < 20 381350 270950
15/07/2005 DICHLORPROP < 40 381350 270950
24/05/2005 DICHLORPROP < 40 381350 270950
16/03/2005 DICHLORPROP < 40 381350 270950
09/02/2005 DICHLORPROP < 40 381350 270950
10/08/2004 DICHLORPROP < 40 381350 270950
02/07/2004 DICHLORPROP < 40 381350 270950
03/06/2004 DICHLORPROP < 40 381350 270950
22/04/2004 DICHLORPROP < 40 381350 270950
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15/03/2004 DICHLORPROP < 40 381350 270950
25/06/2004 DICHLORPROP < 80 381350 270950
15/07/2005 DICHLORVOS < 0.5 381350 270950
15/07/2005 DICHLORVOS < 0.5 381350 270950
14/07/2005 DICHLORVOS < 0.5 381350 270950
10/06/2005 DICHLORVOS < 0.5 381350 270950
24/05/2005 DICHLORVOS < 0.5 381350 270950
24/05/2005 DICHLORVOS < 0.5 381350 270950
14/04/2005 DICHLORVOS < 0.5 381350 270950
13/04/2005 DICHLORVOS < 0.5 381350 270950
16/03/2005 DICHLORVOS < 0.5 381350 270950
16/03/2005 DICHLORVOS < 0.5 381350 270950
10/08/2004 DICHLORVOS < 0.5 381350 270950
10/08/2004 DICHLORVOS < 0.5 381350 270950
12/07/2004 DICHLORVOS < 0.5 381350 270950
02/07/2004 DICHLORVOS < 0.5 381350 270950
01/07/2004 DICHLORVOS < 0.5 381350 270950
25/06/2004 DICHLORVOS < 0.5 381350 270950
25/06/2004 DICHLORVOS < 0.5 381350 270950
03/06/2004 DICHLORVOS < 0.5 381350 270950
03/06/2004 DICHLORVOS < 0.5 381350 270950
15/03/2004 DICHLORVOS < 0.5 381350 270950
15/03/2004 DICHLORVOS < 0.5 381350 270950
14/07/2005 DIELDRIN < 2.5 381350 270950
14/04/2005 DIELDRIN < 2.5 381350 270950
13/04/2005 DIELDRIN < 2.5 381350 270950
15/08/2005 DIELDRIN < 5 381350 270950
15/07/2005 DIELDRIN < 5 381350 270950
10/06/2005 DIELDRIN < 5 381350 270950
24/05/2005 DIELDRIN < 5 381350 270950
16/03/2005 DIELDRIN < 5 381350 270950
09/02/2005 DIELDRIN < 5 381350 270950
10/08/2004 DIELDRIN < 5 381350 270950
12/07/2004 DIELDRIN < 5 381350 270950
25/06/2004 DIELDRIN < 5 381350 270950
03/06/2004 DIELDRIN < 5 381350 270950
22/04/2004 DIELDRIN < 5 381350 270950
15/03/2004 DIELDRIN < 5 381350 270950
15/07/2005 DIFLUROBENZURON < 40 381350 270950
24/05/2005 DIFLUROBENZURON < 40 381350 270950
16/03/2005 DIFLUROBENZURON < 40 381350 270950
09/02/2005 DIFLUROBENZURON < 40 381350 270950
10/08/2004 DIFLUROBENZURON < 40 381350 270950
02/07/2004 DIFLUROBENZURON < 40 381350 270950
25/06/2004 DIFLUROBENZURON < 40 381350 270950
03/06/2004 DIFLUROBENZURON < 40 381350 270950
22/04/2004 DIFLUROBENZURON < 40 381350 270950
15/03/2004 DIFLUROBENZURON < 40 381350 270950
12/07/2004 DIMETHOATE < 10 381350 270950
03/06/2004 DIMETHOATE < 10 381350 270950
22/04/2004 DIMETHOATE < 10 381350 270950
15/03/2004 DIMETHOATE < 10 381350 270950
15/07/2005 DIURON < 50 381350 270950
09/02/2005 DIURON < 50 381350 270950
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10/08/2004 DIURON < 50 381350 270950
22/04/2004 DIURON < 50 381350 270950
15/03/2004 DIURON < 50 381350 270950
16/03/2005 DIURON  55 381350 270950
02/07/2004 DIURON  190 381350 270950
24/05/2005 DIURON  310 381350 270950
03/06/2004 DIURON  503 381350 270950
25/06/2004 DIURON  840 381350 270950
14/07/2005 ENDOSULPHAN ALPHA < 1 381350 270950
14/04/2005 ENDOSULPHAN ALPHA < 1 381350 270950
13/04/2005 ENDOSULPHAN ALPHA < 1 381350 270950
15/08/2005 ENDOSULPHAN ALPHA < 5 381350 270950
15/07/2005 ENDOSULPHAN ALPHA < 5 381350 270950
10/06/2005 ENDOSULPHAN ALPHA < 5 381350 270950
24/05/2005 ENDOSULPHAN ALPHA < 5 381350 270950
16/03/2005 ENDOSULPHAN ALPHA < 5 381350 270950
09/02/2005 ENDOSULPHAN ALPHA < 5 381350 270950
10/08/2004 ENDOSULPHAN ALPHA < 5 381350 270950
12/07/2004 ENDOSULPHAN ALPHA < 5 381350 270950
25/06/2004 ENDOSULPHAN ALPHA < 5 381350 270950
03/06/2004 ENDOSULPHAN ALPHA < 5 381350 270950
22/04/2004 ENDOSULPHAN ALPHA < 5 381350 270950
15/03/2004 ENDOSULPHAN ALPHA < 5 381350 270950
14/07/2005 ENDOSULPHAN BETA < 2 381350 270950
14/04/2005 ENDOSULPHAN BETA < 2 381350 270950
13/04/2005 ENDOSULPHAN BETA < 2 381350 270950
15/08/2005 ENDOSULPHAN BETA < 5 381350 270950
15/07/2005 ENDOSULPHAN BETA < 5 381350 270950
10/06/2005 ENDOSULPHAN BETA < 5 381350 270950
24/05/2005 ENDOSULPHAN BETA < 5 381350 270950
16/03/2005 ENDOSULPHAN BETA < 5 381350 270950
09/02/2005 ENDOSULPHAN BETA < 5 381350 270950
10/08/2004 ENDOSULPHAN BETA < 5 381350 270950
12/07/2004 ENDOSULPHAN BETA < 5 381350 270950
25/06/2004 ENDOSULPHAN BETA < 5 381350 270950
03/06/2004 ENDOSULPHAN BETA < 5 381350 270950
22/04/2004 ENDOSULPHAN BETA < 5 381350 270950
15/03/2004 ENDOSULPHAN BETA < 5 381350 270950
14/07/2005 ENDRIN < 2.5 381350 270950
14/04/2005 ENDRIN < 2.5 381350 270950
13/04/2005 ENDRIN < 2.5 381350 270950
15/08/2005 ENDRIN < 5 381350 270950
15/07/2005 ENDRIN < 5 381350 270950
10/06/2005 ENDRIN < 5 381350 270950
24/05/2005 ENDRIN < 5 381350 270950
16/03/2005 ENDRIN < 5 381350 270950
09/02/2005 ENDRIN < 5 381350 270950
10/08/2004 ENDRIN < 5 381350 270950
12/07/2004 ENDRIN < 5 381350 270950
25/06/2004 ENDRIN < 5 381350 270950
03/06/2004 ENDRIN < 5 381350 270950
22/04/2004 ENDRIN < 5 381350 270950
15/03/2004 ENDRIN < 5 381350 270950
15/08/2005 ETHION < 10 381350 270950
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15/07/2005 ETHION < 10 381350 270950
15/07/2005 ETHION < 10 381350 270950
14/07/2005 ETHION < 10 381350 270950
10/06/2005 ETHION < 10 381350 270950
24/05/2005 ETHION < 10 381350 270950
24/05/2005 ETHION < 10 381350 270950
14/04/2005 ETHION < 10 381350 270950
13/04/2005 ETHION < 10 381350 270950
16/03/2005 ETHION < 10 381350 270950
16/03/2005 ETHION < 10 381350 270950
09/02/2005 ETHION < 10 381350 270950
09/02/2005 ETHION < 10 381350 270950
10/08/2004 ETHION < 10 381350 270950
10/08/2004 ETHION < 10 381350 270950
12/07/2004 ETHION < 10 381350 270950
02/07/2004 ETHION < 10 381350 270950
01/07/2004 ETHION < 10 381350 270950
25/06/2004 ETHION < 10 381350 270950
25/06/2004 ETHION < 10 381350 270950
03/06/2004 ETHION < 10 381350 270950
03/06/2004 ETHION < 10 381350 270950
15/03/2004 ETHION < 10 381350 270950
15/03/2004 ETHION < 10 381350 270950
14/07/2005 FENCHLORPHOS     {RONNEL.} < 1 381350 270950
14/04/2005 FENCHLORPHOS     {RONNEL.} < 1 381350 270950
01/07/2004 FENCHLORPHOS     {RONNEL.} < 1 381350 270950
15/08/2005 FENITROTHION < 1 381350 270950
15/07/2005 FENITROTHION < 1 381350 270950
15/07/2005 FENITROTHION < 1 381350 270950
14/07/2005 FENITROTHION < 1 381350 270950
10/06/2005 FENITROTHION < 1 381350 270950
24/05/2005 FENITROTHION < 1 381350 270950
24/05/2005 FENITROTHION < 1 381350 270950
14/04/2005 FENITROTHION < 1 381350 270950
13/04/2005 FENITROTHION < 1 381350 270950
16/03/2005 FENITROTHION < 1 381350 270950
16/03/2005 FENITROTHION < 1 381350 270950
09/02/2005 FENITROTHION < 1 381350 270950
09/02/2005 FENITROTHION < 1 381350 270950
10/08/2004 FENITROTHION < 1 381350 270950
10/08/2004 FENITROTHION < 1 381350 270950
12/07/2004 FENITROTHION < 1 381350 270950
02/07/2004 FENITROTHION < 1 381350 270950
01/07/2004 FENITROTHION < 1 381350 270950
25/06/2004 FENITROTHION < 1 381350 270950
25/06/2004 FENITROTHION < 1 381350 270950
03/06/2004 FENITROTHION < 1 381350 270950
03/06/2004 FENITROTHION < 1 381350 270950
15/03/2004 FENITROTHION < 1 381350 270950
15/03/2004 FENITROTHION < 1 381350 270950
15/07/2005 FENOPROP < 40 381350 270950
24/05/2005 FENOPROP < 40 381350 270950
16/03/2005 FENOPROP < 40 381350 270950
09/02/2005 FENOPROP < 40 381350 270950
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10/08/2004 FENOPROP < 40 381350 270950
02/07/2004 FENOPROP < 40 381350 270950
25/06/2004 FENOPROP < 40 381350 270950
03/06/2004 FENOPROP < 40 381350 270950
22/04/2004 FENOPROP < 40 381350 270950
15/03/2004 FENOPROP < 40 381350 270950
15/08/2005 FENTHION < 10 381350 270950
15/07/2005 FENTHION < 10 381350 270950
15/07/2005 FENTHION < 10 381350 270950
14/07/2005 FENTHION < 10 381350 270950
10/06/2005 FENTHION < 10 381350 270950
24/05/2005 FENTHION < 10 381350 270950
24/05/2005 FENTHION < 10 381350 270950
14/04/2005 FENTHION < 10 381350 270950
13/04/2005 FENTHION < 10 381350 270950
16/03/2005 FENTHION < 10 381350 270950
16/03/2005 FENTHION < 10 381350 270950
10/08/2004 FENTHION < 10 381350 270950
10/08/2004 FENTHION < 10 381350 270950
12/07/2004 FENTHION < 10 381350 270950
02/07/2004 FENTHION < 10 381350 270950
01/07/2004 FENTHION < 10 381350 270950
25/06/2004 FENTHION < 10 381350 270950
25/06/2004 FENTHION < 10 381350 270950
03/06/2004 FENTHION < 10 381350 270950
03/06/2004 FENTHION < 10 381350 270950
15/03/2004 FENTHION < 10 381350 270950
15/03/2004 FENTHION < 10 381350 270950
15/09/2005 FENURON < 60 381350 270950
15/07/2005 FENURON < 60 381350 270950
24/05/2005 FENURON < 60 381350 270950
16/03/2005 FENURON < 60 381350 270950
09/02/2005 FENURON < 60 381350 270950
10/08/2004 FENURON < 60 381350 270950
02/07/2004 FENURON < 60 381350 270950
25/06/2004 FENURON < 60 381350 270950
03/06/2004 FENURON < 60 381350 270950
22/04/2004 FENURON < 60 381350 270950
15/03/2004 FENURON < 60 381350 270950
15/08/2005 FLUCOFURON < 250 381350 270950
15/07/2005 FLUCOFURON < 250 381350 270950
10/06/2005 FLUCOFURON < 250 381350 270950
24/05/2005 FLUCOFURON < 250 381350 270950
13/04/2005 FLUCOFURON < 250 381350 270950
16/03/2005 FLUCOFURON < 250 381350 270950
09/02/2005 FLUCOFURON < 250 381350 270950
10/08/2004 FLUCOFURON < 250 381350 270950
12/07/2004 FLUCOFURON < 250 381350 270950
25/06/2004 FLUCOFURON < 250 381350 270950
03/06/2004 FLUCOFURON < 250 381350 270950
22/04/2004 FLUCOFURON < 250 381350 270950
15/03/2004 FLUCOFURON < 250 381350 270950
14/07/2005 HCH ALPHA < 1 381350 270950
14/04/2005 HCH ALPHA < 1 381350 270950
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13/04/2005 HCH ALPHA < 1 381350 270950
15/08/2005 HCH ALPHA < 5 381350 270950
15/07/2005 HCH ALPHA < 5 381350 270950
10/06/2005 HCH ALPHA < 5 381350 270950
24/05/2005 HCH ALPHA < 5 381350 270950
16/03/2005 HCH ALPHA < 5 381350 270950
09/02/2005 HCH ALPHA < 5 381350 270950
10/08/2004 HCH ALPHA < 5 381350 270950
12/07/2004 HCH ALPHA < 5 381350 270950
25/06/2004 HCH ALPHA < 5 381350 270950
03/06/2004 HCH ALPHA < 5 381350 270950
22/04/2004 HCH ALPHA < 5 381350 270950
15/03/2004 HCH ALPHA < 5 381350 270950
15/08/2005 HCH BETA < 5 381350 270950
15/07/2005 HCH BETA < 5 381350 270950
14/07/2005 HCH BETA < 5 381350 270950
10/06/2005 HCH BETA < 5 381350 270950
24/05/2005 HCH BETA < 5 381350 270950
14/04/2005 HCH BETA < 5 381350 270950
13/04/2005 HCH BETA < 5 381350 270950
16/03/2005 HCH BETA < 5 381350 270950
09/02/2005 HCH BETA < 5 381350 270950
10/08/2004 HCH BETA < 5 381350 270950
12/07/2004 HCH BETA < 5 381350 270950
25/06/2004 HCH BETA < 5 381350 270950
03/06/2004 HCH BETA < 5 381350 270950
22/04/2004 HCH BETA < 5 381350 270950
15/03/2004 HCH BETA < 5 381350 270950
14/07/2005 HCH DELTA < 1 381350 270950
14/04/2005 HCH DELTA < 1 381350 270950
13/04/2005 HCH DELTA < 1 381350 270950
15/08/2005 HCH DELTA < 5 381350 270950
15/07/2005 HCH DELTA < 5 381350 270950
10/06/2005 HCH DELTA < 5 381350 270950
24/05/2005 HCH DELTA < 5 381350 270950
16/03/2005 HCH DELTA < 5 381350 270950
09/02/2005 HCH DELTA < 5 381350 270950
10/08/2004 HCH DELTA < 5 381350 270950
12/07/2004 HCH DELTA < 5 381350 270950
25/06/2004 HCH DELTA < 5 381350 270950
03/06/2004 HCH DELTA < 5 381350 270950
22/04/2004 HCH DELTA < 5 381350 270950
15/03/2004 HCH DELTA < 5 381350 270950
14/07/2005 HCH GAMMA < 1 381350 270950
14/04/2005 HCH GAMMA < 1 381350 270950
13/04/2005 HCH GAMMA < 1 381350 270950
15/08/2005 HCH GAMMA < 5 381350 270950
15/07/2005 HCH GAMMA < 5 381350 270950
10/06/2005 HCH GAMMA < 5 381350 270950
24/05/2005 HCH GAMMA < 5 381350 270950
16/03/2005 HCH GAMMA < 5 381350 270950
09/02/2005 HCH GAMMA < 5 381350 270950
10/08/2004 HCH GAMMA < 5 381350 270950
12/07/2004 HCH GAMMA < 5 381350 270950
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25/06/2004 HCH GAMMA < 5 381350 270950
03/06/2004 HCH GAMMA < 5 381350 270950
22/04/2004 HCH GAMMA < 5 381350 270950
15/03/2004 HCH GAMMA < 5 381350 270950
15/08/2005 HEPTACHLOR < 5 381350 270950
15/07/2005 HEPTACHLOR < 5 381350 270950
14/07/2005 HEPTACHLOR < 5 381350 270950
10/06/2005 HEPTACHLOR < 5 381350 270950
24/05/2005 HEPTACHLOR < 5 381350 270950
14/04/2005 HEPTACHLOR < 5 381350 270950
13/04/2005 HEPTACHLOR < 5 381350 270950
16/03/2005 HEPTACHLOR < 5 381350 270950
09/02/2005 HEPTACHLOR < 5 381350 270950
12/07/2004 HEPTACHLOR < 5 381350 270950
25/06/2004 HEPTACHLOR < 5 381350 270950
03/06/2004 HEPTACHLOR < 5 381350 270950
22/04/2004 HEPTACHLOR < 5 381350 270950
15/03/2004 HEPTACHLOR < 5 381350 270950
15/08/2005 HEPTACHLOR EPOXIDE < 5 381350 270950
15/07/2005 HEPTACHLOR EPOXIDE < 5 381350 270950
14/07/2005 HEPTACHLOR EPOXIDE < 5 381350 270950
10/06/2005 HEPTACHLOR EPOXIDE < 5 381350 270950
24/05/2005 HEPTACHLOR EPOXIDE < 5 381350 270950
14/04/2005 HEPTACHLOR EPOXIDE < 5 381350 270950
13/04/2005 HEPTACHLOR EPOXIDE < 5 381350 270950
16/03/2005 HEPTACHLOR EPOXIDE < 5 381350 270950
09/02/2005 HEPTACHLOR EPOXIDE < 5 381350 270950
10/08/2004 HEPTACHLOR EPOXIDE < 5 381350 270950
12/07/2004 HEPTACHLOR EPOXIDE < 5 381350 270950
25/06/2004 HEPTACHLOR EPOXIDE < 5 381350 270950
03/06/2004 HEPTACHLOR EPOXIDE < 5 381350 270950
22/04/2004 HEPTACHLOR EPOXIDE < 5 381350 270950
15/03/2004 HEPTACHLOR EPOXIDE < 5 381350 270950
14/07/2005 HEXACHLOROBENZENE < 1 381350 270950
14/04/2005 HEXACHLOROBENZENE < 1 381350 270950
13/04/2005 HEXACHLOROBENZENE < 1 381350 270950
15/08/2005 HEXACHLOROBENZENE < 5 381350 270950
15/07/2005 HEXACHLOROBENZENE < 5 381350 270950
10/06/2005 HEXACHLOROBENZENE < 5 381350 270950
24/05/2005 HEXACHLOROBENZENE < 5 381350 270950
16/03/2005 HEXACHLOROBENZENE < 5 381350 270950
09/02/2005 HEXACHLOROBENZENE < 5 381350 270950
10/08/2004 HEXACHLOROBENZENE < 5 381350 270950
12/07/2004 HEXACHLOROBENZENE < 5 381350 270950
25/06/2004 HEXACHLOROBENZENE < 5 381350 270950
03/06/2004 HEXACHLOROBENZENE < 5 381350 270950
22/04/2004 HEXACHLOROBENZENE < 5 381350 270950
15/03/2004 HEXACHLOROBENZENE < 5 381350 270950
15/09/2005 IOXYNIL < 40 381350 270950
15/07/2005 IOXYNIL < 40 381350 270950
24/05/2005 IOXYNIL < 40 381350 270950
16/03/2005 IOXYNIL < 40 381350 270950
09/02/2005 IOXYNIL < 40 381350 270950
10/08/2004 IOXYNIL < 40 381350 270950
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02/07/2004 IOXYNIL < 40 381350 270950
25/06/2004 IOXYNIL < 40 381350 270950
03/06/2004 IOXYNIL < 40 381350 270950
22/04/2004 IOXYNIL < 40 381350 270950
15/03/2004 IOXYNIL < 40 381350 270950
14/07/2005 ISODRIN < 2.5 381350 270950
14/04/2005 ISODRIN < 2.5 381350 270950
13/04/2005 ISODRIN < 2.5 381350 270950
15/08/2005 ISODRIN < 5 381350 270950
15/07/2005 ISODRIN < 5 381350 270950
10/06/2005 ISODRIN < 5 381350 270950
24/05/2005 ISODRIN < 5 381350 270950
16/03/2005 ISODRIN < 5 381350 270950
09/02/2005 ISODRIN < 5 381350 270950
10/08/2004 ISODRIN < 5 381350 270950
12/07/2004 ISODRIN < 5 381350 270950
25/06/2004 ISODRIN < 5 381350 270950
03/06/2004 ISODRIN < 5 381350 270950
22/04/2004 ISODRIN < 5 381350 270950
15/03/2004 ISODRIN < 5 381350 270950
09/02/2005
ISOPROTURON (DIIP1,3DITHIOLAN-2-
YLIDENEMALONATE) < 50 381350 270950
02/07/2004
ISOPROTURON (DIIP1,3DITHIOLAN-2-
YLIDENEMALONATE) < 50 381350 270950
25/06/2004
ISOPROTURON (DIIP1,3DITHIOLAN-2-
YLIDENEMALONATE) < 50 381350 270950
03/06/2004
ISOPROTURON (DIIP1,3DITHIOLAN-2-
YLIDENEMALONATE) < 50 381350 270950
22/04/2004
ISOPROTURON (DIIP1,3DITHIOLAN-2-
YLIDENEMALONATE) < 50 381350 270950
15/03/2004
ISOPROTURON (DIIP1,3DITHIOLAN-2-
YLIDENEMALONATE) < 50 381350 270950
15/07/2005
ISOPROTURON (DIIP1,3DITHIOLAN-2-
YLIDENEMALONATE) < 60 381350 270950
24/05/2005
ISOPROTURON (DIIP1,3DITHIOLAN-2-
YLIDENEMALONATE) < 60 381350 270950
16/03/2005
ISOPROTURON (DIIP1,3DITHIOLAN-2-
YLIDENEMALONATE)  97 381350 270950
10/08/2004
ISOPROTURON (DIIP1,3DITHIOLAN-2-
YLIDENEMALONATE)  1890 381350 270950
15/07/2005 LINURON < 40 381350 270950
24/05/2005 LINURON < 40 381350 270950
16/03/2005 LINURON < 40 381350 270950
09/02/2005 LINURON < 40 381350 270950
10/08/2004 LINURON < 40 381350 270950
12/07/2004 LINURON < 40 381350 270950
02/07/2004 LINURON < 40 381350 270950
25/06/2004 LINURON < 40 381350 270950
25/06/2004 LINURON < 40 381350 270950
03/06/2004 LINURON < 40 381350 270950
03/06/2004 LINURON < 40 381350 270950
22/04/2004 LINURON < 40 381350 270950
22/04/2004 LINURON < 40 381350 270950
15/03/2004 LINURON < 40 381350 270950
15/03/2004 LINURON < 40 381350 270950
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15/08/2005 MALATHION < 1 381350 270950
15/07/2005 MALATHION < 1 381350 270950
15/07/2005 MALATHION < 1 381350 270950
14/07/2005 MALATHION < 1 381350 270950
10/06/2005 MALATHION < 1 381350 270950
24/05/2005 MALATHION < 1 381350 270950
24/05/2005 MALATHION < 1 381350 270950
14/04/2005 MALATHION < 1 381350 270950
13/04/2005 MALATHION < 1 381350 270950
16/03/2005 MALATHION < 1 381350 270950
16/03/2005 MALATHION < 1 381350 270950
09/02/2005 MALATHION < 1 381350 270950
09/02/2005 MALATHION < 1 381350 270950
10/08/2004 MALATHION < 1 381350 270950
10/08/2004 MALATHION < 1 381350 270950
12/07/2004 MALATHION < 1 381350 270950
02/07/2004 MALATHION < 1 381350 270950
01/07/2004 MALATHION < 1 381350 270950
25/06/2004 MALATHION < 1 381350 270950
25/06/2004 MALATHION < 1 381350 270950
03/06/2004 MALATHION < 1 381350 270950
03/06/2004 MALATHION < 1 381350 270950
15/03/2004 MALATHION < 1 381350 270950
15/03/2004 MALATHION < 1 381350 270950
16/03/2005 MCPA < 40 381350 270950
09/02/2005 MCPA < 40 381350 270950
02/07/2004 MCPA < 40 381350 270950
03/06/2004 MCPA < 40 381350 270950
22/04/2004 MCPA < 40 381350 270950
15/03/2004 MCPA < 40 381350 270950
24/05/2005 MCPA  51 381350 270950
25/06/2004 MCPA  58 381350 270950
15/07/2005 MCPA  119 381350 270950
10/08/2004 MCPA  221 381350 270950
16/03/2005 MECOPROP < 40 381350 270950
09/02/2005 MECOPROP < 40 381350 270950
12/07/2004 MECOPROP < 40 381350 270950
02/07/2004 MECOPROP < 40 381350 270950
25/06/2004 MECOPROP < 40 381350 270950
15/03/2004 MECOPROP < 40 381350 270950
15/03/2004 MECOPROP < 40 381350 270950
03/06/2004 MECOPROP  65 381350 270950
03/06/2004 MECOPROP  66.7 381350 270950
25/06/2004 MECOPROP  80 381350 270950
10/08/2004 MECOPROP  85.5 381350 270950
24/05/2005 MECOPROP  149 381350 270950
15/07/2005 MECOPROP  177 381350 270950
22/04/2004 MECOPROP  534 381350 270950
22/04/2004 MECOPROP  563 381350 270950
14/07/2005 METHOXYCHLOR < 5 381350 270950
14/04/2005 METHOXYCHLOR < 5 381350 270950
15/07/2005 MEVINPHOS < 5 381350 270950
14/07/2005 MEVINPHOS < 5 381350 270950
14/04/2005 MEVINPHOS < 5 381350 270950
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16/03/2005 MEVINPHOS < 5 381350 270950
09/02/2005 MEVINPHOS < 5 381350 270950
10/08/2004 MEVINPHOS < 5 381350 270950
12/07/2004 MEVINPHOS < 5 381350 270950
02/07/2004 MEVINPHOS < 5 381350 270950
01/07/2004 MEVINPHOS < 5 381350 270950
25/06/2004 MEVINPHOS < 5 381350 270950
25/06/2004 MEVINPHOS < 5 381350 270950
03/06/2004 MEVINPHOS < 5 381350 270950
03/06/2004 MEVINPHOS < 5 381350 270950
15/07/2005 MONURON < 40 381350 270950
24/05/2005 MONURON < 40 381350 270950
16/03/2005 MONURON < 40 381350 270950
09/02/2005 MONURON < 40 381350 270950
10/08/2004 MONURON < 40 381350 270950
02/07/2004 MONURON < 40 381350 270950
25/06/2004 MONURON < 40 381350 270950
03/06/2004 MONURON < 40 381350 270950
22/04/2004 MONURON < 40 381350 270950
15/03/2004 MONURON < 40 381350 270950
15/07/2005 NEBURON < 40 381350 270950
24/05/2005 NEBURON < 40 381350 270950
16/03/2005 NEBURON < 40 381350 270950
09/02/2005 NEBURON < 40 381350 270950
10/08/2004 NEBURON < 40 381350 270950
02/07/2004 NEBURON < 40 381350 270950
25/06/2004 NEBURON < 40 381350 270950
03/06/2004 NEBURON < 40 381350 270950
22/04/2004 NEBURON < 40 381350 270950
15/03/2004 NEBURON < 40 381350 270950
12/07/2004 OMETHOATE < 10 381350 270950
25/06/2004 OMETHOATE < 10 381350 270950
03/06/2004 OMETHOATE < 10 381350 270950
22/04/2004 OMETHOATE < 10 381350 270950
15/03/2004 OMETHOATE < 10 381350 270950
15/08/2005 PARATHION {PARATHION ETHYL} < 10 381350 270950
15/07/2005 PARATHION {PARATHION ETHYL} < 10 381350 270950
15/07/2005 PARATHION {PARATHION ETHYL} < 10 381350 270950
14/07/2005 PARATHION {PARATHION ETHYL} < 10 381350 270950
10/06/2005 PARATHION {PARATHION ETHYL} < 10 381350 270950
24/05/2005 PARATHION {PARATHION ETHYL} < 10 381350 270950
24/05/2005 PARATHION {PARATHION ETHYL} < 10 381350 270950
14/04/2005 PARATHION {PARATHION ETHYL} < 10 381350 270950
13/04/2005 PARATHION {PARATHION ETHYL} < 10 381350 270950
16/03/2005 PARATHION {PARATHION ETHYL} < 10 381350 270950
16/03/2005 PARATHION {PARATHION ETHYL} < 10 381350 270950
09/02/2005 PARATHION {PARATHION ETHYL} < 10 381350 270950
09/02/2005 PARATHION {PARATHION ETHYL} < 10 381350 270950
10/08/2004 PARATHION {PARATHION ETHYL} < 10 381350 270950
10/08/2004 PARATHION {PARATHION ETHYL} < 10 381350 270950
12/07/2004 PARATHION {PARATHION ETHYL} < 10 381350 270950
02/07/2004 PARATHION {PARATHION ETHYL} < 10 381350 270950
01/07/2004 PARATHION {PARATHION ETHYL} < 10 381350 270950
25/06/2004 PARATHION {PARATHION ETHYL} < 10 381350 270950
266
25/06/2004 PARATHION {PARATHION ETHYL} < 10 381350 270950
03/06/2004 PARATHION {PARATHION ETHYL} < 10 381350 270950
03/06/2004 PARATHION {PARATHION ETHYL} < 10 381350 270950
15/03/2004 PARATHION {PARATHION ETHYL} < 10 381350 270950
15/03/2004 PARATHION {PARATHION ETHYL} < 10 381350 270950
15/08/2005 PARATHION-METHYL < 15 381350 270950
15/07/2005 PARATHION-METHYL < 15 381350 270950
15/07/2005 PARATHION-METHYL < 15 381350 270950
14/07/2005 PARATHION-METHYL < 15 381350 270950
10/06/2005 PARATHION-METHYL < 15 381350 270950
24/05/2005 PARATHION-METHYL < 15 381350 270950
24/05/2005 PARATHION-METHYL < 15 381350 270950
14/04/2005 PARATHION-METHYL < 15 381350 270950
13/04/2005 PARATHION-METHYL < 15 381350 270950
16/03/2005 PARATHION-METHYL < 15 381350 270950
16/03/2005 PARATHION-METHYL < 15 381350 270950
09/02/2005 PARATHION-METHYL < 15 381350 270950
09/02/2005 PARATHION-METHYL < 15 381350 270950
10/08/2004 PARATHION-METHYL < 15 381350 270950
10/08/2004 PARATHION-METHYL < 15 381350 270950
12/07/2004 PARATHION-METHYL < 15 381350 270950
02/07/2004 PARATHION-METHYL < 15 381350 270950
01/07/2004 PARATHION-METHYL < 15 381350 270950
25/06/2004 PARATHION-METHYL < 15 381350 270950
25/06/2004 PARATHION-METHYL < 15 381350 270950
03/06/2004 PARATHION-METHYL < 15 381350 270950
03/06/2004 PARATHION-METHYL < 15 381350 270950
15/03/2004 PARATHION-METHYL < 15 381350 270950
15/03/2004 PARATHION-METHYL < 15 381350 270950
15/08/2005 PCSD'S (CHLORPHENYLID) < 50 381350 270950
15/07/2005 PCSD'S (CHLORPHENYLID) < 50 381350 270950
10/06/2005 PCSD'S (CHLORPHENYLID) < 50 381350 270950
24/05/2005 PCSD'S (CHLORPHENYLID) < 50 381350 270950
13/04/2005 PCSD'S (CHLORPHENYLID) < 50 381350 270950
16/03/2005 PCSD'S (CHLORPHENYLID) < 50 381350 270950
09/02/2005 PCSD'S (CHLORPHENYLID) < 50 381350 270950
10/08/2004 PCSD'S (CHLORPHENYLID) < 50 381350 270950
12/07/2004 PCSD'S (CHLORPHENYLID) < 50 381350 270950
25/06/2004 PCSD'S (CHLORPHENYLID) < 50 381350 270950
03/06/2004 PCSD'S (CHLORPHENYLID) < 50 381350 270950
22/04/2004 PCSD'S (CHLORPHENYLID) < 50 381350 270950
15/03/2004 PCSD'S (CHLORPHENYLID) < 50 381350 270950
15/08/2005 PENTACHLOROPHENOL < 100 381350 270950
15/07/2005 PENTACHLOROPHENOL < 100 381350 270950
10/06/2005 PENTACHLOROPHENOL < 100 381350 270950
24/05/2005 PENTACHLOROPHENOL < 100 381350 270950
13/04/2005 PENTACHLOROPHENOL < 100 381350 270950
16/03/2005 PENTACHLOROPHENOL < 100 381350 270950
09/02/2005 PENTACHLOROPHENOL < 100 381350 270950
10/08/2004 PENTACHLOROPHENOL < 100 381350 270950
12/07/2004 PENTACHLOROPHENOL < 100 381350 270950
25/06/2004 PENTACHLOROPHENOL < 100 381350 270950
03/06/2004 PENTACHLOROPHENOL < 100 381350 270950
22/04/2004 PENTACHLOROPHENOL < 100 381350 270950
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15/03/2004 PENTACHLOROPHENOL < 100 381350 270950
15/02/2005 PENTACHLOROPHENOL  730 371120 266000
02/03/2005 PENTACHLOROPHENOL < 100 371120 266000
20/01/2005 PENTACHLOROPHENOL  952 371120 266000
12/07/2005 PENTACHLOROPHENOL < 100 371120 266000
17/08/2005 PENTACHLOROPHENOL < 100 371120 266000
08/09/2005 PENTACHLOROPHENOL < 100 371120 266000
04/04/2005 PENTACHLOROPHENOL  272 371120 266000
24/06/2005 PENTACHLOROPHENOL  639 371120 266000
13/05/2005 PENTACHLOROPHENOL < 100 371120 266000
16/07/2004 PENTACHLOROPHENOL  248 371120 266000
13/09/2004 PENTACHLOROPHENOL  2740 371120 266000
29/06/2004 PENTACHLOROPHENOL  397 371120 266000
22/11/2004 PENTACHLOROPHENOL  102 371120 266000
03/12/2004 PENTACHLOROPHENOL  581 371120 266000
22/09/2004 PENTACHLOROPHENOL < 100 371120 266000
12/10/2004 PENTACHLOROPHENOL < 100 371120 266000
18/02/2004 PENTACHLOROPHENOL < 100 371120 266000
15/01/2004 PENTACHLOROPHENOL  134 371120 266000
27/05/2004 PENTACHLOROPHENOL < 100 371120 266000
14/04/2004 PENTACHLOROPHENOL < 100 371120 266000
15/08/2005 PERMETHRIN, CIS < 1 381350 270950
14/07/2005 PERMETHRIN, CIS < 1 381350 270950
14/04/2005 PERMETHRIN, CIS < 1 381350 270950
15/07/2005 PERMETHRIN, CIS < 5 381350 270950
10/06/2005 PERMETHRIN, CIS < 5 381350 270950
24/05/2005 PERMETHRIN, CIS < 5 381350 270950
13/04/2005 PERMETHRIN, CIS < 5 381350 270950
09/02/2005 PERMETHRIN, CIS < 5 381350 270950
10/08/2004 PERMETHRIN, CIS < 5 381350 270950
12/07/2004 PERMETHRIN, CIS < 5 381350 270950
25/06/2004 PERMETHRIN, CIS < 5 381350 270950
03/06/2004 PERMETHRIN, CIS < 5 381350 270950
22/04/2004 PERMETHRIN, CIS < 5 381350 270950
15/03/2004 PERMETHRIN, CIS < 5 381350 270950
15/08/2005 PERMETHRIN, TRANS < 1 381350 270950
14/07/2005 PERMETHRIN, TRANS < 1 381350 270950
14/04/2005 PERMETHRIN, TRANS < 1 381350 270950
15/07/2005 PERMETHRIN, TRANS < 5 381350 270950
10/06/2005 PERMETHRIN, TRANS < 5 381350 270950
24/05/2005 PERMETHRIN, TRANS < 5 381350 270950
13/04/2005 PERMETHRIN, TRANS < 5 381350 270950
09/02/2005 PERMETHRIN, TRANS < 5 381350 270950
10/08/2004 PERMETHRIN, TRANS < 5 381350 270950
12/07/2004 PERMETHRIN, TRANS < 5 381350 270950
25/06/2004 PERMETHRIN, TRANS < 5 381350 270950
03/06/2004 PERMETHRIN, TRANS < 5 381350 270950
22/04/2004 PERMETHRIN, TRANS < 5 381350 270950
15/03/2004 PERMETHRIN, TRANS < 5 381350 270950
15/08/2005 PHORATE < 10 381350 270950
15/07/2005 PHORATE < 10 381350 270950
15/07/2005 PHORATE < 10 381350 270950
14/07/2005 PHORATE < 10 381350 270950
10/06/2005 PHORATE < 10 381350 270950
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24/05/2005 PHORATE < 10 381350 270950
24/05/2005 PHORATE < 10 381350 270950
14/04/2005 PHORATE < 10 381350 270950
13/04/2005 PHORATE < 10 381350 270950
16/03/2005 PHORATE < 10 381350 270950
16/03/2005 PHORATE < 10 381350 270950
10/08/2004 PHORATE < 10 381350 270950
10/08/2004 PHORATE < 10 381350 270950
12/07/2004 PHORATE < 10 381350 270950
02/07/2004 PHORATE < 10 381350 270950
01/07/2004 PHORATE < 10 381350 270950
25/06/2004 PHORATE < 10 381350 270950
25/06/2004 PHORATE < 10 381350 270950
03/06/2004 PHORATE < 10 381350 270950
03/06/2004 PHORATE < 10 381350 270950
15/03/2004 PHORATE < 10 381350 270950
15/03/2004 PHORATE < 10 381350 270950
15/07/2005 PROPAZINE < 14 381350 270950
14/07/2005 PROPAZINE < 14 381350 270950
24/05/2005 PROPAZINE < 14 381350 270950
14/04/2005 PROPAZINE < 14 381350 270950
16/03/2005 PROPAZINE < 14 381350 270950
09/02/2005 PROPAZINE < 14 381350 270950
10/08/2004 PROPAZINE < 14 381350 270950
02/07/2004 PROPAZINE < 14 381350 270950
01/07/2004 PROPAZINE < 14 381350 270950
25/06/2004 PROPAZINE < 14 381350 270950
03/06/2004 PROPAZINE < 14 381350 270950
15/03/2004 PROPAZINE < 14 381350 270950
15/08/2005 PROPETAMPHOS < 1 381350 270950
15/07/2005 PROPETAMPHOS < 1 381350 270950
15/07/2005 PROPETAMPHOS < 1 381350 270950
14/07/2005 PROPETAMPHOS < 1 381350 270950
10/06/2005 PROPETAMPHOS < 1 381350 270950
24/05/2005 PROPETAMPHOS < 1 381350 270950
24/05/2005 PROPETAMPHOS < 1 381350 270950
14/04/2005 PROPETAMPHOS < 1 381350 270950
13/04/2005 PROPETAMPHOS < 1 381350 270950
16/03/2005 PROPETAMPHOS < 1 381350 270950
16/03/2005 PROPETAMPHOS < 1 381350 270950
09/02/2005 PROPETAMPHOS < 1 381350 270950
09/02/2005 PROPETAMPHOS < 1 381350 270950
10/08/2004 PROPETAMPHOS < 1 381350 270950
10/08/2004 PROPETAMPHOS < 1 381350 270950
12/07/2004 PROPETAMPHOS < 1 381350 270950
02/07/2004 PROPETAMPHOS < 1 381350 270950
01/07/2004 PROPETAMPHOS < 1 381350 270950
25/06/2004 PROPETAMPHOS < 1 381350 270950
25/06/2004 PROPETAMPHOS < 1 381350 270950
03/06/2004 PROPETAMPHOS < 1 381350 270950
03/06/2004 PROPETAMPHOS < 1 381350 270950
15/03/2004 PROPETAMPHOS < 1 381350 270950
15/03/2004 PROPETAMPHOS < 1 381350 270950
15/08/2005 SIMAZINE < 30 381350 270950
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15/07/2005 SIMAZINE < 30 381350 270950
15/07/2005 SIMAZINE < 30 381350 270950
14/07/2005 SIMAZINE < 30 381350 270950
10/06/2005 SIMAZINE < 30 381350 270950
24/05/2005 SIMAZINE < 30 381350 270950
14/04/2005 SIMAZINE < 30 381350 270950
13/04/2005 SIMAZINE < 30 381350 270950
16/03/2005 SIMAZINE < 30 381350 270950
16/03/2005 SIMAZINE < 30 381350 270950
09/02/2005 SIMAZINE < 30 381350 270950
09/02/2005 SIMAZINE < 30 381350 270950
10/08/2004 SIMAZINE < 30 381350 270950
12/07/2004 SIMAZINE < 30 381350 270950
01/07/2004 SIMAZINE < 30 381350 270950
25/06/2004 SIMAZINE < 30 381350 270950
25/06/2004 SIMAZINE < 30 381350 270950
03/06/2004 SIMAZINE < 30 381350 270950
03/06/2004 SIMAZINE < 30 381350 270950
15/03/2004 SIMAZINE < 30 381350 270950
15/03/2004 SIMAZINE < 30 381350 270950
02/07/2004 SIMAZINE  87.5 381350 270950
15/08/2005 SULCOFURON < 250 381350 270950
15/07/2005 SULCOFURON < 250 381350 270950
10/06/2005 SULCOFURON < 250 381350 270950
24/05/2005 SULCOFURON < 250 381350 270950
13/04/2005 SULCOFURON < 250 381350 270950
16/03/2005 SULCOFURON < 250 381350 270950
09/02/2005 SULCOFURON < 250 381350 270950
25/06/2004 SULCOFURON < 250 381350 270950
03/06/2004 SULCOFURON < 250 381350 270950
22/04/2004 SULCOFURON < 250 381350 270950
15/03/2004 SULCOFURON < 250 381350 270950
10/08/2004 SULCOFURON < 2500 381350 270950
12/07/2004 SULCOFURON < 2500 381350 270950
14/07/2005 TDE (OP) < 2 381350 270950
14/04/2005 TDE (OP) < 2 381350 270950
13/04/2005 TDE (OP) < 2 381350 270950
15/08/2005 TDE (OP) < 5 381350 270950
15/07/2005 TDE (OP) < 5 381350 270950
10/06/2005 TDE (OP) < 5 381350 270950
24/05/2005 TDE (OP) < 5 381350 270950
16/03/2005 TDE (OP) < 5 381350 270950
09/02/2005 TDE (OP) < 5 381350 270950
10/08/2004 TDE (OP) < 5 381350 270950
12/07/2004 TDE (OP) < 5 381350 270950
25/06/2004 TDE (OP) < 5 381350 270950
03/06/2004 TDE (OP) < 5 381350 270950
22/04/2004 TDE (OP) < 5 381350 270950
15/03/2004 TDE (OP) < 5 381350 270950
14/07/2005 TDE (PP) < 1.5 381350 270950
14/04/2005 TDE (PP) < 1.5 381350 270950
13/04/2005 TDE (PP) < 1.5 381350 270950
15/08/2005 TDE (PP) < 5 381350 270950
15/07/2005 TDE (PP) < 5 381350 270950
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10/06/2005 TDE (PP) < 5 381350 270950
24/05/2005 TDE (PP) < 5 381350 270950
16/03/2005 TDE (PP) < 5 381350 270950
09/02/2005 TDE (PP) < 5 381350 270950
10/08/2004 TDE (PP) < 5 381350 270950
12/07/2004 TDE (PP) < 5 381350 270950
25/06/2004 TDE (PP) < 5 381350 270950
03/06/2004 TDE (PP) < 5 381350 270950
22/04/2004 TDE (PP) < 5 381350 270950
15/03/2004 TDE (PP) < 5 381350 270950
09/02/2005 TRIAZOPHOS < 0.5 381350 270950
10/08/2004 TRIAZOPHOS < 0.5 381350 270950
12/07/2004 TRIAZOPHOS < 0.5 381350 270950
02/07/2004 TRIAZOPHOS < 0.5 381350 270950
01/07/2004 TRIAZOPHOS < 0.5 381350 270950
25/06/2004 TRIAZOPHOS < 0.5 381350 270950
25/06/2004 TRIAZOPHOS < 0.5 381350 270950
03/06/2004 TRIAZOPHOS < 0.5 381350 270950
03/06/2004 TRIAZOPHOS < 0.5 381350 270950
15/07/2005 TRIAZOPHOS < 5 381350 270950
14/07/2005 TRIAZOPHOS < 5 381350 270950
14/04/2005 TRIAZOPHOS < 5 381350 270950
16/03/2005 TRIAZOPHOS < 5 381350 270950
15/07/2005 TRIBUTYL TIN  1 381350 270950
10/06/2005 TRIBUTYL TIN < 1 381350 270950
16/03/2005 TRIBUTYL TIN  1 381350 270950
25/06/2004 TRIBUTYL TIN < 1 381350 270950
03/06/2004 TRIBUTYL TIN < 1 381350 270950
15/03/2004 TRIBUTYL TIN  1.2 381350 270950
13/07/2005 TRIBUTYL TIN  2 381350 270950
10/08/2004 TRIBUTYL TIN  2 381350 270950
12/07/2004 TRIBUTYL TIN  2 381350 270950
22/04/2004 TRIBUTYL TIN  2 381350 270950
24/05/2005 TRIBUTYL TIN  4 381350 270950
09/02/2005 TRIBUTYL TIN  5 381350 270950
15/07/2005 TRICLOPYR < 40 381350 270950
24/05/2005 TRICLOPYR < 40 381350 270950
16/03/2005 TRICLOPYR < 40 381350 270950
09/02/2005 TRICLOPYR < 40 381350 270950
10/08/2004 TRICLOPYR < 40 381350 270950
02/07/2004 TRICLOPYR < 40 381350 270950
25/06/2004 TRICLOPYR < 40 381350 270950
03/06/2004 TRICLOPYR < 40 381350 270950
22/04/2004 TRICLOPYR < 40 381350 270950
15/03/2004 TRICLOPYR < 40 381350 270950
15/08/2005 TRIFLURALIN < 10 381350 270950
15/07/2005 TRIFLURALIN < 10 381350 270950
14/07/2005 TRIFLURALIN < 10 381350 270950
10/06/2005 TRIFLURALIN < 10 381350 270950
24/05/2005 TRIFLURALIN < 10 381350 270950
14/04/2005 TRIFLURALIN < 10 381350 270950
13/04/2005 TRIFLURALIN < 10 381350 270950
16/03/2005 TRIFLURALIN < 10 381350 270950
09/02/2005 TRIFLURALIN < 10 381350 270950
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10/08/2004 TRIFLURALIN < 10 381350 270950
12/07/2004 TRIFLURALIN < 10 381350 270950
25/06/2004 TRIFLURALIN < 10 381350 270950
03/06/2004 TRIFLURALIN < 10 381350 270950
22/04/2004 TRIFLURALIN < 10 381350 270950
15/03/2004 TRIFLURALIN < 10 381350 270950
15/08/2005 TRIPHENYLTIN COMPOUNDS < 1 381350 270950
15/07/2005 TRIPHENYLTIN COMPOUNDS < 1 381350 270950
13/07/2005 TRIPHENYLTIN COMPOUNDS < 1 381350 270950
10/06/2005 TRIPHENYLTIN COMPOUNDS < 1 381350 270950
24/05/2005 TRIPHENYLTIN COMPOUNDS < 1 381350 270950
16/03/2005 TRIPHENYLTIN COMPOUNDS < 1 381350 270950
09/02/2005 TRIPHENYLTIN COMPOUNDS < 1 381350 270950
10/08/2004 TRIPHENYLTIN COMPOUNDS < 1 381350 270950
12/07/2004 TRIPHENYLTIN COMPOUNDS < 1 381350 270950
25/06/2004 TRIPHENYLTIN COMPOUNDS < 1 381350 270950
03/06/2004 TRIPHENYLTIN COMPOUNDS < 1 381350 270950
22/04/2004 TRIPHENYLTIN COMPOUNDS < 1 381350 270950
15/03/2004 TRIPHENYLTIN COMPOUNDS < 1 381350 270950
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Appendix 3
Correction Factor
For each developmental stage, an average of values represented below was used as the 
correction factor. Except time points (TP) values, where TP 3 was used to correct 
individuals from TP3, and TP 4 was used to correct individuals from TP 4 & TP 5.
TK Stage 
(site)
Weight (mg) TL (mm) SVL (mm) HLL (mm)
B A C B A C B A C B A C
17 (YT) 743 446 1.67 40 35 1.14 16.9 14 1.21 9.7 9 1.08
17 (PYL) 418 257 1.63 33.7 29 1.16 13.1 12 1.09 8.6 7 1.23
18 (YT) 453 298 1.52 36 32 1.13 14 12 1.17 14.2 12 1.18
18 (PYL) 437 273 1.60 40.2 37 1.09 14.4 13 1.11 13.3 12 1.11
18 (20’) 365 224 1.63 33 29 1.14 12.5 12 1.04 9.5 9 1.06
19 (PYL) 360 220 1.64 33.3 29 1.15 13 12 1.08 10.9 10 1.09
19 (20’) 360 225 1.60 31.9 29 1.10 14 12 1.17 11.6 12 0.97
20 (YT) 426 268 1.59 34.6 30 1.15 13.4 12 1.12 13.5 12 1.13
20 (20’) 329 216 1.52 30.6 28 1.09 12.8 12 1.07 13.4 11 1.22
21 (YT) 292 199 1.47 29.5 26 1.13 13.4 11 1.22 13.6 13 1.05
21 (PYL) 229 143 1.60 27 25 1.08 12.3 11 1.12 10.4 11 0.95
TP 3 (YT) 237 211 1.12 n/a n/a n/a 15.7 13.2 1.19 16.1 15.2 1.06
TP 4 (YT) 479 453 1.06 n/a n/a n/a 17.3 16.3 1.06 18.6 17.1 1.09
273
